About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
3378 genotypes with 6812 annotations displayed of selected term and subterms
Searched Term: abnormal lipid homeostasis
Allelic Composition
(Genetic Background)		 Annotated Term Reference
0610040J01Rikem1(IMPC)Ccpcz/0610040J01Rikem1(IMPC)Ccpcz
(C57BL/6NCrl-0610040J01Rikem1(IMPC)Ccpcz/Ccpcz) 		increased circulating HDL cholesterol level J:211773
1700008P02Rikem1(IMPC)J/1700008P02Rikem1(IMPC)J
(C57BL/6NJ-1700008P02Rikem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
2010003K11Rikem1Cya/2010003K11Rikem1Cya
(C57BL/6-2010003K11Rikem1Cya/Cya) 		abnormal intestinal lipid absorption J:326325
increased circulating cholesterol level J:326325
increased circulating triglyceride level J:326325
increased liver cholesterol level J:326325
increased liver triglyceride level J:326325
3930402G23Rikem1.1Gonz/3930402G23Rikem1.1Gonz
(C57BL/6J-3930402G23Rikem1.1Gonz) 		increased liver cholesterol level J:340239
increased liver free fatty acids level J:340239
increased liver triglyceride level J:340239
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Rik+
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA) 		decreased circulating ketone body level J:281365
decreased liver triglyceride level J:281365
increased circulating cholesterol level J:281365
increased circulating triglyceride level J:281365
Ay/a
(involves: KK) 		abnormal lipid homeostasis J:26460
Ay/a
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl) 		increased circulating cholesterol level J:177084
increased circulating triglyceride level J:177084
Ay/a
Apoetm1Unc/Apoetm1Unc
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl) 		increased circulating cholesterol level J:177084
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl) 		decreased circulating cholesterol level J:211773
Abca1m4620Dajl/Abca1+
(involves: C3H/HeSnJ * C57BL/6J * SWR) 		decreased circulating cholesterol level J:149088
decreased circulating HDL cholesterol level J:149088
Abca1m4620Dajl/Abca1m4620Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR) 		decreased circulating cholesterol level J:149088
decreased circulating HDL cholesterol level J:149088
increased circulating triglyceride level J:149088
Abca1mpc227H/Abca1mpc227H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased circulating cholesterol level J:234901
Abca1tm1.1Jp/Abca1tm1.1Jp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
Abca1tm1Jdm/Abca1+
(DBA/1LacJ-Abca1tm1Jdm) 		abnormal circulating phospholipid level J:61679
abnormal lipid homeostasis J:61679
decreased circulating cholesterol level J:61679
decreased circulating HDL cholesterol level J:61679
decreased circulating LDL cholesterol level J:61679
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm) 		abnormal circulating phospholipid level J:61679
abnormal lipid homeostasis J:61679
decreased circulating cholesterol level J:60210, J:61679
decreased circulating HDL cholesterol level J:60210, J:61679
decreased circulating LDL cholesterol level J:61679
increased intestinal cholesterol absorption J:61679
Abca1tm1Jdm/Abca1tm1Jdm
(involves: DBA/1LacJ) 		abnormal cholesterol homeostasis J:89906
decreased circulating HDL cholesterol level J:89906
decreased circulating phytosterol level J:87209
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ) 		decreased circulating cholesterol level J:132254
decreased circulating HDL cholesterol level J:132254
Abca1tm1Jdm/Abca1tm1Jdm
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ) 		decreased circulating cholesterol level J:132254
decreased circulating HDL cholesterol level J:132254
Abca1tm1Jp/Abca1+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J) 		abnormal cholesterol homeostasis J:98093
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
Abca1tm1Jp/Abca1+
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		decreased circulating cholesterol level J:107802
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J) 		abnormal cholesterol homeostasis J:98093
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
decreased circulating LDL cholesterol level J:98093
increased circulating triglyceride level J:98093
Abca1tm1Jp/Abca1tm1Jp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL) 		decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		decreased circulating cholesterol level J:107802
decreased circulating HDL cholesterol level J:107802
decreased circulating LDL cholesterol level J:107802
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating cholesterol level J:64390
decreased circulating HDL cholesterol level J:64390
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating cholesterol level J:68431, J:64390
decreased circulating HDL cholesterol level J:68431, J:64390
decreased intestinal cholesterol absorption J:68431
Abca1tm1Wpfl/Abca1tm1Wpfl
Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c) 		decreased brain cholesterol level J:130969
increased cholesterol level J:130969
increased liver cholesterol level J:130969
increased lung cholesterol level J:130969
Abca1tm2Jp/Abca1+
Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal circulating cholesterol level J:104719
decreased circulating HDL cholesterol level J:104719
decreased circulating phospholipid level J:104719
Abca1tm2Jp/Abca1tm2Jp
Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal circulating cholesterol level J:104719
decreased circulating HDL cholesterol level J:104719
decreased circulating phospholipid level J:104719
Abca2tm1Nina/Abca2tm1Nina
(involves: 129X1/SvJ * C57BL/6) 		abnormal lipid level J:123521
Abca3tm1Frm/Abca3tm1Frm
(involves: 129S/SvEv) 		abnormal lipid homeostasis J:120296
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating cholesterol level J:96865
decreased circulating HDL cholesterol level J:96865
Abca8btm1a(EUCOMM)Wtsi/Abca8btm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		decreased circulating cholesterol level J:269226
decreased circulating HDL cholesterol level J:269226
decreased circulating LDL cholesterol level J:269226
decreased circulating triglyceride level J:269226
Abca12el12/Abca12+
(involves: 129/Sv * C57BL/6) 		abnormal lipid homeostasis J:161652
Abca12el12/Abca12el12
(involves: 129/Sv * C57BL/6) 		abnormal lipid homeostasis J:161652
increased cholesterol level J:161652
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J) 		abnormal lipid homeostasis J:144062
Abcb1atm1Bor/Abcb1atm1Bor
Npc1m1N/Npc1m1N
(involves: 129/Ola * BALB/c) 		increased liver cholesterol level J:76395
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H) 		decreased circulating HDL cholesterol level J:211773
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N) 		abnormal lipid homeostasis J:114411
decreased circulating cholesterol level J:114411
decreased feces bile salt level J:175015
decreased intestinal cholesterol absorption J:114411
increased bile salt level J:175015
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J) 		abnormal feces lipid level J:100491
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor) 		decreased vitamin D level J:199949
Abcb4tm1Bor/Abcb4tm1Bor
Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased bile salt level J:175015
increased feces bile salt level J:175015
Abcb4tm1Bor/Abcb4tm1Bor
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N) 		abnormal bile salt homeostasis J:215915
increased bile salt level J:215915
Abcb4tm1Bor/Abcb4tm1Bor
Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		decreased intestinal cholesterol absorption J:100491
Abcb11tm1b(EUCOMM)Hmgu/Abcb11+
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating triglyceride level J:211773
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal bile salt level J:67548
abnormal phospholipid level J:67548
increased bile salt level J:67548
increased cholesterol level J:67548
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:134950
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Abcc3tm1Bor/Abcc3tm1Bor
(involves: 129P2/Ola * FVB/N) 		abnormal bile salt homeostasis J:149653
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal bile salt level J:114229
Abcc3tm1Kruh/Abcc3tm1Kruh
Slc51atm1Pda/Slc51atm1Pda
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		abnormal bile salt homeostasis J:132778
Abcc4Gt(RRC212)Byg/Abcc4Gt(RRC212)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:139829
Abcc6tm1Aabb/Abcc6tm1Aabb
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating HDL cholesterol level J:105062
Abcc9tm1.1Mcn/Abcc9tm1.1Mcn
Tg(Tagln-cre)1Her/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased fatty acid oxidation J:216539
Abcd1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal lipid homeostasis J:44812
Abcd1tm1Kan/Y
(involves: 129 * BALB/cJ * C57BL/6J * Swiss) 		increased fatty acids level J:257393
Abcd1tm1Kan/Y
Gt(ROSA)26Sortm2.1(CAG-ELOVL1)Geno/Gt(ROSA)26Sor+
Cnptm1(cre)Kan/Cnp+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased fatty acids level J:257393
Abcd1tm1Kan/Y
Gt(ROSA)26Sortm2.1(CAG-ELOVL1)Geno/Gt(ROSA)26Sor+
Tg(CMV-cre)1Cgn/0
(involves: 129 * BALB/cJ * C57BL/6J * Swiss) 		increased fatty acids level J:257393
Abcd1tm1Kan/Abcd1tm1Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal lipid homeostasis J:44812
Abcd1tm1Kds/Y
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)) 		abnormal lipid homeostasis J:42479
increased saturated fatty acids level J:42479
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J) 		increased fatty acids level J:94583
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		increased fatty acids level J:94583, J:104122
Abcd1tm1Kds/Abcd1tm1Kds
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)) 		abnormal lipid homeostasis J:42479
increased saturated fatty acids level J:42479
Abcd1tm1Ymd/Y
(involves: 129S/SvEv * C57BL/6J * DBA/2J) 		abnormal lipid homeostasis J:40230
Abcd1tm1Ymd/Abcd1tm1Ymd
(involves: 129S/SvEv * C57BL/6J * DBA/2J) 		abnormal lipid homeostasis J:40230
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased fatty acids level J:94583, J:104122
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J) 		abnormal cholesterol homeostasis J:211773
decreased circulating triglyceride level J:211773
Abcg1tm1Dgen/Abcg1+
Abcg4tm1Dgen/Abcg4tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen) 		abnormal phospholipid level J:117028
increased liver cholesterol level J:117028
increased liver triglyceride level J:117028
increased lung cholesterol level J:117028
increased triglyceride level J:117028
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		lipidosis J:132952
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal lipid level J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
Abcg4tm1Dgen/Abcg4+
(involves: 129P2/OlaHsd) 		abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
Abcg4tm1Dgen/Abcg4tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal cholesterol homeostasis J:141549
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
Abcg2tm1.1(KOMP)Vlcg/Abcg2tm1.1(KOMP)Vlcg
(B6N(Cg)-Abcg2tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Abcg4tm1Dgen/Abcg4tm1Dgen
(Not Specified) 		abnormal lipid level J:141549
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb
Abcg8tm1.1Hobb/Abcg8tm1.1Hobb
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: C57BL/6 * DBA * SJL) 		abnormal intestinal cholesterol absorption J:215443
abnormal phytosterol level J:215443
decreased circulating cholesterol level J:215443
decreased phytosterol level J:215443
increased cholesterol level J:215443
increased circulating phytosterol level J:215443
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb
Abcg8tm1.1Hobb/Abcg8tm1.1Hobb
Tg(CAG-cre/Esr1*)5Amc/?
(involves: C57BL/6 * CBA * SJL) 		abnormal phytosterol level J:215443
decreased cholesterol level J:215443
decreased circulating cholesterol level J:215443
decreased phytosterol level J:215443
increased circulating phytosterol level J:215443
increased intestinal phytosterol absorption J:215443
increased phytosterol level J:215443
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb
Abcg8tm1.1Hobb/Abcg8tm1.1Hobb
Tg(Vil1-cre)997Gum/?
(involves: C57BL/6 * SJL) 		increased circulating phytosterol level J:215443
increased intestinal phytosterol absorption J:215443
increased phytosterol level J:215443
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal phospholipid level J:87209
decreased cholesterol level J:87209
decreased circulating cholesterol level J:87209
increased circulating phytosterol level J:87209
increased circulating triglyceride level J:87209
increased circulating VLDL triglyceride level J:87209
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd) 		abnormal cholesterol homeostasis J:112995
abnormal lipid homeostasis J:112995
Abcg5trac/Abcg5trac
(A/J-Abcg5trac) 		abnormal circulating cholesterol level J:157223
abnormal circulating lipid level J:157223
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz) 		abnormal cholesterol homeostasis J:211773
increased circulating cholesterol level J:211773
increased circulating triglyceride level J:211773
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating cholesterol level J:94759
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased cholesterol level J:94759
decreased circulating cholesterol level J:94759
increased circulating free fatty acids level J:192806
increased circulating phytosterol level J:94759
increased circulating triglyceride level J:94759
Abhd4tm1Crv/Abhd4tm1Crv
(B6.129S6-Abhd4tm1Crv) 		abnormal lipid homeostasis J:276423
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA) 		abnormal lipid level J:199570
abnormal phospholipid level J:199570
decreased fatty acid oxidation J:199570
increased liver cholesterol level J:199570
increased liver free fatty acids level J:199570
increased liver triglyceride level J:199570
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:160725
abnormal lipid level J:160725
decreased circulating triglyceride level J:160725
decreased fatty acids level J:160725
increased liver triglyceride level J:160725
increased triglyceride level J:160725
Abhd5tm1Murm/Abhd5tm1Murm
(B6.129S-Abhd5tm1Murm) 		abnormal ceramide level J:240682
increased triglyceride level J:240682
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal lipid homeostasis J:197835
decreased circulating free fatty acids level J:197835
decreased circulating triglyceride level J:197835
decreased liver triglyceride level J:197835
increased cardiac muscle triglyceride level J:197835
increased skeletal muscle triglyceride level J:197835
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		abnormal lipid level J:215257
decreased liver triglyceride level J:234876
increased fatty acid beta-oxidation J:234876
Abhd8tm1b(EUCOMM)Wtsi/Abhd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Abhd8tm1b(EUCOMM)Wtsi/Bay) 		decreased circulating cholesterol level J:211773
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6) 		abnormal feces lipid level J:294591
Abhd12tm1Crv/Abhd12tm1Crv
(involves: C57BL/6) 		abnormal phospholipid level J:193716
Abhd14atm2a(EUCOMM)Wtsi/Abhd14atm2a(EUCOMM)Wtsi
(C57BL/6N-Abhd14atm2a(EUCOMM)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		abnormal phospholipid level J:232688
Acacatm1Jkus/Acacatm1Jkus
Tg(Fabp1-cre)1Mmt/0
(involves: 129X1/SvJ * C57BL/6J * SJL) 		abnormal lipid homeostasis J:118861
decreased liver triglyceride level J:118861
Acacatm2Sjw/Acacatm2Sjw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB) 		abnormal lipid level J:110200
decreased circulating free fatty acids level J:110200
decreased circulating ketone body level J:110200
decreased fatty acids level J:110200
decreased liver triglyceride level J:110200
increased circulating free fatty acids level J:110200
Acacbtm1.1Dejs/Acacbtm1.1Dejs
(B6.Cg-Acacbtm1.1Dejs) 		abnormal lipid homeostasis J:157000
increased fatty acid oxidation J:157000
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified) 		abnormal lipid homeostasis J:68427
decreased circulating free fatty acids level J:68427
decreased fatty acids level J:68427
decreased liver triglyceride level J:68427
increased circulating ketone body level J:68427
increased circulating triglyceride level J:68427
increased fatty acid beta-oxidation J:68427
increased fatty acid oxidation J:68427
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal lipid homeostasis J:72193
increased circulating free fatty acids level J:51660
increased fatty acids level J:72193
increased unsaturated fatty acids level J:51660
lipidosis J:51660
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ) 		abnormal fatty acid oxidation J:14707
increased circulating HDL cholesterol level J:164460
AcadsHdlq8-C57BL/6J/AcadsHdlq8-C57BL/6J
(involves: C57BL/6J * NZB/BlNJ) 		decreased circulating HDL cholesterol level J:84430
AcadsHdlq8-NZB/BlNJ/AcadsHdlq8-NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ) 		increased circulating HDL cholesterol level J:84430
Acadvltm1Uab/Acadvltm1Uab
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal lipid homeostasis J:72193
Acbd3tm1b(EUCOMM)Hmgu/Acbd3+
(C57BL/6N-Acbd3tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating triglyceride level J:211773
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc) 		abnormal ether lipid level J:299448
abnormal glycerol level J:299448
abnormal lipid homeostasis J:299448
increased fatty acids level J:299448
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating triglyceride level J:211773
Acdacd/Acdacd
(DW/J-Acdacd Pou1f1+) 		abnormal corticosterone level J:18027
decreased circulating corticosterone level J:18027
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi) 		abnormal ceramide level J:235775
abnormal lipid level J:235775
abnormal sphingomyelin level J:235775
decreased sphingosine level J:235775
Acer2em1Mvw/Acer2em1Mvw
(C57BL/6J-Acer2em1Mvw/MvwJ) 		abnormal sphingolipid level J:256650
Acer3tm1Cmao/Acer3tm1Cmao
(B6.129S6-Acer3tm1Cmao/Cmao) 		abnormal ceramide level J:228886
abnormal sphingolipid level J:228886
abnormal sphingomyelin level J:228886
increased sphingosine level J:228886
Acot5tm1a(KOMP)Wtsi/Acot5tm1a(KOMP)Wtsi
(C57BL/6N-Acot5tm1a(KOMP)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal circulating lipid level J:203753
abnormal lipid homeostasis J:203753
abnormal phospholipid level J:203753
increased circulating free fatty acids level J:203753
increased circulating triglyceride level J:203753
increased fatty acids level J:203753
increased liver triglyceride level J:203753
increased triglyceride level J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating cholesterol level J:182660
decreased circulating HDL cholesterol level J:182660
increased circulating triglyceride level J:182660
increased fatty acid oxidation J:182660
increased fatty acids level J:182660
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N) 		abnormal phospholipid level J:335836
increased circulating cholesterol level J:335836
increased circulating phospholipid level J:335836
increased liver cholesterol level J:335836
increased liver triglyceride level J:335836
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6) 		abnormal feces lipid level J:183258
abnormal lipid level J:183258
decreased circulating free fatty acids level J:183258
decreased circulating ketone body level J:183258
decreased liver cholesterol level J:183258
decreased liver triglyceride level J:183258
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J) 		hyperlipidemia J:35794
Acsbg1tm1Mld/Acsbg1tm1Mld
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased fatty acids level J:150391
increased fatty acids level J:150391
Acsl1tm1Rcol/Acsl1tm1Rcol
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal lipid homeostasis J:155714
Acsl1tm1Rcol/Acsl1tm1Rcol
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glycerol level J:162996
decreased fatty acid oxidation J:162996
hyperlipidemia J:162996
increased circulating free fatty acids level J:162996
increased circulating triglyceride level J:162996
increased fatty acids level J:162996
increased triglyceride level J:162996
Acsl4tm1Tty/Acsl4+
(involves: C57BL/6NCrj * CBA/JNCrj) 		increased prostaglandin level J:70023
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Acss1tm1Jsak/Acss1tm1Jsak
(B6.129-Acss1tm1Jsak/Jsak) 		abnormal circulating free fatty acids level J:146647
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased circulating ketone body level J:91350
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J) 		decreased circulating cholesterol level J:160212
decreased circulating free fatty acids level J:160212
decreased circulating HDL cholesterol level J:160212
decreased circulating LDL cholesterol level J:160212
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6) 		abnormal lipid homeostasis J:199525
Actr6tm1a(EUCOMM)Wtsi/Actr6+
(C57BL/6N-Actr6tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating glycerol level J:211773
Acy3em1(IMPC)J/Acy3em1(IMPC)J
(C57BL/6NJ-Acy3em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal triglyceride level J:230573
Adamts16em1(IMPC)H/Adamts16em1(IMPC)H
(C57BL/6N-Adamts16em1(IMPC)H/H) 		increased circulating HDL cholesterol level J:211773
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg) 		decreased circulating free fatty acids level J:280282
decreased fatty acid beta-oxidation J:280282
decreased glycerol level J:280282
increased fatty acids level J:280282
increased liver free fatty acids level J:280282
Adcy2tm1a(KOMP)Wtsi/Adcy2tm1a(KOMP)Wtsi
(C57BL/6N-Adcy2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:211773
Adcy3tm2.1Drs/Adcy3tm2.1Drs
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:281839
Adcy8tm1Ljm/Adcy8tm1Ljm
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal corticosterone level J:63173
Adcy10tm1Lex/Adcy10tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating cholesterol level J:103485
increased triglyceride level J:103485
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6)) 		increased circulating cholesterol level J:71968
increased circulating corticosterone level J:71968
increased circulating free fatty acids level J:71968
increased circulating ketone body level J:71968
increased circulating triglyceride level J:71968
Adgrf5tm1.1Bstc/Adgrf5tm1.2Bstc
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		abnormal lipid level J:196943
increased cholesterol level J:196943
Adgrf5tm1.2Bstc/Adgrf5tm1.2Bstc
(involves: 129S4/SvJae * C57BL/6J) 		abnormal phospholipid level J:196943
increased lung cholesterol level J:196943
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp) 		decreased circulating cholesterol level J:211773
Adgrg6tm1Taki/Adgrg6tm1Taki
(involves: C57BL/6) 		increased cardiac muscle triglyceride level J:202002
Adip1LG/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1) 		decreased circulating cholesterol level J:153477
decreased circulating free fatty acids level J:153477
decreased circulating triglyceride level J:153477
Adip1SM/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x SM/J)F1) 		decreased circulating cholesterol level J:153477
decreased circulating free fatty acids level J:153477
decreased circulating triglyceride level J:153477
Adipoqtm1Chan/Adipoqtm1Chan
(B6.129-Adipoqtm1Chan) 		decreased fatty acid beta-oxidation J:79122
Adipoqtm1Chan/Adipoqtm1Chan
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lipid homeostasis J:138678
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J) 		increased liver triglyceride level J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal lipid level J:77479
increased circulating free fatty acids level J:77479
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6) 		increased circulating triglyceride level J:77876
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/Orl) 		increased circulating triglyceride level J:211773
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc) 		abnormal lipid homeostasis J:122027
increased circulating cholesterol level J:122027
increased liver triglyceride level J:122027
Adipor1tm1Tka/Adipor1tm1Tka
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		increased liver triglyceride level J:117919
Adipor1tm2Tka/Adipor1tm2Tka
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn) 		increased skeletal muscle triglyceride level J:159462
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen) 		abnormal lipid homeostasis J:122027
decreased circulating cholesterol level J:122027
decreased circulating HDL cholesterol level J:122027
decreased liver triglyceride level J:122027
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:129554
decreased circulating HDL cholesterol level J:129554
decreased circulating LDL cholesterol level J:129554
decreased circulating triglyceride level J:129554
decreased circulating VLDL cholesterol level J:129554
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating free fatty acids level J:87718
Adss2tm1b(EUCOMM)Wtsi/Adss2+
(C57BL/6N-Adss2tm1b(EUCOMM)Wtsi/Bay) 		increased circulating HDL cholesterol level J:211773
Adtrpem1Sagh/Adtrpem1Sagh
(involves: C57BL/6) 		increased fatty acids level J:289837
Adtrpem1Sagh/Adtrpem1Sagh
Aig1em1Sagh/Aig1em1Sagh
(involves: C57BL/6) 		increased fatty acids level J:289837
Aebp1tm1Hsro/Aebp1tm1Hsro
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating cholesterol level J:125333
decreased circulating triglyceride level J:125333
Agap2tm1Kye/Agap2tm1Kye
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2) 		decreased circulating triglyceride level J:174775
decreased liver cholesterol level J:174775
decreased liver free fatty acids level J:174775
decreased liver triglyceride level J:174775
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
Agmotm2a(EUCOMM)Wtsi/Agmotm2a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased circulating cholesterol level J:308367
Agmotm2a(EUCOMM)Wtsi/Agmotm2a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		abnormal ether lipid level J:333103
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		abnormal fatty acids level J:146649
abnormal lipid homeostasis J:146649
abnormal phospholipid level J:146649
decreased circulating free fatty acids level J:146649
increased circulating cholesterol level J:231617
increased circulating triglyceride level J:146649
increased liver triglyceride level J:231617, J:146649
Agpat2tm1Garg/Agpat2tm1Garg
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac) 		increased liver triglyceride level J:231617
Agpat3tm1a(EUCOMM)Wtsi/Agpat3tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		abnormal phospholipid level J:245638
Agpat3tm1a(EUCOMM)Wtsi/Agpat3tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N) 		abnormal phospholipid level J:246569
Agpat4tm1Lex/Agpat4tm1Lex
(B6;129S5-Agpat4tm1Lex/Mmucd) 		abnormal phospholipid level J:231388
Agpsbs2/Agpsbs2
(STOCK Agpsbs2/J) 		abnormal lipid level J:171265
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating ketone body level J:199803
decreased circulating VLDL triglyceride level J:199803
decreased liver triglyceride level J:199803
Agrptm1Mws/Agrptm1Mws
(B6.129S1-Agrptm1Mws) 		decreased cholesterol level J:117539
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA) 		decreased circulating aldosterone level J:46506
Agtr2tm1a(EUCOMM)Wtsi/Agtr2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Agtr2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal corticosterone level J:102984
increased circulating corticosterone level J:102984
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd) 		abnormal lipid homeostasis J:105210
abnormal skeletal muscle triglyceride level J:105210
Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal corticosterone level J:102984
increased circulating corticosterone level J:102984
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N) 		increased circulating free fatty acids level J:263253
increased circulating triglyceride level J:263253
Ahrrtm1b(KOMP)Wtsi/Ahrr+
(B6N(Cg)-Ahrrtm1b(KOMP)Wtsi/J) 		decreased circulating HDL cholesterol level J:211773
Ahsgtm1Mbl/Ahsgtm1Mbl
(B6.129-Ahsgtm1Mbl) 		decreased circulating free fatty acids level J:78087
decreased circulating triglyceride level J:78087
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N) 		abnormal lipid homeostasis J:262001
increased circulating triglyceride level J:262001
increased triglyceride level J:262001
Aifm3em1(IMPC)Rbrc/Aifm3em1(IMPC)Rbrc
(C57BL/6NJcl-Aifm3em1(IMPC)Rbrc/Rbrc) 		abnormal cholesterol homeostasis J:211773
abnormal circulating LDL cholesterol level J:211773
Airetm1.1(NCOM)Mfgc/Aire+
(C57BL/6N-Airetm1.1(NCOM)Mfgc/Tcp) 		abnormal cholesterol homeostasis J:211773
Ak4em1(IMPC)Kmpc/Ak4em1(IMPC)Kmpc
(C57BL/6NTac-Ak4em1(IMPC)Kmpc/Kmpc) 		increased circulating cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Akap9tm1a(KOMP)Wtsi/Akap9+
(B6JTyr;B6N-Akap9tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N) 		decreased circulating cholesterol level J:213427
decreased circulating HDL cholesterol level J:213427
decreased circulating LDL cholesterol level J:213427
Akp3tm1Jlm/Akp3tm1Jlm
(involves: 129S2/SvPas * C57BL/6) 		abnormal intestinal lipid absorption J:86263
abnormal lipid level J:86263
increased circulating triglyceride level J:86263
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129) 		increased circulating glycerol level J:208505
increased circulating triglyceride level J:208505
increased liver triglyceride level J:208505
Akt1tm1Nhy/Akt1tm1Nhy
Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129/Sv * C57BL/6 * DBA/1LacJ) 		abnormal lipid homeostasis J:83741
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		decreased liver triglyceride level J:182721
increased fatty acid oxidation J:182721
Akt2tm1.1Mbb/Akt2+
Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd) 		decreased liver triglyceride level J:160759
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb) 		decreased liver triglyceride level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		abnormal lipid homeostasis J:155432
decreased circulating cholesterol level J:155432
decreased liver triglyceride level J:155432
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Lepob/Lepob
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		abnormal lipid homeostasis J:155432
decreased liver triglyceride level J:155432
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		decreased liver triglyceride level J:155432
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr) 		increased circulating triglyceride level J:211773
Albtm1(cre/ERT2)Mtz/Alb+
Nr5a2tm1Sjns/Nr5a2tm1Sjns
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * SJL) 		abnormal bile salt level J:129068
abnormal feces lipid level J:129068
abnormal intestinal lipid absorption J:129068
increased feces bile salt level J:129068
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal bile salt level J:197607
abnormal lipid homeostasis J:197607
decreased liver cholesterol level J:197607
decreased liver triglyceride level J:197607
Aldh1l2tm2e(KOMP)Wtsi/Aldh1l2tm2e(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased fatty acid beta-oxidation J:299012
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating cholesterol level J:165965
decreased circulating HDL cholesterol level J:165965
decreased circulating LDL cholesterol level J:165965
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh2tm1a(EUCOMM)Wtsi/Ieg) 		increased circulating free fatty acids level J:165965
Aldh3a2tm1a(EUCOMM)Wtsi/Aldh3a2tm1a(EUCOMM)Wtsi
Aldh3b2em1Akih/Aldh3b2em1Akih
(involves: C57BL/6J * C57BL/6N) 		abnormal triglyceride level J:330263
decreased ceramide level J:330263
Aldh3a2tm1b(EUCOMM)Wtsi/Aldh3a2tm1b(EUCOMM)Wtsi
(involves: C57BL * C57BL/6J * C57BL/6N * DBA) 		abnormal phospholipid level J:234695
Aldh16a1tm1a(EUCOMM)Wtsi/Aldh16a1tm1a(EUCOMM)Wtsi
(C57BL/6NTac-Aldh16a1tm1a(EUCOMM)Wtsi/WtsiH) 		abnormal lipid homeostasis J:255311
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg
(C57BL/6N-Aldoctm1.1(KOMP)Vlcg) 		decreased circulating cholesterol level J:346664
decreased circulating HDL cholesterol level J:346664
decreased circulating triglyceride level J:346664
increased circulating triglyceride level J:346664
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N) 		decreased circulating cholesterol level J:346664
decreased circulating LDL cholesterol level J:346664
decreased circulating triglyceride level J:346664
decreased liver cholesterol level J:346664
decreased liver triglyceride level J:346664
Alg1tm1b(KOMP)Wtsi/Alg1+
(C57BL/6N-Alg1tm1b(KOMP)Wtsi/Nju) 		abnormal cholesterol homeostasis J:211773
Alg8em1(IMPC)J/Alg8+
(C57BL/6NJ-Alg8em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J) 		abnormal fatty acid oxidation J:198968
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating cholesterol level J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD) 		abnormal circulating cholesterol level J:118221
increased circulating HDL cholesterol level J:118221
increased circulating triglyceride level J:118221
Alox5tm1Bhk/Alox5tm1Bhk
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)) 		abnormal thromboxane level J:68714
decreased leukotriene level J:68714
increased prostaglandin level J:68714
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J) 		increased circulating VLDL cholesterol level J:104825
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv) 		abnormal thromboxane level J:39229
decreased leukotriene level J:39229
increased prostaglandin level J:39229
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased leukotriene level J:100736
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm) 		abnormal leukotriene level J:100736
abnormal prostaglandin level J:100736
Alox12btm1.1Krie/Alox12btm1.1Krie
(involves: 129P2/OlaHsd) 		abnormal lipid level J:196489
Aloxe3tm1.2Krie/Aloxe3tm1.2Krie
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		abnormal lipid level J:196489
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal circulating cholesterol level J:90370
decreased fatty acids level J:90370
decreased triglyceride level J:90370
increased fatty acids level J:90370
Ampd2m4521Dajl/Ampd2m4521Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR) 		increased circulating cholesterol level J:149088
increased circulating LDL cholesterol level J:149088
increased circulating triglyceride level J:149088
Ampd2tm1b(EUCOMM)Hmgu/Ampd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ampd2tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Anapc15tm1.1(KOMP)Vlcg/Anapc15+
(B6N(Cg)-Anapc15tm1.1(KOMP)Vlcg/J) 		increased circulating HDL cholesterol level J:211773
Angptl3hypl/Angptl3hypl
(involves: KK/Snk) 		decreased circulating cholesterol level J:75358
decreased circulating free fatty acids level J:75358
decreased circulating HDL cholesterol level J:75358
decreased circulating LDL cholesterol level J:75358
decreased circulating triglyceride level J:75358
decreased circulating VLDL cholesterol level J:75358
decreased triglyceride level J:75358
Angptl3tm1Akos/Angptl3tm1Akos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating cholesterol level J:103363
decreased circulating triglyceride level J:103363
Angptl3tm1Akos/Angptl3tm1Akos
Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating cholesterol level J:103363
decreased circulating triglyceride level J:103363
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj) 		decreased circulating cholesterol level J:107479
decreased circulating free fatty acids level J:107479
decreased circulating triglyceride level J:107479
decreased circulating VLDL cholesterol level J:107479
Angptl3tm1Lex/Angptl3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating triglyceride level J:149912
Angptl3tm1Lex/Angptl3tm1Lex
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:149912
decreased circulating triglyceride level J:149912
Angptl3tm1Lex/Angptl3tm1Lex
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:149912
decreased circulating triglyceride level J:149912
Angptl3tm2b(KOMP)Wtsi/Angptl3tm2b(KOMP)Wtsi
(C57BL/6N-Angptl3tm2b(KOMP)Wtsi/Ccpcz) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Angptl4Gt(OST352973)Lex/Angptl4Gt(OST352973)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:122968
decreased circulating HDL cholesterol level J:122968
decreased circulating VLDL cholesterol level J:122968
decreased triglyceride level J:122968
Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:103363
decreased circulating triglyceride level J:103363
Angptl4tm1b(EUCOMM)Hmgu/Angptl4tm1b(EUCOMM)Hmgu
(C57BL/6N-Angptl4tm1b(EUCOMM)Hmgu/H) 		decreased circulating triglyceride level J:211773
Angptl4tm1Lex/Angptl4+
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating triglyceride level J:149912
Angptl4tm1Lex/Angptl4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating HDL cholesterol level J:122968
decreased circulating triglyceride level J:149912
decreased circulating VLDL cholesterol level J:122968
decreased triglyceride level J:122968
Angptl4tm2Lex/Angptl4tm2Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased triglyceride level J:149912
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:97552
increased circulating cholesterol level J:97552
increased circulating free fatty acids level J:97552
Angptl8tm1(KOMP)Vlcg/Angptl8+
(involves: C57BL/6NTac) 		decreased circulating triglyceride level J:217262
Angptl8tm1(KOMP)Vlcg/Angptl8tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased circulating triglyceride level J:217262
decreased circulating VLDL triglyceride level J:217262
decreased fatty acids level J:217262
Angptl8tm1Lex/Angptl8tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating triglyceride level J:161922, J:187261
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J) 		increased circulating free fatty acids level J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J) 		increased circulating free fatty acids level J:222913
Ankrd11tm1b(EUCOMM)Wtsi/Ankrd11+
(C57BL/6N-Ankrd11tm1b(EUCOMM)Wtsi/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating free fatty acids level J:130984
increased circulating triglyceride level J:130984
Ano1tm2Jrr/Ano1tm2Jrr
Tg(Cdh16-cre)91Igr/0
(involves: 129S6/SvEvTac * ICR) 		increased circulating aldosterone level J:210158
Ano6em3(IMPC)Tcp/Ano6+
(C57BL/6NCrl-Ano6em3(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Ano8em1(IMPC)J/Ano8em1(IMPC)J
(C57BL/6NJ-Ano8em1(IMPC)J/J) 		increased circulating cholesterol level J:211773
Anp32btm1Mak/Anp32btm1Mak
(C.129P2(B6)-Anp32btm1Mak) 		decreased circulating cholesterol level J:227403
decreased circulating HDL cholesterol level J:227403
anx/anx
(B6C3Fe a/a-anx/J) 		increased circulating cholesterol level J:7689
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		increased circulating cholesterol level J:226582
Ap2a2em1(IMPC)Wtsi/Ap2a2+
(C57BL/6N-Ap2a2em1(IMPC)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2+
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Ap4e1em1(IMPC)J/Ap4e1+
(C57BL/6NJ-Ap4e1em1(IMPC)J/J) 		increased circulating free fatty acids level J:211773
Ap4e1em1(IMPC)J/Ap4e1em1(IMPC)J
(C57BL/6NJ-Ap4e1em1(IMPC)J/J) 		decreased circulating free fatty acids level J:211773
decreased circulating triglyceride level J:211773
Ap4e1em2(IMPC)Mbp/Ap4e1em2(IMPC)Mbp
(C57BL/6NCrl-Ap4e1em2(IMPC)Mbp/Mmucd) 		abnormal cholesterol homeostasis J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ccpcz) 		abnormal cholesterol homeostasis J:211773
Ap4m1tm1b(EUCOMM)Wtsi/Ap4m1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap4m1tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
ApcMin/Apc+
(involves: AKR/J * C57BL/6J) 		hyperlipidemia J:10209
ApcMin/Apc+
(C57BL/6J-ApcMin) 		increased circulating free fatty acids level J:86036
increased circulating triglyceride level J:86036
increased prostaglandin level J:85142
ApcMin/Apc+
Hsd11b2tm1.1Mzz/Hsd11b2tm1.1Mzz
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		abnormal corticosterone level J:205456
ApcMin/Apc+
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased prostaglandin level J:64401
ApcMin/Apc+
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased prostaglandin level J:64401
Apctm2Rak/Apc+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL) 		increased circulating cholesterol level J:234310
increased circulating triglyceride level J:234310
Apctm2Tno/Apc+
(involves: C57BL/6J) 		hyperlipidemia J:86036
increased circulating cholesterol level J:86036
increased circulating free fatty acids level J:86036
increased circulating triglyceride level J:86036
Apmapem1(IMPC)J/Apmapem1(IMPC)J
(C57BL/6NJ-Apmapem1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Apoa1tm1(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J) 		decreased circulating cholesterol level J:81908
Apoa1tm1Bres/Apoa1+
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating HDL cholesterol level J:40819
Apoa1tm1Bres/Apoa1tm1Bres
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating cholesterol level J:40819
decreased circulating HDL cholesterol level J:40819
decreased circulating LDL cholesterol level J:40819
decreased circulating VLDL cholesterol level J:40819
increased circulating triglyceride level J:40819
Apoa1tm1Bres/Apoa1tm1Bres
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating HDL cholesterol level J:40819
Apoa1tm1Bres/Apoa1tm1Bres
Tg(Mt1-CETP)#Tall/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J) 		decreased circulating HDL cholesterol level J:40819
Apoa1tm1Unc/Apoa1+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating cholesterol level J:2109
decreased circulating HDL cholesterol level J:2109
Apoa1tm1Unc/Apoa1+
(B6.129P2-Apoa1tm1Unc) 		decreased circulating cholesterol level J:22986
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc/J) 		decreased circulating cholesterol level J:114205
decreased circulating HDL cholesterol level J:114205
decreased circulating phospholipid level J:114205
increased circulating cholesterol level J:114205
increased circulating triglyceride level J:114205
Apoa1tm1Unc/Apoa1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating cholesterol level J:2109
decreased circulating HDL cholesterol level J:2109
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc) 		decreased circulating cholesterol level J:22986
Apoa1tm1Unc/Apoa1tm1Unc
(involves: 129P2/OlaHsd) 		decreased circulating cholesterol level J:129136
decreased circulating HDL cholesterol level J:129136
decreased circulating phospholipid level J:129136
Apoa1tm1Unc/Apoa1tm1Unc
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc) 		decreased cholesterol level J:85174
decreased circulating cholesterol level J:85174
decreased circulating HDL cholesterol level J:85174
decreased circulating LDL cholesterol level J:85174
decreased circulating VLDL cholesterol level J:85174
decreased liver cholesterol level J:85174
increased circulating triglyceride level J:85174
xanthoma J:85174
Apoa1tm1Unc/Apoa1tm1Unc
Tg(APOA1)1Rub/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:129136
increased circulating HDL cholesterol level J:129136
increased circulating triglyceride level J:129136
Apoa1tm1Unc/Apoa1tm1Unc
Tg(APOA2)3Rub/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:129136
increased circulating triglyceride level J:129136
Apoa1tm2(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J) 		abnormal cholesterol homeostasis J:81908
decreased circulating cholesterol level J:81908
decreased circulating HDL cholesterol level J:81908
Apoa2b/?
(involves: KK * RR) 		increased circulating cholesterol level J:99474
Apoa2tm1Bres/Apoa2+
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * 129S4/SvJae) 		decreased circulating cholesterol level J:37250
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae) 		abnormal cholesterol homeostasis J:37250
decreased circulating cholesterol level J:37250
decreased circulating free fatty acids level J:37250
decreased circulating HDL cholesterol level J:37250
Apoa2tm1Bres/Apoa2tm1Bres
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * 129S4/SvJae) 		decreased circulating cholesterol level J:37250
decreased circulating HDL cholesterol level J:37250
Apoa4tm1Bres/Apoa4tm1Bres
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6)) 		abnormal cholesterol homeostasis J:43015
abnormal lipid homeostasis J:43015
decreased circulating cholesterol level J:43015
decreased circulating HDL cholesterol level J:43015
decreased circulating triglyceride level J:43015
decreased circulating VLDL triglyceride level J:43015
Apoa5tm1Hgc/Apoa5+
(involves: 129X1/SvJ * C57BL/6) 		increased circulating VLDL cholesterol level J:72092
Apoa5tm1Hgc/Apoa5tm1Hgc
(involves: 129X1/SvJ * C57BL/6) 		increased circulating triglyceride level J:72092
increased circulating VLDL cholesterol level J:72092
Apobtm1.1Zc/Apob+
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating LDL cholesterol level J:65191
decreased circulating VLDL cholesterol level J:65191
Apobtm1.1Zc/Apobtm1.1Zc
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating HDL cholesterol level J:65191
decreased circulating LDL cholesterol level J:65191
decreased circulating triglyceride level J:65191
decreased circulating VLDL cholesterol level J:65191
Apobtm1Mae/Apob+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal triglyceride level J:113171
decreased circulating cholesterol level J:113171
Apobtm1Mae/Apobtm1Mae
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal circulating HDL cholesterol level J:36426
decreased circulating cholesterol level J:36426
decreased circulating LDL cholesterol level J:36426
decreased circulating VLDL cholesterol level J:36426
Apobtm1Sgy/Apobtm1Sgy
(involves: 129/Sv * C57BL/6) 		decreased circulating LDL cholesterol level J:33830
decreased circulating triglyceride level J:33830
Apobtm1Sgy/Apobtm1Sgy
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:41510
increased circulating triglyceride level J:41510
increased circulating VLDL cholesterol level J:41510
Apobtm1Unc/Apob+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal circulating cholesterol level J:16352
decreased circulating HDL cholesterol level J:16352
decreased circulating triglyceride level J:16352
Apobtm1Unc/Apobtm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal circulating cholesterol level J:16352
decreased circulating HDL cholesterol level J:16352
decreased circulating triglyceride level J:16352
Apobtm1Zc/Apob+
(involves: 129/Sv * C57BL/6) 		decreased circulating cholesterol level J:76047
decreased circulating HDL cholesterol level J:76047
decreased circulating LDL cholesterol level J:76047
decreased circulating triglyceride level J:76047
decreased circulating VLDL cholesterol level J:76047
Apobtm1Zc/Apobtm1.1Zc
(involves: 129/Sv * C57BL/6) 		decreased circulating cholesterol level J:76047
decreased circulating HDL cholesterol level J:76047
decreased circulating LDL cholesterol level J:76047
decreased circulating triglyceride level J:76047
decreased circulating VLDL cholesterol level J:76047
Apobtm1Zc/Apobtm1Zc
(involves: 129/Sv * C57BL/6) 		decreased circulating cholesterol level J:76047
decreased circulating triglyceride level J:76047
Apobtm2Sgy/Apobtm2Sgy
(involves: 129/Sv * C57BL/6) 		increased circulating LDL cholesterol level J:33830
increased circulating triglyceride level J:33830
Apobtm2Sgy/Apobtm2Sgy
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal cholesterol homeostasis J:41510
decreased circulating cholesterol level J:41510
increased circulating HDL cholesterol level J:41510
increased circulating triglyceride level J:41510
increased circulating VLDL cholesterol level J:41510
increased circulating VLDL triglyceride level J:41510
Apobtm2Sgy/Apobtm2Sgy
Apoetm1Unc/Apoetm1Unc
Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal circulating cholesterol level J:133453
decreased circulating HDL cholesterol level J:133453
increased circulating cholesterol level J:133453
increased circulating free fatty acids level J:133453
increased circulating triglyceride level J:133453
increased circulating VLDL cholesterol level J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased circulating cholesterol level J:227165
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal circulating cholesterol level J:133453
decreased circulating HDL cholesterol level J:133453
increased circulating cholesterol level J:133453
increased circulating free fatty acids level J:133453
increased circulating LDL cholesterol level J:133453
increased circulating triglyceride level J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL) 		increased circulating cholesterol level J:227165
Apobtm2Sgy/Apobtm4Sgy
(involves: 129/Sv * 129S4/SvJae * C57BL/6) 		decreased circulating cholesterol level J:46549
Apobtm3Sgy/Apob+
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal cholesterol homeostasis J:23315
decreased circulating cholesterol level J:23315
decreased circulating HDL cholesterol level J:23315
Apobtm5Sgy/Apobtm5Sgy
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating LDL cholesterol level J:51549
decreased circulating VLDL cholesterol level J:51549
Apobec1tm1Chan/Apobec1tm1Chan
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating HDL cholesterol level J:36051
Apobec1tm1Chan/Apobec1tm1Chan
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae) 		abnormal circulating cholesterol level J:48202
decreased circulating cholesterol level J:48202
increased circulating cholesterol level J:48202
increased circulating triglyceride level J:48202
Apobec1tm1Chan/Apobec1tm1Chan
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		abnormal circulating cholesterol level J:48202
decreased circulating triglyceride level J:48202
increased circulating cholesterol level J:48202
increased circulating triglyceride level J:48202
Apobec1tm1Chan/Apobec1tm1Chan
Tg(CETP)5203Tall/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		abnormal circulating cholesterol level J:48202
decreased circulating HDL cholesterol level J:48202
decreased circulating triglyceride level J:48202
increased circulating cholesterol level J:48202
increased circulating triglyceride level J:48202
Apobec1tm1Ddsn/Apobec1tm1Ddsn
(B6.129S4-Apobec1tm1Ddsn) 		abnormal lipid homeostasis J:108052
abnormal triglyceride level J:108052
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Fggtm1Fjc/Fggtm1Fjc
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Fggtm1Fjc Apobec1tm1Ddsn Ldlrtm1Her) 		increased circulating LDL cholesterol level J:132734
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:49125
increased circulating LDL cholesterol level J:49125
increased circulating triglyceride level J:49125
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Apobec1tm1Ddsn Ldlrtm1Her) 		increased circulating LDL cholesterol level J:132734
Apobec1tm1Ishi/Apobec1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:41982
increased cholesterol level J:41982
Apobec1tm1Ishi/Apobec1tm1Ishi
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:41982
increased circulating triglyceride level J:41982
Apobec1tm1Rub/Apobec1tm1Rub
(involves: C57BL/6 * DBA) 		abnormal lipid homeostasis J:74021
decreased circulating HDL cholesterol level J:74021
increased circulating LDL cholesterol level J:74021
Apobec1tm1Rub/Apobec1tm1Rub
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:79196
decreased circulating LDL cholesterol level J:79196
increased circulating HDL cholesterol level J:79196
increased circulating triglyceride level J:79196
increased circulating VLDL triglyceride level J:79196
Apoc1tm1Lmh/Apoc1tm1Lmh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating cholesterol level J:22858
abnormal lipid level J:117482
increased cholesterol level J:117482
increased circulating cholesterol level J:22858
increased circulating triglyceride level J:22858
increased liver triglyceride level J:117482
Apoc1tm1Lmh/Apoc1tm1Lmh
Tg(CETP)5203Tall/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J) 		abnormal lipid level J:117482
abnormal phospholipid level J:117482
increased bile salt level J:117482
increased cholesterol level J:117482
increased liver triglyceride level J:117482
Apoc1tm2Lmh/Apoc1tm2Lmh
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal cholesterol homeostasis J:28261
increased circulating cholesterol level J:28261
Apoc2em1Arem/Apoc2+
(involves: C57BL/6 * FVB/NJ) 		increased circulating HDL cholesterol level J:227332
increased circulating triglyceride level J:227332
increased circulating VLDL triglyceride level J:227332
Apoc2em1Arem/Apoc2em1Arem
(involves: C57BL/6 * FVB/NJ) 		abnormal circulating cholesterol level J:227332
decreased circulating HDL cholesterol level J:227332
increased circulating triglyceride level J:227332
increased circulating VLDL triglyceride level J:227332
Apoc2em2Arem/Apoc2+
(involves: C57BL/6 * CBA) 		increased circulating HDL cholesterol level J:227332
increased circulating triglyceride level J:227332
increased circulating VLDL triglyceride level J:227332
Apoc2em2Arem/Apoc2em2Arem
(involves: C57BL/6 * CBA) 		abnormal circulating cholesterol level J:227332
decreased circulating HDL cholesterol level J:227332
increased circulating triglyceride level J:227332
increased circulating VLDL triglyceride level J:227332
Apoc3tm1Unc/Apoc3+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating cholesterol level J:21750
decreased circulating HDL cholesterol level J:21750
decreased circulating triglyceride level J:21750
Apoc3tm1Unc/Apoc3+
(involves: 129) 		decreased circulating cholesterol level J:21750
decreased circulating LDL cholesterol level J:21750
decreased circulating triglyceride level J:21750
decreased circulating VLDL cholesterol level J:21750
Apoc3tm1Unc/Apoc3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:21750
decreased circulating cholesterol level J:21750
decreased circulating HDL cholesterol level J:21750
decreased circulating LDL cholesterol level J:21750
decreased circulating triglyceride level J:21750
decreased circulating VLDL cholesterol level J:21750
Apoc3tm1Unc/Apoc3tm1Unc
(involves: 129) 		decreased circulating cholesterol level J:21750
decreased circulating LDL cholesterol level J:21750
decreased circulating triglyceride level J:21750
decreased circulating VLDL cholesterol level J:21750
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J) 		decreased circulating triglyceride level J:105136
increased circulating ketone body level J:105136
lipidosis J:105136
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Apodtm1Dsan/Apodtm1Dsan
(either: B6.129X1-Apodtm1Dsan or C.129X1-Apodtm1Dsan) 		abnormal lipid homeostasis J:143809
Apoeshl/Apoeshl
(KOR-Apoeshl) 		increased circulating cholesterol level J:75488
xanthoma J:75488
Apoeshl/Apoeshl
(C3.KOR-Apoeshl) 		increased circulating cholesterol level J:75488
xanthoma J:75488
Apoeshl/Apoeshl
(C.KOR-Apoeshl) 		increased circulating cholesterol level J:75488
xanthoma J:75488
Apoeshl/Apoeshl
(B6.KOR-Apoeshl) 		increased circulating cholesterol level J:75488
xanthoma J:75488
Apoeshl/Apoeshl
(involves: C3H/He * KOR) 		increased circulating cholesterol level J:54051
xanthoma J:54051
Apoeshl/Apoeshl
(involves: BALB/c * KOR) 		increased circulating cholesterol level J:54051
xanthoma J:54051
Apoeshl/Apoeshl
(involves: C57BL/6 * KOR) 		increased circulating cholesterol level J:54051
xanthoma J:54051
Apoeshl/Apoetm1Unc
(involves: 129P2/OlaHsd * KOR) 		increased circulating cholesterol level J:54051
xanthoma J:54051
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
(involves: 129S1/Sv * C57BL/6J) 		increased circulating cholesterol level J:136987
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
Igs7tm1(tetO-Apoe)Gaga/0
(involves: 129S1/Sv * C57BL/6J) 		increased circulating cholesterol level J:136987
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:67282, J:48565
abnormal lipid level J:67282, J:48565
hyperlipidemia J:48565
increased circulating cholesterol level J:67282, J:48565
increased circulating triglyceride level J:67282, J:48565
xanthoma J:48565
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		abnormal lipid homeostasis J:67282
decreased susceptibility to hyperlipidemia J:67282
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd * C57BL/6N) 		abnormal phospholipid level J:60590
decreased brain cholesterol level J:60590
increased circulating cholesterol level J:60590
increased circulating LDL cholesterol level J:60590
increased circulating VLDL cholesterol level J:60590
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd) 		abnormal circulating cholesterol level J:104859
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev) 		decreased cardiac muscle triglyceride level J:219838
decreased cholesterol level J:219838
decreased circulating cholesterol level J:219838
decreased circulating triglyceride level J:219838
decreased liver cholesterol level J:219838
decreased liver triglyceride level J:219838
decreased skeletal muscle triglyceride level J:219838
decreased triglyceride level J:219838
increased cholesterol level J:219838
Apoetm1Bres/Apoe+
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J)) 		increased circulating cholesterol level J:2809
Apoetm1Bres/Apoetm1Bres
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J)) 		abnormal circulating LDL cholesterol level J:2809
increased circulating cholesterol level J:2809, J:42426
increased circulating VLDL cholesterol level J:2809
increased triglyceride level J:2809
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss) 		decreased circulating HDL cholesterol level J:42927
increased circulating cholesterol level J:42927
increased circulating triglyceride level J:42927
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:29950
xanthoma J:43846
Apoetm1Bres/Apoetm1Bres
(B6.129P2-Apoetm1Bres) 		abnormal circulating cholesterol level J:68574
xanthoma J:68574
Apoetm1Bres/Apoetm1Bres
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Apoetm1Bres Esr1tm1Ksk) 		abnormal circulating cholesterol level J:68574
Apoetm1Bres/Apoetm1Bres
Fn1tm1Bwg/Fn1tm1Bwg
(involves: 129S4/SvJae * C57BL/6) 		abnormal cholesterol homeostasis J:90917
decreased circulating VLDL cholesterol level J:90917
Apoetm1Bres/Apoetm1Bres
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased circulating cholesterol level J:40921
increased circulating phospholipid level J:40921
Apoetm1Bres/Apoetm1Bres
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss) 		decreased circulating HDL cholesterol level J:42927
Apoetm1Khw/Apoetm1Khw
(involves: 129S4/SvJae * C57BL/6) 		increased circulating cholesterol level J:75681
increased circulating LDL cholesterol level J:75681
increased circulating triglyceride level J:75681
increased circulating VLDL cholesterol level J:75681
Apoetm1Khw/Apoetm1Khw
Tg(Mx1-cre)29-4Her/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased circulating cholesterol level J:75681
increased circulating LDL cholesterol level J:75681
increased circulating triglyceride level J:75681
increased circulating VLDL cholesterol level J:75681
Apoetm1Khw/Apoetm1Khw
Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Khw Tg(Mx1-cre)29-4Her) 		abnormal circulating lipid level J:196923
hyperlipidemia J:196923
increased circulating cholesterol level J:196923
increased circulating VLDL cholesterol level J:196923
Apoetm1Lmh/Apoe+
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:22347
increased circulating cholesterol level J:22347
increased circulating HDL cholesterol level J:22347
increased circulating VLDL cholesterol level J:22347
Apoetm1Lmh/Apoetm1Lmh
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:22347
increased circulating cholesterol level J:22347
increased circulating HDL cholesterol level J:22347
increased circulating VLDL cholesterol level J:22347
xanthoma J:24054
Apoetm1Lmh/Apoetm1Lmh
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:117317
increased circulating HDL cholesterol level J:117317
increased circulating LDL cholesterol level J:117317
increased circulating triglyceride level J:117317
Apoetm1Lmh/Apoetm1Lmh
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		decreased circulating cholesterol level J:90547
decreased circulating LDL cholesterol level J:90547
decreased circulating triglyceride level J:90547
decreased circulating VLDL cholesterol level J:90547
increased circulating cholesterol level J:117317
increased circulating HDL cholesterol level J:117317
increased circulating LDL cholesterol level J:117317
increased circulating triglyceride level J:117317
Apoetm1Rraf/Apoetm1Rraf
Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Rraf Tg(Mx1-cre)29-4Her) 		abnormal circulating cholesterol level J:196923
decreased circulating VLDL cholesterol level J:196923
hyperlipidemia J:196923
increased circulating cholesterol level J:196923
Apoetm1Unc/Apoe+
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating triglyceride level J:16573
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		abnormal circulating cholesterol level J:73202
decreased circulating HDL cholesterol level J:91058
decreased circulating triglyceride level J:93987
hyperlipidemia J:101576
increased circulating cholesterol level J:104609, J:97385, J:125978, J:91058, J:101576, J:73202, J:133606
increased circulating HDL cholesterol level J:226403
increased circulating LDL cholesterol level J:91058, J:101576, J:93987
increased circulating triglyceride level J:91058, J:101576, J:73202
increased circulating VLDL cholesterol level J:91058, J:101576, J:93987
xanthoma J:43846, J:73202
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating HDL cholesterol level J:16573
hyperlipidemia J:80689
increased circulating cholesterol level J:40136, J:41510, J:16573, J:80689
increased circulating LDL cholesterol level J:16573
increased circulating triglyceride level J:16573, J:80689
increased circulating VLDL cholesterol level J:41510, J:16573
increased prostaglandin level J:125376
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd) 		abnormal circulating cholesterol level J:48202
increased circulating cholesterol level J:48202
increased circulating corticosterone level J:101973
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		abnormal lipid level J:125366
increased circulating cholesterol level J:61287
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr) 		increased circulating cholesterol level J:133606
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal cholesterol homeostasis J:75567
abnormal lipid homeostasis J:75567
decreased circulating HDL cholesterol level J:75567
increased circulating cholesterol level J:75567
increased circulating phospholipid level J:75567
Apoetm1Unc/Apoetm1Unc
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * C57BL/6N) 		decreased circulating cholesterol level J:338121
increased circulating triglyceride level J:338121
Apoetm1Unc/Apoetm1Unc
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * SJL) 		increased circulating cholesterol level J:101788
increased circulating LDL cholesterol level J:101788
increased circulating triglyceride level J:101788
increased circulating VLDL cholesterol level J:101788
Apoetm1Unc/Apoetm1Unc
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		abnormal lipid level J:61672
decreased circulating triglyceride level J:61672
increased cholesterol level J:61672
xanthoma J:61672
Apoetm1Unc/Apoetm1Unc
Crptm1Hjf/Crptm1Hjf
(B6.Cg-Crptm1Hjf Apoetm1Unc) 		decreased circulating HDL cholesterol level J:170409
decreased circulating triglyceride level J:170409
increased circulating HDL cholesterol level J:170409
Apoetm1Unc/Apoetm1Unc
Csf1op/Csf1op
(involves: 129P2/OlaHsd * C3HeB/Fe * C57BL/6) 		increased circulating cholesterol level J:40136
Apoetm1Unc/Apoetm1Unc
Cyp4f13Gt(OST14770)Lex/Cyp4f13Gt(OST14770)Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		decreased cholesterol level J:289999
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		decreased circulating HDL cholesterol level J:184647
increased circulating cholesterol level J:184647
increased circulating LDL cholesterol level J:184647
increased circulating triglyceride level J:184647
increased circulating VLDL cholesterol level J:184647
Apoetm1Unc/Apoetm1Unc
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Apoetm1Unc) 		decreased circulating cholesterol level J:102223
decreased circulating triglyceride level J:102223
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr) 		increased circulating cholesterol level J:133606
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr) 		decreased circulating cholesterol level J:121671
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc) 		decreased circulating HDL cholesterol level J:91058
increased circulating cholesterol level J:200141, J:91058
increased circulating LDL cholesterol level J:91058
increased circulating triglyceride level J:91058
increased circulating VLDL cholesterol level J:91058
Apoetm1Unc/Apoetm1Unc
Hdl5C57BL/6J/Hdl5C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Hdlq19C57BL/6J/Hdlq19C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Hdlq86C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:129301
increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Hdlq86C3H/HeJ/Hdlq86C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:129301
increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Hdlq91C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Hsd11b1tm1Lex/Hsd11b1tm1Lex
(B6.129-Hsd11b1tm1Lex Apoetm1Unc) 		decreased cholesterol level J:199430
hyperlipidemia J:199430
Apoetm1Unc/Apoetm1Unc
Il1rntm1Dih/Il1rntm1Dih
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		decreased circulating cholesterol level J:132570
Apoetm1Unc/Apoetm1Unc
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating cholesterol level J:105858
decreased circulating VLDL cholesterol level J:105858
increased circulating LDL cholesterol level J:105858
Apoetm1Unc/Apoetm1Unc
Klf15tm1Jain/Klf15tm1Jain
(involves: 129P2/OlaHsd * 129X1/SvJ) 		increased circulating cholesterol level J:203920
increased circulating triglyceride level J:203920
Apoetm1Unc/Apoetm1Unc
Lcattm1Hgc/Lcattm1Hgc
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal cholesterol homeostasis J:75567
abnormal lipid homeostasis J:75567
Apoetm1Unc/Apoetm1Unc
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased circulating cholesterol level J:59491
Apoetm1Unc/Apoetm1Unc
Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL) 		increased circulating cholesterol level J:130923
Apoetm1Unc/Apoetm1Unc
Lipgtm1Tq/Lipgtm1Tq
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		increased circulating cholesterol level J:93987
increased circulating HDL cholesterol level J:93987
increased circulating LDL cholesterol level J:93987
increased circulating phospholipid level J:93987
increased circulating triglyceride level J:93987
increased circulating VLDL cholesterol level J:93987
Apoetm1Unc/Apoetm1Unc
Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd) 		abnormal circulating cholesterol level J:151434
abnormal circulating lipid level J:151434
hyperlipidemia J:151434
increased circulating cholesterol level J:151434
increased circulating triglyceride level J:151434
Apoetm1Unc/Apoetm1Unc
Msr1tm1Csk/Msr1tm1Csk
(either: (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J * ICR) or (involves: 129P2/OlaHsd * 129X1/SvJ * 129/Sv * ICR)) 		increased circulating cholesterol level J:39079
Apoetm1Unc/Apoetm1Unc
Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129-Nceh1tm1Ishi Apoetm1Unc) 		abnormal cholesterol homeostasis J:152385
Apoetm1Unc/Apoetm1Unc
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating triglyceride level J:143903
Apoetm1Unc/Apoetm1Unc
Nhdlq11C3H/HeJ/Nhdlq11C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Nhdlq11C3H/HeJ/Nhdlq11C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Nhdlq12C3H/HeJ/Nhdlq12C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Nhdlq12C57BL/6J/Nhdlq12C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		decreased cholesterol level J:64566
Apoetm1Unc/Apoetm1Unc
Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c) 		increased circulating VLDL cholesterol level J:104996
Apoetm1Unc/Apoetm1Unc
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Apoetm1Unc Pik3cgtm1Dwu) 		decreased circulating cholesterol level J:121582
Apoetm1Unc/Apoetm1Unc
Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv * B6.129P2-Apoetm1Unc/J) 		increased circulating cholesterol level J:97471
Apoetm1Unc/Apoetm1Unc
Pnhdlc1C57BL/6J/Pnhdlc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Pnhdlc6C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased circulating LDL cholesterol level J:129301
increased circulating VLDL cholesterol level J:129301
Apoetm1Unc/Apoetm1Unc
Ptgdrtm1Dgen/Ptgdrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased cholesterol level J:192168
increased circulating cholesterol level J:192168
increased circulating triglyceride level J:192168
Apoetm1Unc/Apoetm1Unc
Rag2tm1Fwa/Rag2+
(involves: 129P2/OlaHsd * 129S/SvEv) 		decreased circulating cholesterol level J:59156
decreased circulating HDL cholesterol level J:59156
Apoetm1Unc/Apoetm1Unc
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv) 		decreased circulating cholesterol level J:59156
decreased circulating HDL cholesterol level J:59156
Apoetm1Unc/Apoetm1Unc
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129-Serpine1tm1Mlg Apoetm1Unc) 		increased circulating cholesterol level J:61287
Apoetm1Unc/Apoetm1Unc
Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal bile salt homeostasis J:228944
decreased circulating cholesterol level J:228944
Apoetm1Unc/Apoetm1Unc
Soat1tm1Far/Soat1tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J) 		abnormal cholesterol homeostasis J:61147
abnormal cholesterol level J:61147
decreased circulating cholesterol level J:61147
decreased circulating VLDL cholesterol level J:61147
xanthoma J:61147
Apoetm1Unc/Apoetm1Unc
Soat2tm1Far/Soat2tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J) 		decreased circulating cholesterol level J:81836
increased circulating HDL cholesterol level J:81836
increased circulating triglyceride level J:81836
Apoetm1Unc/Apoetm1Unc
Spp1tm1Rit/Spp1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:103051
increased circulating triglyceride level J:103051
Apoetm1Unc/Apoetm1Unc
Spp1tm1Rit/Spp1tm1Rit
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:103051
increased circulating triglyceride level J:103051
Apoetm1Unc/Apoetm1Unc
Tg(APOC1)1Bres/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		hyperlipidemia J:80689
increased circulating cholesterol level J:80689
increased circulating LDL cholesterol level J:80689
increased circulating triglyceride level J:80689
increased circulating VLDL cholesterol level J:80689
increased circulating VLDL triglyceride level J:80689
Apoetm1Unc/Apoetm1Unc
Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Apoetm1Unc Tg(CMV-Serpine1)1Dgi) 		increased circulating cholesterol level J:61287
Apoetm1Unc/Apoetm1Unc
Tg(Cyp21a1-Apoe)614Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal circulating cholesterol level J:130658
Apoetm1Unc/Apoetm1Unc
Tg(Cyp21a1-Apoe)619Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal lipid level J:130658
increased circulating cholesterol level J:130658
Apoetm1Unc/Apoetm1Unc
Tg(NOS3)2Crom/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased circulating cholesterol level J:80701
Apoetm1Unc/Apoetm1Unc
Tg(NOS3)3Crom/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased circulating cholesterol level J:80701
Apoetm1Unc/Apoetm1Unc
Thbs4tm1Olsa/Thbs4tm1Olsa
(involves: 129P2/OlaHsd * C57BL/6J) 		increased cholesterol level J:345752
Apoetm1Unc/Apoetm1Unc
Trigq3C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Trigq3C3H/HeJ/Trigq3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Trigq4C3H/HeJ/Trigq4C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Trigq4C3H/HeJ/Trigq4C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased triglyceride level J:129301
Apoetm1Unc/Apoetm1Unc
Ttpatm1Far/Ttpatm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal lipid homeostasis J:66419
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:41705
abnormal lipid level J:41705
abnormal triglyceride level J:41705
decreased circulating LDL cholesterol level J:41705
decreased circulating VLDL cholesterol level J:74417
decreased circulating VLDL triglyceride level J:74417
increased circulating cholesterol level J:41705
increased circulating HDL cholesterol level J:74417
increased circulating triglyceride level J:74417
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal circulating lipid level J:146721
Apoetm2(APOE_i2)Sfu/Apoetm2(APOE_i2)Sfu
(involves: 129P2/OlaHsd) 		decreased circulating cholesterol level J:104859
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating lipid level J:151284
abnormal lipid level J:74417
decreased circulating HDL cholesterol level J:74417
decreased circulating triglyceride level J:74417
increased circulating VLDL cholesterol level J:74417
increased circulating VLDL triglyceride level J:74417
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal circulating lipid level J:146721
increased circulating cholesterol level J:146721
increased circulating triglyceride level J:146721
Apoetm3(APOE_i3)Sfu/Apoetm3(APOE_i3)Sfu
(involves: 129P2/OlaHsd) 		decreased circulating cholesterol level J:104859
Apoetm4Mae/Apoetm4Mae
(129S6/SvEvTac-Apoetm4Mae) 		abnormal circulating lipid level J:172417
increased circulating cholesterol level J:172417
increased circulating HDL cholesterol level J:172417
increased circulating triglyceride level J:172417
increased circulating VLDL cholesterol level J:172417
Apoftm1(KOMP)Vlcg/Apof+
(involves: C57BL/6J * C57BL/6NTac) 		abnormal cholesterol homeostasis J:185314
decreased circulating triglyceride level J:185314
increased circulating HDL cholesterol level J:185314
Apoftm1(KOMP)Vlcg/Apoftm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		abnormal cholesterol homeostasis J:185314
decreased circulating triglyceride level J:185314
increased liver cholesterol level J:185314
Apol6em1Hsul/Apol6em1Hsul
(Not Specified) 		decreased circulating cholesterol level J:344362
decreased circulating HDL cholesterol level J:344362
decreased circulating triglyceride level J:344362
increased circulating free fatty acids level J:344362
Apomtm1Cchr/Apomtm1Cchr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating cholesterol level J:130647
decreased circulating triglyceride level J:130647
Apomtm1Stf/Apomtm1Stf
(Not Specified) 		decreased circulating HDL cholesterol level J:138581
Apptm1Ck/Apptm1Ck
Psen1tm1Mpm/Psen1tm1Mpm
(involves: 129 * 129S1/Sv * 129X1/SvJ) 		increased circulating corticosterone level J:191170
Apptm1Dbo/Apptm1Dbo
Npc1m1N/Npc1m1N
(C.Cg-Apptm1Dbo Npc1m1N) 		increased brain cholesterol level J:172769
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Aqp3tm1Ask/Aqp3tm1Ask
(involves: C57BL/6J) 		decreased circulating triglyceride level J:61675
Aqp3tm2b(EUCOMM)Wtsi/Aqp3tm2b(EUCOMM)Wtsi
(C57BL/6N-Aqp3tm2b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased glycerol level J:125011
Aqp7tm1Nlsn/Aqp7tm1Nlsn
(involves: 129S1/Sv * C57BL/6) 		decreased urine glycerol level J:147631
Aqp7tm1Tfun/Aqp7tm1Tfun
(B6N.129X1-Aqp7tm1Tfun) 		decreased circulating glycerol level J:95278
increased glycerol level J:95278
Aqp8tm1Ask/Aqp8tm1Ask
(involves: 129/Sv * C57BL/6 * CD-1) 		increased circulating cholesterol level J:104681
increased circulating triglyceride level J:104681
Aqp9tm1Nlsn/Aqp9tm1Nlsn
(involves: 129S1/Sv * C57BL/6) 		increased circulating glycerol level J:123742
increased circulating triglyceride level J:123742
Aqp9tm1Nlsn/Aqp9tm1Nlsn
Leprdb/Leprdb
(involves: 129S1/Sv * C57BL/6 * C57BLKS/J) 		increased circulating glycerol level J:123742
Aqp11tm1.1Nlsn/Aqp11tm1.1Nlsn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		decreased circulating free fatty acids level J:194939
decreased circulating glycerol level J:194939
decreased circulating ketone body level J:194939
decreased circulating triglyceride level J:194939
increased circulating HDL cholesterol level J:194939
Aqp12tm1Rai/Aqp12tm1Rai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased cholesterol level J:155920
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		increased circulating triglyceride level J:98775
increased liver triglyceride level J:98775
increased skeletal muscle triglyceride level J:98775
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating triglyceride level J:196857
Arhgap20em1(IMPC)J/Arhgap20em1(IMPC)J
(C57BL/6NJ-Arhgap20em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Arhgap22tm1a(KOMP)Wtsi/Arhgap22tm1a(KOMP)Wtsi
(C57BL/6N-Arhgap22tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:211773
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA) 		increased circulating cholesterol level J:57995
Arhgef4tm1a(KOMP)Wtsi/Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating triglyceride level J:165965
Arhgef38tm1a(KOMP)Wtsi/Arhgef38tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef38tm1a(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J) 		increased circulating triglyceride level J:211773
Armc3em1(IMPC)J/Armc3+
(C57BL/6NJ-Armc3em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Armc5tm1Stra/Armc5+
(involves: 129 * C57BL/6N * Swiss) 		decreased circulating corticosterone level J:244906
increased circulating corticosterone level J:244906
Armc10em1(IMPC)J/Armc10em1(IMPC)J
(C57BL/6NJ-Armc10em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Arr3em1(IMPC)J/Arr3em1(IMPC)J
(C57BL/6NJ-Arr3em1(IMPC)J/J) 		decreased circulating triglyceride level J:211773
Arrb2tm1.1(KOMP)Vlcg/Arrb2+
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Arrb2tm1.1(KOMP)Vlcg/Arrb2tm1.1(KOMP)Vlcg
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Arrdc3Gt(CSE151)Byg/Arrdc3+
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating ketone body level J:179646
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:179646
decreased circulating triglyceride level J:179646
increased circulating ketone body level J:179646
Arsatm1Gie/Arsatm1Gie
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:37978, J:52310
Art5em1(IMPC)J/Art5em1(IMPC)J
(C57BL/6NJ-Art5em1(IMPC)J/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Arv1tm1.2Geno/Arv1+
(involves: C57BL/6 * C57BL/6J) 		increased circulating cholesterol level J:263695
increased circulating HDL cholesterol level J:263695
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		abnormal bile salt homeostasis J:263695
decreased circulating cholesterol level J:263695
decreased circulating HDL cholesterol level J:263695
decreased circulating triglyceride level J:263695
decreased liver cholesterol level J:263695
decreased liver free fatty acids level J:263695
decreased liver triglyceride level J:263695
decreased unsaturated fatty acids level J:263695
increased bile salt level J:263695
increased saturated fatty acids level J:263695
increased unsaturated fatty acids level J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		abnormal circulating lipid level J:241193
decreased circulating cholesterol level J:241193
decreased circulating HDL cholesterol level J:241193
increased fatty acid oxidation J:241193
Asah1tm1.1Jhkh/Asah1+
Smpd1tm1Esc/Smpd1+
(involves: 129S1/Sv) 		abnormal ceramide level J:199833
Asah1tm1.1Jhkh/Asah1tm1.1Jhkh
(Not Specified) 		abnormal ceramide level J:199833
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6) 		abnormal sphingomyelin level J:285931
increased ceramide level J:285931
increased sphingosine level J:285931
Asah1tm1Esc/Asah1+
(involves: 129S1/Sv * C57BL/6) 		abnormal lipid homeostasis J:74647
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1) 		abnormal ceramide level J:232306
Asah2tm1Rlp/Asah2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal lipid level J:110485
Asgr2tm1Her/Asgr2tm1Her
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:21380
Asic1em1(IMPC)Mbp/Asic1em1(IMPC)Mbp
(C57BL/6N-Asic1em1(IMPC)Mbp/MbpMmucd) 		increased circulating triglyceride level J:211773
Aspanur7/Aspanur7
(involves: C57BL/6J) 		abnormal sphingolipid level J:226682
Aspmtm1a(KOMP)Wtsi/Aspmtm1a(KOMP)Wtsi
(C57BL/6N-Aspmtm1a(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating glycerol level J:211773
increased circulating HDL cholesterol level J:211773
Aspntm1b(EUCOMM)Hmgu/Aspntm1b(EUCOMM)Hmgu
(C57BL/6N-Aspntm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Aspscr1tm1.1Jsbo/Aspscr1tm1.1Jsbo
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn) 		decreased fatty acid oxidation J:308358
increased skeletal muscle triglyceride level J:308358
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(C57BL/6N-Asxl1tm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating free fatty acids level J:165965
decreased circulating triglyceride level J:165965
Asxl2tm1b(EUCOMM)Hmgu/Asxl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Asxl2tm1b(EUCOMM)Hmgu/Tcp) 		increased circulating cholesterol level J:211773
Atad2btm1b(EUCOMM)Hmgu/Atad2btm1b(EUCOMM)Hmgu
(C57BL/6N-Atad2btm1b(EUCOMM)Hmgu/Ics) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Atad3atm1a(KOMP)Wtsi/Atad3a+
(C57BL/6N-Atad3atm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Atad3atm1c(KOMP)Wtsi/Atad3atm1c(KOMP)Wtsi
Myl1tm1(cre)Sjb/Myl1+
(B6J.Cg-Myl1tm1(cre)Sjb Atad3atm1c(KOMP)Wtsi) 		abnormal cholesterol homeostasis J:263681
Atg2bem1(IMPC)J/Atg2bem1(IMPC)J
(C57BL/6NJ-Atg2bem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Atg4bGt(A029E06)Wrst/Atg4bGt(A029E06)Wrst
(involves: 129S2/SvPas * C57BL/6) 		abnormal lipid homeostasis J:163712
Atg4btm1b(EUCOMM)Hmgu/Atg4btm1b(EUCOMM)Hmgu
(C57BL/6N-Atg4btm1b(EUCOMM)Hmgu/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Atg101em1Nmz/Atg101em1Nmz
(involves: C57BL/6JJcl) 		abnormal lipid homeostasis J:300057
Ath9FVB/NCr/Ath9C57BL/6J
(involves: C57BL/6J * FVB/NCr) 		increased circulating HDL cholesterol level J:76127
Ath9FVB/NCr/Ath9FVB/NCr
(involves: C57BL/6J * FVB/NCr) 		increased circulating HDL cholesterol level J:76127
Atn1tm1b(EUCOMM)Wtsi/Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm) 		increased circulating triglyceride level J:211773
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd * Black Swiss) 		increased circulating corticosterone level J:117414
Atp6ap2tm1.1Ics/Y
Tg(NPHS2-cre)295Lbh/0
(involves: C57BL/6 * C57BL/6N * SJL) 		increased circulating cholesterol level J:232697
Atp6v0d1em1Nju/Atp6v0d1em1Nju
Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ) 		decreased circulating triglyceride level J:346448
increased circulating cholesterol level J:346448
increased circulating free fatty acids level J:346448
increased liver cholesterol level J:346448
increased liver free fatty acids level J:346448
increased liver triglyceride level J:346448
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp) 		decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Atp8b1tm1Nbf/Atp8b1tm1Nbf
(involves: 129S1/SvImJ * 129S4/SvJae) 		abnormal bile salt level J:89817
Atp8b1tm1Nbf/Atp8b1tm1Nbf
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		abnormal bile salt homeostasis J:215915
increased bile salt level J:215915
Atp11cem1(IMPC)J/Y
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Atp11cem1(IMPC)J/Atp11cem1(IMPC)J
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Atp13a3em1(IMPC)J/Atp13a3em1(IMPC)J
(C57BL/6NJ-Atp13a3em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid level J:135320
increased circulating cholesterol level J:135320
Atxn7l2em1(IMPC)Mbp/Atxn7l2em1(IMPC)Mbp
(C57BL/6NCrl-Atxn7l2em1(IMPC)Mbp/Mmucd) 		increased circulating HDL cholesterol level J:211773
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J) 		abnormal circulating corticosterone level J:110099
Avpr1btm1Gzt/Avpr1btm1Gzt
(involves: 129 * C57BL/6J) 		decreased circulating corticosterone level J:87707
B4galnt1tm1Rlp/B4galnt1tm1Rlp
St3gal5tm1Rlp/St3gal5tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal ganglioside level J:96830
abnormal lipid homeostasis J:96830
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased circulating cholesterol level J:144416
decreased circulating triglyceride level J:144416
increased circulating ketone body level J:144416
Banpem1(IMPC)J/Banp+
(C57BL/6NJ-Banpem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Baz1btm2a(KOMP)Wtsi/Baz1b+
(Not Specified) 		decreased circulating cholesterol level J:165965
decreased circulating HDL cholesterol level J:165965
Bbs2tm1.1Huss/Bbs2tm1.1Huss
(involves: 129S6/SvEv * C57BL/6) 		increased ceramide level J:296033
increased circulating triglyceride level J:296033
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd) 		abnormal circulating lipid level J:134093
increased circulating cholesterol level J:134093
increased circulating HDL cholesterol level J:134093
increased circulating LDL cholesterol level J:134093
increased circulating VLDL cholesterol level J:134093
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H) 		decreased circulating triglyceride level J:211773
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating free fatty acids level J:189019
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N) 		abnormal lipid homeostasis J:129967
decreased circulating free fatty acids level J:129967
decreased circulating ketone body level J:129967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		decreased fatty acid oxidation J:278806
increased liver triglyceride level J:278806
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL) 		abnormal cholesterol homeostasis J:181308
abnormal triglyceride level J:181308
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		abnormal lipid level J:271078
decreased ceramide level J:271078
decreased circulating free fatty acids level J:271078
decreased circulating triglyceride level J:271078
decreased liver triglyceride level J:271078
Bco1tm1Dnp/Bco1tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating cholesterol level J:128383
increased circulating free fatty acids level J:128383
Bco2tm1Dnp/Bco2+
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver triglyceride level J:170742
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6) 		increased liver triglyceride level J:170742
Bcorl1em1(IMPC)Tcp/Y
(C57BL/6NCrl-Bcorl1em1(IMPC)Tcp/Cmmr) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Bdnftm3Jae/Bdnftm3Jae
Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * CBA/J) 		increased cholesterol level J:71969
Bdt3DBA/2J/Bdt3DBA/2J
(involves: C57BL/6J * DBA/2J) 		increased circulating VLDL cholesterol level J:104825
Becn1tm1b(KOMP)Wtsi/Becn1+
(C57BL/6N-Becn1tm1b(KOMP)Wtsi/Ieg) 		decreased circulating HDL cholesterol level J:211773
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		increased circulating triglyceride level J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		increased circulating triglyceride level J:126780
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(C57BL/6N-Bhlhe40tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating glycerol level J:211773
decreased circulating HDL cholesterol level J:211773
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating lipid level J:177569
abnormal lipid level J:177569
abnormal phospholipid level J:177569
decreased circulating cholesterol level J:177569
decreased circulating HDL cholesterol level J:177569
decreased circulating phospholipid level J:177569
increased triglyceride level J:177569
Bloc1s1tm1a(EUCOMM)Hmgu/Bloc1s1+
(C57BL/6N-Bloc1s1tm1a(EUCOMM)Hmgu/Ics) 		increased circulating cholesterol level J:165965
Bloc1s2tm1.1(KOMP)Mbp/Bloc1s2+
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J) 		decreased circulating free fatty acids level J:211773
Bltp3bem1(IMPC)J/Bltp3bem1(IMPC)J
(C57BL/6NJ-Bltp3bem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N) 		decreased fatty acid beta-oxidation J:237631
increased fatty acids level J:237631
increased liver triglyceride level J:237631
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J) 		abnormal lipid level J:177865
decreased circulating HDL cholesterol level J:177865
decreased circulating VLDL triglyceride level J:177865
increased circulating cholesterol level J:177865
increased circulating free fatty acids level J:177865
increased circulating HDL cholesterol level J:177865
increased circulating LDL cholesterol level J:177865
increased circulating triglyceride level J:177865
increased circulating VLDL cholesterol level J:177865
increased liver triglyceride level J:177865
increased skeletal muscle triglyceride level J:177865
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129) 		abnormal lipid homeostasis J:131694
Bnip3em1(IMPC)Mbp/Bnip3em1(IMPC)Mbp
(C57BL/6N-Bnip3em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
Boctm1b(KOMP)Wtsi/Boctm1b(KOMP)Wtsi
(C57BL/6N-Boctm1b(KOMP)Wtsi/H) 		increased circulating triglyceride level J:211773
Bodwt1C3H/HeJ/Bodwt1C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		abnormal circulating cholesterol level J:106521
increased circulating HDL cholesterol level J:106521
increased circulating triglyceride level J:106521
Bodwt1C3H/HeJ/Bodwt1C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		abnormal circulating cholesterol level J:106521
increased circulating HDL cholesterol level J:106521
increased circulating triglyceride level J:106521
Bpnt1tm1Yrk/Bpnt1tm1Yrk
(involves: 129S/SvEv * C57BL/6) 		decreased cholesterol level J:194247
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		abnormal circulating lipid level J:159964
increased circulating cholesterol level J:159964
increased circulating triglyceride level J:159964
Brd7tm2a(EUCOMM)Wtsi/Brd7+
(Not Specified) 		decreased circulating LDL cholesterol level J:175295
Brd9em1(IMPC)Tcp/Brd9+
(C57BL/6N-Brd9em1(IMPC)Tcp/Cmmr) 		increased circulating HDL cholesterol level J:211773
Brwd1em1(IMPC)Tcp/Brwd1em1(IMPC)Tcp
(C57BL/6N-Brwd1em1(IMPC)Tcp/Cmmr) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Bsbob3SPRET/EiJ/?
Bsbob4SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ) 		increased circulating cholesterol level J:90614
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Ddx4-cre)1Dcas/0
(involves: 129 * 129S4/SvJaeSor * FVB/N) 		abnormal phospholipid level J:211072
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor) 		increased circulating cholesterol level J:211072
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal lipid homeostasis J:183701
decreased circulating free fatty acids level J:183701
decreased circulating glycerol level J:183701
decreased circulating triglyceride level J:183701
increased circulating free fatty acids level J:183701
increased circulating glycerol level J:183701
increased circulating triglyceride level J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		abnormal phospholipid level J:211072
increased circulating cholesterol level J:211072, J:173404
increased circulating triglyceride level J:173404
increased liver triglyceride level J:173404
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		abnormal triglyceride level J:260853
increased liver triglyceride level J:260853
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno) 		abnormal lipid homeostasis J:200947
decreased circulating free fatty acids level J:200947
decreased circulating triglyceride level J:200947
increased circulating HDL cholesterol level J:200947
increased liver triglyceride level J:200947
Bsndtm1Suc/Bsndtm1Suc
(involves: 129S4/SvJae * C57BL/6) 		increased circulating aldosterone level J:175265
Btbd9tm1b(EUCOMM)Wtsi/Btbd9tm1b(EUCOMM)Wtsi
(C57BL/6N-Btbd9tm1b(EUCOMM)Wtsi/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Btbd16tm2b(EUCOMM)Hmgu/Btbd16tm2b(EUCOMM)Hmgu
(C57BL/6N-Btbd16tm2b(EUCOMM)Hmgu/Bay) 		decreased circulating triglyceride level J:211773
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J) 		decreased circulating cholesterol level J:211773
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex) 		increased circulating cholesterol level J:344722
increased circulating ketone body level J:344722
C1qtnf1em1(IMPC)Mbp/C1qtnf1em1(IMPC)Mbp
(C57BL/6N-C1qtnf1em1(IMPC)Mbp/MbpMmucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex) 		abnormal lipid homeostasis J:241403
decreased circulating free fatty acids level J:241403
decreased circulating triglyceride level J:241403
decreased liver cholesterol level J:241403
decreased liver triglyceride level J:241403
increased liver triglyceride level J:241403
C1qtnf2tm1Lex/C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex) 		abnormal phospholipid level J:282612
decreased cholesterol level J:282612
decreased circulating cholesterol level J:282612
decreased circulating HDL cholesterol level J:282612
decreased circulating LDL cholesterol level J:282612
decreased liver cholesterol level J:282612
decreased liver triglyceride level J:282612
increased circulating free fatty acids level J:282612
increased circulating glycerol level J:282612
increased circulating triglyceride level J:282612
increased circulating VLDL cholesterol level J:282612
increased circulating VLDL triglyceride level J:282612
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased liver triglyceride level J:237401
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg) 		increased liver triglyceride level J:212299
C2cd4bem1(IMPC)Wtsi/C2cd4bem1(IMPC)Wtsi
(C57BL/6N-C2cd4bem1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm) 		decreased circulating free fatty acids level J:284780
decreased fatty acid oxidation J:284780
increased liver triglyceride level J:284780
C3tm1Crr/C3tm1Crr
(B6;129S4-C3tm1Crr/J) 		decreased circulating free fatty acids level J:214214
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6) 		abnormal lipid homeostasis J:60633, J:58966
decreased circulating triglyceride level J:60633
increased circulating free fatty acids level J:60633, J:58966
increased triglyceride level J:58966
C3tm1Hrc/C3tm1Hrc
(involves: 129) 		abnormal intestinal lipid absorption J:87945
increased circulating free fatty acids level J:87945
increased triglyceride level J:87945
C3tm1Hrc/C3tm1Hrc
Lepob/Lepob
(involves: 129 * C57BL/6) 		abnormal lipid homeostasis J:80546
increased circulating free fatty acids level J:80546
increased triglyceride level J:80546
C3ar1tm1Cge/C3ar1tm1Cge
(B6.129S4(C)-C3ar1tm1Cge) 		decreased circulating free fatty acids level J:214214
decreased circulating phospholipid level J:214214
C3ar1tm1Cge/C3ar1tm1Cge
C5ar1tm1Cge/C5ar1tm1Cge
(B6.Cg-C3ar1tm1Cge C5ar1tm1Cge) 		decreased circulating free fatty acids level J:214214
decreased circulating phospholipid level J:214214
C4bptm1b(KOMP)Wtsi/C4bptm1b(KOMP)Wtsi
(C57BL/6N-C4bptm1b(KOMP)Wtsi/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
C5ar1tm1Cge/C5ar1tm1Cge
(B6.129S4(Cg)-C5ar1tm1Cge) 		decreased circulating free fatty acids level J:214214
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6) 		increased fatty acid oxidation J:123294
Cacfd1tm1Lex/Cacfd1tm1Lex
(B6;129S5-Cacfd1tm1Lex/Mmucd) 		increased circulating cholesterol level J:171883
increased circulating triglyceride level J:171883
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA) 		abnormal lipid level J:105212
decreased circulating triglyceride level J:105212
Cacna2d3tm1b(KOMP)Wtsi/Cacna2d3+
(B6N(Cg)-Cacna2d3tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
decreased circulating triglyceride level J:211773
Cacng3tm1Dgen/Cacng3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:101679
increased circulating HDL cholesterol level J:101679
Camsap3tm1a(EUCOMM)Wtsi/Camsap3+
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
increased circulating glycerol level J:211773
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cap2tm1a(EUCOMM)Wtsi/Ieg) 		decreased circulating triglyceride level J:165965
Capn10tm1b(EUCOMM)Wtsi/Capn10tm1b(EUCOMM)Wtsi
(C57BL/6N-Capn10tm1b(EUCOMM)Wtsi/Ics) 		abnormal cholesterol homeostasis J:211773
Car7tm1b(KOMP)Wtsi/Car7+
(B6N(Cg)-Car7tm1b(KOMP)Wtsi/J) 		increased circulating free fatty acids level J:211773
Carmil2tm1b(KOMP)Mbp/Carmil2tm1b(KOMP)Mbp
(C57BL/6N-Carmil2tm1b(KOMP)Mbp/Orl) 		abnormal cholesterol homeostasis J:211773
Casp8tm1Clie/Casp8tm1Clie
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased bile salt level J:218665
Casq1tm1b(EUCOMM)Wtsi/Casq1tm1b(EUCOMM)Wtsi
(C57BL/6N-Casq1tm1b(EUCOMM)Wtsi/Ics) 		abnormal cholesterol homeostasis J:211773
Catb/Catb
(Not Specified) 		decreased circulating cholesterol level J:5205, J:5351
decreased circulating triglyceride level J:5205, J:5351
Cav1em2(IMPC)Ics/Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6) 		abnormal lipid level J:112452
decreased liver triglyceride level J:112452
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal circulating free fatty acids level J:75192
abnormal lipid homeostasis J:75192
increased circulating triglyceride level J:75192
increased circulating VLDL triglyceride level J:75192
Cav1tm1Mls/Cav1tm1Mls
(B6.Cg-Cav1tm1Mls) 		abnormal triglyceride level J:105133
decreased fatty acids level J:105133
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls) 		abnormal free fatty acids level J:182288
increased circulating glycerol level J:182288
increased triglyceride level J:182288
Cav1tm1Pesch/Cav1tm1Pesch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn) 		decreased circulating glycerol level J:182288
Cavin1tm1Pfp/Cavin1tm1Pfp
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal circulating lipid level J:143425
hyperlipidemia J:143425
increased circulating free fatty acids level J:143425
increased circulating triglyceride level J:143425
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6) 		abnormal lipid homeostasis J:94416
decreased circulating free fatty acids level J:94416
decreased liver triglyceride level J:94416
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6) 		decreased circulating free fatty acids level J:121012
decreased circulating triglyceride level J:121012
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi) 		decreased circulating cholesterol level J:236022
decreased circulating glycerol level J:236022
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Cc2d1btm1a(KOMP)Wtsi/Cc2d1b+
(Not Specified) 		decreased circulating free fatty acids level J:165965
Cc2d1btm1a(KOMP)Wtsi/Cc2d1btm1a(KOMP)Wtsi
(Not Specified) 		decreased circulating free fatty acids level J:165965
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J) 		increased unsaturated fatty acids level J:228688
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J) 		decreased liver triglyceride level J:220560
Ccdc18tm1a(EUCOMM)Wtsi/Ccdc18tm1a(EUCOMM)Wtsi
(C57BL/6N-Ccdc18tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
increased circulating glycerol level J:211773
increased circulating triglyceride level J:211773
Ccdc77tm1a(EUCOMM)Wtsi/Ccdc77tm1a(EUCOMM)Wtsi
(C57BL/6N-Ccdc77tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm) 		increased circulating free fatty acids level J:189183
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp) 		decreased circulating cholesterol level J:332421
decreased circulating LDL cholesterol level J:332421
decreased circulating triglyceride level J:332421
decreased liver triglyceride level J:332421
Ccdc92tm1b(KOMP)Mbp/Ccdc92tm1b(KOMP)Mbp
(C57BL/6N-Ccdc92tm1b(KOMP)Mbp/Ucd) 		decreased circulating cholesterol level J:211773
Ccdc120tm1.1(KOMP)Vlcg/Y
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Cckartm1Kpn/Cckartm1Kpn
(involves: 129S/SvEv) 		abnormal bile salt homeostasis J:91998
abnormal cholesterol homeostasis J:91998
increased intestinal cholesterol absorption J:91998
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J) 		decreased circulating free fatty acids level J:110277
Ccl2tm1Rol/Ccl2tm1Rol
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased circulating triglyceride level J:75837
increased circulating VLDL cholesterol level J:75837
Ccl9tm1(KOMP)Vlcg/Ccl9tm1(KOMP)Vlcg
(C57BL/6N-Ccl9tm1(KOMP)Vlcg/Ucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ccnqtm1.1(KOMP)Vlcg/Ccnq+
(C57BL/6N-Ccnqtm1.1(KOMP)Vlcg/Ucd) 		increased circulating triglyceride level J:211773
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6) 		decreased circulating cholesterol level J:224589
decreased circulating free fatty acids level J:224589
decreased circulating triglyceride level J:224589
decreased liver triglyceride level J:224589
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		abnormal cholesterol homeostasis J:81363
abnormal lipid homeostasis J:81363
Cd1d1tm1Luc/Cd1d1tm1Luc
Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Cd1d1tm1Luc Ldlrtm1Her) 		decreased circulating VLDL cholesterol level J:110061
Cd4tm1Mak/Cd4tm1Mak
(B6.129S2-Cd4tm1Mak/J) 		abnormal bile salt level J:133047
Cd22tm1b(EUCOMM)Wtsi/Cd22tm1b(EUCOMM)Wtsi
(C57BL/6N-Cd22tm1b(EUCOMM)Wtsi/Tcp) 		increased circulating cholesterol level J:211773
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd) 		decreased circulating triglyceride level J:211773
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6) 		abnormal cholesterol homeostasis J:56081
abnormal intestinal lipid absorption J:123605
abnormal lipid homeostasis J:56081
abnormal triglyceride level J:123605
decreased cardiac muscle triglyceride level J:83611
decreased intestinal cholesterol absorption J:123605
increased circulating cholesterol level J:56081
increased circulating HDL cholesterol level J:56081
increased circulating ketone body level J:126461
increased circulating triglyceride level J:56081
increased circulating VLDL triglyceride level J:56081
increased fatty acids level J:56081
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe) 		abnormal circulating lipid level J:87372
abnormal fatty acids level J:87372
abnormal lipid level J:87372
decreased fatty acids level J:87372
decreased liver free fatty acids level J:135594
decreased liver triglyceride level J:135594
increased circulating free fatty acids level J:87372
increased circulating ketone body level J:87372
increased circulating triglyceride level J:87372
increased fatty acids level J:87372
increased liver triglyceride level J:87372
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv) 		abnormal triglyceride level J:220343
decreased circulating triglyceride level J:220343
Cd36tm2.1Mfe/Cd36tm2.1Mfe
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk) 		decreased cardiac muscle triglyceride level J:225392
decreased fatty acid oxidation J:225392
decreased fatty acids level J:225392
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lipid level J:108938
decreased cholesterol level J:108938
Cdc20bem1(IMPC)Wtsi/Cdc20bem1(IMPC)Wtsi
(C57BL/6N-Cdc20bem1(IMPC)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Cdc42tm1b(EUCOMM)Hmgu/Cdc42+
(C57BL/6N-Cdc42tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cdca7lem1(IMPC)Mbp/Cdca7lem1(IMPC)Mbp
(C57BL/6NCrl-Cdca7lem1(IMPC)Mbp/Mmucd) 		increased circulating cholesterol level J:211773
Cdca8tm1a(KOMP)Wtsi/Cdca8+
(C57BL/6N-Cdca8tm1a(KOMP)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:175295
increased circulating LDL cholesterol level J:175295
Cdh9tm1b(KOMP)Wtsi/Cdh9tm1b(KOMP)Wtsi
(C57BL/6N-Cdh9tm1b(KOMP)Wtsi/Ics) 		increased circulating cholesterol level J:211773
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA) 		decreased circulating cholesterol level J:272566
decreased circulating triglyceride level J:272566
Cdk12em1(IMPC)Tcp/Cdk12+
(C57BL/6NCrl-Cdk12em1(IMPC)Tcp/Tcp) 		decreased circulating HDL cholesterol level J:211773
Cdk15tm1b(KOMP)Wtsi/Cdk15tm1b(KOMP)Wtsi
(B6N(Cg)-Cdk15tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj) 		decreased liver triglyceride level J:195460
decreased skeletal muscle triglyceride level J:195460
increased liver triglyceride level J:195460
increased skeletal muscle triglyceride level J:195460
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas) 		increased circulating cholesterol level J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		increased circulating cholesterol level J:118516
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv) 		increased circulating cholesterol level J:118516
Cdkn1btm1Kin/Cdkn1b+
Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J) 		hyperlipidemia J:96047
Cdkn1btm1Kin/Cdkn1btm1Kin
Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J) 		hyperlipidemia J:96047
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating triglyceride level J:181979
decreased fatty acid oxidation J:181979
increased skeletal muscle triglyceride level J:181979
Ceacam16tm1.1(KOMP)Wtsi/Ceacam16tm1.1(KOMP)Wtsi
(B6N(Cg)-Ceacam16tm1.1(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Ceacam23em1(IMPC)Wtsi/Ceacam23em1(IMPC)Wtsi
(C57BL/6N-Ceacam23em1(IMPC)Wtsi/WtsiOulu) 		increased circulating HDL cholesterol level J:211773
Cebpam4443Dajl/Cebpam4443Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR) 		increased circulating cholesterol level J:149088
increased circulating HDL cholesterol level J:149088
increased circulating LDL cholesterol level J:149088
increased circulating triglyceride level J:149088
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal lipid homeostasis J:93579
decreased circulating cholesterol level J:93579
decreased circulating HDL cholesterol level J:93579
decreased circulating LDL cholesterol level J:93579
decreased liver cholesterol level J:93579
decreased liver triglyceride level J:93579
increased circulating free fatty acids level J:93579
increased circulating VLDL cholesterol level J:93579
Cebpatm1Gonz/Cebpatm1Gonz
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N) 		increased circulating free fatty acids level J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:89611, J:35795
Cebpatm1Timc/Cebpatm1Timc
(Not Specified) 		increased circulating triglyceride level J:163725
Cebpatm5Nerl/Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:120098
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1) 		abnormal circulating free fatty acids level J:52286
abnormal lipid homeostasis J:62132, J:52286
decreased circulating free fatty acids level J:62132, J:52286
decreased circulating triglyceride level J:52286
increased circulating corticosterone level J:52286
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6) 		decreased triglyceride level J:117502
increased circulating triglyceride level J:117502
Celtm1Dyh/Celtm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal intestinal lipid absorption J:124658
Celtm1Dyh/Celtm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal intestinal lipid absorption J:32099
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal intestinal lipid absorption J:124658
decreased circulating cholesterol level J:124658
decreased intestinal cholesterol absorption J:124658
Celtm1Eaf/Celtm1Eaf
(involves: 129S4/SvJae) 		abnormal intestinal lipid absorption J:54090
Celf4tm1a(EUCOMM)Wtsi/Celf4+
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Cenphtm1b(EUCOMM)Hmgu/Cenph+
(C57BL/6N-Cenphtm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating HDL cholesterol level J:211773
Cenpotm1b(KOMP)Mbp/Cenpo+
(B6N(Cg)-Cenpotm1b(KOMP)Mbp/J) 		decreased circulating cholesterol level J:211773
decreased circulating free fatty acids level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac) 		increased circulating triglyceride level J:206667
Cerktm1Fbor/Cerktm1Fbor
(involves: BALB/c) 		abnormal ceramide level J:137892
Cers1fln/Cers1fln
(NOD.Cg-Cers1fln/Sz) 		abnormal lipid homeostasis J:172719
abnormal lipid level J:172719
Cers1tm1.1Kwi/Cers1tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:193419
abnormal lipid level J:193419
Cers2Gt(S16-4B1)Sor/Cers2Gt(S16-4B1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal lipid homeostasis J:156841
Cers3tm1.1Rsnd/Cers3tm1.1Rsnd
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid level J:179754
Cers4tm1.1Kwi/Cers4tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal ceramide level J:213606
abnormal sphingomyelin level J:213606
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N) 		abnormal ceramide level J:215519
increased fatty acid oxidation J:215519
Cers6tm1.1Kwi/Cers6tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:201327
Cers6tm1Arte/Cers6tm1Arte
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6N * FVB/N) 		abnormal ceramide level J:215519
Cert1Gt(RRF047)Byg/Cert1Gt(RRF047)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:146172
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac) 		abnormal circulating lipid level J:158743
decreased circulating cholesterol level J:158743
decreased circulating free fatty acids level J:158743
decreased circulating glycerol level J:158743
decreased circulating triglyceride level J:158743
decreased circulating VLDL cholesterol level J:158743
decreased circulating VLDL triglyceride level J:158743
decreased liver triglyceride level J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6) 		abnormal lipid homeostasis J:262803
decreased saturated fatty acids level J:262803
hyperlipidemia J:262803
increased circulating cholesterol level J:262803
increased circulating free fatty acids level J:262803
increased circulating phospholipid level J:262803
increased circulating triglyceride level J:262803
increased circulating VLDL cholesterol level J:262803
increased circulating VLDL triglyceride level J:262803
increased liver cholesterol level J:262803
increased liver triglyceride level J:262803
increased unsaturated fatty acids level J:262803
Ces2atm1(KOMP)Vlcg/Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg) 		decreased circulating triglyceride level J:335459
increased ceramide level J:335459
increased cholesterol level J:335459
increased liver cholesterol level J:335459
increased liver triglyceride level J:335459
Ces3bem1(IMPC)J/Ces3bem1(IMPC)J
(C57BL/6NJ-Ces3bem1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Cfap119tm1b(EUCOMM)Hmgu/Cfap119tm1b(EUCOMM)Hmgu
(C57BL/6N-Cfap119tm1b(EUCOMM)Hmgu/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J) 		abnormal phospholipid level J:58571
Chab1AKR/J/Chab1AKR/J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab1AKR/J/Chab1DBA/2J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab2AKR/J/Chab2AKR/J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab2AKR/J/Chab2DBA/2J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab3AKR/J/Chab3AKR/J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab3AKR/J/Chab3DBA/2J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab4AKR/J/Chab4AKR/J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab4AKR/J/Chab4DBA/2J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab5AKR/J/Chab5AKR/J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab5AKR/J/Chab5DBA/2J
(involves: AKR/J * DBA/2J) 		increased intestinal cholesterol absorption J:72737
Chab6129P3/J/Chab6SJL/J
(involves: 129P3/J * SJL/J) 		decreased intestinal cholesterol absorption J:72737
Chab6SJL/J/Chab6SJL/J
(involves: 129P3/J * SJL/J) 		decreased intestinal cholesterol absorption J:72737
Chab7129P3/J/Chab7SJL/J
(involves: 129P3/J * SJL/J) 		decreased intestinal cholesterol absorption J:72737
Chab7SJL/J/Chab7SJL/J
(involves: 129P3/J * SJL/J) 		decreased intestinal cholesterol absorption J:72737
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		lipidosis J:146743
Chd6em1(IMPC)Mbp/Chd6em1(IMPC)Mbp
(C57BL/6N-Chd6em1(IMPC)Mbp/MbpMmucd) 		abnormal cholesterol homeostasis J:211773
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi) 		abnormal circulating lipid level J:330596
decreased circulating cholesterol level J:330596
decreased circulating free fatty acids level J:330596
decreased circulating glycerol level J:330596
decreased circulating triglyceride level J:330596
Chgatm1Skmt/Chgatm1Skmt
(involves: 129S1/Sv * C57BL/6J) 		abnormal corticosterone level J:99805
ChkaGt(XH252)Byg/Chka+
(involves: 129P2/OlaHsd * C57BL/6) 		increased liver triglyceride level J:130726
Chkbrmd/Chkbrmd
(involves: BALB/cByJ * C57BL/6J) 		abnormal lipid level J:108320
Chldq1MRL/MpJ/Chldq1MRL/MpJ
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq1MRL/MpJ/Chldq1SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq2MRL/MpJ/Chldq2MRL/MpJ
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq2MRL/MpJ/Chldq2SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq3MRL/MpJ/Chldq3MRL/MpJ
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033, J:123776
increased circulating HDL cholesterol level J:106033, J:123776
Chldq3MRL/MpJ/Chldq3SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq4MRL/MpJ/Chldq4MRL/MpJ
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq4MRL/MpJ/Chldq4SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating cholesterol level J:106033
increased circulating HDL cholesterol level J:106033
Chldq7NZB/BlNJ/Chldq7NZB/BlNJ
(involves: NZB/BlNJ * RF/J) 		increased circulating HDL cholesterol level J:123776
Chldq7NZB/BlNJ/Chldq7RF/J
(involves: NZB/BlNJ * RF/J) 		increased circulating HDL cholesterol level J:123776
Chldq9NZB/BlNJ/Chldq9RF/J
(involves: NZB/BlNJ * RF/J) 		decreased circulating HDL cholesterol level J:123776
Chldq9RF/J/Chldq9RF/J
(involves: NZB/BlNJ * RF/J) 		decreased circulating HDL cholesterol level J:123776
Chldq12NZB/BlNJ/Chldq12NZB/BlNJ
(involves: NZB/BlNJ * RF/J) 		increased circulating cholesterol level J:123776
increased circulating HDL cholesterol level J:123776
Chldq12NZB/BlNJ/Chldq12RF/J
(involves: NZB/BlNJ * RF/J) 		increased circulating cholesterol level J:123776
increased circulating HDL cholesterol level J:123776
Chlq1DBA/2J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J) 		abnormal circulating corticosterone level J:104331
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Chohd2/Chohd2+
(C3HeB/FeJ-Chohd2/Ieg) 		increased circulating cholesterol level J:94145
Chohd3/Chohd3+
(C3HeB/FeJ-Chohd3/Ieg) 		increased circulating cholesterol level J:94145
Chohd4/Chohd4+
(C3HeB/FeJ-Chohd4/Ieg) 		increased circulating cholesterol level J:94145
Chohd5/Chohd5+
(C3HeB/FeJ-Chohd5/Ieg) 		increased circulating cholesterol level J:94145
increased circulating HDL cholesterol level J:94145
increased circulating LDL cholesterol level J:94145
Chohd6/Chohd6+
(C3HeB/FeJ-Chohd6/Ieg) 		increased circulating cholesterol level J:94145
increased circulating HDL cholesterol level J:94145
increased circulating LDL cholesterol level J:94145
chohr1/chohr1
(C3HeB/FeJ-chohr1/Ieg) 		increased circulating cholesterol level J:94145
increased circulating HDL cholesterol level J:94145
chohr2/chohr2
(C3HeB/FeJ-chohr2/Ieg) 		increased circulating cholesterol level J:94145
increased circulating HDL cholesterol level J:94145
increased circulating LDL cholesterol level J:94145
chohr3/chohr3
(C3HeB/FeJ-chohr3/Ieg) 		increased circulating cholesterol level J:94145
increased circulating HDL cholesterol level J:94145
increased circulating LDL cholesterol level J:94145
Chol6CAST/Ei/Chol6CAST/Ei
(involves: CAST/Ei * DBA/2J) 		abnormal circulating cholesterol level J:83460
increased circulating cholesterol level J:83460
Chol7129S1/SvImJ/Chol7129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating cholesterol level J:88732
Chol7129S1/SvImJ/Chol7CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating cholesterol level J:88732
Chol8129S1/SvImJ/Chol8CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating cholesterol level J:88732
Chol8CAST/Ei/Chol8CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating cholesterol level J:88732
Chol9129S1/SvImJ/Chol9CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating cholesterol level J:88732
Chol9CAST/Ei/Chol9CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating cholesterol level J:88732
Chol10129S1/SvImJ/Chol10129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating cholesterol level J:89282
Chol10129S1/SvImJ/Chol10RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating cholesterol level J:89282
Chol11129S1/SvImJ/Chol11129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating cholesterol level J:89282
Chol11129S1/SvImJ/Chol11RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating cholesterol level J:89282
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating triglyceride level J:67919
Chrna7tm1b(EUCOMM)Hmgu/Chrna7tm1b(EUCOMM)Hmgu
(C57BL/6N-Chrna7tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Chuktm1Mpa/Chuktm1Mpa
Tg(KRT14-cre)1Cgn/?
(involves: C57BL/6) 		decreased circulating free fatty acids level J:122320
increased cholesterol level J:122320
CiartGt(IST11761C7)Tigm/CiartGt(IST11761C7)Tigm
(C57BL/6-CiartGt(IST11761C7)Tigm) 		increased circulating corticosterone level J:209571
Cib2tm1b(EUCOMM)Wtsi/Cib2tm1b(EUCOMM)Wtsi
(C57BL/6N-Cib2tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glycerol level J:211773
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ) 		abnormal lipid homeostasis J:85229
decreased circulating triglyceride level J:85229
decreased fatty acids level J:85229
Cidebtm1Pli/Cidebtm1Pli
(Not Specified) 		decreased circulating free fatty acids level J:126556
decreased circulating triglyceride level J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel) 		abnormal circulating lipid level J:226899
increased circulating free fatty acids level J:226899
increased circulating triglyceride level J:226899
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg) 		increased circulating cholesterol level J:211773
Cidectm1Pli/Cidectm1Pli
(Not Specified) 		decreased circulating free fatty acids level J:140122
decreased circulating ketone body level J:140122
decreased circulating triglyceride level J:140122
Cidectm1Pli/Cidectm1Pli
Lepob/Lepob
(involves: C57BL/10J) 		decreased circulating free fatty acids level J:140122
decreased circulating triglyceride level J:140122
Cisd1em1(IMPC)Hmgu/Cisd1em1(IMPC)Hmgu
(C57BL/6N-Cisd1em1(IMPC)Hmgu/Ieg) 		decreased circulating triglyceride level J:211773
Cisd2tm1a(EUCOMM)Wtsi/Cisd2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cisd2tm1a(EUCOMM)Wtsi/H) 		decreased circulating triglyceride level J:165965
Clcn1em1(IMPC)Mbp/Clcn1em1(IMPC)Mbp
(C57BL/6NCrl-Clcn1em1(IMPC)Mbp/MbpMmucd) 		abnormal cholesterol homeostasis J:211773
decreased circulating HDL cholesterol level J:211773
Clcn2em1Uis/Clcn2+
(C57BL/6N-Clcn2em1Uis) 		increased circulating aldosterone level J:282228
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd) 		abnormal cholesterol homeostasis J:211773
increased circulating cholesterol level J:211773
Cldn4tm1.1Jhou/Cldn4tm1.1Jhou
Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek) 		increased circulating aldosterone level J:216399
Cldn7tm1Yche/Cldn7tm1Yche
(involves: C57BL/6) 		increased circulating aldosterone level J:155363
Cldn8tm1.1Jhou/Cldn8tm1.1Jhou
Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn8tm1.1Jhou Tg(Aqp2-cre)1Dek) 		increased circulating aldosterone level J:220813
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg) 		abnormal circulating non-HDL cholesterol level J:279934
decreased circulating free fatty acids level J:279934
decreased circulating triglyceride level J:279934
Cldn16tm1.1Dmu/Cldn16tm1.1Dmu
(involves: 129 * BALB/cJ * C57BL/6) 		abnormal vitamin D level J:159706
Cldn19tm1.1(KOMP)Vlcg/Cldn19tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn19tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Cldn23em1(IMPC)J/Cldn23em1(IMPC)J
(C57BL/6NJ-Cldn23em1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Cldnd2tm1b(EUCOMM)Hmgu/Cldnd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cldnd2tm1b(EUCOMM)Hmgu/Orl) 		abnormal cholesterol homeostasis J:211773
Clk2tm1.1Ppgr/Clk2tm1.1Ppgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6NTac * FVB/N) 		abnormal fatty acid oxidation J:229283
decreased liver triglyceride level J:229283
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz) 		increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt) 		decreased circulating corticosterone level J:98343
increased circulating cholesterol level J:98343
increased circulating triglyceride level J:98343
Clockm1Jt/Clockm1Jt
(involves: C57BL/6) 		abnormal lipid homeostasis J:131694
Clockm1Jt/Clockm1Jt
(C57BL/6J-Clockm1Jt/J) 		abnormal intestinal lipid absorption J:153782
Clockm1Jt/Clockm1Jt
Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR) 		increased circulating cholesterol level J:135847
increased circulating free fatty acids level J:135847
increased circulating triglyceride level J:135847
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating glycerol level J:211773
Clpstm1Lowe/Clpstm1Lowe
(involves: 129S6/SvEvTac * Black Swiss) 		decreased circulating triglyceride level J:75167
increased circulating cholesterol level J:75167
steatorrhea J:75167
Clpstm2.1Lowe/Clpstm2.1Lowe
(B6.129X1-Clpstm2.1Lowe) 		decreased circulating HDL cholesterol level J:159587
increased circulating cholesterol level J:159587
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6) 		increased circulating ketone body level J:148522
Cmklr2tm1.1Dgen/Cmklr2tm1.1Dgen
(involves: C57BL/6J) 		increased circulating LDL cholesterol level J:273922
Cmpk2tm1b(KOMP)Wtsi/Cmpk2tm1b(KOMP)Wtsi
(C57BL/6N-Cmpk2tm1b(KOMP)Wtsi/H) 		increased circulating cholesterol level J:211773
Cnot3em1(IMPC)Rbrc/Cnot3+
(C57BL/6NJcl-Cnot3em1(IMPC)Rbrc/Rbrc) 		decreased circulating triglyceride level J:211773
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya) 		decreased circulating triglyceride level J:180033
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya) 		abnormal circulating lipid level J:274297
increased circulating ketone body level J:274297
Cnpy2tm1.2Zhli/Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli) 		decreased circulating triglyceride level J:277868
Cnr1tm1Zim/Cnr1tm1Zim
(involves: 129 * C57BL/6J) 		increased circulating corticosterone level J:144423
Cog2tm1a(KOMP)Wtsi/Cog2+
(B6JTyr;B6N-Cog2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating triglyceride level J:175295
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		increased triglyceride level J:187378
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		increased bile salt level J:217463
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased liver triglyceride level J:210545
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased circulating cholesterol level J:213764
decreased liver triglyceride level J:210545
increased bile salt level J:213764
increased circulating cholesterol level J:210545
increased circulating triglyceride level J:210545
Col1a1tm4(tetO-Jun/Fosl2)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		decreased liver triglyceride level J:210545
Col4a5tm1b(EUCOMM)Wtsi/Y
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm) 		increased circulating cholesterol level J:211773
increased circulating triglyceride level J:211773
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Col6a3em1(IMPC)Kmpc/Col6a3em1(IMPC)Kmpc
(C57BL/6NTac-Col6a3em1(IMPC)Kmpc/Kmpc) 		increased circulating LDL cholesterol level J:211773
Col9a2tm1b(EUCOMM)Wtsi/Col9a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col9a2tm1b(EUCOMM)Wtsi/H) 		increased circulating triglyceride level J:211773
Col9a3em1(IMPC)Tcp/Col9a3em1(IMPC)Tcp
(C57BL/6N-Col9a3em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Col11a2tm1b(KOMP)Wtsi/Col11a2+
(C57BL/6N-Col11a2tm1b(KOMP)Wtsi/Ieg) 		decreased circulating triglyceride level J:211773
Col18a1tm1.1(KOMP)Vlcg/Col18a1tm1.1(KOMP)Vlcg
(B6N(Cg)-Col18a1tm1.1(KOMP)Vlcg/J) 		decreased circulating HDL cholesterol level J:211773
increased circulating free fatty acids level J:211773
increased circulating triglyceride level J:211773
Col18a1tm1Hms/Col18a1tm1Hms
(B6.129S4-Col18a1tm1Hms) 		increased circulating triglyceride level J:167008
increased circulating VLDL triglyceride level J:167008
Colec10em2(IMPC)Tcp/Colec10em2(IMPC)Tcp
(C57BL/6NCrl-Colec10em2(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Copg1tm1a(EUCOMM)Wtsi/Copg1+
(C57BL/6N-Copg1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N) 		hyperlipidemia J:249129
Cptm1Samd/Cptm1Samd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:78092
Cptm1Yos/Cptm1Yos
(C.129P2-Cptm1Yos) 		abnormal lipid homeostasis J:142713
Cpdem1(IMPC)J/Cpd+
(C57BL/6NJ-Cpdem1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J) 		increased circulating cholesterol level J:19043, J:18161
increased circulating HDL cholesterol level J:19043, J:18161
increased circulating LDL cholesterol level J:19043
increased circulating triglyceride level J:19043
increased circulating VLDL cholesterol level J:19043
Cpefat/Cpefat
Find2C57BLKS/J/Find2C57BLKS/J
(involves: C57BLKS/J * HRS/J) 		increased circulating cholesterol level J:100832
Cpgi5563tm1.1(NCC)Wcs/Cpgi5563tm1.1(NCC)Wcs
(C57BL/6N-Cpgi5563tm1.1(NCC)Wcs/Wtsi) 		decreased circulating cholesterol level J:277622
decreased circulating triglyceride level J:277622
Cpne1em1(IMPC)Kmpc/Cpne1em1(IMPC)Kmpc
(C57BL/6NTac-Cpne1em1(IMPC)Kmpc/Kmpc) 		abnormal cholesterol homeostasis J:211773
Cps1em1(IMPC)H/Cps1+
(C57BL/6NTac-Cps1em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cpt1atm1Pwo/Cpt1a+
(either: 129S6/SvEvTac-Cpt1atm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac)) 		increased circulating free fatty acids level J:101934
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:148205
Cpt1ctm1Fghe/Cpt1ctm1Fghe
(B6.129S-Cpt1ctm1Fghe) 		abnormal lipid level J:186508
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6) 		hyperlipidemia J:109455
increased circulating triglyceride level J:109455
Cq1C57BL/6J/Cq1C57BL/6J
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:54322
Cq1KK/Cq1C57BL/6J
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:54322
Cq1KK/Cq1KK
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:54322
Cq2KK/Cq2C57BL/6J
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:54322
Cq2KK/Cq2KK
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:54322
Cq2KK/Cq2KK
Cq3C57BL/6J/Cq3C57BL/6J
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:108417
Cq3C57BL/6J/?
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:108417
Cq4C57BL/6J/Cq4KK-A(y)
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:87328
Cq4KK-A(y)/Cq4KK-A(y)
(involves: C57BL/6J * KK-Ay) 		increased circulating cholesterol level J:87328
Cq5KK-A(y)/Cq5KK-A(y)
(involves: KK-Ay * RR) 		increased circulating cholesterol level J:87328
Cq6C57BL/6J/Cq6RR
(involves: C57BL/6J * RR) 		increased circulating cholesterol level J:94251
Cq6RR/Cq6RR
(involves: C57BL/6J * RR) 		increased circulating cholesterol level J:94251
Cracdltm1b(KOMP)Wtsi/Cracdltm1b(KOMP)Wtsi
(C57BL/6N-Cracdltm1b(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Crattm1.1Pbrc/Crattm1.1Pbrc
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB) 		decreased circulating free fatty acids level J:184778
decreased circulating triglyceride level J:184778
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp) 		decreased circulating free fatty acids level J:208570
decreased liver triglyceride level J:208570
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac) 		abnormal lipid level J:345514
abnormal phospholipid level J:345514
decreased liver triglyceride level J:345514
decreased skeletal muscle triglyceride level J:345514
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA) 		decreased circulating free fatty acids level J:75361
decreased triglyceride level J:75361
CrebrfGt(YHD319)Byg/CrebrfGt(YHD319)Byg
(B6.129P2-CrebrfGt(YHD319)Byg) 		decreased circulating corticosterone level J:192857
Creg1em1Yal/Creg1em1Yal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal lipid homeostasis J:263073
increased liver cholesterol level J:263073
increased liver free fatty acids level J:263073
Creld2tm1.1Emass/Creld2tm1.1Emass
(B6.129P2(SJL)-Creld2tm1.1Emass) 		increased ceramide level J:316411
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J) 		abnormal corticosterone level J:208708
increased circulating cholesterol level J:208708
increased circulating corticosterone level J:208708
increased circulating triglyceride level J:208708
increased urine corticosterone level J:208708
Crhtm1Maj/Crh+
Tg(MECP2)1Hzo/0
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal corticosterone level J:181213
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J) 		abnormal circulating corticosterone level J:23082
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating corticosterone level J:90690, J:72196, J:102987, J:105629, J:54256
decreased circulating corticosterone level J:105629
Crhtm2.1Maj/Crhtm2.1Maj
Tg(Sim1-cre)1Lowl/?
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased circulating corticosterone level J:238330
Crhtm2.2Maj/Crhtm2.2Maj
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased circulating corticosterone level J:238330
Crhr1tm1Jde/Crhr1tm1Jde
(involves: 129S2/SvPas * C57BL/6J) 		abnormal corticosterone level J:176339
Crhr1tm2.3Jde/Crhr1tm2.3Jde
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac) 		decreased circulating corticosterone level J:187372
Crhr1tm2Jde/Crhr1tm2Jde
(involves: 129S2/SvPas * C57BL/6) 		decreased circulating corticosterone level J:187372
Crhr1tm2Wrst/Crhr1tm2Wrst
Tg(Camk2a-cre)159Kln/0
(involves: 129S2/SvPas * C57BL/6) 		increased circulating corticosterone level J:85745
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating cholesterol level J:83683
decreased circulating free fatty acids level J:83683
decreased circulating triglyceride level J:83683
Crispld2tm1.1(KOMP)Vlcg/Crispld2+
(C57BL/6N-Crispld2tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating triglyceride level J:211773
Crptm1Hjf/Crptm1Hjf
Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crptm1Hjf Ldlrtm1Her) 		decreased circulating LDL cholesterol level J:170409
decreased circulating VLDL cholesterol level J:170409
increased circulating cholesterol level J:170409
increased circulating triglyceride level J:170409
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating triglyceride level J:142448
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N) 		decreased circulating corticosterone level J:151618
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating free fatty acids level J:167211
Crygstm1b(KOMP)Wtsi/Crygstm1b(KOMP)Wtsi
(B6N(Cg)-Crygstm1b(KOMP)Wtsi/2J) 		increased circulating HDL cholesterol level J:211773
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg) 		abnormal lipid level J:102499
increased circulating free fatty acids level J:102499
increased circulating triglyceride level J:102499
Csf2raem1Szut/Csf2raem1Szut
(C57BL/6-Csf2raem1Szut) 		increased cholesterol level J:322934
Csmd3em1(IMPC)Mbp/Csmd3em1(IMPC)Mbp
(C57BL/6NCrl-Csmd3em1(IMPC)Mbp/Mmucd) 		decreased circulating HDL cholesterol level J:211773
Csnk1g3tm1a(EUCOMM)Wtsi/Csnk1g3tm1a(EUCOMM)Wtsi
(C57BL/6N-Csnk1g3tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd) 		decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ) 		increased circulating cholesterol level J:184220
increased circulating HDL cholesterol level J:184220
increased circulating LDL cholesterol level J:184220
Cstbtm1b(EUCOMM)Wtsi/Cstbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cstbtm1b(EUCOMM)Wtsi/Orl) 		increased circulating triglyceride level J:211773
Cstf1em1(IMPC)J/Cstf1+
(C57BL/6NJ-Cstf1em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Ct45atm1e(KOMP)Wtsi/Y
(C57BL/6N-Ct45atm1e(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Ct45atm1e(KOMP)Wtsi/Ct45atm1e(KOMP)Wtsi
(C57BL/6N-Ct45atm1e(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd) 		decreased circulating free fatty acids level J:176727
increased circulating cholesterol level J:176727
Cthtm1Iish/Cthtm1Iish
(B6.129-Cthtm1Iish/Iish) 		increased circulating triglyceride level J:166184
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Ctsstm1Hap/Ctsstm1Hap
Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Ctsstm1Hap Ldlrtm1Her) 		decreased circulating cholesterol level J:82520
decreased circulating LDL cholesterol level J:82520
Cul3tm1.1Arte/Cul3+
(involves: C57BL/6J * C57BL/6N) 		increased circulating aldosterone level J:229424
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs
Ldlrtm1Her/Ldlr+
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J) 		decreased circulating cholesterol level J:95279
decreased circulating LDL cholesterol level J:95279
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs
Ldlrtm1Her/Ldlrtm1Her
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J) 		decreased circulating cholesterol level J:95279
decreased circulating LDL cholesterol level J:95279
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA) 		decreased circulating cholesterol level J:126841
decreased liver triglyceride level J:126841
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN) 		hyperlipidemia J:91486
Cyb561tm1a(EUCOMM)Wtsi/Cyb561tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cyb561tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H) 		increased circulating triglyceride level J:211773
Cybbtm1.1Abk/Cybbtm1.1Abk
Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk) 		decreased cholesterol level J:245699
decreased circulating LDL cholesterol level J:245699
decreased triglyceride level J:245699
increased circulating HDL cholesterol level J:245699
Cybrd1tm1b(EUCOMM)Hmgu/Cybrd1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cybrd1tm1b(EUCOMM)Hmgu/H) 		increased circulating HDL cholesterol level J:211773
Cygbtm1b(EUCOMM)Wtsi/Cygbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cygbtm1b(EUCOMM)Wtsi/Tcp) 		decreased circulating cholesterol level J:211773
Cyp2a12em1Utr/Cyp2a12em1Utr
(C57BL/6J-Cyp2a12em1Utr) 		abnormal bile salt homeostasis J:302190
decreased intestinal cholesterol absorption J:302190
Cyp2a12em1Utr/Cyp2a12em1Utr
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2a12em1Utr Cyp2c70em1Utr) 		abnormal bile salt homeostasis J:302190
abnormal cholesterol homeostasis J:302190
decreased bile salt level J:302190
decreased circulating cholesterol level J:302190
decreased feces bile salt level J:302190
decreased intestinal cholesterol absorption J:302190
Cyp2b10tm1a(KOMP)Wtsi/Cyp2b10tm1a(KOMP)Wtsi
(C57BL/6N-Cyp2b10tm1a(KOMP)Wtsi) 		abnormal lipid oxidation J:339440
Cyp2c23Gt(OST85045)Lex/Cyp2c23Gt(OST85045)Lex
(129-Cyp2c23Gt(OST85045)Lex) 		decreased circulating aldosterone level J:204734
Cyp2c23tm1b(EUCOMM)Hmgu/Cyp2c23tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp2c23tm1b(EUCOMM)Hmgu/J) 		increased circulating cholesterol level J:211773
Cyp2c70em1Sjka/Cyp2c70em1Sjka
(C57BL/6-Cyp2c70em1Sjka) 		abnormal bile salt homeostasis J:330641
increased bile salt level J:330641
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr) 		abnormal bile salt homeostasis J:302190
decreased bile salt level J:302190
decreased feces bile salt level J:302190
decreased intestinal cholesterol absorption J:302190
increased circulating cholesterol level J:302190
increased liver cholesterol level J:302190
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte) 		decreased circulating cholesterol level J:241121
decreased circulating HDL cholesterol level J:241121
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1+
(involves: C57BL/6NTac) 		abnormal vitamin D level J:223194
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal vitamin D level J:223194
Cyp4a14tm1Jhc/Cyp4a14tm1Jhc
(involves: 129S6/SvEvTac * 129X1/SvJ) 		abnormal lipid homeostasis J:77631
Cyp4b1tm1b(KOMP)Wtsi/Cyp4b1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4b1tm1b(KOMP)Wtsi/Ieg) 		decreased circulating triglyceride level J:211773
Cyp4f18tm1.1Pchr/Cyp4f18tm1.1Pchr
(B6.Cg-Cyp4f18tm1.1Pchr) 		abnormal fatty acid oxidation J:212489
decreased leukotriene level J:212489
Cyp4f39em1Akih/Cyp4f39em1Akih
(C57BL/6J-Cyp4f39em1Akih) 		decreased ceramide level J:286705
Cyp4v3tm1(KOMP)Vlcg/Cyp4v3tm1(KOMP)Vlcg
(B6(Cg)-Cyp4v3tm1(KOMP)Vlcg) 		abnormal fatty acids level J:230232
Cyp7a1tm1b(EUCOMM)Wtsi/Cyp7a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7a1tm1b(EUCOMM)Wtsi/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cyp7a1tm1Rus/Cyp7a1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal bile salt homeostasis J:34342
abnormal bile salt level J:34870
abnormal lipid homeostasis J:34870
decreased intestinal cholesterol absorption J:114411
steatorrhea J:34342
Cyp7b1tm1Rus/Cyp7b1tm1Rus
(involves: 129S/SvEv * C57BL/6J) 		abnormal cholesterol homeostasis J:62589, J:62587
Cyp8b1tm1Rus/Cyp8b1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal bile salt homeostasis J:100246, J:100206
abnormal bile salt level J:100206
abnormal lipid homeostasis J:100206
decreased circulating cholesterol level J:100246
decreased intestinal cholesterol absorption J:100206
steatorrhea J:100206
Cyp11a1tm1.1Bcc/Cyp11a1tm1.1Bcc
(B6.129(FVB)-Cyp11a1tm1.1Bcc) 		abnormal corticosterone level J:191801
Cyp11a1tm1Bcc/Cyp11a1tm1Bcc
(involves: 129 * C57BL/6) 		abnormal lipid level J:78062
decreased circulating aldosterone level J:78062
decreased circulating corticosterone level J:78062
Cyp11a1tm2Bcc/Cyp11a1tm2Bcc
(Not Specified) 		decreased circulating corticosterone level J:133007
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating corticosterone level J:147610
decreased urine corticosterone level J:147610
Cyp11b2tm1Hsk/Cyp11b2tm1Hsk
(involves: 129S6/SvEvTac) 		decreased circulating aldosterone level J:99269
increased circulating corticosterone level J:99269
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac) 		increased circulating cholesterol level J:65805
increased circulating HDL cholesterol level J:65805
increased circulating triglyceride level J:65805
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:79603
increased circulating cholesterol level J:82070
increased circulating triglyceride level J:82070
Cyp24a1tm1Star/Cyp24a1tm1Star
(involves: 129S4/SvJae) 		abnormal vitamin D level J:63457
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J) 		abnormal bile salt homeostasis J:115373
abnormal circulating cholesterol level J:48127
abnormal feces lipid level J:115373
decreased bile salt level J:115373
decreased feces bile salt level J:115373
decreased intestinal cholesterol absorption J:115373
decreased lung cholesterol level J:115373
increased cholesterol level J:115373, J:48127
increased circulating cholesterol level J:115373
increased circulating triglyceride level J:115373
increased circulating VLDL cholesterol level J:115373
increased circulating VLDL triglyceride level J:115373
increased fatty acids level J:115373
increased liver triglyceride level J:115373
increased sterol level J:115373
increased vitamin D level J:48127
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(B6.129-Cyp27a1tm1Elt/J) 		abnormal vitamin D level J:223194
Cyp27a1tm1Elt/Cyp27a1tm1Elt
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		abnormal vitamin D level J:223194
Cyp46a1tm1Rus/Cyp46a1tm1Rus
(involves: 129 * C57BL/6J) 		abnormal cholesterol homeostasis J:84116
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C57BL/6-Cysltr2tm1Ykn) 		abnormal prostaglandin level J:94488
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi) 		abnormal bile salt homeostasis J:272118
abnormal feces lipid level J:272118
decreased circulating triglyceride level J:272118
decreased liver triglyceride level J:272118
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp) 		decreased circulating triglyceride level J:211773
Dab2tm2.1Xxx/Dab2tm2.2Xxx
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating cholesterol level J:205046
increased circulating LDL cholesterol level J:205046
Daglatm1Pado/Daglatm1Pado
(C57BL/6-Daglatm1Pado) 		abnormal lipid level J:157850
DaglbGt(OST195261)Lex/DaglbGt(OST195261)Lex
(B6.129S5-DaglbGt(OST195261)Lex) 		abnormal lipid level J:157850
Daptm1a(KOMP)Mbp/Daptm1a(KOMP)Mbp
(C57BL/6N-Daptm1a(KOMP)Mbp/Wtsi) 		increased circulating free fatty acids level J:211773
Dars2tm1a(KOMP)Wtsi/Dars2+
(C57BL/6N-Dars2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Dbhtm1Rpa/Dbhtm1Rpa
(either: (involves: 129S7/SvEvBrd * 129/SvCpj) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		increased circulating corticosterone level J:97566
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J) 		increased circulating corticosterone level J:85772
Dbitm1Smdp/Dbitm1Smdp
(B6JBomTac.129-Dbitm1Smdp) 		abnormal cholesterol homeostasis J:168744
increased circulating cholesterol level J:168744
increased liver cholesterol level J:168744
increased liver triglyceride level J:168744
Dbitm1Smdp/Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ) 		increased liver cholesterol level J:204137
increased liver triglyceride level J:204137
Dbitm2.1Smdp/Dbitm2.2Smdp
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased liver cholesterol level J:204137
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Bay) 		decreased circulating cholesterol level J:211773
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas) 		decreased circulating aldosterone level J:164398
Dctn4em1(IMPC)Wtsi/Dctn4+
(C57BL/6N-Dctn4em1(IMPC)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Ddctm1.1Rhrs/Ddctm1.1Rhrs
Tg(Ggt1-cre)M3Egn/0
(involves: 129 * C57BL/6 * SJL) 		decreased circulating aldosterone level J:175630
Ddctm1.1Rhrs/Ddctm1.1Rhrs
Tg(Ggt1-cre)M3Egn/0
(129.Cg-Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn) 		decreased circulating aldosterone level J:175630
Ddhd2tm1Crv/Ddhd2tm1Crv
(involves: C57BL/6) 		abnormal lipid level J:216446
increased triglyceride level J:216446
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		increased cholesterol level J:214136
Ddx51tm1a(KOMP)Wtsi/Ddx51+
(C57BL/6N-Ddx51tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh) 		increased fatty acids level J:151622
Defb14tm1b(KOMP)Wtsi/Defb14tm1b(KOMP)Wtsi
(C57BL/6N-Defb14tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glycerol level J:211773
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd) 		abnormal ceramide level J:203554
Degs1Gt(OST368559)Lex/Degs1Gt(OST368559)Lex
(involves: 129S5/SvEvBrd) 		abnormal ceramide level J:203554
Degs2tm1Akih/Degs2tm1Akih
(Not Specified) 		decreased ceramide level J:335270
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129S/SvEv) 		abnormal vitamin D level J:133151
Del(6Slco1b2-Slco1a5)1Nki/+
(involves: 129P2/OlaHsd * C57BL/6) 		increased bile salt level J:163765
increased circulating HDL cholesterol level J:163765
increased circulating triglyceride level J:163765
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating free fatty acids level J:227939
Del(7Saa1-Saa2)1Itl/Del(7Saa1-Saa2)1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal cholesterol homeostasis J:165605
increased circulating cholesterol level J:165605
increased circulating phospholipid level J:165605
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:109005
decreased circulating HDL cholesterol level J:109005
decreased circulating triglyceride level J:109005
Del(11Irf1-D11Mit23)1Rub/+
(129/Sv-Del(11Irf1-D11Mit23)1Rub) 		increased circulating VLDL triglyceride level J:60187
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub) 		increased cardiac muscle triglyceride level J:60187
increased cholesterol level J:60187
increased circulating free fatty acids level J:60187
increased circulating triglyceride level J:60187
increased circulating VLDL triglyceride level J:60187
increased liver cholesterol level J:60187
increased liver triglyceride level J:60187
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal cholesterol homeostasis J:80679
decreased circulating cholesterol level J:80679
decreased liver cholesterol level J:80679
increased circulating cholesterol level J:80679
increased circulating phytosterol level J:80679
increased intestinal phytosterol absorption J:80679
increased liver cholesterol level J:80679
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA) 		abnormal circulating lipid level J:276600
decreased circulating HDL cholesterol level J:276600
decreased liver cholesterol level J:276600
decreased liver free fatty acids level J:276600
increased circulating VLDL triglyceride level J:276600
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver cholesterol level J:111346
decreased liver triglyceride level J:111346
Dgat1tm1Ryyo/Dgat1tm1Ryyo
(involves: C57BL/6) 		decreased circulating triglyceride level J:155626
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		abnormal lipid level J:88742
abnormal phospholipid level J:88742
decreased circulating free fatty acids level J:88742
decreased circulating triglyceride level J:88742
decreased fatty acids level J:88742
decreased liver triglyceride level J:88742
decreased triglyceride level J:88742
decreased unsaturated fatty acids level J:88742
DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak/DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak
(involves: C3H * C57BL/6 * DBA/2 * ICR) 		abnormal lipid level J:163104
Dgkiem1(IMPC)Wtsi/Dgkiem1(IMPC)Wtsi
(C57BL/6N-Dgkiem1(IMPC)Wtsi/Wtsi) 		increased circulating glycerol level J:295189, J:211773
Dgkkem1(IMPC)Ics/Y
(C57BL/6N-Dgkkem1(IMPC)Ics/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		increased circulating cholesterol level J:294620
Dhcr7tm1.1Sbpa/Dhcr7tm1.1Sbpa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Dhcr7tm1.1Sbpa Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal bile salt homeostasis J:303316
abnormal sterol level J:303316
decreased liver cholesterol level J:303316
increased bile salt level J:303316
Dhcr7tm1Fdp/Dhcr7tm1Fdp
(involves: 129S4/SvJae) 		abnormal cholesterol homeostasis J:68084, J:165301
decreased cholesterol level J:68084
Dhcr7tm1Fdp/Dhcr7tm2Fdp
(involves: 129S4/SvJae) 		abnormal cholesterol level J:106758
decreased cholesterol level J:106758
Dhcr7tm1Gst/Dhcr7tm1Gst
(involves: 129P2/OlaHsd) 		abnormal cholesterol homeostasis J:71611
abnormal lipid level J:71611
decreased brain cholesterol level J:71611
decreased liver cholesterol level J:71611
Dhcr7tm1Gst/Dhcr7tm1Gst
(B6.129P2-Dhcr7tm1Gst) 		decreased lung cholesterol level J:93296
decreased sterol level J:93296
increased circulating corticosterone level J:93296
Dhcr7tm1Gst/Dhcr7tm1Gst
Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N) 		decreased brain cholesterol level J:141730
decreased circulating cholesterol level J:141730
decreased liver cholesterol level J:141730
decreased lung cholesterol level J:141730
Dhcr7tm2Fdp/Dhcr7tm2Fdp
(involves: 129S4/SvJae) 		abnormal cholesterol level J:106758
decreased cholesterol level J:106758
Dhcr24tm1a(EUCOMM)Wtsi/Dhcr24+
(B6JTyr;B6N-Dhcr24tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating triglyceride level J:175295
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * C57BL/6N) 		abnormal sterol level J:304449
decreased circulating cholesterol level J:304449
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Dhcr24tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal sterol level J:304449
decreased liver cholesterol level J:304449
Dhcr24tm1Lex/Dhcr24tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal circulating cholesterol level J:87402
decreased circulating cholesterol level J:87402
Dhrs7bem1(IMPC)Mbp/Dhrs7b+
(C57BL/6NCrl-Dhrs7bem1(IMPC)Mbp/MbpMmucd) 		increased circulating HDL cholesterol level J:211773
Dhtkd1tm1Mmgu/Dhtkd1tm1Mmgu
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating cholesterol level J:288186
decreased circulating glycerol level J:288186
decreased circulating triglyceride level J:288186
increased circulating phospholipid level J:288186
Dhx30tm1.1(KOMP)Vlcg/Dhx30+
(C57BL/6N-Dhx30tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Dhx40tm1(NCOM)Cmhd/Dhx40tm1(NCOM)Cmhd
(C57BL/6N-Dhx40tm1(NCOM)Cmhd/Tcp) 		decreased circulating cholesterol level J:165965
Diaph3tm1b(KOMP)Mbp/Diaph3+
(C57BL/6N-Diaph3tm1b(KOMP)Mbp/J) 		decreased circulating free fatty acids level J:211773
decreased circulating triglyceride level J:211773
Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6) 		increased circulating cholesterol level J:328215
Dio1tm1Vag/Dio1tm1Vag
(involves: 129 * C57BL/6) 		decreased circulating cholesterol level J:104508
Dip2btm1a(EUCOMM)Wtsi/Dip2b+
(B6JTyr;B6N-Dip2btm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating free fatty acids level J:175295
Dkk3tm1Cni/Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6) 		increased circulating aldosterone level J:188335
Dkk3tm1Cni/Dkk3tm1Cni
Kcnk3tm1Sgb/Kcnk3tm1Sgb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating aldosterone level J:188335
Dlg4tm2.1Grnt/Dlg4tm2.1Grnt
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating corticosterone level J:175436
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J)) 		hyperlipidemia J:77909
increased circulating cholesterol level J:77909
Dll1m1Mhda/Dll1+
(C3HeB/FeJ-Dll1m1Mhda) 		decreased circulating cholesterol level J:150183
decreased circulating triglyceride level J:150183
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos) 		decreased circulating cholesterol level J:150183
decreased circulating triglyceride level J:150183
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH) 		decreased circulating cholesterol level J:211773
Dnajc2em1(IMPC)J/Dnajc2+
(C57BL/6NJ-Dnajc2em1(IMPC)J/Mmjax) 		increased circulating triglyceride level J:211773
Dnajc7tm1.2Neg/Dnajc7tm1.2Neg
(involves: 129S/SvEv * C57BL/6 * CBA) 		increased circulating cholesterol level J:225381
Dnajc9tm1.1(KOMP)Vlcg/Dnajc9+
(C57BL/6N-Dnajc9tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg) 		abnormal lipid homeostasis J:204025
decreased circulating free fatty acids level J:204025
decreased circulating triglyceride level J:204025
decreased liver cholesterol level J:204025
Dnase2btm1a(EUCOMM)Hmgu/Dnase2btm1a(EUCOMM)Hmgu
(C57BL/6N-Dnase2btm1a(EUCOMM)Hmgu/H) 		increased circulating HDL cholesterol level J:165965
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Dntttm2b(KOMP)Wtsi/Dntttm2b(KOMP)Wtsi
(C57BL/6N-Dntttm2b(KOMP)Wtsi/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Dock9em1(IMPC)J/Dock9em1(IMPC)J
(C57BL/6NJ-Dock9em1(IMPC)J/J) 		abnormal cholesterol homeostasis J:211773
Dop1btm1a(EUCOMM)Wtsi/Dop1btm1a(EUCOMM)Wtsi
(C57BL/6N-Dop1btm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating free fatty acids level J:211773
decreased circulating glycerol level J:211773
Dpp9tm1a(EUCOMM)Hmgu/Dpp9+
(C57BL/6N-Dpp9tm1a(EUCOMM)Hmgu/Cnrm) 		decreased circulating triglyceride level J:165965
Dpy19l3tm1a(EUCOMM)Wtsi/Dpy19l3tm1a(EUCOMM)Wtsi
(C57BL/6N-Dpy19l3tm1a(EUCOMM)Wtsi/Ics) 		decreased circulating free fatty acids level J:165965
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased circulating corticosterone level J:110599
Dsg1cem1(IMPC)Mbp/Dsg1cem1(IMPC)Mbp
(C57BL/6N-Dsg1cem1(IMPC)Mbp/Ucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Dtx1em1(IMPC)H/Dtx1em1(IMPC)H
(C57BL/6N-Dtx1em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		decreased circulating cholesterol level J:129718
decreased circulating free fatty acids level J:129718
decreased circulating triglyceride level J:129718
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased prostaglandin level J:126383
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi) 		increased circulating glycerol level J:211773
Dusp7tm1(KOMP)Wtsi/Dusp7tm1(KOMP)Wtsi
(C57BL/6N-Dusp7tm1(KOMP)Wtsi/Nju) 		abnormal cholesterol homeostasis J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Dusp16em1(IMPC)Tcp/Dusp16em1(IMPC)Tcp
(C57BL/6NCrl-Dusp16em1(IMPC)Tcp/Tcp) 		decreased circulating HDL cholesterol level J:211773
Dusp26em1Jhxia/Dusp26em1Jhxia
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased liver cholesterol level J:279111
increased liver free fatty acids level J:279111
increased liver triglyceride level J:279111
Dusp26tm1a(KOMP)Wtsi/Dusp26tm1a(KOMP)Wtsi
(C57BL/6N-Dusp26tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Dymem1(IMPC)Tcp/Dymem1(IMPC)Tcp
(C57BL/6N-Dymem1(IMPC)Tcp/Tcp) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Dync1i2tm1a(EUCOMM)Wtsi/Dync1i2+
(C57BL/6N-Dync1i2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
E2f1tm1Meg/E2f1tm1Meg
E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		decreased circulating triglyceride level J:138289
E130308A19Rikem1(IMPC)J/E130308A19Rikem1(IMPC)J
(C57BL/6NJ-E130308A19Rikem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Echdc1em1(IMPC)J/Echdc1em1(IMPC)J
(C57BL/6NJ-Echdc1em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:346664
increased circulating LDL cholesterol level J:346664
increased circulating triglyceride level J:346664
increased circulating VLDL cholesterol level J:346664
increased circulating VLDL triglyceride level J:346664
Echs1em1Jynz/Echs1+
(C57BL/6-Echs1em1Jynz) 		abnormal free fatty acids level J:283707
abnormal lipid level J:283707
Eci1tm1Wst/Eci1tm1Wst
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lipid level J:76763
increased triglyceride level J:76763
increased unsaturated fatty acids level J:76763
Ecrg4tm1b(EUCOMM)Hmgu/Ecrg4tm1b(EUCOMM)Hmgu
(C57BL/6N-Ecrg4tm1b(EUCOMM)Hmgu/Orl) 		increased circulating cholesterol level J:211773
Ecscrtm1a(KOMP)Wtsi/Ecscrtm1a(KOMP)Wtsi
(involves: C57BL/6N) 		increased circulating free fatty acids level J:236657
increased circulating glycerol level J:236657
increased circulating triglyceride level J:236657
Edaraddcr/Edaraddcr
(B6C3Fe a/a-Edaraddcr/J) 		abnormal lipid level J:5870
Edem1em1(IMPC)Kmpc/Edem1em1(IMPC)Kmpc
(C57BL/6NTac-Edem1em1(IMPC)Kmpc/Kmpc) 		increased circulating HDL cholesterol level J:211773
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac) 		increased circulating ketone body level J:201436
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6) 		increased liver triglyceride level J:105638
Ehd2tm1.1Cbm/Ehd2tm1.1Cbm
(B6N.129(Cg)-Ehd2tm1.1Cbm) 		decreased circulating free fatty acids level J:285350
Ehhadhtm1Jkr/Ehhadhtm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:104835
Ehhadhtm1Jkr/Ehhadhtm1Jkr
Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal bile salt level J:99925
abnormal lipid homeostasis J:104835
abnormal lipid level J:89945, J:104835
decreased fatty acids level J:89945
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ) 		decreased fatty acid oxidation J:207678
increased circulating free fatty acids level J:207678
increased liver triglyceride level J:207678
Ehmt1tm1b(EUCOMM)Hmgu/Ehmt1+
(C57BL/6N-Ehmt1tm1b(EUCOMM)Hmgu/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster) 		steatorrhea J:70005
Eif4a2em1(IMPC)J/Eif4a2em1(IMPC)J
(C57BL/6NJ-Eif4a2em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Eif4e3tm1a(KOMP)Wtsi/Eif4e3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eif4e3tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Elk3em1(IMPC)Ics/Elk3+
(C57BL/6N-Elk3em1(IMPC)Ics/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(C57BL/6N-Elk4tm1a(EUCOMM)Wtsi/H) 		decreased circulating cholesterol level J:165965
decreased circulating HDL cholesterol level J:165965
decreased circulating triglyceride level J:165965
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating glycerol level J:165965
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H) 		decreased circulating cholesterol level J:165965
decreased circulating HDL cholesterol level J:165965
Elmod2tm1b(EUCOMM)Hmgu/Elmod2+
(C57BL/6N-Elmod2tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Elovl1tm1.1Akih/Elovl1tm1.1Akih
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * DBA) 		abnormal ceramide level J:204477
abnormal phospholipid level J:204477
abnormal sphingomyelin level J:204477
Elovl2em1Haml/Elovl2em1Haml
(C57BL/6N-Elovl2em1Haml) 		decreased unsaturated fatty acids level J:284063
increased unsaturated fatty acids level J:284063
Elovl2tm1Jaco/Elovl2tm1Jaco
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased fatty acids level J:168856
Elovl4tm1Rayy/Elovl4+
(involves: 129 * C57BL/6J) 		abnormal fatty acids level J:114752
Elovl4tm3Kzh/Elovl4tm3Kzh
Tg(Rho-cre)#Yzl/?
(Not Specified) 		decreased unsaturated fatty acids level J:194246
Elovl4tm3Kzh/Elovl4tm3Kzh
Tg(Rho-icre)1Ck/?
(involves: C57BL/6 * SJL) 		decreased unsaturated fatty acids level J:194246
Elovl5em1(IMPC)Tcp/Elovl5em1(IMPC)Tcp
(C57BL/6NCrl-Elovl5em1(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
increased circulating HDL cholesterol level J:211773
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(B6;129S5-Elovl6Gt(OST222498)Lex/Orl) 		decreased circulating cholesterol level J:82809
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal fatty acids level J:130031
abnormal lipid homeostasis J:130031
decreased fatty acid oxidation J:130031
Elovl6tm1b(EUCOMM)Hmgu/Elovl6tm1b(EUCOMM)Hmgu
(C57BL/6N-Elovl6tm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Emcnem1(IMPC)Wtsi/Emcnem1(IMPC)Wtsi
(C57BL/6N-Emcnem1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Emid1tm1a(EUCOMM)Wtsi/Emid1tm1a(EUCOMM)Wtsi
(C57BL/6N-Emid1tm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating free fatty acids level J:165965
EnamAbte2/Enam+
(C3HeB/FeJ-EnamAbte2) 		decreased circulating cholesterol level J:220423
decreased circulating triglyceride level J:220423
Enamabte/Enam+
(C3HeB/FeJ-Enamabte) 		decreased circulating cholesterol level J:220423
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl) 		increased liver triglyceride level J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl) 		increased circulating triglyceride level J:225402
increased liver triglyceride level J:225402
Ensaem1(IMPC)J/Ensaem1(IMPC)J
(C57BL/6NJ-Ensaem1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg) 		decreased circulating glycerol level J:165965
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased cholesterol level J:163795
decreased triglyceride level J:163795
Entr1em1(IMPC)Mbp/Entr1em1(IMPC)Mbp
(C57BL/6N-Entr1em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Epb41l5tm1a(EUCOMM)Hmgu/Epb41l5+
(C57BL/6N-Epb41l5tm1a(EUCOMM)Hmgu/H) 		decreased circulating glycerol level J:165965
Ephx2tm1Gonz/Ephx2tm1Gonz
(B6.129X1-Ephx2tm1Gonz) 		abnormal lipid level J:208344
epi/?
(involves: CBA/J) 		abnormal feces lipid level J:5421
steatorrhea J:5421
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating cholesterol level J:173769
increased circulating free fatty acids level J:173769
increased circulating ketone body level J:173769
increased circulating triglyceride level J:173769
increased liver cholesterol level J:173769
increased liver triglyceride level J:173769
Eprs1tm1.1Xen/Eprs1tm1.1Xen
(C57BL/6-Eprs1tm1.1Xen) 		increased fatty acid beta-oxidation J:244749
Eps8l2tm1b(EUCOMM)Wtsi/Eps8l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eps8l2tm1b(EUCOMM)Wtsi/H) 		decreased circulating cholesterol level J:211773
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eps15tm1a(KOMP)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:175295
increased circulating LDL cholesterol level J:175295
Epxtm1b(EUCOMM)Wtsi/Epxtm1b(EUCOMM)Wtsi
(C57BL/6N-Epxtm1b(EUCOMM)Wtsi/Orl) 		increased circulating triglyceride level J:211773
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased liver triglyceride level J:117488
Ercc8em1(IMPC)H/Ercc8em1(IMPC)H
(C57BL/6N-Ercc8em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ermnem1(IMPC)H/Ermnem1(IMPC)H
(C57BL/6N-Ermnem1(IMPC)H/H) 		increased circulating triglyceride level J:211773
Ern1tm1Rjk/Ern1tm2.1Rjk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal lipid level J:171230
decreased circulating cholesterol level J:171230
increased liver triglyceride level J:171230
Esco1tm1(KOMP)Wtsi/Esco1tm1(KOMP)Wtsi
(C57BL/6N-Esco1tm1(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating cholesterol level J:66077
increased circulating HDL cholesterol level J:66077
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating cholesterol level J:66077
increased circulating HDL cholesterol level J:66077
Esr1tm4.2Ksk/Esr1tm4.2Ksk
Mir22tm1Boet/Mir22tm1Boet
Tg(Ckmm-cre)5Khn/0
(involves: 129S2/SvPas * C57BL/6 * FVB) 		increased fatty acid oxidation J:266382
Esrratm1Vgi/Esrratm1Vgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:86433
increased triglyceride level J:119525
Etfbkmtem1Yshk/Etfbkmtem1Yshk
(C57BL/6J-Etfbkmtem1Yshk) 		increased fatty acid beta-oxidation J:260200
Etnppltm1.2Mrl/Etnppltm1.2Mrl
(C57BL/6-Etnppltm1.2Mrl/Tac) 		abnormal phospholipid level J:309545
Etv6em1(IMPC)Rbrc/Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Ezh2tm1a(EUCOMM)Wtsi/Ezh2+
(C57BL/6N-Ezh2tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating triglyceride level J:175295
Fa2hem1(IMPC)Mbp/Fa2hem1(IMPC)Mbp
(C57BL/6NCrl-Fa2hem1(IMPC)Mbp/MbpMmucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Fa2htm1.1Hama/Fa2htm1.1Hama
(involves: 129 * C57BL/6) 		abnormal galactolipid level J:171655
abnormal lipid level J:171655
decreased cholesterol level J:171655
Fa2htm1Hama/Fa2htm1Hama
Cnptm1(cre)Kan/Cnp+
(involves: 129 * C57BL/6) 		abnormal galactolipid level J:171655
abnormal lipid level J:171655
Faahtm1.1Flee/Faah+
(B6.Cg-Faahtm1.1Flee) 		increased anandamide level J:221783
Faahtm1.1Flee/Faahtm1.1Flee
(B6.Cg-Faahtm1.1Flee) 		increased anandamide level J:221783
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:87278
abnormal lipid level J:87278
decreased liver triglyceride level J:87278
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto) 		abnormal circulating lipid level J:64975
decreased circulating cholesterol level J:64975
increased circulating glycerol level J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal free fatty acids level J:167535
abnormal lipid homeostasis J:167535
abnormal triglyceride level J:167535
decreased fatty acids level J:167535
decreased triglyceride level J:167535
increased circulating free fatty acids level J:167535
increased circulating triglyceride level J:167535
increased fatty acids level J:167535
increased triglyceride level J:167535
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c) 		abnormal lipid homeostasis J:54614
increased circulating free fatty acids level J:54614
Fabp4tm1Brsp/Fabp4tm1Brsp
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased circulating triglyceride level J:37027
increased fatty acids level J:37027
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		decreased triglyceride level J:217245
increased circulating free fatty acids level J:217245
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob) 		decreased circulating cholesterol level J:111878
decreased circulating triglyceride level J:111878
decreased liver triglyceride level J:111878
increased fatty acids level J:111878
Fabp6tm1Lbal/Fabp6tm1Lbal
(B6.129-Fabp6tm1Lbal) 		abnormal bile salt homeostasis J:195544
decreased circulating cholesterol level J:195544
decreased circulating triglyceride level J:195544
decreased liver cholesterol level J:195544
increased bile salt level J:195544
Fabp7tm1Owad/Fabp7tm1Owad
(B6.Cg-Fabp7tm1Owad) 		decreased fatty acids level J:111540
Fads1Gt(IST11525H2)Tigm/Fads1+
(C57BL/6-Fads1Gt(IST11525H2)Tigm) 		decreased prostaglandin level J:186265
increased prostaglandin level J:186265
Fads1Gt(IST11525H2)Tigm/Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm) 		abnormal circulating lipid level J:186265
abnormal lipid level J:186265
decreased prostaglandin level J:186265
increased prostaglandin level J:186265
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating triglyceride level J:211773
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J) 		increased liver triglyceride level J:153293
Fads2tm1Wst/Fads2tm1Wst
(involves: 129P2/OlaHsd) 		decreased prostaglandin level J:140341
decreased thromboxane level J:140341
decreased unsaturated fatty acids level J:140341
Fads3tm1a(KOMP)Wtsi/Fads3tm1a(KOMP)Wtsi
(C57BL/6-Fads3tm1a(KOMP)Wtsi) 		decreased fatty acids level J:256005
decreased liver free fatty acids level J:256005
increased fatty acids level J:256005
increased liver free fatty acids level J:256005
Faf2tm1Tfji/Faf2tm1Tfji
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * CBA * DBA) 		decreased circulating free fatty acids level J:235325
decreased circulating phospholipid level J:235325
decreased circulating triglyceride level J:235325
decreased circulating VLDL triglyceride level J:235325
increased circulating phospholipid level J:235325
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi) 		increased circulating free fatty acids level J:258290
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal vitamin D level J:185208
Fam81bem1(IMPC)J/Fam81bem1(IMPC)J
(C57BL/6NJ-Fam81bem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Fam83gtm1a(EUCOMM)Wtsi/Fam83gtm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating triglyceride level J:165965
Fam117btm1a(EUCOMM)Wtsi/Fam117btm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating cholesterol level J:165965
decreased circulating HDL cholesterol level J:165965
decreased circulating triglyceride level J:165965
Fam161atm1b(KOMP)Wtsi/Fam161atm1b(KOMP)Wtsi
(C57BL/6N-Fam161atm1b(KOMP)Wtsi/J) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Fam186btm1b(KOMP)Mbp/Fam186btm1b(KOMP)Mbp
(C57BL/6N-Fam186btm1b(KOMP)Mbp/J) 		increased circulating HDL cholesterol level J:211773
Fam210atm1b(EUCOMM)Wtsi/Fam210a+
(C57BL/6N-Fam210atm1b(EUCOMM)Wtsi/Tcp) 		increased circulating triglyceride level J:211773
Fam234btm1a(EUCOMM)Wtsi/Fam234btm1a(EUCOMM)Wtsi
(C57BL/6N-Fam234btm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating cholesterol level J:165965
decreased circulating LDL cholesterol level J:165965
decreased circulating triglyceride level J:165965
Far1em1(IMPC)Wtsi/Far1em1(IMPC)Wtsi
(C57BL/6N-Far1em1(IMPC)Wtsi) 		abnormal ether lipid level J:339470
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(B6N(Cg)-Far2tm2b(KOMP)Wtsi/2J) 		abnormal lipid level J:267002
Farp2tm1a(KOMP)Wtsi/Farp2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Farp2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating triglyceride level J:175295
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating cholesterol level J:127793
decreased liver cholesterol level J:127793
decreased saturated fatty acids level J:127793
increased circulating free fatty acids level J:127793
increased triglyceride level J:127793
Fasntm1Sem/Fasntm1Sem
Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		abnormal fatty acids level J:127482
decreased circulating free fatty acids level J:127482
increased circulating triglyceride level J:127482
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
Fbrsem1(IMPC)J/Fbrs+
(C57BL/6NJ-Fbrsem1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Fbxo9tm1b(EUCOMM)Hmgu/Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju) 		decreased circulating triglyceride level J:211773
Fbxo41tm1.1(KOMP)Vlcg/Fbxo41tm1.1(KOMP)Vlcg
(C57BL/6N-Fbxo41tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
Fcer1gtm1Rav/Fcer1gtm1Rav
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal lipid level J:87617
Ffal1C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		increased circulating free fatty acids level J:84091
Ffaq2NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating free fatty acids level J:138463
Ffaq3NZB/BlNJ/Ffaq3NZB/BlNJ
Ffaq4NZB/BlNJ/Ffaq4NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating free fatty acids level J:138463
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal triglyceride level J:141957
decreased circulating triglyceride level J:141957
increased liver triglyceride level J:141957
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified) 		abnormal circulating triglyceride level J:129843
Ffar2tm1Lex/Ffar2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J) 		abnormal circulating free fatty acids level J:138134
Ffar2tm2Soff/Ffar2tm2Soff
Ffar3tm2.1Soff/Ffar3tm2.1Soff
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA) 		decreased circulating free fatty acids level J:227939
Ffar3tm1Gzt/Ffar3tm1Gzt
(involves: C57BL/6) 		increased circulating ketone body level J:172798
Ffar3tm1Reh/Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver triglyceride level J:143567
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		abnormal lipid level J:182599
increased circulating cholesterol level J:182599
increased circulating HDL cholesterol level J:182599
increased circulating LDL cholesterol level J:182599
increased liver triglyceride level J:182599
Fgd4tm1a(EUCOMM)Wtsi/Fgd4tm1a(EUCOMM)Wtsi
(C57BL/6N-Fgd4tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd) 		decreased circulating cholesterol level J:211773
Fgf10tm1b(EUCOMM)Wtsi/Fgf10+
(C57BL/6N-Fgf10tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Fgf20em1(IMPC)Ccpcz/Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Fgf21tm1.1Djm/Fgf21tm1.1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating ketone body level J:150831
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf) 		abnormal lipid homeostasis J:157309
abnormal lipid level J:157309
decreased fatty acids level J:157309
increased circulating cholesterol level J:157309
increased circulating triglyceride level J:157309
increased liver triglyceride level J:157309
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit) 		abnormal circulating free fatty acids level J:157334
decreased circulating free fatty acids level J:157334
increased circulating free fatty acids level J:157334
increased circulating ketone body level J:157334
Fgf23tm1.1Kew/Fgf23tm1.1Kew
(B6.129-Fgf23tm1.1Kew) 		abnormal vitamin D level J:180061
Fgf23tm1Sliu/Fgf23+
PhexHyp/Y
(involves: 129S/SvEv * C57BL/6) 		abnormal vitamin D level J:110579
Fgf23tm1Sliu/Fgf23tm1Sliu
(involves: 129S/SvEv * C57BL/6) 		abnormal vitamin D level J:110579
Fgf23tm1Sliu/Fgf23tm1Sliu
PhexHyp/Y
(involves: 129S/SvEv * C57BL/6) 		abnormal vitamin D level J:110579
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA) 		abnormal vitamin D level J:88172
decreased circulating triglyceride level J:88172
increased circulating cholesterol level J:88172
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		decreased circulating cholesterol level J:199844
decreased circulating free fatty acids level J:199844
decreased circulating HDL cholesterol level J:199844
increased liver triglyceride level J:199844
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6) 		decreased circulating cholesterol level J:302658
decreased circulating LDL cholesterol level J:302658
increased liver cholesterol level J:302658
increased liver triglyceride level J:302658
Fhl1tm1a(EUCOMM)Wtsi/Fhl1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fhl1tm1a(EUCOMM)Wtsi/H) 		decreased circulating cholesterol level J:165965
Firrmtm1a(EUCOMM)Hmgu/Firrm+
(C57BL/6N-Firrmtm1a(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:165965
increased circulating HDL cholesterol level J:165965
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal fatty acids level J:212437
Fkbp4em1(IMPC)Mbp/Fkbp4em1(IMPC)Mbp
(C57BL/6N-Fkbp4em1(IMPC)Mbp/MbpMmucd) 		abnormal cholesterol homeostasis J:211773
Fkbp5tm1Dvds/Fkbp5tm1Dvds
(involves: 129X1/SvJ * C57BL/6 * Swiss Webster) 		decreased circulating corticosterone level J:177683
Fl1saA/J/?
(involves: A/JSlc * SM/JNshm) 		abnormal lipid level J:124974
increased liver triglyceride level J:124974
Fl1saSM/JNshm/Fl1saSM/JNshm
(A/J-Chr 12SM/J/Nshm) 		decreased liver triglyceride level J:124974
Fl2saA/JNshm/Fl2saA/JNshm
(involves: A/JSlc * SM/JNshm) 		abnormal lipid level J:124974
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac) 		abnormal lipid level J:198332
increased cholesterol level J:198332
Flvcr2tm1a(EUCOMM)Hmgu/Flvcr2+
(C57BL/6N-Flvcr2tm1a(EUCOMM)Hmgu/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
fm/fm
(involves: CBA/H) 		abnormal cholesterol level J:5112
abnormal sphingomyelin level J:5112
sphingomyelinosis J:5112
Fmnl2em2(IMPC)Tcp/Fmnl2em2(IMPC)Tcp
(C57BL/6NCrl-Fmnl2em2(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe) 		decreased circulating cholesterol level J:223365
decreased circulating HDL cholesterol level J:223365
decreased circulating LDL cholesterol level J:223365
decreased fatty acid oxidation J:223365
decreased triglyceride level J:223365
increased fatty acid oxidation J:223365
Fndc5em21Gpt/Fndc5em21Gpt
(C57BL/6JGpt-Fndc5em21Cd/Gpt) 		abnormal circulating lipid level J:247171
abnormal fatty acid oxidation J:247171
Fndc7tm1.1(KOMP)Vlcg/Fndc7tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc7tm1.1(KOMP)Vlcg/Ucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Folr1tm1.1(KOMP)Vlcg/Folr1+
(C57BL/6N-Folr1tm1.1(KOMP)Vlcg/Tcp) 		abnormal cholesterol homeostasis J:211773
Foxa1tm1Stf/Foxa1+
(Not Specified) 		decreased circulating HDL cholesterol level J:138581
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified) 		decreased circulating triglyceride level J:57493
increased circulating cortisol level J:57493
Foxa2tm1.1Stf/Foxa2tm1.1Stf
Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln) 		decreased circulating free fatty acids level J:155391
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating free fatty acids level J:95662
increased circulating triglyceride level J:95662
increased liver triglyceride level J:95662
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk) 		abnormal lipid homeostasis J:216477
decreased circulating cholesterol level J:216477
Foxo1tm1Rdp/Foxo1tm1Rdp
Irs1tm1Mfw/Irs1tm1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB) 		abnormal triglyceride level J:137845
decreased circulating cholesterol level J:137845
decreased circulating free fatty acids level J:137845
decreased circulating HDL cholesterol level J:137845
decreased circulating triglyceride level J:137845
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified) 		abnormal lipid homeostasis J:179687
decreased circulating cholesterol level J:179687
decreased circulating free fatty acids level J:179687
decreased circulating triglyceride level J:179687
decreased circulating VLDL triglyceride level J:179687
decreased liver triglyceride level J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac) 		decreased liver cholesterol level J:179687
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg) 		decreased circulating cholesterol level J:236585
decreased liver triglyceride level J:236585
Fpr3tm1b(EUCOMM)Hmgu/Fpr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Fpr3tm1b(EUCOMM)Hmgu/Ics) 		increased circulating cholesterol level J:211773
Frrs1tm1a(EUCOMM)Wtsi/Frrs1+
(C57BL/6N-Frrs1tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J) 		increased circulating cholesterol level J:152163
increased circulating HDL cholesterol level J:152163
increased circulating triglyceride level J:152163
Ftotm1a(EUCOMM)Wtsi/Ftotm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ftotm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Fuca1tm1Tlub/Fuca1tm1Tlub
(involves: 129S2/SvPas * C57BL/6) 		increased brain cholesterol level J:235359
Fyco1tm1.1Arte/Fyco1tm1.1Arte
Tg(Prm-cre)58Og/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J * C57BL/6NTac) 		abnormal phospholipid level J:336796
Fyco1tm1.2Arte/Fyco1tm1.2Arte
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac * FVB/N) 		abnormal phospholipid level J:336796
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased liver triglyceride level J:209000
increased circulating free fatty acids level J:209000
increased circulating glycerol level J:225236
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd) 		decreased liver triglyceride level J:219653
G6pc1em1Jyc/G6pc1em1Jyc
(involves: 129S4/SvJae * C57BL/6) 		increased circulating cholesterol level J:320697
increased circulating triglyceride level J:320697
increased liver triglyceride level J:320697
G6pc1tm1.1Ics/G6pc1tm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J) 		increased circulating cholesterol level J:195257
increased circulating triglyceride level J:195257
increased liver triglyceride level J:195257
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae) 		abnormal lipid homeostasis J:33212
increased circulating cholesterol level J:33212
increased circulating triglyceride level J:33212
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		increased circulating cholesterol level J:155990
increased circulating triglyceride level J:155990
G6pc2tm1Lex/G6pc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating triglyceride level J:141593
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased circulating cholesterol level J:117664
Gab1tm1Gsf/Gab1tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:98318
decreased circulating free fatty acids level J:98318
decreased circulating triglyceride level J:98318
Galtm1Wyn/Galtm1Wyn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucocorticoid level J:84420
Galctwi/Galctwi
(B6.CE-Galctwi/J) 		abnormal lipid level J:165361
abnormal sphingomyelin level J:165361
Galctwi/Galctwi
(involves: CE/J) 		abnormal lipid level J:78223
Galctwi/Galctwi
Glb1tm1Adz/Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		abnormal lipid level J:63197
Galctwi/Galctwi
Glb1tm1Adz/Glb1tm1Adz
(involves: 129P2/OlaHsd * C57BL/6J * CE/J) 		abnormal lipid level J:63197
Galnt2tm1.2Mrl/Galnt2tm1.2Mrl
(involves: C57BL/6) 		decreased circulating HDL cholesterol level J:251899
increased triglyceride level J:251899
Galnt3tcal/Galnt3tcal
(involves: C3H * C57BL/6J) 		increased vitamin D level J:187064
Galnt3tm1Mjec/Galnt3tm1Mjec
(involves: 129S/SvEv * C57BL/6J) 		abnormal vitamin D level J:151805
Galnt11tm1Kgth/Galnt11tm1Kgth
(B6NHsd.Cg-Galnt11tm1Kgth) 		increased circulating LDL cholesterol level J:287843
Galr3tm1Lex/Galr3tm1Lex
(B6;129S5-Galr3tm1Lex/Orl) 		increased cholesterol level J:82809
increased triglyceride level J:82809
Gars1em1(IMPC)Tcp/Gars1+
(C57BL/6NCrl-Gars1em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb) 		decreased circulating cholesterol level J:191142
decreased circulating triglyceride level J:191142
decreased liver triglyceride level J:191142
Gatmtm1b(KOMP)Wtsi/Gatmtm1b(KOMP)Wtsi
(C57BL/6N-Gatmtm1b(KOMP)Wtsi/Ieg) 		decreased circulating cholesterol level J:211773
Gba1tm1.1Pmis/Gba1tm1.1Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased circulating HDL cholesterol level J:167081
Gba1tm1.1Pmis/Gba1tm1.2Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased circulating HDL cholesterol level J:167081
Gba1tm1Karl/Gba1tm1Karl
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal lipid homeostasis J:127108
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating cholesterol level J:76409
Gba1tm2Karl/Gba1tm2Karl
Tg(KRT14-cre)8Brn/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal lipid homeostasis J:127108
Gba2tm1Rus/Gba2tm1Rus
(involves: 129S6/SvEv * C57BL/6J) 		abnormal lipid level J:114991
Gctm1.1(KOMP)Vlcg/Gctm1.1(KOMP)Vlcg
(C57BL/6N-Gctm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Gctm1Nec/Gctm1Nec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal vitamin D level J:52225
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd) 		increased circulating cholesterol level J:211773
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL) 		decreased triglyceride level J:81772
increased circulating LDL cholesterol level J:81772
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL) 		increased bile salt level J:208604
Gcgrtm1Mjch/Gcgrtm1Mjch
Leprtm1Jke/Leprtm1Jke
(involves: 129 * 129X1/SvJ * C57BL/6J * SJL) 		increased liver triglyceride level J:216393
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		increased bile salt level J:208604
Gcktm1.2Mgn/Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating free fatty acids level J:51826
Gcktm1Ts/Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J)) 		abnormal circulating cholesterol level J:29255
increased circulating triglyceride level J:29255
Gdatm1a(KOMP)Wtsi/Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Gde1tm1b(EUCOMM)Hmgu/Gde1+
(C57BL/6N-Gde1tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
Gdf15tm1Sjl/Gdf15tm1Sjl
Leprdb/Leprdb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J) 		increased cholesterol level J:202996
increased circulating HDL cholesterol level J:202996
Gemin4em1(IMPC)Ics/Gemin4+
(C57BL/6N-Gemin4em1(IMPC)Ics/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Gena327/Gena327+
(involves: BALB/c * C3H/HeH) 		increased circulating triglyceride level J:82809, J:79719
Gena360/Gena360+
(involves: BALB/c * C3H/HeH) 		decreased circulating cholesterol level J:82809, J:79719
decreased circulating HDL cholesterol level J:82809, J:79719
Gena381/Gena381+
(involves: BALB/c * C3H/HeH) 		decreased cholesterol level J:169366
Gena391/Gena391+
(involves: BALB/c * C3H/He) 		increased circulating HDL cholesterol level J:82809
increased circulating triglyceride level J:82809
Gfertm1(KOMP)Mbp/Gfer+
(involves: C57BL/6J * C57BL/6N) 		abnormal lipid oxidation J:224792
Gfertm1.1Crg/Gfertm1.1Crg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		decreased liver cholesterol level J:227242
increased liver cholesterol level J:227242
increased liver triglyceride level J:227242
Gfm1tm1a(EUCOMM)Wtsi/Gfm1+
(C57BL/6N-Gfm1tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:175295
Gfpt1tm1b(EUCOMM)Wtsi/Gfpt1+
(C57BL/6N-Gfpt1tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Gfraltm1Lex/Gfraltm1Lex
(B6.129S5-Gfraltm1Lex) 		abnormal circulating triglyceride level J:254140
abnormal free fatty acids level J:254140
Ggps1tm1b(EUCOMM)Wtsi/Ggps1+
(C57BL/6N-Ggps1tm1b(EUCOMM)Wtsi/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ghrtm1.1Masp/Ghrtm1.1Masp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased circulating triglyceride level J:152627
decreased liver triglyceride level J:152627
increased circulating free fatty acids level J:152627
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		abnormal circulating lipid level J:105686
decreased circulating cholesterol level J:105686
decreased circulating HDL cholesterol level J:105686
decreased circulating LDL cholesterol level J:105686
decreased circulating triglyceride level J:105686
decreased circulating VLDL cholesterol level J:105686
increased circulating corticosterone level J:105686
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6) 		increased circulating corticosterone level J:103286
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J) 		increased circulating triglyceride level J:211773
Gimap6tm1b(KOMP)Wtsi/Gimap6tm1b(KOMP)Wtsi
(C57BL/6N-Gimap6tm1b(KOMP)Wtsi/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Gja8Aey69/Gja8Aey69
H3c14Aey69/H3c14Aey69
(C3HeB/FeJ) 		hypolipidemia J:277247
Gk5m1Btlr/Gk5m1Btlr
(C57BL/6J-Gk5m1Btlr) 		abnormal ceramide level J:243852
abnormal lipid level J:243852
increased cholesterol level J:243852
increased triglyceride level J:243852
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased circulating glycerol level J:43449
increased fatty acids level J:43449
increased urine glycerol level J:43449
Gktm1Wjc/Gk+
(involves: 129S7/SvEvBrd) 		decreased fatty acids level J:148831
Glg1tm1a(KOMP)Wtsi/Glg1+
(C57BL/6N-Glg1tm1a(KOMP)Wtsi/Wtsi) 		increased circulating glycerol level J:211773
increased circulating triglyceride level J:211773
Glis3tm1.2Chan/Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		increased circulating ketone body level J:177082
Glra4tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra4tm1b(KOMP)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Gm94tm1b(KOMP)Wtsi/Gm94+
(C57BL/6N-Gm94tm1b(KOMP)Wtsi/J) 		increased circulating cholesterol level J:211773
Gm5127em1(IMPC)J/Y
(C57BL/6NJ-Gm5127em1(IMPC)J/Mmjax) 		increased circulating triglyceride level J:211773
Gm5134tm1a(EUCOMM)Hmgu/Gm5134tm1a(EUCOMM)Hmgu
(C57BL/6N-Gm5134tm1a(EUCOMM)Hmgu/H) 		decreased circulating triglyceride level J:165965
Gm20646em1(IMPC)Wtsi/Gm20646em1(IMPC)Wtsi
(C57BL/6N-Gm20646em1(IMPC)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq) 		increased circulating triglyceride level J:341056
Gna11tm1a(EUCOMM)Wtsi/Gna11tm1a(EUCOMM)Wtsi
(C57BL/6N-Gna11tm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating triglyceride level J:165965
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd) 		increased circulating triglyceride level J:172091
increased liver triglyceride level J:172091
Gna14em1(IMPC)Kmpc/Gna14em1(IMPC)Kmpc
(C57BL/6NTac-Gna14em1(IMPC)Kmpc/Kmpc) 		abnormal cholesterol homeostasis J:211773
Gnai1tm1Drs/Gnai1tm1Drs
Gnai3tm1Lbi/Gnai3tm1Lbi
(involves: 129S/SvEv) 		abnormal thromboxane level J:104683
Gnao1tm1b(EUCOMM)Hmgu/Gnao1+
(C57BL/6N-Gnao1tm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1) 		decreased circulating cholesterol level J:60971
decreased circulating triglyceride level J:60971
Gnastm3Lsw/Gnastm3Lsw
Ren1tm2(cre)Gom/Ren1+
(involves: 129S6/SvEvTac * Black Swiss) 		decreased circulating aldosterone level J:118076
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss * CD-1) 		increased circulating triglyceride level J:99237
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased circulating triglyceride level J:102504
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0
(involves: FVB) 		decreased circulating free fatty acids level J:159612
decreased circulating triglyceride level J:159612
decreased liver triglyceride level J:159612
decreased skeletal muscle triglyceride level J:159612
increased circulating corticosterone level J:159612
increased fatty acid oxidation J:159612
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Slc5a2-cre)1Tauc/0
(involves: C57BL/6 * DBA/2) 		decreased vitamin D level J:233851
Gnb2em1(IMPC)J/Gnb2em1(IMPC)J
(C57BL/6NJ-Gnb2em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6) 		increased circulating cholesterol level J:147857
Gnpattm1Just/Gnpattm1Just
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid homeostasis J:84690
Golph3em1(IMPC)Tcp/Golph3em1(IMPC)Tcp
(C57BL/6NCrl-Golph3em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ) 		decreased circulating cholesterol level J:134068
decreased circulating triglyceride level J:134068
decreased liver triglyceride level J:134068
increased circulating ketone body level J:134068
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal fatty acids level J:84541
abnormal lipid homeostasis J:84541
decreased circulating cholesterol level J:84541
decreased circulating HDL cholesterol level J:84541
decreased circulating triglyceride level J:84541
decreased circulating VLDL triglyceride level J:84541
decreased liver triglyceride level J:84541
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6) 		decreased circulating cholesterol level J:213618
increased circulating cholesterol level J:213618
increased liver cholesterol level J:213618
Gpbar1tm1Gvas/Gpbar1tm1Gvas
(involves: 129S1/SvImJ * C57BL/6) 		abnormal cholesterol homeostasis J:115877
Gpbar1tm1Ktan/Gpbar1tm1Ktan
(involves: 129X1/SvJ * C57BL/6N) 		abnormal bile salt homeostasis J:114971
increased circulating cholesterol level J:114971
Gpc4tm2b(EUCOMM)Wtsi/Gpc4tm2b(EUCOMM)Wtsi
(C57BL/6N-Gpc4tm2b(EUCOMM)Wtsi/J) 		abnormal cholesterol homeostasis J:211773
Gpcpd1em1(IMPC)Tcp/Gpcpd1+
(C57BL/6N-Gpcpd1em1(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB) 		increased glycerophosphocholine level J:345630
Gpd2tm1Tka/Gpd2tm1Tka
(B6.Cg-Gpd2tm1Tka) 		increased circulating cholesterol level J:124766
Gpd2tm1Tka/Gpd2tm1Tka
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct) 		increased circulating free fatty acids level J:124766
increased circulating glycerol level J:124766
increased liver triglyceride level J:124766
Gpihbp1tm1Sgy/Gpihbp1tm1Sgy
(Not Specified) 		decreased circulating HDL cholesterol level J:129764
increased circulating cholesterol level J:129764
increased circulating triglyceride level J:129764
increased circulating VLDL cholesterol level J:129764
Gpld1tm1.1(KOMP)Vlcg/Gpld1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpld1tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
Gpm6btm1KanPlp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased cholesterol level J:193310
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen) 		abnormal cholesterol homeostasis J:111942
increased circulating cholesterol level J:111942
increased circulating HDL cholesterol level J:111942
increased circulating LDL cholesterol level J:111942
increased liver triglyceride level J:111942
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6) 		increased circulating cholesterol level J:189617
increased circulating triglyceride level J:189617
Gpr35em2Niess/Gpr35em2Niess
Cx3cr1tm2.1(cre/ERT2)Litt/Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6N) 		abnormal corticosterone level J:300275
Gpr39tm1Lex/Gpr39tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:124913
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating triglyceride level J:302257
increased liver triglyceride level J:302257
Gpr82tm1Shbg/Y
(C3Fe.Cg-Gpr82tm1Shbg) 		decreased circulating VLDL cholesterol level J:301613
decreased triglyceride level J:301613
Gpr82tm1Shbg/Gpr82tm1Shbg
(C3Fe.Cg-Gpr82tm1Shbg) 		decreased circulating VLDL cholesterol level J:301613
decreased triglyceride level J:301613
Gpr142tm1Lex/Gpr142tm1Lex
(B6.129S-Gpr142tm1Lex) 		abnormal circulating non-HDL cholesterol level J:249154
Gpr146em1(IMPC)H/Gpr146em1(IMPC)H
(C57BL/6NTac-Gpr146em1(IMPC)H/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:144372
Gpx1tm1Mgr/Gpx1tm1Mgr
(involves: 129 * C57BL/6J) 		abnormal lipid level J:62395
Gramd1bem1Pton/Gramd1bem1Pton
(involves: C57BL/6N) 		abnormal cholesterol homeostasis J:266462
decreased circulating corticosterone level J:266462
Gramd1ctm1a(KOMP)Wtsi/Gramd1ctm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Gramd1ctm1a(KOMP)Wtsi/JMmucd) 		decreased bile salt level J:347902
decreased circulating corticosterone level J:347902
increased circulating cortisol level J:347902
increased liver cholesterol level J:347902
increased liver triglyceride level J:347902
Gramd1ctm1b(KOMP)Wtsi/Gramd1ctm1b(KOMP)Wtsi
(C57BL/6N-Gramd1ctm1b(KOMP)Wtsi/J) 		increased circulating triglyceride level J:211773
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Adipoq-cre)#Pesch/0
(involves: 129S/SvEv * FVB) 		decreased fatty acid oxidation J:213603
Grhl3tm1a(EUCOMM)Wtsi/Grhl3+
(C57BL/6N-Grhl3tm1a(EUCOMM)Wtsi/Ics) 		decreased circulating triglyceride level J:165965
Grhl3tm1Bogi/Grhl3tm1Bogi
(involves: C57BL/6J) 		abnormal lipid level J:114626
Grid2Lc/Grid2+
(involves: C57BL/6 * CBA) 		increased circulating corticosterone level J:44206
Grin2dtm1a(EUCOMM)Wtsi/Grin2dtm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating triglyceride level J:165965
Grin3btm1b(KOMP)Wtsi/Grin3btm1b(KOMP)Wtsi
(C57BL/6N-Grin3btm1b(KOMP)Wtsi/H) 		decreased circulating triglyceride level J:211773
Grm3tm1b(KOMP)Wtsi/Grm3tm1b(KOMP)Wtsi
(C57BL/6N-Grm3tm1b(KOMP)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
gro22/gro22
(Not Specified) 		decreased circulating cholesterol level J:85113
Grxcr1em1(IMPC)J/Grxcr1em1(IMPC)J
(C57BL/6NJ-Grxcr1em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Gsk3atm1a(EUCOMM)Wtsi/Gsk3atm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Gsk3atm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glycerol level J:175295
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd) 		increased circulating corticosterone level J:200517
Gstk1tm1Pgb/Gstk1tm1Pgb
(BALB/c-Gstk1tm1Pgb) 		decreased circulating triglyceride level J:177201
Gt(ROSA)26Sortm1(CAG-Foxo1*)Jcbr/Gt(ROSA)26Sor+
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		decreased circulating corticosterone level J:134336
Gt(ROSA)26Sortm1(CAG-Nr2f2)Tsa/Gt(ROSA)26Sor+
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		decreased fatty acid oxidation J:227012
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Hprt1tm6(CAG-fat-1)Geno/Hprt1tm6(CAG-fat-1)Geno
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal fatty acids level J:213660
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sortm1(cre/ERT2)Tyj
Nus1tm1.1Qrm/Nus1tm1.1Qrm
(involves: 129 * C57BL/6 * SJL) 		abnormal lipid homeostasis J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Tardbptm1.1Pcw/Tardbptm1.1Pcw
(involves: 129 * C57BL/6 * SJL) 		abnormal lipid oxidation J:164406
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg
Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N) 		abnormal lipid homeostasis J:201507
abnormal lipid level J:201507
Gt(ROSA)26Sortm1(Gphb5)Lmac/Gt(ROSA)26Sor+
(Not Specified) 		decreased circulating cholesterol level J:96633
decreased triglyceride level J:96633
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		decreased liver triglyceride level J:169459
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB) 		increased circulating free fatty acids level J:194290
increased liver triglyceride level J:194290
Gt(ROSA)26Sortm1.1(Alb-PCSK9)Mby/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6N) 		increased circulating cholesterol level J:280156
increased circulating LDL cholesterol level J:280156
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		abnormal circulating lipid level J:166829
decreased circulating LDL cholesterol level J:166829
increased circulating free fatty acids level J:166829
increased circulating HDL cholesterol level J:166829
increased circulating triglyceride level J:166829
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		abnormal circulating lipid level J:166829
decreased circulating LDL cholesterol level J:166829
increased circulating free fatty acids level J:166829
increased circulating HDL cholesterol level J:166829
increased circulating triglyceride level J:166829
Gt(ROSA)26Sortm1.1(CAG-Upp1,-GFP)Gp/Gt(ROSA)26Sor+
(involves: C57BL/6 * FVB/N) 		decreased fatty acid beta-oxidation J:195165
Gt(ROSA)26Sortm8(RNAi:Crhr1)Rkuhn/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating corticosterone level J:151155
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1Tg(Alb1-Myc)166.8Sst
(involves: C57BL/6J * CBA/J) 		increased circulating corticosterone level J:190478
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased circulating corticosterone level J:182346
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar) 		increased liver triglyceride level J:178241
Guloem1(IMPC)Ccpcz/Guloem1(IMPC)Ccpcz
(C57BL/6NCrl-Guloem1(IMPC)Ccpcz/Ccpcz) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Gulotm1Mae/Gulotm1Mae
(involves: 129 * C57BL/6) 		decreased circulating HDL cholesterol level J:59931
increased circulating cholesterol level J:59931
Gusbmps/Gusbmps
(involves: C57BL/6By) 		decreased circulating cholesterol level J:13923
Gyg1tm1a(KOMP)Wtsi/Gyg1tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal lipid oxidation J:244440
Gys2tm1.1Arte/Gys2+
(Not Specified) 		increased liver triglyceride level J:208923
Gys2tm1.1Arte/Gys2tm1.1Arte
(Not Specified) 		increased liver triglyceride level J:208923
Gys2tm1.1Pro/Gys2tm1.1Pro
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA) 		abnormal circulating ketone body level J:162043
abnormal triglyceride level J:162043
increased liver triglyceride level J:162043
Gys2tm1a(KOMP)Wtsi/Gys2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Gys2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glycerol level J:175295
H1f10tm1.1(KOMP)Vlcg/H1f10+
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
H3f3btm1.1(KOMP)Mbp/H3f3btm1.1(KOMP)Mbp
(C57BL/6N-H3f3btm1.1(KOMP)Mbp/Tcp) 		increased circulating cholesterol level J:211773
H6pdtm1c(EUCOMM)Wtsi/H6pdtm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		abnormal corticosterone level J:292236
decreased circulating free fatty acids level J:292236
H6pdtm1Pmst/H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating corticosterone level J:189132, J:108281
Hacd2tm1b(EUCOMM)Hmgu/Hacd2tm1b(EUCOMM)Hmgu
(involves: C57BL/6N) 		abnormal lipid oxidation J:333944
abnormal phospholipid level J:333944
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg) 		abnormal fatty acid oxidation J:179084
abnormal lipid homeostasis J:179084
decreased circulating ketone body level J:179084
increased circulating free fatty acids level J:179084
increased circulating triglyceride level J:179084
Hadhtm1Csta/Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		abnormal fatty acids level J:166803
increased fatty acids level J:166803
Hadhatm1Jib/Hadha+
(involves: 129X1/SvJ * NIH Black Swiss) 		increased circulating free fatty acids level J:101304
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan) 		abnormal lipid homeostasis J:117738
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating free fatty acids level J:211773
increased circulating HDL cholesterol level J:211773
Hcar2tm1Soff/Hcar2tm1Soff
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:82225
Hdac3tm1.1Eno/Hdac3tm1.1Eno
Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6) 		abnormal lipid level J:144604
increased cardiac muscle triglyceride level J:144604
Hdac3tm1Swh/Hdac3tm1.1Swh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased cholesterol level J:134288
increased circulating cholesterol level J:134288
increased circulating LDL cholesterol level J:134288
increased circulating triglyceride level J:134288
increased liver triglyceride level J:134288
Hdl1C57BL/6J/?
(involves: C57BL/6J * CAST/Ei) 		increased circulating HDL cholesterol level J:66421
Hdl2CAST/EiJ/?
(involves: C57BL/6J * CAST/Ei) 		increased circulating HDL cholesterol level J:66421
Hdl3C57BL/6J/?
(involves: C57BL/6J * CAST/Ei) 		increased circulating HDL cholesterol level J:66421
Hdl4CAST/EiJ/?
(involves: C57BL/6J * CAST/Ei) 		increased circulating HDL cholesterol level J:66421
Hdl5C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		increased circulating HDL cholesterol level J:84091
increased circulating LDL cholesterol level J:84091
Hdl6DBA/2J/?
(involves: C57BL/6J * DBA/2J) 		increased circulating HDL cholesterol level J:84091
Hdl7DBA/2J/Hdl7DBA/2J
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdl34C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:38473
Hdl35C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:38473
Hdl36C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:38473
Hdl40C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:38473
Hdlcl1C57BL/6J/Hdlcl1C57BL/6J
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ) 		increased circulating HDL cholesterol level J:94548
Hdlcl2C57BL/6J/Hdlcl2PERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ) 		increased circulating HDL cholesterol level J:94548
Hdlq2NZB/BlNJ/Hdlq2NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:76707, J:89309
Hdlq2NZB/BlNJ/Hdlq2SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:76707, J:89309
Hdlq3NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:76707
Hdlq4NZB/BlNJ/Hdlq4SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:76707
Hdlq5C57BL/6J/Hdlq5C57BL/6J
(involves: C57BL/6J * NZB/BlNJ) 		decreased circulating HDL cholesterol level J:84430
Hdlq5NZB/BlNJ/Hdlq5NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ) 		increased circulating HDL cholesterol level J:84430
Hdlq6C57BL/6J/Hdlq6C57BL/6J
(involves: C57BL/6J * NZB/BlNJ) 		decreased circulating HDL cholesterol level J:84430
Hdlq6NZB/BlNJ/Hdlq6NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ) 		increased circulating HDL cholesterol level J:84430
Hdlq7C57BL/6J/Hdlq7C57BL/6J
(involves: C57BL/6J * NZB/BlNJ) 		decreased circulating HDL cholesterol level J:84430
Hdlq7C57BL/6J/Hdlq7C57BL/6J
Hdlq9C57BL/6J/Hdlq9C57BL/6J
(involves: C57BL/6J * NZB/BlNJ) 		decreased circulating HDL cholesterol level J:84430
Hdlq7NZB/BlNJ/Hdlq7NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ) 		increased circulating HDL cholesterol level J:84430
Hdlq10CAST/Ei/Hdlq10CAST/Ei
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdlq10CAST/Ei/Hdlq10CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating HDL cholesterol level J:88732
Hdlq10CAST/Ei/Hdlq10DBA/2J
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdlq11DBA/2J/Hdlq11CAST/Ei
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdlq11DBA/2J/Hdlq11DBA/2J
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdlq12DBA/2J/Hdlq12CAST/EiJ
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdlq12DBA/2J/Hdlq12DBA/2J
(involves: CAST/Ei * DBA/2J) 		increased circulating HDL cholesterol level J:83460
Hdlq13129S1/SvImJ/Hdlq13129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating HDL cholesterol level J:88732
Hdlq13129S1/SvImJ/Hdlq13CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating HDL cholesterol level J:88732
Hdlq14129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:88486
Hdlq14C57BL/6J/Hdlq14C57BL/6J
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:88486
Hdlq15129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089, J:88486
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ
Hdlq58C57BL/6J/Hdlq58C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ
Hdlq60129S1/SvImJ/Hdlq60C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ
Hdlq60C57BL/6J/Hdlq60C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq15C57BL/6J/Hdlq15C57BL/6J
Hdlq19129S1/SvImJ/Hdlq19129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:88486
Hdlq16129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:88486
Hdlq17129S1/SvImJ/Hdlq17129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:88486
Hdlq17129S1/SvImJ/Hdlq17129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating HDL cholesterol level J:89282
Hdlq17129S1/SvImJ/Hdlq17C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:88486
Hdlq18129S1/SvImJ/Hdlq18129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:88486
Hdlq18129S1/SvImJ/Hdlq18129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating HDL cholesterol level J:89282
Hdlq18129S1/SvImJ/Hdlq18C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:88486
Hdlq18C57BL/6J/Hdlq18C57BL/6J
Hdlq59C57BL/6J/Hdlq59C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:144089
Hdlq20NZB/BlNJ/Hdlq20NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq20NZB/BlNJ/Hdlq20SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq21NZB/BlNJ/Hdlq21NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq21NZB/BlNJ/Hdlq21SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq22NZB/BlNJ/Hdlq22NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq22NZB/BlNJ/Hdlq22SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq23NZB/BlNJ/Hdlq23NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq23NZB/BlNJ/Hdlq23SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq24NZB/BlNJ/Hdlq24NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq24NZB/BlNJ/Hdlq24SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq25NZB/BlNJ/Hdlq25NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq25NZB/BlNJ/Hdlq25SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq26NZB/BlNJ/Hdlq26NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq27NZB/BlNJ/Hdlq27NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq28NZB/BlNJ/Hdlq28NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq28NZB/BlNJ/Hdlq28SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq29NZB/BlNJ/Hdlq29NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq29NZB/BlNJ/Hdlq29SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq30NZB/BlNJ/Hdlq30NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq30NZB/BlNJ/Hdlq30SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq31NZB/BlNJ/Hdlq31NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq31NZB/BlNJ/Hdlq31SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq32NZB/BlNJ/Hdlq32NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:89309
Hdlq33PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq34PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq35PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq37PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq37PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq40A/J/Hdlq40C57BL/6J
Hdlq41A/J/?
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq42A/J/Hdlq42A/J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq42A/J/Hdlq42C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq42C57BL/6J/Hdlq42C57BL/6J
Hdlq44A/J/Hdlq44A/J
(involves: A/J * C57BL/6J) 		decreased circulating HDL cholesterol level J:114073
Hdlq43C57BL/6J/Hdlq43C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq44A/J/Hdlq44C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq44C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq44C57BL/6J/Hdlq44C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq45A/J/Hdlq45C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq45C57BL/6J/Hdlq45C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq46C57BL/6J/Hdlq46C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq47C57BL/6J/Hdlq47C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq48C57BL/6J/Hdlq48C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq49A/J/Hdlq49C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq49C57BL/6J/Hdlq49C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq50A/J/Hdlq50C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq50C57BL/6J/Hdlq50C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq51A/J/Hdlq51C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq51C57BL/6J/Hdlq51C57BL/6J
(involves: A/J * C57BL/6J) 		increased circulating HDL cholesterol level J:114073
Hdlq52129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq53129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq54129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq55129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq56C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq57129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq67129S1/SvImJ/?
(involves: 129S1/SvImJ * CAST/Ei) 		increased circulating HDL cholesterol level J:88732
Hdlq83PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq83PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ) 		increased circulating HDL cholesterol level J:112668
Hdlq89RIIIS/J/?
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating HDL cholesterol level J:89282
Hdlq90RIIIS/J/?
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating HDL cholesterol level J:89282
Hdlq92C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Hdlq99129S1/SvImJ/Hdlq99129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating HDL cholesterol level J:89282
Hdlq99129S1/SvImJ/Hdlq99RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J) 		increased circulating HDL cholesterol level J:89282
Hdlq102129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Heatr3tm1a(EUCOMM)Hmgu/Heatr3+
(C57BL/6N-Heatr3tm1a(EUCOMM)Hmgu/Ics) 		increased circulating glycerol level J:165965
Hellstm1a(EUCOMM)Wtsi/Hellstm1a(EUCOMM)Wtsi
(C57BL/6N-Hellstm1a(EUCOMM)Wtsi/Ieg) 		decreased circulating cholesterol level J:165965
decreased circulating LDL cholesterol level J:165965
decreased circulating triglyceride level J:165965
Helz2tm1Tesa/Helz2tm1Tesa
(B6.Cg-Helz2tm1Tesa) 		abnormal lipid level J:218127
decreased liver triglyceride level J:218127
Hexblysd/Hexblysd
(B6.Cg-Hexblysd/J) 		abnormal lipid homeostasis J:301674
Hfetm2Sly/Hfetm2Sly
(involves: 129X1/SvJ * C57BL/6J) 		decreased brain cholesterol level J:213886
Hgsnatem4(IMPC)Tcp/Hgsnatem4(IMPC)Tcp
(C57BL/6NCrl-Hgsnatem4(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Hif1atm1Stom/Hif1atm1Stom
Tg(Vil1-cre)20Syr/0
(B6.Cg-Hif1atm1Stom Tg(Vil1-cre)20Syr) 		increased bile salt level J:325395
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo) 		decreased circulating cholesterol level J:160941
decreased circulating HDL cholesterol level J:160941
decreased circulating LDL cholesterol level J:160941
decreased circulating triglyceride level J:160941
decreased circulating VLDL triglyceride level J:160941
decreased liver triglyceride level J:160941
increased circulating cholesterol level J:160941
Hilpdatm1Xen/Hilpdatm1Xen
(C57BL/6-Hilpdatm1Xen) 		increased circulating HDL cholesterol level J:301866
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J) 		decreased circulating triglyceride level J:237329
increased circulating cholesterol level J:237329
increased circulating corticosterone level J:237329
increased liver triglyceride level J:237329
hipr/hipr
(involves: C57BL/6J) 		increased circulating corticosterone level J:196485
Hkdc1tm1a(KOMP)Wtsi/Hkdc1+
(involves: C57BL/6N) 		decreased liver triglyceride level J:240354
Hlb206/?
(C57BL/6J-Hlb206) 		decreased circulating HDL cholesterol level J:82961
Hlb211/?
(involves: 129 * C57BL/6) 		increased circulating HDL cholesterol level J:82961
Hlb212/?
(involves: 129 * C57BL/6) 		increased circulating HDL cholesterol level J:82961
Hlb216/?
(C57BL/6J-Hlb216) 		decreased circulating HDL cholesterol level J:82961
Hlb237/?
(C57BL/6J-Hlb237) 		decreased circulating cholesterol level J:82961
decreased circulating HDL cholesterol level J:82961
Hlb239/?
(involves: 129 * C57BL/6) 		increased circulating cholesterol level J:82961
increased circulating HDL cholesterol level J:82961
Hlb240/?
(involves: 129 * C57BL/6) 		increased circulating HDL cholesterol level J:82961
hlb241/?
(C57BL/6J-hlb241/J) 		decreased circulating HDL cholesterol level J:82961
increased circulating cholesterol level J:82961
hlb242/?
(C57BL/6J-hlb242/J) 		increased circulating cholesterol level J:82961
hlb243/hlb243
(C57BL/6J-hlb243/J) 		increased circulating cholesterol level J:82961
increased circulating HDL cholesterol level J:82961
Hlb245/?
(C57BL/6J-Hlb245/J) 		increased circulating cholesterol level J:82961
Hlb250/?
(involves: 129 * C57BL/6) 		increased circulating HDL cholesterol level J:82961
Hlb252/?
(involves: 129 * C57BL/6) 		decreased circulating cholesterol level J:82961
decreased circulating HDL cholesterol level J:82961
Hlb280/?
(C57BL/6J-Hlb280/J) 		increased circulating HDL cholesterol level J:82961
Hlb295/?
(C57BL/6J-Hlb295) 		decreased circulating HDL cholesterol level J:82961
Hlb299/?
(C57BL/6J-Hlb299/J) 		increased circulating cholesterol level J:82961
Hlb300/?
(C57BL/6J-Hlb300) 		increased circulating cholesterol level J:82961
hlb388/hlb388
(C57BL/6J-hlb388/J) 		increased circulating HDL cholesterol level J:77944
Hlb395/?
(C57BL/6J-Hlb395) 		increased circulating triglyceride level J:82961
Hlb396/?
(C57BL/6J-Hlb396) 		increased circulating HDL cholesterol level J:82961
Hlb397/?
(C57BL/6J-Hlb397/J) 		increased circulating HDL cholesterol level J:82961
Hlb446/?
(C57BL/6J-Hlb446/J) 		increased circulating HDL cholesterol level J:82961
Hlb476/?
(C57BL/6J-Hlb476/J) 		increased circulating HDL cholesterol level J:82961
Hlb477/Hlb477
(C57BL/6J-Hlb477/J) 		increased circulating HDL cholesterol level J:82961
hlb497/hlb497
(C57BL/6J-hlb497/J) 		increased circulating triglyceride level J:82961
hlb505/?
(C57BL/6J-hlb505/J) 		increased circulating triglyceride level J:77944
Hlb529/?
(C57BL/6J-Hlb529/J) 		increased circulating HDL cholesterol level J:82961
hlb560/?
(C57BL/6J-hlb560/J) 		increased circulating triglyceride level J:77944
Hlb561/?
(C57BL/6J-Hlb561/J) 		increased circulating HDL cholesterol level J:82961
Hlb586/?
(C57BL/6J-Hlb586/J) 		increased circulating HDL cholesterol level J:82961
Hlb589/?
(C57BL/6J-Hlb589/J) 		increased circulating HDL cholesterol level J:82961
Hlb592/?
(C57BL/6J-Hlb592/J) 		increased circulating HDL cholesterol level J:82961
Hlb594/?
(C57BL/6J-Hlb594/J) 		increased circulating HDL cholesterol level J:82961
Hmgcrem1Bcgen/Hmgcrem1Bcgen
(Not Specified) 		increased circulating triglyceride level J:299971
Hmgcrem1Bcgen/Hmgcrem1Bcgen
Usp20em1Gpt/Usp20em1Gpt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA) 		increased circulating triglyceride level J:299971
Hmgcrtm2Ishi/Hmgcrtm2Ishi
Tg(Alb1-cre)1Dlr/0
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased circulating cholesterol level J:201488
decreased circulating LDL cholesterol level J:201488
decreased circulating triglyceride level J:201488
decreased liver cholesterol level J:201488
increased circulating cholesterol level J:201488
increased circulating free fatty acids level J:201488
increased circulating LDL cholesterol level J:201488
increased circulating phospholipid level J:201488
increased fatty acids level J:201488
increased liver triglyceride level J:201488
increased unsaturated fatty acids level J:201488
Hmgcs2em1(IMPC)Tcp/Hmgcs2+
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		abnormal circulating ketone body level J:326918
Hmgcs2em1(IMPC)Tcp/Hmgcs2em1(IMPC)Tcp
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp) 		decreased circulating ketone body level J:326918
increased liver triglyceride level J:326918
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ) 		decreased circulating corticosterone level J:199604
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating corticosterone level J:199604
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N) 		decreased circulating free fatty acids level J:214639
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J) 		increased cholesterol level J:47008
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas) 		increased circulating cholesterol level J:31627
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas) 		increased circulating cholesterol level J:31627
Hnf1btm1Mya/Hnf1btm3Mya
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal lipid homeostasis J:75935
increased circulating cholesterol level J:75935
increased circulating triglyceride level J:75935
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N) 		decreased circulating cholesterol level J:67396
decreased circulating HDL cholesterol level J:67396
decreased circulating triglyceride level J:67396
Hnf4atm1b(EUCOMM)Hmgu/Hnf4a+
(C57BL/6N-Hnf4atm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Hnf4atm2.1Mwei/Hnf4atm2.1Mwei
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		abnormal lipid homeostasis J:106993
decreased circulating cholesterol level J:106993
decreased circulating free fatty acids level J:106993
decreased circulating triglyceride level J:106993
increased circulating ketone body level J:106993
Hpgdtm1Bhk/Hpgdtm1Bhk
(involves: 129P2/OlaHsd) 		increased prostaglandin level J:74466
Hpgdtm1Bhk/Hpgdtm1Bhk
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal prostaglandin level J:105183
Hpgdtm1Ljm/Hpgdtm1Ljm
(involves: 129S6/SvEvTac * C57BL/6) 		increased prostaglandin level J:130001
HpnHlb320/?
(C57BL/6J-HpnHlb320/J) 		decreased circulating HDL cholesterol level J:82961
increased circulating cholesterol level J:82961
HpnHlb320/Hpn+
(involves: C57BL/6J * C57L/J) 		decreased circulating cholesterol level J:187708
decreased circulating HDL cholesterol level J:187708
decreased circulating triglyceride level J:187708
HpnHlb320/HpnHlb320
(C57BL/6J-HpnHlb320/J) 		decreased circulating cholesterol level J:187708
decreased circulating HDL cholesterol level J:187708
decreased circulating triglyceride level J:187708
HpnHlb320/HpnHlb320
(involves: C57BL/6J * C57L/J) 		decreased circulating cholesterol level J:187708
decreased circulating HDL cholesterol level J:187708
decreased circulating triglyceride level J:187708
Hprt1tm1.1(CAG-Smpd1)Jhkh/Hprt1+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal ceramide level J:199833
Hprt1tm6(CAG-fat-1)Geno/Y
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal fatty acids level J:213660
Hrem1(IMPC)H/Hrem1(IMPC)H
(C57BL/6NTac-Hrem1(IMPC)H/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Hrhr/Hrhr
Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1) 		decreased prostaglandin level J:121635
Hrhr/Hrhr
Ptgs2tm1Unc/Ptgs2+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1) 		decreased prostaglandin level J:121635
Hrhr/Hrhr
Tg(KRT14-Ptgs2)1Sumf/0
(involves: C57BL/6 * DBA/2 * FVB/N * SKH1) 		increased prostaglandin level J:121635
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn) 		increased circulating free fatty acids level J:107191
increased liver triglyceride level J:107191
increased skeletal muscle triglyceride level J:107191
Hs2st1tm1.1Je/Hs2st1tm1.1Je
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hs2st1tm1.1Je Speer6-ps1Tg(Alb-cre)21Mgn) 		abnormal lipid homeostasis J:158299
increased circulating triglyceride level J:158299
Hsd3b7tm1Rus/Hsd3b7tm1Rus
(involves: 129S/SvEv * C57BL/6J) 		abnormal bile salt homeostasis J:122973
abnormal cholesterol homeostasis J:122973
decreased circulating triglyceride level J:122973
decreased intestinal cholesterol absorption J:122973
increased fatty acids level J:122973
increased liver triglyceride level J:122973
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd) 		decreased circulating corticosterone level J:189059
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1+
(involves: C57BL/6Jcl * C57BL/6N) 		abnormal corticosterone level J:214146
increased circulating corticosterone level J:214146
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N) 		abnormal corticosterone level J:214146
increased circulating corticosterone level J:214146
Hsd11b1tm1Ggla/Hsd11b1tm1Ggla
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		decreased circulating corticosterone level J:189059
increased circulating HDL cholesterol level J:189059
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1) 		abnormal circulating cholesterol level J:72402
abnormal corticosterone level J:67184, J:45085
abnormal lipid homeostasis J:72402
decreased circulating triglyceride level J:72402
increased circulating cholesterol level J:72402
increased circulating HDL cholesterol level J:72402
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(B6.129P2(Cg)-Hsd11b1tm1Yko) 		decreased circulating LDL cholesterol level J:89080
increased circulating HDL cholesterol level J:89080
Hsd11b2tm1Yko/Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1) 		decreased circulating aldosterone level J:53391
Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal bile salt level J:99925
abnormal lipid homeostasis J:104835
abnormal lipid level J:62314
increased fatty acids level J:201698
Hsd17b4tm2Baes/Hsd17b4tm2Baes
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased fatty acids level J:201698
Hsd17b4tm2Baes/Hsd17b4tm2Baes
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		increased fatty acids level J:201698
Hsd17b7tm1Mpo/Hsd17b7tm1Mpo
(involves: 129S7/SvEvBrd) 		abnormal lipid homeostasis J:160004
Hsd17b13tm1Lex/Hsd17b13tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N) 		decreased fatty acid beta-oxidation J:273927
increased liver triglyceride level J:273927
Hsf2bptm1a(EUCOMM)Hmgu/Hsf2bptm1a(EUCOMM)Hmgu
(C57BL/6N-Hsf2bptm1a(EUCOMM)Hmgu/Cnrm) 		increased circulating HDL cholesterol level J:165965
Hspa5tm1.1(KOMP)Vlcg/Hspa5+
(C57BL/6N-Hspa5tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Hspb3tm1.1(KOMP)Vlcg/Hspb3tm1.1(KOMP)Vlcg
(C57BL/6N-Hspb3tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
htd/htd
(C3H/HeJ-htd/J) 		increased circulating corticosterone level J:68094
Htr2ctm1Arte/Y
(involves: C57BL/6) 		increased circulating corticosterone level J:228775
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk) 		decreased circulating cholesterol level J:142503
decreased circulating triglyceride level J:142503
HypchNZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom) 		increased circulating cholesterol level J:83735
Hyplip2MRL/MpJ/Hyplip2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ) 		decreased circulating HDL cholesterol level J:92871
increased circulating cholesterol level J:92871
increased triglyceride level J:92871
Iars1em2Nsas/Iars1em2Nsas
(C57BL/6-Iars1em2Nsas) 		increased liver triglyceride level J:340986
Icam1tm1Jcgr/Icam1tm1Jcgr
Ldlrtm1Her/Ldlrtm1Her
Vcam1tm1Dmil/Vcam1tm1Dmil
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:69597
Idetm1a(EUCOMM)Wtsi/Idetm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Idetm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg) 		decreased circulating corticosterone level J:192287
Ift25tm1a(EUCOMM)Wtsi/Ift25+
(B6JTyr;B6N-Ift25tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:175295
increased circulating glycerol level J:175295
Ift43tm1b(EUCOMM)Hmgu/Ift43+
(C57BL/6N-Ift43tm1b(EUCOMM)Hmgu/Bay) 		increased circulating cholesterol level J:211773
Ift88Tg737Rpw/Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw) 		increased bile salt level J:73583
Ift88Tg737Rpw/Ift88Tg737Rpw
(C3.FVB-Ift88Tg737Rpw) 		increased bile salt level J:73583
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini) 		abnormal liver triglyceride level J:271356
decreased circulating cholesterol level J:271356
decreased circulating free fatty acids level J:271356
decreased circulating triglyceride level J:271356
Igfalstm1b(KOMP)Wtsi/Igfalstm1b(KOMP)Wtsi
(C57BL/6N-Igfalstm1b(KOMP)Wtsi/Tcp) 		abnormal cholesterol homeostasis J:211773
increased circulating cholesterol level J:211773
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating triglyceride level J:168345
Iigp1cem1Btlr/Iigp1cem1Btlr
(C57BL/6J-Iigp1cem1Btlr) 		abnormal lipid oxidation J:333470
decreased liver free fatty acids level J:333470
increased circulating triglyceride level J:333470
increased liver triglyceride level J:333470
Iigp1cM1Btlr/Iigp1c+
(C57BL/6J-Iigp1cM1Btlr) 		increased liver triglyceride level J:333470
Iigp1cM1Btlr/Iigp1cM1Btlr
(C57BL/6J-Iigp1cM1Btlr) 		increased liver triglyceride level J:333470
Iigp1cM2Btlr/Iigp1c+
(C57BL/6J-Iigp1cM2Btlr) 		increased liver triglyceride level J:333470
Iigp1cM2Btlr/Iigp1cM2Btlr
(C57BL/6J-Iigp1cM2Btlr) 		increased liver triglyceride level J:333470
Ikzf2em2(IMPC)H/Ikzf2em2(IMPC)H
(C57BL/6NTac-Ikzf2em2(IMPC)H/H) 		increased circulating cholesterol level J:211773
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating corticosterone level J:47429
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating corticosterone level J:47429
Il1rntm1Dih/Il1rntm1Dih
(B6.129S-Il1rntm1Dih) 		decreased circulating cholesterol level J:76336
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J) 		decreased circulating cholesterol level J:76336
Il2ratm1b(EUCOMM)Wtsi/Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl) 		abnormal cholesterol homeostasis J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Il4/Il13tm1.1Lky/Il4/Il13tm1.1Lky
Il4/Il13tm1.1Lky/Il4/Il13tm1.1Lky
(involves: 129P2/OlaHsd * BALB/c) 		decreased fatty acids level J:178294
Il4ratm2Fbb/Il4ratm2Fbb
Lyz2tm1(cre)Ifo/?
(involves: 129P2/OlaHsd * BALB/c) 		decreased fatty acids level J:178294
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid level J:129479
decreased circulating cholesterol level J:129479
increased circulating cholesterol level J:129479
increased fatty acids level J:129479
increased leukotriene level J:62283
increased liver triglyceride level J:129479
Il12atm1b(EUCOMM)Hmgu/Il12atm1b(EUCOMM)Hmgu
(C57BL/6N-Il12atm1b(EUCOMM)Hmgu/H) 		increased circulating HDL cholesterol level J:211773
Il13tm1.1(KOMP)Vlcg/Il13tm1.1(KOMP)Vlcg
(C57BL/6N-Il13tm1.1(KOMP)Vlcg/Ucd) 		increased circulating HDL cholesterol level J:211773
Il17rcem1(IMPC)Mbp/Il17rcem1(IMPC)Mbp
(C57BL/6NCrl-Il17rcem1(IMPC)Mbp/MbpMmucd) 		decreased circulating triglyceride level J:211773
Il21rtm1Lex/Il21rtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating triglyceride level J:103485
Il25tm1Lex/Il25tm1Lex
(B6;129S5-Il25tm1Lex/Orl) 		increased circulating triglyceride level J:82809
Ilktm1Star/Ilktm1Star
Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased circulating cholesterol level J:129244
IlkapGt(OST55141)Lex/IlkapGt(OST55141)Lex
(B6;129S5-IlkapGt(OST55141)Lex/Ieg) 		increased cholesterol level J:82809
Ilruntm1a(KOMP)Wtsi/Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal cholesterol homeostasis J:302091
abnormal circulating non-HDL cholesterol level J:302091
decreased circulating cholesterol level J:302091
decreased circulating HDL cholesterol level J:302091
decreased circulating LDL cholesterol level J:302091
decreased circulating phospholipid level J:302091
decreased circulating triglyceride level J:302091
decreased circulating VLDL triglyceride level J:302091
decreased liver cholesterol level J:302091
decreased liver triglyceride level J:302091
Impactem1(IMPC)Ccpcz/Impactem1(IMPC)Ccpcz
(C57BL/6NCrl-Impactem1(IMPC)Ccpcz/Ccpcz) 		increased circulating HDL cholesterol level J:211773
Ing5em1(IMPC)J/Ing5em1(IMPC)J
(C57BL/6NJ-Ing5em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Inpp5ktm1Brd/Inpp5k+
(B6.Cg-Inpp5ktm1Brd) 		decreased cholesterol level J:139745
decreased circulating free fatty acids level J:139745
decreased circulating triglyceride level J:139745
Inppl1tm1Glas/Inppl1tm1Glas
(involves: C57BL/6J) 		abnormal lipid homeostasis J:96048
decreased circulating cholesterol level J:96048
decreased circulating free fatty acids level J:96048
decreased circulating triglyceride level J:96048
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas) 		increased circulating triglyceride level J:40377
Ins2Akita/?
(involves: C57BL/6NSlc) 		decreased circulating triglyceride level J:130021
decreased liver triglyceride level J:130021
decreased skeletal muscle triglyceride level J:130021
Ins2Akita/Ins2Akita
Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Ins2Akita Ldlrtm1Her) 		increased circulating cholesterol level J:174983
increased circulating HDL cholesterol level J:174983
increased circulating LDL cholesterol level J:174983
increased circulating triglyceride level J:174983
increased circulating VLDL cholesterol level J:174983
Ins2tm1Delt/Ins2+
(involves: 129S2/SvPas * Black Swiss) 		increased circulating ketone body level J:94589
Insig1em1(IMPC)Ccpcz/Insig1em1(IMPC)Ccpcz
(C57BL/6N-Insig1em1(IMPC)Ccpcz/Ccpcz) 		abnormal cholesterol homeostasis J:211773
Insig1tm1.1Aztc/Insig1tm1.1Aztc
(Not Specified) 		decreased circulating triglyceride level J:208931
Insig1tm1Mbjg/Insig1tm1Mbjg
Insig2tm1Mbjg/Insig2tm1Mbjg
Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL) 		abnormal cholesterol homeostasis J:101203
abnormal lipid homeostasis J:101203
decreased circulating triglyceride level J:101203
increased circulating cholesterol level J:101203
increased fatty acids level J:101203
increased liver cholesterol level J:101203
increased liver triglyceride level J:101203
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		increased circulating free fatty acids level J:32538
increased circulating triglyceride level J:32538
Insrtm1Jja/Insrtm1Jja
Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2) 		increased triglyceride level J:80773
Insrtm1Khn/Insrtm1Khn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB) 		abnormal lipid homeostasis J:63878
decreased circulating free fatty acids level J:63878
decreased circulating triglyceride level J:63878
increased bile salt level J:92861
Insrtm1Khn/Insrtm1Khn
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6J * FVB) 		increased fatty acids level J:51266
increased triglyceride level J:51266
Insrtm1Khn/Insrtm1Khn
Tg(Myhca-cre)1Abel/0
(involves: 129S4/SvJae * FVB) 		abnormal lipid homeostasis J:75348
Insrtm1Khn/Insrtm1Khn
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6J * SJL) 		increased circulating triglyceride level J:64790
Insrtm1Khn/Insrtm1Khn
Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB) 		increased circulating free fatty acids level J:169404
Ints12tm1b(EUCOMM)Wtsi/Ints12+
(C57BL/6N-Ints12tm1b(EUCOMM)Wtsi/H) 		increased circulating triglyceride level J:211773
Ipo7em1(IMPC)Mbp/Ipo7+
(C57BL/6N-Ipo7em1(IMPC)Mbp/Ucd) 		increased circulating triglyceride level J:211773
Irf4tm1Rdf/Irf4tm1Rdf
Tg(Ucp1-cre)1Evdr/0
(involves: 129S1/Sv * C57BL/6J * FVB) 		decreased fatty acid oxidation J:214637
Irf8tm1b(KOMP)Wtsi/Irf8tm1b(KOMP)Wtsi
(C57BL/6N-Irf8tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Irgm1em1(IMPC)Wtsi/Irgm1em1(IMPC)Wtsi
(C57BL/6N-Irgm1em1(IMPC)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Irs1tm1Jos/Irs1tm1Jos
Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		decreased circulating free fatty acids level J:80976
decreased circulating triglyceride level J:80976
decreased triglyceride level J:80976
Irs1tm1Mfw/Irs1tm1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal triglyceride level J:137845
decreased circulating cholesterol level J:137845
decreased circulating free fatty acids level J:137845
decreased circulating HDL cholesterol level J:137845
decreased circulating triglyceride level J:137845
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA) 		abnormal lipid level J:47029
decreased circulating HDL cholesterol level J:47029
increased circulating free fatty acids level J:99746
increased circulating triglyceride level J:47029, J:99746
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal lipid homeostasis J:96047
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA) 		increased circulating cholesterol level J:99746
increased circulating free fatty acids level J:99746
increased circulating HDL cholesterol level J:99746
increased circulating triglyceride level J:99746
Irs2tm2Tka/Irs2tm2Tka
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6) 		increased circulating cholesterol level J:93416
increased circulating triglyceride level J:93416
Ism1em1(IMPC)Ccpcz/Ism1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ism1em1(IMPC)Ccpcz/Ccpcz) 		increased circulating cholesterol level J:211773
Itga8tm1b(KOMP)Wtsi/Itga8+
(C57BL/6N-Itga8tm1b(KOMP)Wtsi/J) 		increased circulating free fatty acids level J:211773
Itgb1tm1Efu/Itgb1tm1Efu
Tg(Vil1-cre)997Gum/0
(involves: 129X1/SvJ * C57BL/6J * SJL) 		abnormal circulating lipid level J:119155
steatorrhea J:119155
Itgb3tm1Hyn/Itgb3tm1Hyn
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:83615
Itgbl1em1(IMPC)Kmpc/Itgbl1em1(IMPC)Kmpc
(C57BL/6NTac-Itgbl1em1(IMPC)Kmpc/Kmpc) 		increased circulating triglyceride level J:211773
Itm2cem2(IMPC)Tcp/Itm2cem2(IMPC)Tcp
(C57BL/6NCrl-Itm2cem2(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Itpr2tm1Kmik/Itpr2tm1Kmik
Itpr3tm1Kmik/Itpr3tm1Kmik
(involves: 129S4/SvJae * C57BL/6J) 		abnormal feces lipid level J:101380
steatorrhea J:101380
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa) 		decreased liver triglyceride level J:144968
decreased skeletal muscle triglyceride level J:144968
Jag1tm1Frad/Jag1tm1Frad
Tg(Tagln-cre)1Her/0
(B6.Cg-Jag1tm1Frad Tg(Tagln-cre)1Her) 		increased circulating cholesterol level J:166890
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		decreased circulating cholesterol level J:199153
decreased triglyceride level J:199153
Jakmip3em1(IMPC)J/Jakmip3em1(IMPC)J
(C57BL/6NJ-Jakmip3em1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J) 		decreased liver triglyceride level J:210545
increased circulating cholesterol level J:210545
Kash5em1(IMPC)J/Kash5em1(IMPC)J
(C57BL/6NJ-Kash5em1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Kat2bem1(IMPC)Wtsi/Kat2bem1(IMPC)Wtsi
(C57BL/6N-Kat2bem1(IMPC)Wtsi/WtsiIeg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Kat8em1(IMPC)Mbp/Kat8+
(C57BL/6N-Kat8em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
Kat8tm1.2Avo/Kat8tm1.2Avo
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		increased fatty acids level J:291094
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr) 		increased liver triglyceride level J:236520
Kcna6tm1Lex/Kcna6tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating triglyceride level J:103485
Kcnab3tm1.1(KOMP)Vlcg/Kcnab3tm1.1(KOMP)Vlcg
(C57BL/6N-Kcnab3tm1.1(KOMP)Vlcg/Ucd) 		abnormal cholesterol homeostasis J:211773
Kcne1tm1Sfh/Kcne1tm1Sfh
(involves: 129S1/Sv) 		increased circulating aldosterone level J:77288
Kcne3tm1Gwab/Kcne3tm1Gwab
(involves: C57BL/6) 		decreased circulating HDL cholesterol level J:210381
increased circulating aldosterone level J:210381
increased circulating cholesterol level J:210381
increased circulating LDL cholesterol level J:210381
Kcnh3tm1.1(KOMP)Vlcg/Kcnh3+
(C57BL/6N-Kcnh3tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba
Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating aldosterone level J:131927
Kcnk3tm1Sgb/Kcnk3tm1Sgb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating aldosterone level J:188335
Kctd1em1(IMPC)J/Kctd1em1(IMPC)J
(C57BL/6NJ-Kctd1em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Kctd19em1(IMPC)J/Kctd19em1(IMPC)J
(C57BL/6NJ-Kctd19em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Kdm3atm1.1Jsak/Kdm3atm1.1Jsak
(involves: C57BL/6 * CBA) 		increased circulating cholesterol level J:158258
increased circulating triglyceride level J:158258
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha) 		hyperlipidemia J:147295
increased circulating cholesterol level J:147295
increased circulating free fatty acids level J:147295
increased circulating triglyceride level J:147295
Kics2tm1b(KOMP)Wtsi/Kics2tm1b(KOMP)Wtsi
(C57BL/6N-Kics2tm1b(KOMP)Wtsi/Nju) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Kif2ctm1.1(KOMP)Vlcg/Kif2c+
(C57BL/6N-Kif2ctm1.1(KOMP)Vlcg/Rbrc) 		increased circulating triglyceride level J:211773
Kif13bGt(AF0005)Wtsi/Kif13bGt(AF0005)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating cholesterol level J:282570
increased circulating HDL cholesterol level J:282570
increased circulating LDL cholesterol level J:282570
Kif13btm1.1Noh/Kif13btm1.1Noh
(B6.Cg-Kif13btm1.1Noh) 		increased circulating cholesterol level J:208261
increased circulating HDL cholesterol level J:208261
increased circulating LDL cholesterol level J:208261
Kif13btm1b(EUCOMM)Wtsi/Kif13btm1b(EUCOMM)Wtsi
(C57BL/6N-Kif13btm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Kif18btm1a(EUCOMM)Wtsi/Kif18b+
(C57BL/6N-Kif18btm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Kif26btm2b(KOMP)Wtsi/Kif26b+
(C57BL/6N-Kif26btm2b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae) 		decreased circulating cholesterol level J:181650
decreased circulating triglyceride level J:181650
KitMhdasco5/KitMhdasco5
(C3HeB/FeJ-KitMhdasco5) 		decreased circulating cholesterol level J:125831
decreased circulating HDL cholesterol level J:125831
decreased circulating LDL cholesterol level J:125831
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J) 		increased vitamin D level J:229255
Kltm1Yin/Kltm1Yin
(Not Specified) 		abnormal vitamin D level J:86859
Klbtm1.1Akha/Klbtm1.1Akha
(C57BL/6-Klbtm1.1Akha) 		abnormal circulating cholesterol level J:195570
abnormal circulating ketone body level J:195570
decreased circulating cholesterol level J:195570
Klbtm1.2Sakl/Klb+
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased circulating cholesterol level J:189018
decreased circulating free fatty acids level J:189018
decreased circulating triglyceride level J:189018
decreased liver cholesterol level J:189018
decreased liver triglyceride level J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased circulating triglyceride level J:189018
Klbtm1.2Sakl/Klbtm1.2Sakl
Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6) 		decreased circulating free fatty acids level J:189018
Klbtm1Yin/Klbtm1Yin
(involves: C57BL/6 * CBA) 		abnormal bile salt homeostasis J:100209
Klc2tm1e(EUCOMM)Wtsi/Klc2tm1e(EUCOMM)Wtsi
(C57BL/6N-Klc2tm1e(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Klf14tm1.1Yec/Klf14tm1.1Yec
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased circulating HDL cholesterol level J:226403
Klf15hlb444/?
(C57BL/6J-Klf15hlb444/J) 		increased circulating triglyceride level J:77944
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain) 		increased circulating ketone body level J:129763
increased glycerol level J:129763
Klhl3tm1.1Slin/Klhl3+
(Not Specified) 		increased circulating aldosterone level J:284284
Klhl3tm1.1Slin/Klhl3tm1.1Slin
(Not Specified) 		increased circulating aldosterone level J:284284
Klhl5tm1b(EUCOMM)Hmgu/Klhl5tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl5tm1b(EUCOMM)Hmgu/Ccpcz) 		increased circulating triglyceride level J:211773
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH) 		increased circulating cholesterol level J:203736
increased circulating triglyceride level J:203736
increased liver free fatty acids level J:203736
increased liver triglyceride level J:203736
Kmt2ctm1.1Jwle/Kmt2c+
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd * 129X1/SvJ) 		increased bile salt level J:301497
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd) 		increased bile salt level J:301497
Kpna1tm1.2Yyo/Kpna1tm1.2Yyo
(involves: 129S2/SvPas * C57BL/6 * SJL) 		decreased circulating cholesterol level J:188099
Kpna2em1(IMPC)Mbp/Kpna2+
(C57BL/6N-Kpna2em1(IMPC)Mbp/Ucd) 		abnormal cholesterol homeostasis J:211773
Krt7tm1b(KOMP)Wtsi/Krt7tm1b(KOMP)Wtsi
(C57BL/6N-Krt7tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating free fatty acids level J:211773
decreased circulating HDL cholesterol level J:211773
Krt34em1(IMPC)Ccpcz/Krt34em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt34em1(IMPC)Ccpcz/Ccpcz) 		increased circulating HDL cholesterol level J:211773
Krtap17-1tm1.1(KOMP)Vlcg/Krtap17-1tm1.1(KOMP)Vlcg
(C57BL/6N-Krtap17-1tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		decreased fatty acids level J:244365
Lactbtm1.1(KOMP)Mbp/Lactbtm1.1(KOMP)Mbp
(C57BL/6N-Lactbtm1.1(KOMP)Mbp/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Lama2dy/Lama2dy
(129P1/ReJ-Lama2dy/J) 		abnormal galactolipid level J:7911
abnormal lipid level J:7911
increased cholesterol level J:7911
Lama5tm2Jhm/Lama5tm1Jhm
Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		increased circulating cholesterol level J:185850
Lamb2npht/Lamb2npht
(involves: C57BL/6) 		increased circulating cholesterol level J:208069
increased circulating triglyceride level J:208069
Lamp2tm1Amcu/Y
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal lipid homeostasis J:215605
increased liver triglyceride level J:215605
Larp1em1(IMPC)Mbp/Larp1+
(C57BL/6N-Larp1em1(IMPC)Mbp/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Larp6em1(IMPC)Tcp/Larp6em1(IMPC)Tcp
(C57BL/6NCrl-Larp6em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Lca5lem1(IMPC)Ics/Lca5lem1(IMPC)Ics
(C57BL/6N-Lca5lem1(IMPC)Ics/Ics) 		increased circulating cholesterol level J:211773
Lcattm1Hgc/Lcat+
(involves: C57BL/6 * DBA) 		decreased circulating cholesterol level J:41208
Lcattm1Hgc/Lcattm1Hgc
(involves: C57BL/6 * DBA) 		abnormal lipid homeostasis J:41208
abnormal lipid level J:41208
decreased cholesterol level J:41208
decreased circulating cholesterol level J:41208
decreased circulating HDL cholesterol level J:41208
increased cholesterol level J:41208
Lcattm1Hgc/Lcattm1Hgc
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal cholesterol homeostasis J:75567
abnormal lipid homeostasis J:75567
decreased circulating HDL cholesterol level J:75567
Lcattm1Hgc/Lcattm1Hgc
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA) 		abnormal cholesterol homeostasis J:89015, J:75567
abnormal lipid homeostasis J:89015, J:75567
decreased circulating HDL cholesterol level J:89015, J:75567
decreased circulating LDL cholesterol level J:89015
increased circulating cholesterol level J:75567
increased circulating triglyceride level J:89015, J:75567
increased circulating VLDL cholesterol level J:89015, J:75567
Lcattm1Hgc/Lcattm1Hgc
Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		abnormal lipid homeostasis J:93775
decreased circulating HDL cholesterol level J:93775
decreased circulating LDL cholesterol level J:93775
decreased circulating triglyceride level J:93775
increased circulating cholesterol level J:93775
increased circulating phospholipid level J:93775
increased circulating VLDL cholesterol level J:93775
Lcattm1Nsa/Lcat+
(involves: 129X1/SvJ * C57BL/6J) 		abnormal cholesterol homeostasis J:39237
abnormal lipid level J:39237
decreased circulating cholesterol level J:39237
decreased circulating HDL cholesterol level J:39237
increased circulating triglyceride level J:39237
Lcattm1Nsa/Lcattm1Nsa
(involves: 129X1/SvJ * C57BL/6J) 		abnormal cholesterol homeostasis J:39237
abnormal lipid level J:39237
decreased circulating cholesterol level J:39237
decreased circulating HDL cholesterol level J:39237
increased circulating triglyceride level J:39237
Lcattm1Nsa/Lcattm1Nsa
(B6.Cg-Lcattm1Nsa) 		abnormal circulating phospholipid level J:69299
abnormal lipid level J:69299
decreased circulating cholesterol level J:69299
decreased circulating HDL cholesterol level J:69299
decreased circulating VLDL cholesterol level J:69299
increased circulating triglyceride level J:69299
Lch/Lch+
(involves: BALB/c * C3H/HeH) 		decreased circulating cholesterol level J:72447, J:79719
decreased circulating HDL cholesterol level J:72447, J:79719
Lch2/Lch2+
(involves: BALB/c * C3H/HeH) 		decreased circulating cholesterol level J:79719, J:79307
decreased circulating HDL cholesterol level J:79719, J:79307
Lclat1tm1Arai/Lclat1tm1Arai
(C57BL/6-Lclat1tm1Arai) 		abnormal lipid homeostasis J:183129
Lclat1tm1Yugs/Lclat1tm1Yugs
(B6.Cg-Lclat1tm1Yugs) 		abnormal lipid homeostasis J:163077
increased fatty acid oxidation J:163077
Lcn2tm1Aade/Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade) 		increased circulating cholesterol level J:169355
increased circulating LDL cholesterol level J:169355
increased liver triglyceride level J:169355
Ldhatm1a(EUCOMM)Wtsi/Ldha+
(B6JTyr;B6N-Ldhatm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:175295
LdlrHlb301/Ldlr+
(C57BL/6J-LdlrHlb301/J) 		increased circulating cholesterol level J:82961
increased circulating HDL cholesterol level J:82961
LdlrHlb301/LdlrHlb301
(C57BL/6J-LdlrHlb301/J) 		increased circulating cholesterol level J:82961
increased circulating HDL cholesterol level J:82961
LdlrRgsc366/Ldlr+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased circulating cholesterol level J:133634
Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal circulating lipid level J:67282
decreased circulating cholesterol level J:67282
decreased circulating HDL cholesterol level J:67282
Ldlrtm1b(EUCOMM)Wtsi/Ldlrtm1b(EUCOMM)Wtsi
(C57BL/6N-Ldlrtm1b(EUCOMM)Wtsi/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ldlrtm1Her/Ldlr+
(B6.129S7-Ldlrtm1Her) 		increased circulating cholesterol level J:72027
increased circulating triglyceride level J:72027
Ldlrtm1Her/Ldlr+
Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		increased circulating cholesterol level J:72027
increased circulating HDL cholesterol level J:72027
increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased circulating corticosterone level J:108412
increased circulating cholesterol level J:175559
increased circulating free fatty acids level J:175559
increased circulating LDL cholesterol level J:102291
increased circulating triglyceride level J:175559
increased liver cholesterol level J:175559
increased liver triglyceride level J:175559
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd) 		abnormal circulating cholesterol level J:48202
abnormal circulating LDL cholesterol level J:84694
increased circulating cholesterol level J:84694, J:228420, J:48202
increased circulating LDL cholesterol level J:114949, J:169834, J:84694
increased circulating triglyceride level J:48202
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:96110
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her) 		abnormal circulating cholesterol level J:100916, J:130278
abnormal triglyceride level J:130278
decreased circulating HDL cholesterol level J:130794
increased circulating cholesterol level J:61287, J:135078, J:137264, J:72027
increased circulating HDL cholesterol level J:72027
increased circulating LDL cholesterol level J:130794, J:72027
increased circulating triglyceride level J:130278, J:137264, J:72027
increased circulating VLDL cholesterol level J:130278, J:130794
increased circulating VLDL triglyceride level J:130278
increased liver cholesterol level J:72027
increased liver triglyceride level J:130278
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J) 		decreased circulating triglyceride level J:85174
increased cholesterol level J:85174
increased circulating cholesterol level J:104609, J:85174
increased circulating HDL cholesterol level J:85174
increased circulating LDL cholesterol level J:85174, J:149005
increased circulating triglyceride level J:149005
increased circulating VLDL cholesterol level J:85174, J:149005
increased liver cholesterol level J:85174
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA) 		abnormal cholesterol homeostasis J:75567
abnormal lipid homeostasis J:75567
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		increased circulating cholesterol level J:114480
increased circulating LDL cholesterol level J:114480
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased circulating cholesterol level J:29950
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		abnormal circulating cholesterol level J:72027
hyperlipidemia J:72027
increased circulating cholesterol level J:72027
increased circulating HDL cholesterol level J:72027
increased circulating triglyceride level J:72027
increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
Ldlrtm1Her/Ldlrtm1Her
Lipctm1Unc/Lipctm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal lipid level J:108412
decreased circulating corticosterone level J:108412
increased circulating cholesterol level J:108412
increased circulating HDL cholesterol level J:108412
increased circulating LDL cholesterol level J:108412
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
(involves: 129S7/SvEvBrd) 		abnormal cholesterol level J:67929
increased circulating cholesterol level J:67929
increased circulating LDL cholesterol level J:67929
increased circulating triglyceride level J:67929
increased circulating VLDL cholesterol level J:67929
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		increased circulating cholesterol level J:117317
increased circulating triglyceride level J:117317
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		increased circulating cholesterol level J:67929
increased circulating LDL cholesterol level J:67929
increased circulating triglyceride level J:67929
increased circulating VLDL cholesterol level J:67929
Ldlrtm1Her/Ldlrtm1Her
Lrpap1tm1Her/Lrpap1tm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal lipid level J:43736
increased circulating cholesterol level J:43736
increased circulating triglyceride level J:43736
Ldlrtm1Her/Ldlrtm1Her
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:142788
Ldlrtm1Her/Ldlrtm1Her
Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ) 		abnormal circulating VLDL cholesterol level J:116503
decreased circulating cholesterol level J:116503
decreased circulating HDL cholesterol level J:116503
decreased circulating LDL cholesterol level J:116503
Ldlrtm1Her/Ldlrtm1Her
Mobq6CAST/EiJ/Mobq6CAST/EiJ
(B6.CAST-Mobq6CAST/EiJ) 		decreased circulating cholesterol level J:116503
decreased circulating HDL cholesterol level J:116503
decreased circulating LDL cholesterol level J:116503
decreased circulating VLDL cholesterol level J:116503
Ldlrtm1Her/Ldlrtm1Her
Npc1m1N/Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c) 		decreased brain cholesterol level J:130969
increased cholesterol level J:130969
increased circulating LDL cholesterol level J:104996, J:130969
increased liver cholesterol level J:130969
increased lung cholesterol level J:130969
Ldlrtm1Her/Ldlrtm1Her
Nr0b2tm1.1Mjev/Nr0b2tm1.1Mjev
(involves: 129S/SvEvBrd * 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		decreased circulating LDL cholesterol level J:149005
increased circulating HDL cholesterol level J:149005
Ldlrtm1Her/Ldlrtm1Her
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA) 		abnormal cholesterol homeostasis J:184536
decreased circulating cholesterol level J:184536
decreased circulating triglyceride level J:184536
increased liver cholesterol level J:184536
Ldlrtm1Her/Ldlrtm1Her
Nr5a2tm1Sjns/Nr5a2tm1Sjns
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * DBA) 		abnormal feces lipid level J:215556
abnormal sterol level J:215556
Ldlrtm1Her/Ldlrtm1Her
Nr5a2tm3.1Sjns/Nr5a2tm3.1Sjns
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N) 		abnormal cholesterol homeostasis J:215556
decreased cholesterol level J:215556
decreased circulating LDL cholesterol level J:215556
decreased circulating triglyceride level J:215556
increased liver cholesterol level J:215556
Ldlrtm1Her/Ldlrtm1Her
Olr1tm1Meht/Olr1tm1Meht
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6) 		decreased circulating HDL cholesterol level J:130794
increased circulating LDL cholesterol level J:130794
increased circulating VLDL cholesterol level J:130794
Ldlrtm1Her/Ldlrtm1Her
Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ) 		increased circulating LDL cholesterol level J:169834
Ldlrtm1Her/Ldlrtm1Her
Scd1ab-2J/Scd1ab-2J
(B6.Cg-Ldlrtm1Her Scd1ab-2J) 		abnormal circulating cholesterol level J:130278
abnormal lipid level J:130278
abnormal triglyceride level J:130278
decreased circulating triglyceride level J:130278
decreased circulating VLDL cholesterol level J:130278
decreased circulating VLDL triglyceride level J:130278
decreased liver triglyceride level J:130278
Ldlrtm1Her/Ldlrtm1Her
Scd1ab-J/Scd1ab-J
(B6.Cg-Ldlrtm1Her Scd1ab-J) 		abnormal lipid level J:130278
decreased circulating cholesterol level J:130278
decreased circulating triglyceride level J:130278
decreased circulating VLDL cholesterol level J:130278
decreased circulating VLDL triglyceride level J:130278
decreased liver triglyceride level J:130278
Ldlrtm1Her/Ldlrtm1Her
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S-Serpine1tm1Mlg Ldlrtm1Her) 		increased circulating cholesterol level J:61287
Ldlrtm1Her/Ldlrtm1Her
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		decreased circulating cholesterol level J:61147
xanthoma J:61147
Ldlrtm1Her/Ldlrtm1Her
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:96110
Ldlrtm1Her/Ldlrtm1Her
Tg(APOC1)1Lmh/?
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:65146
increased circulating triglyceride level J:65146
increased circulating VLDL cholesterol level J:65146
increased circulating VLDL triglyceride level J:65146
Ldlrtm1Her/Ldlrtm1Her
Tg(APOC3)3707Bres/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J) 		increased circulating LDL cholesterol level J:37861
increased circulating VLDL cholesterol level J:37861
Ldlrtm1Her/Ldlrtm1Her
Tg(APOC3)3707Bres/?
Tg(Mt1-CETP)#Tall/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J) 		decreased circulating HDL cholesterol level J:37861
increased circulating LDL cholesterol level J:37861
increased circulating triglyceride level J:37861
increased circulating VLDL cholesterol level J:37861
Ldlrtm1Her/Ldlrtm1Her
Tg(APOM)NCchr/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * CBA) 		abnormal cholesterol homeostasis J:130647
decreased circulating triglyceride level J:130647
Ldlrtm1Her/Ldlrtm1Her
Tg(APPSWE)2576Kha/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		increased circulating cholesterol level J:114480
increased circulating LDL cholesterol level J:114480
Ldlrtm1Her/Ldlrtm1Her
Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Ldlrtm1Her Tg(CMV-Serpine1)1Dgi) 		increased circulating cholesterol level J:61287
Ldlrtm1Her/Ldlrtm1Her
Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		abnormal circulating cholesterol level J:100916
Ldlrtm1Her/Ldlrtm1Her
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		increased circulating cholesterol level J:76336
increased circulating triglyceride level J:76336
Ldlrtm1Her/Ldlrtm1Her
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir Ldlrtm1Her) 		decreased circulating cholesterol level J:102502
Ldlrap1Gt(OST149604)Lex/Ldlrap1Gt(OST149604)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:102291
increased circulating LDL cholesterol level J:102291
Ldlrap1tm1Her/Ldlrap1tm1Her
(involves: 129S6/SvEvTac) 		abnormal circulating LDL cholesterol level J:84694
increased circulating cholesterol level J:84694
increased circulating LDL cholesterol level J:84694
increased circulating triglyceride level J:84694
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst) 		increased circulating cholesterol level J:167736
increased circulating triglyceride level J:167736
Lepob/Lepob
(involves: C57BL/6J) 		abnormal corticosterone level J:13151
increased circulating corticosterone level J:60001
Lepob/Lepob
(B6.Cg-Lepob/J) 		abnormal circulating cholesterol level J:18161
increased circulating cholesterol level J:18161
increased circulating HDL cholesterol level J:18161
increased circulating LDL cholesterol level J:18161
increased circulating triglyceride level J:18161, J:104171
increased circulating VLDL cholesterol level J:18161
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6) 		increased circulating cholesterol level J:107169
increased circulating corticosterone level J:107169, J:76479
increased circulating triglyceride level J:107169
Lepob/Lepob
(involves: 129 * C57BL/6) 		abnormal lipid level J:121534
Lepob/Lepob
(BKS.Cg-Lepob/J) 		abnormal circulating cholesterol level J:18161
increased circulating cholesterol level J:18161
increased circulating HDL cholesterol level J:18161
increased circulating LDL cholesterol level J:18161
increased circulating triglyceride level J:18161
increased circulating VLDL cholesterol level J:18161
Lepob/Lepob
(B6.Cg-Lepob/JBomTac) 		increased circulating triglyceride level J:149091
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs) 		decreased liver triglyceride level J:199803
increased liver triglyceride level J:199803
Lepob/Lepob
(involves: C57BL/6) 		increased circulating cholesterol level J:72027
increased circulating HDL cholesterol level J:72027
increased circulating triglyceride level J:72027
increased liver cholesterol level J:72027
increased liver triglyceride level J:72027
Lepob/Lepob
(BTBR.Cg-Lepob/WiscJ) 		increased cholesterol level J:185261
increased circulating triglyceride level J:106121, J:185261
Lepob/Lepob
(B6.Cg-Lepob/JRj) 		increased cholesterol level J:277927
increased circulating free fatty acids level J:277927
Lepob/Lepob
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae) 		increased circulating cholesterol level J:231617
increased circulating triglyceride level J:231617
increased liver triglyceride level J:231617
Lepob/Lepob
Nfe2l2tm1.1Jgpi/Nfe2l2tm1.1Jgpi
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		increased circulating triglyceride level J:208590
Lepob/Lepob
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob) 		decreased liver triglyceride level J:208590
increased circulating triglyceride level J:208590
Lepob/Lepob
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating corticosterone level J:107169
increased circulating cholesterol level J:107169
increased circulating triglyceride level J:107169
Lepob/Lepob
Npy2rtm1Pern/Npy2rtm1Pern
(involves: 129 * BALB/c * C57BL/10J) 		decreased circulating free fatty acids level J:102651
decreased circulating LDL cholesterol level J:102651
increased circulating cholesterol level J:102651
increased circulating HDL cholesterol level J:102651
increased triglyceride level J:102651
Lepob/Lepob
Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:76479
Lepob/Lepob
Nr1i3tm1Dgen/Nr1i3tm1Dgen
(B6.Cg-Nr1i3tm1Dgen Lepob) 		decreased circulating triglyceride level J:149091
Lepob/Lepob
Plin4tm1Vlcg/Plin4tm1Vlcg
(involves: C57BL/6J) 		decreased cardiac muscle triglyceride level J:195987
Lepob/Lepob
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6) 		abnormal circulating corticosterone level J:85176
Lepob/Lepob
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		increased circulating triglyceride level J:116568
Lepob/Lepob
Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6) 		abnormal lipid homeostasis J:121534
decreased liver triglyceride level J:121534
decreased triglyceride level J:121534
increased circulating free fatty acids level J:121534
increased circulating triglyceride level J:121534
Lepob/Lepob
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fatty acid beta-oxidation J:189021
increased liver triglyceride level J:189021
Lepob/Lepob
Tg(Eno2-Pomc)1Mobb/?
(involves: C3H * C57BL/6) 		abnormal fatty acids level J:86303
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl) 		abnormal lipid level J:171755
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl) 		increased circulating cholesterol level J:313303
increased circulating HDL cholesterol level J:313303
increased circulating LDL cholesterol level J:313303
increased circulating triglyceride level J:313303
increased liver triglyceride level J:313303
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas) 		increased circulating cholesterol level J:174584
Leprdb/Lepr+
Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J) 		abnormal circulating cholesterol level J:186924
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl) 		increased circulating cholesterol level J:313303
increased circulating HDL cholesterol level J:313303
increased circulating LDL cholesterol level J:313303
increased circulating triglyceride level J:313303
increased liver triglyceride level J:313303
Leprdb/Leprdb
(involves: C57BLKS/J) 		hyperlipidemia J:96047
increased circulating cholesterol level J:232827
increased circulating corticosterone level J:89242
increased circulating free fatty acids level J:106871, J:232827
increased circulating triglyceride level J:232827
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J) 		abnormal circulating cholesterol level J:18161
abnormal circulating lipid level J:18161
increased circulating cholesterol level J:18161
increased circulating HDL cholesterol level J:18161
increased circulating LDL cholesterol level J:18161
increased circulating triglyceride level J:18161, J:82334
increased circulating VLDL cholesterol level J:18161
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J) 		abnormal circulating cholesterol level J:18161
abnormal circulating lipid level J:18161
decreased circulating triglyceride level J:91813
decreased prostaglandin level J:185546
increased circulating cholesterol level J:18161
increased circulating HDL cholesterol level J:18161
increased circulating LDL cholesterol level J:18161
increased circulating triglyceride level J:18161
increased circulating VLDL cholesterol level J:18161
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/JOrlRj) 		increased cholesterol level J:277927
increased circulating ketone body level J:277927
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb) 		increased circulating cholesterol level J:313303
increased circulating HDL cholesterol level J:313303
increased circulating LDL cholesterol level J:313303
increased circulating triglyceride level J:313303
increased liver triglyceride level J:313303
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb) 		increased circulating cholesterol level J:346348
increased circulating triglyceride level J:346348
Leprdb/Leprdb
Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA) 		increased circulating cholesterol level J:232827
increased circulating free fatty acids level J:232827
increased circulating triglyceride level J:232827
increased liver triglyceride level J:232827
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Agrp-cre)1Gsb/0
(involves: 129 * FVB/N) 		decreased liver triglyceride level J:199803
Leprtm1.1Chua/Leprtm1.2Chua
Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:183754
Leprtm1.2Chua/Leprtm1.2Chua
Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:183754
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J) 		increased circulating cholesterol level J:184572
increased circulating triglyceride level J:184572
increased liver triglyceride level J:184572
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ) 		increased liver triglyceride level J:216393
Leprtm1Jke/Leprtm1Jke
Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased circulating cholesterol level J:184572
decreased circulating triglyceride level J:184572
decreased liver triglyceride level J:184572
increased circulating cholesterol level J:184572
increased circulating triglyceride level J:184572
increased liver triglyceride level J:184572
Leprtm1Mgmj/Leprtm1Mgmj
(B6.129-Leprtm1Mgmj) 		increased circulating triglyceride level J:82334
Leprottm1.2Damj/Leprottm1.2Damj
(involves: 129S2/SvPas * C57BL/6N * FVB/N) 		decreased cholesterol level J:349250
Lexis1tm1.1Pton/Lexis1tm1.1Pton
(B6.Cg-Lexis1tm1.1Pton) 		increased liver cholesterol level J:233670
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1) 		increased liver triglyceride level J:116073
Lgals7tm1a(EUCOMM)Wtsi/Lgals7tm1a(EUCOMM)Wtsi
(C57BL/6N-Lgals7tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
increased circulating glycerol level J:211773
Lgals12tm1Ftl/Lgals12tm1Ftl
(B6.129-Lgals12tm1Ftl) 		abnormal free fatty acids level J:180097
decreased triglyceride level J:180097
increased glycerol level J:180097
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6 * MF1) 		decreased circulating triglyceride level J:87585
Lima1tm1.1Blsg/Lima1+
(involves: C57BL/6 * FVB/N) 		decreased circulating cholesterol level J:263730
decreased intestinal cholesterol absorption J:263730
Lima1tm1.1Blsg/Lima1tm1.1Blsg
(involves: C57BL/6 * FVB/N) 		decreased intestinal cholesterol absorption J:263730
Lima1tm1Blsg/Lima1+
Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2) 		decreased intestinal cholesterol absorption J:263730
Lima1tm1Blsg/Lima1tm1Blsg
Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2) 		decreased circulating cholesterol level J:263730
decreased circulating HDL cholesterol level J:263730
decreased circulating LDL cholesterol level J:263730
decreased circulating VLDL cholesterol level J:263730
decreased intestinal cholesterol absorption J:263730
decreased liver cholesterol level J:263730
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac) 		abnormal lipid oxidation J:270182
decreased liver triglyceride level J:270182
decreased unsaturated fatty acids level J:270182
increased circulating cholesterol level J:270182
increased circulating ketone body level J:270182
increased circulating LDL cholesterol level J:270182
increased liver cholesterol level J:270182
increased unsaturated fatty acids level J:270182
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1) 		abnormal lipid level J:68812
decreased circulating HDL cholesterol level J:68812
increased circulating free fatty acids level J:68812
increased circulating LDL cholesterol level J:68812
increased liver cholesterol level J:49674
increased liver triglyceride level J:49674
Lipctm1Unc/Lipctm1Unc
(involves: 129) 		abnormal circulating cholesterol level J:22938
abnormal circulating phospholipid level J:22938
increased circulating cholesterol level J:22938
increased circulating HDL cholesterol level J:22938
Lipctm1Unc/Lipctm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal circulating cholesterol level J:22938
abnormal circulating phospholipid level J:22938
increased circulating cholesterol level J:22938
increased circulating HDL cholesterol level J:22938
Lipctm1Unc/Lipctm1Unc
(B6.129P2-Lipctm1Unc) 		decreased circulating corticosterone level J:108412
increased circulating cholesterol level J:120962
increased circulating triglyceride level J:120962
Lipetm1Gam/Lipetm1Gam
(involves: 129S4/SvJae * BALB/c) 		abnormal circulating cholesterol level J:82299
abnormal circulating free fatty acids level J:82299
decreased liver triglyceride level J:82299
Lipetm1Ishi/Lipetm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased circulating free fatty acids level J:59889
decreased circulating glycerol level J:59889
increased triglyceride level J:59889
Lipetm1Ishi/Lipetm1Ishi
(B6.129S7-Lipetm1Ishi) 		abnormal cholesterol homeostasis J:152385
increased circulating cholesterol level J:152385
increased circulating free fatty acids level J:152385
increased circulating triglyceride level J:152385
Lipetm1Ishi/Lipetm1Ishi
Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129S7-Nceh1tm1Ishi Lipetm1Ishi) 		abnormal cholesterol homeostasis J:152385
increased circulating cholesterol level J:152385
increased circulating free fatty acids level J:152385
increased circulating triglyceride level J:152385
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J) 		abnormal feces lipid level J:133126
Lipetm1Land/Lipetm1Land
(involves: 129) 		abnormal lipid homeostasis J:106148
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal fatty acids level J:74644
abnormal lipid level J:74644
abnormal triglyceride level J:74644
decreased cardiac muscle triglyceride level J:74644
decreased liver triglyceride level J:74644
increased triglyceride level J:74644
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd) 		decreased circulating free fatty acids level J:84822
decreased circulating triglyceride level J:84822
decreased liver triglyceride level J:84822
Lipgtm1Chan/Lipg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal cholesterol homeostasis J:82390
increased circulating cholesterol level J:82390
increased circulating HDL cholesterol level J:82390
Lipgtm1Chan/Lipgtm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal cholesterol homeostasis J:82390
increased circulating cholesterol level J:82390
increased circulating HDL cholesterol level J:82390
increased circulating phospholipid level J:82390
Lipgtm1Tq/Lipg+
(B6.129S6-Lipgtm1Tq) 		increased circulating HDL cholesterol level J:81821
increased circulating phospholipid level J:81821
increased circulating triglyceride level J:81821
Lipgtm1Tq/Lipgtm1Tq
(B6.129S6-Lipgtm1Tq) 		increased circulating cholesterol level J:81821
increased circulating HDL cholesterol level J:81821
increased circulating phospholipid level J:81821
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac * C57BL/6J) 		increased circulating cholesterol level J:93987
increased circulating HDL cholesterol level J:93987
increased circulating phospholipid level J:93987
increased circulating triglyceride level J:93987
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac) 		abnormal circulating HDL cholesterol level J:129942
Lipilpd1/Lipilpd1
(involves: CD-1) 		increased circulating triglyceride level J:46789
increased liver triglyceride level J:46789
Lipq1BALB/cJ/Lipq1C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ) 		increased circulating cholesterol level J:88731
increased circulating HDL cholesterol level J:88731
Lipq1C57BL/6By/Lipq1C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ) 		increased circulating cholesterol level J:88731
increased circulating HDL cholesterol level J:88731
Lipq2BALB/cJ/Lipq2BALB/cJ
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ) 		increased circulating cholesterol level J:88731
increased circulating HDL cholesterol level J:88731
Lipq3BALB/cJ/Lipq3C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ) 		increased circulating cholesterol level J:88731
increased circulating HDL cholesterol level J:88731
Lipq3C57BL/6By/Lipq3C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ) 		increased circulating cholesterol level J:88731
increased circulating HDL cholesterol level J:88731
Lith12CAST/EiJ/Lith12CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal lipid homeostasis J:84711
Lith13129S1/SvImJ/Lith13129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal lipid homeostasis J:84711
Lith14129S1/SvImJ/Lith14CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal lipid homeostasis J:84711
Lith14CAST/EiJ/Lith14CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal lipid homeostasis J:84711
Lith25129S1/SvImJ/Lith25CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal lipid homeostasis J:84711
Lith25CAST/EiJ/Lith25CAST/EiJ
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal lipid homeostasis J:84711
Llgl2tm1b(KOMP)Wtsi/Llgl2+
(C57BL/6N-Llgl2tm1b(KOMP)Wtsi/J) 		decreased circulating HDL cholesterol level J:211773
Lmf1cld/Lmf1cld
(STOCK T/tw73) 		increased circulating cholesterol level J:7083
increased circulating triglyceride level J:7083
Lmf1Gt(OST195742)Lex/Lmf1Gt(OST195742)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		hyperlipidemia J:223457
increased circulating cholesterol level J:223457
increased circulating triglyceride level J:223457
Lmnaem1Fenz/Lmna+
(C57BL/6-Lmnaem1Fenz) 		increased circulating cholesterol level J:338760
increased circulating LDL cholesterol level J:338760
increased liver triglyceride level J:338760
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased circulating ketone body level J:221850
Lmnatm1Gbon/Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6) 		increased triglyceride level J:95528
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6J) 		decreased circulating triglyceride level J:75101
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd) 		abnormal cholesterol homeostasis J:211773
decreased circulating HDL cholesterol level J:211773
Lncenc1em1Smoc/Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc) 		decreased circulating cholesterol level J:306153
decreased circulating HDL cholesterol level J:306153
decreased circulating LDL cholesterol level J:306153
decreased circulating triglyceride level J:306153
decreased liver cholesterol level J:306153
decreased liver triglyceride level J:306153
Lncenc1em2Smoc/Lncenc1em2Smoc
(C57BL/6J-Lncenc1em2Smoc) 		decreased circulating triglyceride level J:306153
Lnpeptm1Ske/Lnpeptm1Ske
(B6.129S-Lnpeptm1Ske) 		decreased circulating cholesterol level J:220356
Lonp1tm1b(EUCOMM)Hmgu/Lonp1+
(C57BL/6N-Lonp1tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating HDL cholesterol level J:211773
Lonrf3tm1a(KOMP)Wtsi/Y
(C57BL/6N-Lonrf3tm1a(KOMP)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Lpar3tm1Jch/Lpar3tm1Jch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased prostaglandin level J:98434
Lpcat1rd11-2J/Lpcat1rd11-2J
(B6.Cg-Lpcat1rd11-2J/BocJ) 		abnormal phospholipid level J:163743
Lpcat1rd11/Lpcat1rd11
(B6.Cg-Lpcat1rd11/BocJ) 		abnormal phospholipid level J:163743
Lpcat2em1(IMPC)J/Lpcat2em1(IMPC)J
(C57BL/6NJ-Lpcat2em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased circulating triglyceride level J:220827
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL) 		abnormal lipid homeostasis J:220827
abnormal lipid level J:220827
abnormal phospholipid level J:220827
decreased circulating triglyceride level J:220827
decreased circulating VLDL phospholipid level J:220827
decreased circulating VLDL triglyceride level J:220827
increased liver cholesterol level J:220827
increased liver triglyceride level J:220827
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6N * SJL) 		abnormal lipid level J:220827
decreased circulating triglyceride level J:220827
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld/J) 		increased fatty acids level J:121022
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld) 		abnormal cholesterol homeostasis J:82882
abnormal lipid homeostasis J:82882
abnormal lipid level J:82882
abnormal phospholipid level J:82882
abnormal triglyceride level J:82882
decreased circulating LDL cholesterol level J:63448
decreased circulating VLDL cholesterol level J:63448
decreased fatty acids level J:63448
decreased triglyceride level J:82882
increased cholesterol level J:82882
increased circulating HDL cholesterol level J:63448
increased circulating triglyceride level J:82882
increased circulating VLDL triglyceride level J:147417
increased fatty acids level J:82882
increased liver triglyceride level J:147417, J:82882
increased triglyceride level J:82882
Lpin1fld/Lpin1fld
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased liver triglyceride level J:220917
decreased triglyceride level J:220917
Lpin1fld/Lpin1fld
Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased liver triglyceride level J:220917
decreased triglyceride level J:220917
Lpin2tm1Reue/Lpin2tm1Reue
(involves: C57BL/6J) 		decreased circulating free fatty acids level J:189894
decreased circulating triglyceride level J:189894
increased liver triglyceride level J:189894
Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J) 		decreased triglyceride level J:220917
Lpltm1Bres/Lpl+
(involves: 129S4/SvJae * C57BL/6J) 		abnormal lipid homeostasis J:30062
increased circulating cholesterol level J:30062
increased circulating triglyceride level J:30062
increased circulating VLDL cholesterol level J:30062
increased circulating VLDL triglyceride level J:30062
Lpltm1Bres/Lpl+
(involves: 129S4/SvJae) 		increased cholesterol level J:134171
increased triglyceride level J:134171
Lpltm1Bres/Lpl+
Tg(Myh6-LPL*)357Ijg/0
(involves: 129S4/SvJae) 		abnormal lipid level J:134550
increased fatty acids level J:134550
Lpltm1Bres/Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J) 		abnormal lipid homeostasis J:30062
decreased circulating HDL cholesterol level J:30062
decreased circulating LDL cholesterol level J:30062
increased circulating cholesterol level J:30062
increased circulating triglyceride level J:30062
increased circulating VLDL cholesterol level J:30062
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6) 		abnormal lipid level J:90737
decreased cardiac muscle triglyceride level J:90737
decreased fatty acids level J:90737
increased circulating triglyceride level J:90737
increased circulating VLDL triglyceride level J:90737
Lpltm1Ijg/Lpltm1Ijg
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N) 		increased circulating triglyceride level J:110484
Lpltm1Sem/Lpl+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:25652
increased circulating cholesterol level J:25652
increased circulating HDL cholesterol level J:25652
increased circulating phospholipid level J:25652
increased circulating triglyceride level J:25652
increased circulating VLDL triglyceride level J:25652
Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating HDL cholesterol level J:25652
hyperlipidemia J:25652
increased circulating cholesterol level J:25652
increased circulating phospholipid level J:25652
increased circulating triglyceride level J:25652
Lprq1MRL/MpJ/Lprq1MRL/MpJ
(involves: BALB/cJ * MRL/MpJ) 		decreased circulating cholesterol level J:53728
decreased circulating VLDL cholesterol level J:53728
Lprq2MRL/MpJ/Lprq2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ) 		decreased circulating HDL cholesterol level J:53728
Lprq3NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:29072
Lprq4NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J) 		abnormal circulating cholesterol level J:29072
increased circulating HDL cholesterol level J:29072
Lrbaem1(IMPC)Wtsi/Lrbaem1(IMPC)Wtsi
(C57BL/6N-Lrbaem1(IMPC)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Lrig3tm1.1Hhed/Lrig3tm1.1Hhed
(B6.129(Cg)-Lrig3tm1.1Hhed) 		decreased circulating glycerol level J:242435
decreased circulating HDL cholesterol level J:242435
Lrp1tm2Her/Lrp1tm2Her
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL) 		abnormal lipid level J:167724
decreased brain cholesterol level J:167724
decreased triglyceride level J:167724
Lrp1tm2Her/Lrp1tm2Her
Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal circulating lipid level J:127398
abnormal lipid homeostasis J:127398
decreased circulating free fatty acids level J:127398
decreased liver triglyceride level J:127398
Lrp2tm1Tew/Lrp2tm1Tew
Tg(APOE-cre)VITew/0
(Not Specified) 		abnormal vitamin D level J:81496
Lrp5tm1Jsak/Lrp5+
(involves: C57BL/6 * CBA) 		increased cholesterol level J:81174
Lrp5tm1Jsak/Lrp5tm1Jsak
(involves: C57BL/6 * CBA) 		increased cholesterol level J:81174
increased circulating VLDL cholesterol level J:81174
Lrp6Gt(LST067)Byg/Lrp6+
(involves: 129P2/OlaHsd) 		abnormal lipid homeostasis J:155275
Lrp6Gt(LST067)Byg/Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg) 		decreased liver triglyceride level J:182772
Lrp6tm1Arma/Lrp6+
(C57BL/6-Lrp6tm1Arma) 		increased cholesterol level J:210538
increased circulating LDL cholesterol level J:210538
increased circulating triglyceride level J:210538
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma) 		abnormal fatty acids level J:210538
abnormal lipid homeostasis J:210538
hyperlipidemia J:210538
increased cholesterol level J:210538
increased circulating LDL cholesterol level J:210538
increased circulating triglyceride level J:210538
increased circulating VLDL triglyceride level J:210538
increased liver cholesterol level J:210538, J:225450
increased liver triglyceride level J:210538
Lrrk1tm1b(KOMP)Wtsi/Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Lrrk2tm1.1Hlme/Lrrk2tm1.1Hlme
(involves: C57BL/6 * C57BL/6J) 		abnormal lipid level J:223350
Lst1tm1.1(KOMP)Vlcg/Lst1tm1.1(KOMP)Vlcg
(C57BL/6N-Lst1tm1.1(KOMP)Vlcg/Ucd) 		increased circulating triglyceride level J:211773
Ltbp1tm1a(EUCOMM)Wtsi/Ltbp1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ltbp1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Ltkem1(IMPC)H/Ltkem1(IMPC)H
(C57BL/6NTac-Ltkem1(IMPC)H/H) 		increased circulating HDL cholesterol level J:211773
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Lypd3tm1.1(KOMP)Vlcg/Lypd3+
(C57BL/6N-Lypd3tm1.1(KOMP)Vlcg/Ucd) 		increased circulating triglyceride level J:211773
Lyplal1em1Espel/Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel) 		decreased liver triglyceride level J:340413
increased circulating triglyceride level J:340413
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac) 		decreased liver triglyceride level J:234643
increased circulating triglyceride level J:234643
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6) 		abnormal lipid homeostasis J:222253
decreased circulating phospholipid level J:222253
Malrd1C57BL/6ByJ/Malrd1C57BL/6ByJ
(involves: A/J * C57BL/6J) 		decreased circulating LDL cholesterol level J:61563
decreased circulating VLDL cholesterol level J:61563
Mamld1tm1.1(NCOM)Mfgc/Y
(C57BL/6N-Mamld1tm1.1(NCOM)Mfgc/Tcp) 		abnormal cholesterol homeostasis J:211773
Map3k1tm1a(KOMP)Wtsi/Map3k1+
(C57BL/6N-Map3k1tm1a(KOMP)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Map3k10tm1b(EUCOMM)Hmgu/Map3k10tm1b(EUCOMM)Hmgu
(C57BL/6N-Map3k10tm1b(EUCOMM)Hmgu/Cnrm) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mapk8tm1Jcbr/Mapk8tm1Jcbr
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased liver triglyceride level J:158650
Mapk8tm1Rjd/Mapk8tm1Rjd
Mapk9tm2.1Rjd/Mapk9tm2.1Rjd
Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd) 		abnormal lipid homeostasis J:192551
Mapk8ip1tm3.1Rjd/Mapk8ip1tm3.1Rjd
(B6.129S6-Mapk8ip1tm3.1Rjd) 		decreased liver triglyceride level J:163808
Marchf5tm1.1Ygi/Marchf5tm1.1Ygi
Tg(Emx1-cre)#Ito/0
(involves: C57BL/6) 		abnormal phospholipid level J:284572
Marchf9tm1a(EUCOMM)Wtsi/Marchf9tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating HDL cholesterol level J:165965
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating cholesterol level J:120128
decreased circulating triglyceride level J:120128
Mark4Gt(XG191)Byg/Mark4Gt(XG191)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:192469
decreased circulating triglyceride level J:192469
Mboat4tm2Vlcg/Mboat4tm2Vlcg
(Not Specified) 		increased bile salt level J:180107
Mboat7tm1a(KOMP)Wtsi/Mboat7tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		abnormal lipid homeostasis J:199847
Mboat7tm1Arai/Mboat7tm1Arai
(B6.129P2-Mboat7tm1Arai) 		decreased fatty acids level J:200247
increased fatty acids level J:200247
Mbpshi/Mbpshi
(SWV-Mbpshi) 		decreased brain cholesterol level J:9907
decreased cholesterol level J:9907
MbsydC57BL/6J/MbsydPERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ) 		increased circulating triglyceride level J:94548
Mbtps1tm1Jdh/Mbtps1tm1Jdh
Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		abnormal intestinal lipid absorption J:72930
abnormal lipid homeostasis J:72930
decreased circulating cholesterol level J:72930
decreased circulating triglyceride level J:72930
decreased liver triglyceride level J:72930
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt) 		decreased circulating cholesterol level J:94077, J:123123
decreased circulating HDL cholesterol level J:123123
increased circulating LDL cholesterol level J:123123
Mc2rtm1Dchi/Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi) 		decreased circulating aldosterone level J:127445
decreased circulating corticosterone level J:127445
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl) 		decreased circulating triglyceride level J:178147
Mc3rtm1Butl/Mc3rtm1Butl
Tg(Nr5a1-cre)2Lowl/0
(involves: C57BL/6J * FVB/NJ) 		decreased circulating triglyceride level J:178147
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J) 		increased circulating free fatty acids level J:177386
increased liver triglyceride level J:177386
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu) 		increased circulating cholesterol level J:285412
increased liver triglyceride level J:285412
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA) 		abnormal lipid homeostasis J:192213
increased circulating ketone body level J:192213
Mchr1tm1Sqn/Mchr1tm1Sqn
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating corticosterone level J:81787
Mcutm1b(EUCOMM)Hmgu/Mcu+
(C57BL/6N-Mcutm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mdktm1.1(KOMP)Mbp/Mdktm1.1(KOMP)Mbp
(C57BL/6N-Mdktm1.1(KOMP)Mbp/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased brain cholesterol level J:198551
increased circulating cholesterol level J:198551
increased circulating LDL cholesterol level J:198551
increased circulating triglyceride level J:198551
increased liver triglyceride level J:198551
Mecp2tm1.1Jae/Y
(B6.Cg-Mecp2tm1.1Jae) 		increased brain cholesterol level J:198551
increased liver triglyceride level J:198551
Med13tm1Eno/Med13tm1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N) 		increased circulating cholesterol level J:186193
increased circulating triglyceride level J:186193
increased liver triglyceride level J:186193
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ) 		increased liver triglyceride level J:298822
Med23em1(IMPC)Wtsi/Med23+
(C57BL/6N-Med23em1(IMPC)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:211773
Megf6em1(IMPC)Kmpc/Megf6em1(IMPC)Kmpc
(C57BL/6NTac-Megf6em1(IMPC)Kmpc/Kmpc) 		increased circulating cholesterol level J:211773
Memo1tm1.1Neh/Memo1tm1.1Neh
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		increased vitamin D level J:206626
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6) 		increased circulating corticosterone level J:191261
Mettl16tm1b(KOMP)Mbp/Mettl16+
(C57BL/6N-Mettl16tm1b(KOMP)Mbp/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mettl22tm1.1(KOMP)Vlcg/Mettl22tm1.1(KOMP)Vlcg
(C57BL/6N-Mettl22tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mexistm1.1Pton/Mexistm1.1Pton
(involves: C57BL/6) 		abnormal lipid homeostasis J:264834
increased cholesterol level J:264834
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp) 		decreased circulating triglyceride level J:211773
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls) 		abnormal lipid homeostasis J:234197
decreased circulating triglyceride level J:194781
decreased triglyceride level J:194781
decreased unsaturated fatty acids level J:234197
increased fatty acid oxidation J:194781
increased unsaturated fatty acids level J:234197
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi) 		abnormal ceramide level J:250123
decreased sphingosine level J:250123
increased sphingosine level J:250123
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm
(B6.Cg-Mgat4atm1.1Jxm) 		increased circulating free fatty acids level J:117542
increased circulating triglyceride level J:117542
Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(B6.129-Mgat4btm1.1Jxm) 		decreased circulating VLDL cholesterol level J:212313
MgllGt(OST113734)Lex/MgllGt(OST113734)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased fatty acids level J:165274
Mglltm1.1Rzim/Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:172679
decreased circulating glycerol level J:172679
decreased circulating ketone body level J:172679
decreased circulating triglyceride level J:172679
decreased liver triglyceride level J:172679
Mgst1em1(IMPC)J/Mgst1em1(IMPC)J
(C57BL/6NJ-Mgst1em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mia2cpto/Mia2cpto
(C57BL/6-Mia2cpto) 		decreased circulating cholesterol level J:176259
decreased circulating HDL cholesterol level J:176259
decreased circulating triglyceride level J:176259
decreased circulating VLDL triglyceride level J:176259
Mia2tm1Zhxu/Mia2tm1Zhxu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA) 		decreased circulating cholesterol level J:268333
decreased circulating triglyceride level J:268333
increased liver cholesterol level J:268333
increased liver triglyceride level J:268333
Micos13tm1.1(KOMP)Vlcg/Micos13+
(C57BL/6N-Micos13tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Mier1tm1a(EUCOMM)Wtsi/Mier1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Mier1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating free fatty acids level J:165965
Miga2tm1a(KOMP)Wtsi/Miga2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Miga2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Mindy1tm1a(EUCOMM)Wtsi/Mindy1tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating free fatty acids level J:165965
decreased circulating glycerol level J:165965
Mir22tm1Boet/Mir22tm1Boet
(B6.129S2-Mir22tm1Boet) 		decreased circulating free fatty acids level J:266382
increased fatty acid oxidation J:266382
Mir32em1Gpt/Mir32em1Gpt
Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt) 		decreased circulating cholesterol level J:344660
decreased circulating LDL cholesterol level J:344660
decreased liver cholesterol level J:344660
decreased liver triglyceride level J:344660
Mir33tm1.1Koho/Mir33tm1.1Koho
(involves: C57BL/6) 		abnormal cholesterol homeostasis J:165420
increased circulating cholesterol level J:165420
increased circulating HDL cholesterol level J:165420
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6) 		decreased circulating cholesterol level J:190066
decreased circulating HDL cholesterol level J:190066
decreased circulating triglyceride level J:190066
decreased circulating VLDL cholesterol level J:190066
increased liver cholesterol level J:190066
increased liver triglyceride level J:190066
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ) 		decreased circulating cholesterol level J:190067
decreased circulating HDL cholesterol level J:190067
increased bile salt level J:190067
increased liver triglyceride level J:190067
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal lipid homeostasis J:190067
decreased circulating cholesterol level J:190067
decreased circulating HDL cholesterol level J:190067
decreased circulating LDL cholesterol level J:190067
increased bile salt level J:190067
increased liver triglyceride level J:190067
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6) 		increased circulating triglyceride level J:190154
Mirc1tm1.1Tyj/Mirc1tm1.1Tyj
Pkd1tm1.1Pcha/Pkd1tm2Som
Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR) 		increased fatty acid oxidation J:244067
Mirc13tm1.1Mtm/Mirc13tm1.1Mtm
(Not Specified) 		abnormal lipid homeostasis J:256444
abnormal phospholipid level J:256444
abnormal sphingomyelin level J:256444
decreased liver triglyceride level J:256444
decreased saturated fatty acids level J:256444
increased bile salt level J:256444
increased ceramide level J:256444
Mirc36tm1.1Jcav/Mirc36+
(B6.129-Mirc36tm1.1Jcav) 		decreased circulating ketone body level J:216177
Mirc54tm1.1Syu/Mirc54tm1.1Syu
(Not Specified) 		decreased circulating cholesterol level J:310890
decreased circulating triglyceride level J:310890
decreased liver triglyceride level J:310890
Mlxiptm1.2Lchan/Mlxiptm1.2Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased fatty acid oxidation J:217834
Mlxipltm1Kuy/Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal lipid homeostasis J:89865
decreased circulating cholesterol level J:89865
decreased circulating free fatty acids level J:89865
decreased fatty acids level J:89865
Mlxipltm1Kuy/Mlxipltm1Kuy
(B6.129S6-Mlxipltm1Kuy/J) 		decreased circulating cholesterol level J:273754
decreased circulating triglyceride level J:273754
decreased liver triglyceride level J:273754
Mmp8tm1.1(KOMP)Vlcg/Mmp8tm1.1(KOMP)Vlcg
(C57BL/6N-Mmp8tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Mmp9tm1Arnd/Mmp9tm1Arnd
(B6.129P2-Mmp9tm1Arnd) 		increased prostaglandin level J:110450
Mmuttm1.1Mrb/Mmuttm1.1Mrb
(involves: C57BL/6) 		abnormal fatty acids level J:237040
Mmuttm1Pai/Mmuttm1.1Mrb
(involves: 129S1/Sv * C57BL/6) 		abnormal fatty acids level J:237040
abnormal sphingolipid level J:237040
Mobq1129P3/J/Mobq1129P3/J
(involves: 129P3/J * C57BL/10SnJ) 		decreased circulating cholesterol level J:24238
Mobq1BALB/cJ/Mobq1BALB/cJ
(involves: BALB/cJ * C57BL/10SnJ) 		decreased circulating cholesterol level J:24238
Mobq1C57BL/6J/Mobq1SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei) 		increased circulating cholesterol level J:88297
Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ) 		decreased circulating cholesterol level J:116503
decreased circulating free fatty acids level J:116503
decreased circulating triglyceride level J:116503
Mocosem2(IMPC)Ics/Mocos+
(C57BL/6N-Mocosem2(IMPC)Ics/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Mogat2tm1.1Ryyo/Mogat2tm1.1Ryyo
(B6.Cg-Mogat2tm1.1Ryyo) 		decreased circulating triglyceride level J:155626
Mogat2tm1Far/Mogat2tm1Far
(B6.129S4-Mogat2tm1Far) 		abnormal intestinal lipid absorption J:149373
decreased circulating cholesterol level J:149373
decreased circulating LDL cholesterol level J:149373
decreased circulating triglyceride level J:149373
decreased circulating VLDL cholesterol level J:149373
decreased susceptibility to hyperlipidemia J:149373
Morc2aem1(IMPC)Wtsi/Morc2a+
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		decreased circulating HDL cholesterol level J:211773
Mpc1tm1c(EUCOMM)Wtsi/Mpc1tm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		decreased circulating cholesterol level J:236662
decreased circulating triglyceride level J:236662
increased circulating ketone body level J:236662
increased fatty acid oxidation J:236662
increased triglyceride level J:236662
Mpc2em2Finc/Mpc2em2Finc
(involves: C57BL/6) 		decreased circulating triglyceride level J:211781
increased circulating ketone body level J:211781
mpc96H/mpc96H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased circulating HDL cholesterol level J:234901
decreased circulating LDL cholesterol level J:234901
Mpv17/Mpv17
(CFW-Mpv17/J) 		increased circulating cholesterol level J:10661
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz) 		decreased circulating cholesterol level J:199257
decreased circulating corticosterone level J:199257
decreased circulating free fatty acids level J:199257
decreased circulating phospholipid level J:199257
decreased circulating triglyceride level J:199257
decreased liver triglyceride level J:199257
Mraptm1.2Geno/Mraptm1.2Geno
(involves: C57BL/6) 		decreased circulating corticosterone level J:278935
Mrps12em1.2Afi/Mrps12em1.2Afi
(B6N(Cg)-Mrps12em1.2Afi) 		increased cholesterol level J:284101
Ms4a4dem1(IMPC)J/Ms4a4dem1(IMPC)J
(C57BL/6NJ-Ms4a4dem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd) 		increased circulating triglyceride level J:211773
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean) 		decreased circulating cholesterol level J:146513
decreased circulating triglyceride level J:146513
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid level J:75178
Msto1em1(IMPC)Tcp/Msto1+
(C57BL/6N-Msto1em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Msx1tm1b(KOMP)Wtsi/Msx1+
(C57BL/6N-Msx1tm1b(KOMP)Wtsi/J) 		increased circulating free fatty acids level J:211773
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd) 		abnormal lipid homeostasis J:120459
Mt1tm1Rch/Mt1tm1Rch
Mt2tm1Rch/Mt2tm1Rch
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:120459
mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		increased circulating triglyceride level J:344247
Mta1tm1a(EUCOMM)Wtsi/Mta1+
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH) 		increased circulating triglyceride level J:175295
Mta1tm1a(EUCOMM)Wtsi/Mta1tm1a(EUCOMM)Wtsi
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH) 		decreased circulating LDL cholesterol level J:175295
Mta3tm3a(KOMP)Wtsi/Mta3tm3a(KOMP)Wtsi
(Not Specified) 		decreased circulating cholesterol level J:165965
decreased circulating LDL cholesterol level J:165965
Mtarc1tm1.1Vlcg/Mtarc1tm1.1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac) 		abnormal phospholipid level J:346201
decreased liver triglyceride level J:346201
Mtfmtem1Heb/Mtfmt+
(C57BL/6-Mtfmtem1Heb) 		decreased circulating triglyceride level J:334467
decreased liver triglyceride level J:334467
decreased triglyceride level J:334467
Mthfrtm1Rzn/Mthfr+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		abnormal lipid homeostasis J:67779
Mthfrtm1Rzn/Mthfrtm1Rzn
(involves: 129S1/Sv * 129X1/SvJ * BALB/c) 		abnormal lipid homeostasis J:67779
Mtlnem1Rlbd/Mtlnem1Rlbd
(involves: C57BL/6J * SJL/J) 		decreased fatty acid beta-oxidation J:263464
Mtortm1a(EUCOMM)Wtsi/Mtor+
(C57BL/6N-Mtortm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
increased circulating LDL cholesterol level J:175295
Mttptm1Chan/Mttptm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal circulating cholesterol level J:53390
abnormal triglyceride level J:53390
decreased circulating HDL cholesterol level J:53390
decreased circulating LDL cholesterol level J:53390
decreased circulating VLDL cholesterol level J:53390
decreased circulating VLDL triglyceride level J:53390
Mttptm1Sgy/Mttp+
(involves: 129S4/SvJae) 		abnormal circulating cholesterol level J:48934
abnormal circulating lipid level J:48934
abnormal lipid homeostasis J:48934
abnormal lipid level J:48934
decreased circulating cholesterol level J:48934
decreased circulating LDL cholesterol level J:48934
decreased circulating VLDL cholesterol level J:48934
increased liver cholesterol level J:48934
increased liver triglyceride level J:48934
Mttptm1Sgy/Mttptm1Sgy
(involves: 129S4/SvJae) 		abnormal lipid homeostasis J:48934
Mttptm2Sgy/Mttptm2Sgy
Tg(Mx1-cre)1Cgn/Tg(Mx1-cre)1Cgn
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased circulating cholesterol level J:83459
decreased circulating HDL cholesterol level J:83459
decreased circulating LDL cholesterol level J:83459
decreased circulating triglyceride level J:83459
decreased circulating VLDL cholesterol level J:83459
increased liver cholesterol level J:83459
increased liver triglyceride level J:83459
Muc1tm1Gend/Muc1tm1Gend
(involves: FVB) 		abnormal intestinal lipid absorption J:96078
decreased intestinal cholesterol absorption J:96078
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn) 		increased circulating triglyceride level J:194148
Myf5tm3(cre)Sor/Myf5+
Stat5btm1Mam/Stat5btm1Mam
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		increased circulating triglyceride level J:119237
Myg1tm1Mphi/Myg1tm1Mphi
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal corticosterone level J:154911
Myh7btm1a(KOMP)Wtsi/Myh7btm1a(KOMP)Wtsi
(C57BL/6N-Myh7btm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Myo18bem2(IMPC)Ics/Myo18b+
(C57BL/6N-Myo18bem2(IMPC)Ics/Ics) 		increased circulating triglyceride level J:211773
Mysm1tm1a(KOMP)Wtsi/Mysm1+
(Not Specified) 		decreased circulating triglyceride level J:165965
Mysm1tm1a(KOMP)Wtsi/Mysm1tm1a(KOMP)Wtsi
(Not Specified) 		decreased circulating cholesterol level J:165965
decreased circulating triglyceride level J:165965
Myzapem1(IMPC)J/Myzapem1(IMPC)J
(C57BL/6NJ-Myzapem1(IMPC)J/Mmjax) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Naa40tm1Qwzh/Naa40tm1Qwzh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh) 		abnormal lipid homeostasis J:183119
decreased circulating LDL cholesterol level J:183119
decreased circulating VLDL triglyceride level J:183119
decreased liver free fatty acids level J:183119
decreased liver triglyceride level J:183119
increased fatty acid oxidation J:183119
Nab1em1(IMPC)H/Nab1em1(IMPC)H
(C57BL/6NTac-Nab1em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu
(C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Nadk2tm1a(EUCOMM)Wtsi/Nadk2tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac) 		decreased fatty acid oxidation J:255700
increased circulating free fatty acids level J:255700
increased circulating triglyceride level J:255700
increased liver triglyceride level J:255700
Napepldtm1.2Ueda/Napepldtm1.2Ueda
(B6.129S6-Napepldtm1.2Ueda) 		abnormal lipid homeostasis J:177598
Naxetm1.1Lfan/Naxetm1.1Lfan
Tg(APOA1)1Rub/0
(involves: C57BL/6 * C57BL/6J) 		increased circulating HDL cholesterol level J:261549
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg
(C57BL/6N-Ncaldtm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Ncapd3em1(IMPC)J/Ncapd3+
(C57BL/6NJ-Ncapd3em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129S7-Nceh1tm1Ishi) 		abnormal cholesterol homeostasis J:152385
Ncf1em1(IMPC)Mbp/Ncf1em1(IMPC)Mbp
(C57BL/6N-Ncf1em1(IMPC)Mbp/MbpMmucd) 		decreased circulating HDL cholesterol level J:211773
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J) 		increased liver triglyceride level J:161276
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating cholesterol level J:144060
decreased circulating free fatty acids level J:144060
decreased circulating HDL cholesterol level J:144060
decreased circulating triglyceride level J:144060
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6) 		increased liver triglyceride level J:207622
Ncoa6tm1Jkr/Ncoa6tm1Jkr
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal lipid level J:269856
Ncoa6tm2Jxu/Ncoa6tm2Jxu
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal bile salt homeostasis J:129067
abnormal circulating triglyceride level J:129067
abnormal lipid homeostasis J:129067
increased circulating cholesterol level J:129067
Ncor1tm1.1Ics/Ncor1tm1.1Ics
Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		decreased circulating cholesterol level J:178827
decreased circulating HDL cholesterol level J:178827
decreased circulating LDL cholesterol level J:178827
Ncor1tm1Anh/Ncor1tm1Anh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased circulating LDL cholesterol level J:142045
Ncor1tm1Laz/Ncor1tm1Laz
(C57BL/6-Ncor1tm1Laz) 		increased circulating free fatty acids level J:142342
increased circulating ketone body level J:142342
Ndst3tm1.1Grob/Ndst3tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		decreased circulating cholesterol level J:138557
decreased circulating HDL cholesterol level J:138557
Ndufa1tm1.1Nay/Y
(involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac) 		abnormal cholesterol homeostasis J:257477
abnormal corticosterone level J:257477
abnormal sphingolipid level J:257477
decreased circulating corticosterone level J:257477
decreased liver cholesterol level J:257477
increased fatty acids level J:257477
Ndufs1tm1b(EUCOMM)Hmgu/Ndufs1+
(C57BL/6N-Ndufs1tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating triglyceride level J:211773
Ndufs6Gt(AR0138)Wtsi/Ndufs6Gt(AR0138)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased fatty acids level J:183619
Nedd4ltm1.2Blyg/Nedd4ltm1.2Blyg
(involves: 129X1/SvJ * C57BL/6J) 		increased circulating aldosterone level J:148641
Negr1m1H/Negr1m1H
(C3.Cg-Negr1m1H) 		decreased liver triglyceride level J:189719
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6) 		increased circulating triglyceride level J:106077
Nelfcdem1(IMPC)J/Nelfcd+
(C57BL/6NJ-Nelfcdem1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Nemftm1b(EUCOMM)Hmgu/Nemf+
(B6N(Cg)-Nemftm1b(EUCOMM)Hmgu/J) 		decreased circulating cholesterol level J:211773
Nepntm1b(KOMP)Wtsi/Nepntm1b(KOMP)Wtsi
(C57BL/6N-Nepntm1b(KOMP)Wtsi/Ucd) 		decreased circulating triglyceride level J:211773
Nestm1b(KOMP)Wtsi/Nestm1b(KOMP)Wtsi
(C57BL/6N-Nestm1b(KOMP)Wtsi/J) 		decreased circulating cholesterol level J:211773
Neu2em1Kyp/Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp) 		increased circulating cholesterol level J:321653
increased circulating free fatty acids level J:321653
increased circulating triglyceride level J:321653
increased liver free fatty acids level J:321653
increased muscle free fatty acids level J:321653
Neu4tm1Avps/Neu4tm1Avps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal lipid level J:135246
increased cholesterol level J:135246
increased lung cholesterol level J:135246
increased unsaturated fatty acids level J:135246
Neurog3tm1Fgu/Neurog3tm3.1Ggr
Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal intestinal lipid absorption J:161480
decreased circulating cholesterol level J:161480
decreased circulating HDL cholesterol level J:161480
decreased circulating triglyceride level J:161480
steatorrhea J:161480
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr
Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal intestinal lipid absorption J:161480
decreased circulating cholesterol level J:161480
decreased circulating HDL cholesterol level J:161480
decreased circulating triglyceride level J:161480
steatorrhea J:161480
Nexmifem1(IMPC)Tcp/Y
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Nfasctm1a(EUCOMM)Hmgu/Nfasc+
(C57BL/6N-Nfasctm1a(EUCOMM)Hmgu/Ics) 		increased circulating triglyceride level J:165965
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(B6.129X1-Nfe2l2tm1Ywk) 		abnormal lipid homeostasis J:165602
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nfkb1tm1a(KOMP)Wtsi/Wtsi) 		increased circulating free fatty acids level J:175295
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbid+
(C57BL/6N-Nfkbidtm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating free fatty acids level J:165965
decreased circulating triglyceride level J:165965
Ngdntm1b(EUCOMM)Wtsi/Ngdn+
(C57BL/6N-Ngdntm1b(EUCOMM)Wtsi/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Nhdlq1129S1/SvImJ/Nhdlq1CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal circulating cholesterol level J:88732
Nhdlq1CAST/Ei/Nhdlq1CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal circulating cholesterol level J:88732
Nhdlq2129S1/SvImJ/?
(involves: 129S1/SvImJ * CAST/Ei) 		abnormal circulating cholesterol level J:88732
Nhdlq3129S1/SvImJ/Nhdlq3RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J) 		abnormal lipid homeostasis J:89282
Nhdlq3RIIIS/J/Nhdlq3RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J) 		abnormal lipid homeostasis J:89282
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		abnormal circulating cholesterol level J:93243
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ
Nhdlq5C57BL/6J/Nhdlq5C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		abnormal circulating cholesterol level J:93243
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ
Nhdlq7C57BL/6J/Nhdlq7C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		abnormal circulating cholesterol level J:93243
Nhdlq9DBA/2J/?
(involves: DBA/2J * PERA/EiJ) 		abnormal circulating cholesterol level J:112668
Nhdlq10PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ) 		abnormal circulating cholesterol level J:112668
Nhlh2tm1b(KOMP)Mbp/Nhlh2tm1b(KOMP)Mbp
(C57BL/6N-Nhlh2tm1b(KOMP)Mbp/Tcp) 		abnormal cholesterol homeostasis J:211773
Nil/Nil+
(involves: A/Cam) 		abnormal intestinal lipid absorption J:33328
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu) 		increased skeletal muscle triglyceride level J:332575
Nipa1tm1a(KOMP)Wtsi/Nipa1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nipa1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:175295
Nipal4tm1Akih/Nipal4tm1Akih
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj) 		decreased ceramide level J:261184
decreased sphingosine level J:261184
increased ceramide level J:261184
increased sphingosine level J:261184
Nischtm1b(EUCOMM)Hmgu/Nischtm1b(EUCOMM)Hmgu
(C57BL/6N-Nischtm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6) 		decreased circulating triglyceride level J:64018
steatorrhea J:64018
Nlgn2tm1.1Gchn/Nlgn2tm1.1Gchn
(involves: 129S/SvEv * C57BL/6J) 		increased circulating corticosterone level J:272181
Nlrp3tm1Bhk/Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J) 		increased liver triglyceride level J:256504
Nmutm1Mko/Nmutm1Mko
(involves: 129 * C57BL/6) 		abnormal lipid homeostasis J:93213
decreased circulating corticosterone level J:93213
increased circulating cholesterol level J:93213
increased circulating free fatty acids level J:93213
increased triglyceride level J:93213
NntC57BL/6J/NntC57BL/6J
(C57BL/6J) 		decreased circulating corticosterone level J:185986
Nntem1(IMPC)H/Nntem1(IMPC)H
(C57BL/6N-Nntem1(IMPC)H/H) 		increased circulating cholesterol level J:211773
Nodaltm1b(EUCOMM)Wtsi/Nodal+
(C57BL/6N-Nodaltm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh) 		increased circulating triglyceride level J:155090
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		increased prostaglandin level J:100308
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		increased circulating LDL cholesterol level J:155090
increased circulating triglyceride level J:155090
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:97522
increased circulating triglyceride level J:155090
Nos3tm1.2Taka/Nos3tm1.2Taka
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		increased circulating triglyceride level J:187860
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh) 		increased circulating triglyceride level J:155090
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6) 		decreased prostaglandin level J:108540
Nos3tm1Plh/Nos3tm1Plh
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased prostaglandin level J:108540
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd) 		hyperlipidemia J:103153
increased circulating cholesterol level J:103153
increased circulating free fatty acids level J:103153
increased circulating triglyceride level J:103153
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6) 		increased circulating free fatty acids level J:198075
increased circulating LDL cholesterol level J:198075
Notumem1(IMPC)Tcp/Notum+
(C57BL/6NCrl-Notumem1(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Npbwr1tm1Rck/Npbwr1tm1Rck
(involves: 129P/Ola * C57BL/6J) 		abnormal lipid homeostasis J:94820
Npc1m1N/Npc1m1N
(involves: BALB/c) 		abnormal phospholipid level J:204311
decreased brain cholesterol level J:104996, J:130969
increased brain cholesterol level J:104996
increased cholesterol level J:104996, J:130969
increased circulating cholesterol level J:18511
increased lipid level J:204311
increased liver cholesterol level J:130969
increased lung cholesterol level J:204311, J:130969
lipidosis J:204311, J:18511
Npc1m1N/Npc1m1N
(involves: 129S1/Sv * BALB/c * C57BL/6) 		abnormal lipid homeostasis J:89617
increased liver cholesterol level J:89617
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J) 		decreased liver cholesterol level J:179744
increased ganglioside level J:179744
increased liver cholesterol level J:179744
Npc1m1N/Npc1m1N
(involves: BALB/c * C57BL/6 * CBA) 		increased ganglioside level J:144240
Npc1m1N/Npc1m1N
(B6.C-Npc1m1N) 		abnormal lipid homeostasis J:221855
abnormal lipid level J:221855
abnormal sphingomyelin level J:221855
increased brain cholesterol level J:157113
increased ceramide level J:221855
increased liver cholesterol level J:221855
Npc1m1N/Npc1m1N
(BALB/c-Npc1m1N) 		abnormal ceramide level J:221855
abnormal lipid homeostasis J:221855
abnormal lipid level J:221855
abnormal sphingomyelin level J:221855
increased brain cholesterol level J:172769, J:221855
increased ganglioside level J:221855
increased liver cholesterol level J:221855
Npc1m1N/Npc1m1N
(involves: BALB/c * C3H/HeJ * C57BL/6J) 		increased brain cholesterol level J:188345
Npc1m1N/Npc1m1N
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6) 		abnormal lipid homeostasis J:89617
increased liver cholesterol level J:89617
Npc1m1N/Npc1m1N
Tg(CAG-RAB9A)500Repa/0
(involves: BALB/c * C57BL/6 * CBA) 		decreased ganglioside level J:144240
Npc1m1N/Npc1m1N
Tg(PRNP-APPSweInd)8Dwst/0
(involves: BALB/c * C3H/HeJ * C57BL/6J) 		increased brain cholesterol level J:188345
Npc1m1N/Npc1tm1.1Apl
Tg(CAG-cre/Esr1*)5Amc/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(CAG-cre/Esr1*)5Amc) 		increased brain cholesterol level J:176888
Npc1m1N/Npc1tm1.1Apl
Tg(Syn1-cre)671Jxm/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(Syn1-cre)671Jxm) 		increased brain cholesterol level J:176888
Npc1m1N/Npc1tm1.2Apl
(B6.Cg-Npc1m1N/Npc1tm1.2Apl) 		increased cholesterol level J:157113
Npc1nmf164/Npc1nmf164
(C57BL/6J-Npc1nmf164/J) 		abnormal lipid level J:179744
decreased liver cholesterol level J:179744
increased brain cholesterol level J:179744
increased liver cholesterol level J:179744
sphingomyelinosis J:179744
Npc1spm/Npc1spm
(C57BLKS/J-Npc1spm/J) 		abnormal cholesterol level J:7245
increased liver cholesterol level J:102782, J:7245
sphingomyelinosis J:7245
Npc1tm1.1Apl/Npc1tm1.2Apl
Tg(Pcp2-cre)2Mpin/0
(B6.Cg-Npc1tm1.1Apl/Npc1tm1.2Apl Tg(Pcp2-cre)2Mpin) 		increased cholesterol level J:157113
Npc1tm1.1Dso/Npc1+
(B6.129-Npc1tm1.1Dso) 		increased brain cholesterol level J:221855
Npc1tm1.1Dso/Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso) 		abnormal cholesterol homeostasis J:221855
abnormal lipid homeostasis J:221855
abnormal sphingolipid level J:221855
increased brain cholesterol level J:221855
increased ceramide level J:221855
increased ganglioside level J:221855
increased lipid level J:221855
increased liver cholesterol level J:221855
sphingomyelinosis J:221855
Npc1tm1Mbjg/Npc1tm1Mbjg
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal lipid level J:176587
increased cholesterol level J:176587
increased liver cholesterol level J:176587
Npc1tm1Tacf/Npc1tm1Tacf
(B6(Cg)-Npc1tm1Tacf) 		increased ceramide level J:266795
increased liver cholesterol level J:266795
Npc1tm1Tacf/Npc1tm2Tacf
(B6(Cg)-Npc1tm1Tacf Npc1tm2Tacf) 		increased ceramide level J:266795
increased liver cholesterol level J:266795
Npc1l1tm1a(EUCOMM)Hmgu/Npc1l1tm1a(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6N) 		abnormal intestinal cholesterol absorption J:226578
decreased circulating cholesterol level J:226578
Npc1l1tm1a(EUCOMM)Hmgu/Npc1l1tm1a(EUCOMM)Hmgu
(involves: C57BL/6N) 		decreased intestinal cholesterol absorption J:263730
Npc1l1tm1Swa/Npc1l1tm1Swa
(involves: 129P2/OlaHsd * C57BL/6) 		decreased intestinal cholesterol absorption J:89712
decreased liver cholesterol level J:89712
Npc1l1tm1Yaio/Npc1l1tm1Yaio
(C57BL/6-Npc1l1tm1Yaio) 		abnormal cholesterol homeostasis J:98568
abnormal circulating LDL cholesterol level J:98568
abnormal intestinal lipid absorption J:98568
abnormal lipid homeostasis J:98568
abnormal triglyceride level J:98568
decreased circulating cholesterol level J:98568
decreased circulating HDL cholesterol level J:98568
decreased intestinal cholesterol absorption J:98568
decreased susceptibility to hyperlipidemia J:98568
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6) 		abnormal lipid homeostasis J:89617
increased liver cholesterol level J:89617
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c) 		abnormal lipid level J:204311
abnormal phospholipid level J:204311
increased lung cholesterol level J:204311
lipidosis J:204311
Npcdem1(IMPC)J/Npcdem1(IMPC)J
(C57BL/6NJ-Npcdem1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Nphp3pcy/Nphp3pcy
(involves: DBA/2Fg * KK) 		abnormal cholesterol homeostasis J:2203
abnormal circulating phospholipid level J:2203
abnormal phospholipid level J:2203
increased circulating cholesterol level J:2203
Nphs2tm1Antc/Nphs2tm3.1Antc
Tg(CAG-cre/Esr1*)86Lbgn/0
(involves: 129 * C57BL/6 * DBA) 		increased circulating cholesterol level J:166320
Nphs2tm2.1Antc/Nphs2tm3.1Antc
Tg(CAG-cre/Esr1*)86Lbgn/0
(involves: 129S2/SvPas * C57BL/6 * DBA) 		increased circulating cholesterol level J:245693
NplGt(OST15553)Lex/NplGt(OST15553)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating cholesterol level J:103485
Npr1tm1.1Rsha/Npr1+
(involves: C57BL/6) 		increased circulating aldosterone level J:201932
Npr1tm1.1Rsha/Npr1tm1.1Rsha
(involves: C57BL/6) 		increased circulating aldosterone level J:201932
Nptntm1b(EUCOMM)Hmgu/Nptntm1b(EUCOMM)Hmgu
(C57BL/6N-Nptntm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL) 		increased circulating corticosterone level J:180396
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating free fatty acids level J:47972
Npy1rtm1Tped/Npy1rtm1Tped
(B6.129P2-Npy1rtm1Tped) 		increased circulating corticosterone level J:87424
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6) 		decreased circulating corticosterone level J:107169
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:77345, J:97455
Npy5rem1(IMPC)H/Npy5rem1(IMPC)H
(C57BL/6NTac-Npy5rem1(IMPC)H/H) 		increased circulating HDL cholesterol level J:211773
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd) 		increased circulating corticosterone level J:87424
Npy6rtm1Hhzg/Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6) 		abnormal circulating corticosterone level J:210546
Npytm1(rtTA,tetO-cre/EGFP)Snby/Npy+
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:162000
Nqo1tm1Akj/Nqo1tm1Akj
(involves: C57BL/6) 		increased circulating triglyceride level J:120478
increased triglyceride level J:120478
Nr0b1em2(IMPC)Wtsi/Y
(C57BL/6N-Nr0b1em2(IMPC)Wtsi/Wtsi) 		increased circulating LDL cholesterol level J:211773
Nr0b1tm1.1Lja/Y
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal lipid homeostasis J:71710
Nr0b2tm1.1Mjev/Nr0b2tm1.1Mjev
(involves: 129S/SvEvBrd * 129S4/SvJae) 		decreased circulating cholesterol level J:149005
decreased circulating HDL cholesterol level J:149005
decreased circulating LDL cholesterol level J:149005
decreased circulating VLDL cholesterol level J:149005
Nr0b2tm1Ddm/Nr0b2tm1Ddm
(involves: 129 * C57BL/6) 		abnormal bile salt homeostasis J:77065
abnormal bile salt level J:77065
decreased circulating cholesterol level J:77065
increased bile salt level J:77065
increased liver triglyceride level J:77065
Nr0b2tm1Mjev/Nr0b2tm1Mjev
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEvBrd * C57BL/6 * DBA) 		decreased circulating cholesterol level J:149005
decreased circulating LDL cholesterol level J:149005
Nr0b2tm1Rus/Nr0b2tm1Rus
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile salt homeostasis J:102129
abnormal bile salt level J:102129
abnormal lipid homeostasis J:102129
increased intestinal cholesterol absorption J:102129
Nr1d1tm1.1Rev/Nr1d1tm1.1Rev
Nr1d2tm1.1Rev/Nr1d2tm1.1Rev
Tg(CAG-cre/Esr1*)5Amc/0
(involves: BALB/cJ * C57BL/6 * C57BL/6J * CBA) 		decreased circulating triglyceride level J:183855
increased circulating free fatty acids level J:183855
Nr1d1tm1Schb/Nr1d1tm1Schb
(involves: 129S2/SvPas) 		abnormal bile salt homeostasis J:153064
decreased liver cholesterol level J:153064
decreased liver triglyceride level J:153064
increased circulating HDL cholesterol level J:153064
increased circulating LDL cholesterol level J:153064
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid level J:234268
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal cholesterol homeostasis J:81790
abnormal lipid homeostasis J:81790
abnormal lipid level J:234268
Nr1h2tm1.1Nph/Nr1h2tm1.1Nph
(B6.129-Nr1h2tm1.1Nph) 		abnormal cholesterol homeostasis J:169945
abnormal lipid homeostasis J:169945
Nr1h2tm1Djm/Nr1h2tm1Djm
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac) 		increased liver cholesterol level J:64343
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA) 		abnormal lipid homeostasis J:184536
increased liver cholesterol level J:184536
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating LDL cholesterol level J:82096
increased liver cholesterol level J:82096
Nr1h3tm1Dgen/Nr1h3tm1Dgen
(Not Specified) 		abnormal cholesterol homeostasis J:112995
abnormal lipid homeostasis J:112995
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal bile salt homeostasis J:47971
increased circulating cholesterol level J:47971
increased circulating LDL cholesterol level J:47971
increased liver cholesterol level J:243753, J:47971
Nr1h3tm1Djm/Nr1h3tm1Djm
Nus1tm1.1Qrm/Nus1tm1.1Qrm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		increased liver cholesterol level J:243753
Nr1h4tm1.1Gonz/Nr1h4tm1.1Gonz
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6) 		increased bile salt level J:129978
increased circulating cholesterol level J:129978
increased circulating triglyceride level J:129978
Nr1h4tm1.1Gonz/Nr1h4tm1.1Gonz
Tg(Vil1-cre)997Gum/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		abnormal bile salt homeostasis J:129978
increased bile salt level J:129978
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj) 		decreased circulating free fatty acids level J:200842
increased bile salt level J:200842
increased circulating cholesterol level J:200842
increased liver triglyceride level J:200842
Nr1h4tm1.2Auw/Nr1h4tm1.2Auw
(involves: 129 * C57BL/6J) 		increased bile salt level J:157882
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N) 		abnormal bile salt homeostasis J:64792
abnormal bile salt level J:64792
increased bile salt level J:121075
increased circulating cholesterol level J:64792
increased circulating phospholipid level J:64792
increased circulating triglyceride level J:64792
increased liver cholesterol level J:64792
increased liver triglyceride level J:64792
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ) 		increased bile salt level J:129978
increased circulating cholesterol level J:129978
increased circulating triglyceride level J:129978
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(STOCK Nr1h4tm1Gonz/J) 		increased circulating cholesterol level J:149005
increased circulating triglyceride level J:149005
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6) 		increased bile salt level J:118204
Nr1h4tm1Kok/Nr1h4tm1Kok
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal bile salt homeostasis J:86154
increased bile salt level J:86154
Nr1i3tm1Dgen/Nr1i3tm1Dgen
(B6.129-Nr1i3tm1Dgen) 		abnormal lipid oxidation J:149091
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj) 		abnormal lipid homeostasis J:169333
decreased circulating cholesterol level J:169333
decreased circulating LDL cholesterol level J:169333
decreased circulating triglyceride level J:169333
decreased liver triglyceride level J:169333
Nr2f2tm1Vco/Nr2f2+
Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA) 		abnormal lipid level J:98195
decreased fatty acids level J:98195
increased circulating triglyceride level J:98195
Nr3c1Gt(ESKN92)Hgs/Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs) 		abnormal circulating corticosterone level J:141205
increased circulating aldosterone level J:141205
increased circulating corticosterone level J:141205
increased liver triglyceride level J:141205
Nr3c1tm1.1Mvc/Nr3c1+
Tg(Sim1-cre)1Lowl/0
(involves: 129 * C57BL/6 * FVB) 		increased circulating corticosterone level J:179918
Nr3c1tm1Dage/Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL) 		decreased circulating corticosterone level J:147914
Nr3c1tm1Dage/Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL) 		decreased circulating corticosterone level J:147914
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating corticosterone level J:27441
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * 129/Sv) 		increased circulating corticosterone level J:98065
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Camk2a-cre/ERT2)2Gsc/0
(involves: 129P2/OlaHsd * FVB/N) 		increased circulating corticosterone level J:125230
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL) 		increased circulating glucocorticoid level J:57315
Nr3c1tm2Ljm/Nr3c1tm2Ljm
Tg(Camk2a-cre)T50Stl/?
(involves: 129 * BALB/c * C57BL/6 * CBA) 		increased circulating corticosterone level J:96260
Nr3c1tm3Gsc/Nr3c1tm3Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating corticosterone level J:67720
Nr3c2tm1Gsc/Nr3c2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating aldosterone level J:77285
Nr3c2tm1Gsc/Nr3c2tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating aldosterone level J:77285
Nr3c2tm2Gsc/Nr3c2tm2Gsc
Tg(Aqp2-cre/ERT2)4Gsc/0
(involves: C57BL/6 * FVB/N) 		increased circulating aldosterone level J:169670
Nr5a1tm1.1Hain/Nr5a1tm1.1Hain
(Not Specified) 		abnormal corticosterone level J:175843
Nr5a2tm1Bel/Nr5a2+
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal bile salt level J:89523
decreased circulating cholesterol level J:91695
Nr5a2tm1Sakl/Nr5a2tm1Sakl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased circulating cholesterol level J:135822
Nr5a2tm1Sakl/Nr5a2tm1Sakl
Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL) 		decreased circulating cholesterol level J:135822
Nr5a2tm3.1Sjns/Nr5a2tm3.1Sjns
(B6J.B6N(Cg)-Nr5a2tm3.1Sjns) 		abnormal bile salt homeostasis J:215556
Nrastm1b(EUCOMM)Hmgu/Nras+
(C57BL/6N-Nrastm1b(EUCOMM)Hmgu/H) 		increased circulating HDL cholesterol level J:211773
Nrxn1tm1b(KOMP)Wtsi/Nrxn1tm1b(KOMP)Wtsi
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Nrxn2em1(IMPC)H/Nrxn2em1(IMPC)H
(C57BL/6NTac-Nrxn2em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
increased circulating triglyceride level J:211773
Nsftm1b(KOMP)Mbp/Nsf+
(C57BL/6N-Nsftm1b(KOMP)Mbp/J) 		decreased circulating HDL cholesterol level J:211773
Nsmce1em1(IMPC)Wtsi/Nsmce1+
(C57BL/6N-Nsmce1em1(IMPC)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased circulating cholesterol level J:213427
decreased circulating free fatty acids level J:213427
decreased circulating glycerol level J:213427
decreased circulating HDL cholesterol level J:213427
decreased circulating LDL cholesterol level J:213427
Ntf5tm1b(EUCOMM)Hmgu/Ntf5tm1b(EUCOMM)Hmgu
(C57BL/6N-Ntf5tm1b(EUCOMM)Hmgu/Ics) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2+
(C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H) 		increased circulating HDL cholesterol level J:211773
Ntrk2tm1Rohr/Ntrk2+
(Not Specified) 		abnormal circulating corticosterone level J:179918
decreased circulating corticosterone level J:179918
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		abnormal circulating corticosterone level J:210229
abnormal lipid level J:210229
Nuak2tm1Esu/Nuak2+
(B6.129S4-Nuak2tm1Esu) 		decreased circulating free fatty acids level J:139603
increased circulating triglyceride level J:139603
Nucb2tm1.2Vdix/Nucb2tm1.2Vdix
(involves: C57BL/6) 		increased circulating free fatty acids level J:270674
Nucks1tm1b(EUCOMM)Hmgu/Nucks1tm1b(EUCOMM)Hmgu
(C57BL/6N-Nucks1tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
increased circulating cholesterol level J:211773
Numbtm1Zili/Numbtm1Zili
Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129/Sv * C57BL/6) 		abnormal intestinal cholesterol absorption J:226578
decreased circulating cholesterol level J:226578
Nup205em1(IMPC)J/Nup205+
(C57BL/6NJ-Nup205em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Nus1tm1.1Qrm/Nus1tm1.1Qrm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL) 		abnormal circulating cholesterol level J:243753
abnormal lipid homeostasis J:243753
decreased liver cholesterol level J:243753
increased circulating free fatty acids level J:243753
increased circulating triglyceride level J:243753
increased liver free fatty acids level J:243753
increased liver triglyceride level J:243753
Nxntm1b(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ccpcz) 		increased circulating HDL cholesterol level J:211773
increased circulating triglyceride level J:211773
Nxnl1tm1.2Tlev/Nxnl1tm1.2Tlev
(involves: BALB/c * BALB/cJ * C57BL/6) 		abnormal lipid homeostasis J:186370
Nxph4tm1Lex/Nxph4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased circulating triglyceride level J:171883
Obp2atm1b(EUCOMM)Wtsi/Obp2atm1b(EUCOMM)Wtsi
(C57BL/6N-Obp2atm1b(EUCOMM)Wtsi/Ics) 		increased circulating cholesterol level J:211773
Obrq13A/J/Obrq13A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased circulating cholesterol level J:145148
decreased circulating triglyceride level J:145148
Obrq14A/J/Obrq14A/J
(C57BL/6J-Chr 17A/J/NaJ) 		increased circulating cholesterol level J:145148
Obrq15A/J/Obrq15A/J
(C57BL/6J-Chr 17A/J/NaJ) 		increased circulating free fatty acids level J:145148
Obrq16A/J/Obrq16A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased liver triglyceride level J:145148
Obrq17A/J/Obrq17A/J
(C57BL/6J-Chr 17A/J/NaJ) 		decreased circulating triglyceride level J:145148
Obsty5SM/J/?
(involves: LG/J * SM/J) 		increased circulating cholesterol level J:94605
Oca2p-30PUb/Oca2p-x
(Not Specified) 		abnormal circulating cholesterol level J:89922
abnormal circulating HDL cholesterol level J:89922
abnormal lipid homeostasis J:89922
increased circulating cholesterol level J:89922
increased circulating triglyceride level J:89922
oed/oed
(STOCK pc-oed) 		abnormal cholesterol homeostasis J:5609
abnormal circulating cholesterol level J:5609
abnormal circulating HDL cholesterol level J:5609
abnormal lipid homeostasis J:5609
decreased circulating cholesterol level J:5609
decreased circulating LDL cholesterol level J:5609
decreased fatty acids level J:5609
decreased triglyceride level J:5609
Olahem1Kedk/Olahem1Kedk
(involves: C57BL/6) 		abnormal lipid level J:353571
decreased fatty acids level J:353571
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr) 		decreased fatty acid beta-oxidation J:184716
increased circulating triglyceride level J:184716
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl) 		abnormal phospholipid level J:188346
increased liver triglyceride level J:188346
Opn3tm2c(EUCOMM)Wtsi/Opn3tm2c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ) 		abnormal circulating glycerol level J:287419
Optntm1a(EUCOMM)Wtsi/Optntm1a(EUCOMM)Wtsi
(C57BL/6N-Optntm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Or1e32em1(IMPC)Mbp/Or1e32em1(IMPC)Mbp
(C57BL/6NCrl-Or1e32em1(IMPC)Mbp/Mmucd) 		abnormal cholesterol homeostasis J:211773
Or4m1em1Tshu/Or4m1em1Tshu
(involves: C57BL/6J) 		decreased circulating cholesterol level J:279017
decreased circulating free fatty acids level J:279017
decreased circulating triglyceride level J:279017
decreased liver cholesterol level J:279017
decreased liver triglyceride level J:279017
Or9g4em1(IMPC)Mbp/Or9g4em1(IMPC)Mbp
(C57BL/6N-Or9g4em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Orai1Gt(XL922)Byg/Orai1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased leukotriene level J:130479
Orai1Gt(XL922)Byg/Orai1Gt(XL922)Byg
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased leukotriene level J:130479
Orm2em1Bcgen/Orm2+
(involves: C57BL/6J) 		increased circulating triglyceride level J:333118
increased liver triglyceride level J:333118
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J) 		increased circulating LDL cholesterol level J:333118
increased circulating triglyceride level J:333118
increased liver triglyceride level J:333118
Ormdl1em1Pdra/Ormdl1em1Pdra
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl1em1Pdra Ormdl3em1Pdra) 		increased ceramide level J:349248
increased sphingosine level J:349248
Ormdl2em1Pdra/Ormdl2em1Pdra
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl2em1Pdra Ormdl3em1Pdra) 		increased ceramide level J:328837
increased sphingosine level J:328837
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl3em1Pdra) 		increased ceramide level J:349248, J:328837
increased sphingosine level J:349248, J:328837
Osbpl8Gt(DD0748)Wtsi/Osbpl8Gt(DD0748)Wtsi
(B6.129P2-Osbpl8Gt(DD0748)Wtsi) 		increased circulating cholesterol level J:199891
increased circulating phospholipid level J:199891
increased circulating triglyceride level J:199891
Osbpl11tm1b(EUCOMM)Hmgu/Osbpl11+
(C57BL/6N-Osbpl11tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating triglyceride level J:211773
Osmtm1b(KOMP)Wtsi/Osmtm1b(KOMP)Wtsi
(C57BL/6N-Osmtm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		increased circulating cholesterol level J:214124
increased circulating free fatty acids level J:214124
increased circulating triglyceride level J:214124
increased liver cholesterol level J:214124
increased liver triglyceride level J:214124
Ostm1om/Ostm1om
(C3HeB/FeJ-Ostm1om) 		decreased circulating LDL cholesterol level J:195249
decreased circulating triglyceride level J:195249
Otcem1(IMPC)Tcp/Otc+
(C57BL/6NCrl-Otcem1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Otud6atm1(KOMP)Vlcg/Otud6atm1(KOMP)Vlcg
(C57BL/6N-Otud6atm1(KOMP)Vlcg/Nju) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Otud7btm1(NCOM)Cmhd/Otud7btm1(NCOM)Cmhd
(C57BL/6N-Otud7btm1(NCOM)Cmhd/Tcp) 		decreased circulating cholesterol level J:165965
Oxct1tm1a(KOMP)Wtsi/Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi) 		increased circulating ketone body level J:170537
Oxtrtm1.1(KOMP)Vlcg/Oxtrtm1.1(KOMP)Vlcg
(C57BL/6N-Oxtrtm1.1(KOMP)Vlcg/Rbrc) 		increased circulating LDL cholesterol level J:211773
P2rx7tm1a(EUCOMM)Wtsi/P2rx7tm1a(EUCOMM)Wtsi
(C57BL/6N-P2rx7tm1a(EUCOMM)Wtsi/Ieg) 		decreased circulating glycerol level J:165965
P2ry13tm1Dgen/P2ry13tm1Dgen
(B6N.Cg-P2ry13tm1Dgen) 		decreased circulating cholesterol level J:170217
decreased circulating glycerol level J:170217
decreased circulating HDL cholesterol level J:170217
decreased circulating LDL cholesterol level J:170217
decreased fatty acids level J:170217
increased feces cholesterol level J:170217
P2ry13tm1Loma/P2ry13tm1Loma
(B6.129-P2ry13tm1Loma) 		decreased liver cholesterol level J:166205
Pabpc4tm1a(KOMP)Wtsi/Pabpc4tm1a(KOMP)Wtsi
(C57BL/6N-Pabpc4tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Pacrgem1(IMPC)J/Pacrgem1(IMPC)J
(C57BL/6NJ-Pacrgem1(IMPC)J/J) 		increased circulating HDL cholesterol level J:211773
Padi3tm1b(KOMP)Wtsi/Padi3tm1b(KOMP)Wtsi
(C57BL/6N-Padi3tm1b(KOMP)Wtsi/Orl) 		increased circulating HDL cholesterol level J:211773
Padi4em1(IMPC)Mbp/Padi4em1(IMPC)Mbp
(C57BL/6N-Padi4em1(IMPC)Mbp/MbpMmucd) 		decreased circulating cholesterol level J:211773
increased circulating triglyceride level J:211773
Pahem1Skym/Pahem1Skym
(C57BL/6J-Pahem1Skym) 		decreased circulating cholesterol level J:305392
decreased circulating HDL cholesterol level J:305392
decreased circulating LDL cholesterol level J:305392
Pak1tm1b(EUCOMM)Hmgu/Pak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Pak1tm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Palb2tm1.1(KOMP)Vlcg/Palb2+
(C57BL/6N-Palb2tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Palmem1(IMPC)Wtsi/Palmem1(IMPC)Wtsi
(C57BL/6N-Palmem1(IMPC)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Pank1tm1.1Suja/Pank1tm1.1Suja
(involves: 129S/SvEv * C57BL/6J) 		abnormal triglyceride level J:161798
decreased circulating triglyceride level J:161798
decreased liver triglyceride level J:161798
increased liver triglyceride level J:161798
Pank1tm1.1Suja/Pank1tm1.1Suja
(involves: 129S/SvEv) 		decreased fatty acid oxidation J:189609
Pank1tm1.1Suja/Pank1tm1.1Suja
Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal fatty acids level J:189609
decreased fatty acid oxidation J:189609
increased circulating ketone body level J:189609
increased liver triglyceride level J:189609
Park7em1(IMPC)H/Park7em1(IMPC)H
(C57BL/6NTac-Park7em1(IMPC)H/H) 		increased circulating HDL cholesterol level J:211773
Parp4em1(IMPC)Mbp/Parp4em1(IMPC)Mbp
(C57BL/6N-Parp4em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
Parvbtm1a(EUCOMM)Wtsi/Parvbtm1a(EUCOMM)Wtsi
(C57BL/6N-Parvbtm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating cholesterol level J:165965
Pax5tm1b(EUCOMM)Wtsi/Pax5+
(C57BL/6N-Pax5tm1b(EUCOMM)Wtsi/Ieg) 		increased circulating triglyceride level J:211773
Pax6tm1Pgr/Pax6tm2Pgr
Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI) 		increased circulating ketone body level J:90642
Pax6tm2Pgr/Pax6tm2Pgr
Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB * NMRI) 		increased circulating ketone body level J:90642
Pax7tm1.1(KOMP)Vlcg/Pax7+
(C57BL/6N-Pax7tm1.1(KOMP)Vlcg/J) 		decreased circulating triglyceride level J:211773
Pbx3tm1a(EUCOMM)Wtsi/Pbx3tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating cholesterol level J:165965
increased circulating cholesterol level J:165965
Pcdh15av-3J/Pcdh15av-3J
(C57BL/6J-Pcdh15av-3J/J) 		abnormal circulating lipid level J:320724
decreased circulating cholesterol level J:320724
decreased circulating triglyceride level J:320724
Pcdhb13em1(IMPC)Tcp/Pcdhb13em1(IMPC)Tcp
(C57BL/6N-Pcdhb13em1(IMPC)Tcp/Tcp) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Pck1tm1.1Lre/Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased circulating ketone body level J:73977
decreased circulating triglyceride level J:73977
decreased liver triglyceride level J:73977
Pck1tm1.1Mgn/Pck1tm1.1Mgn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac) 		increased circulating free fatty acids level J:63929
increased circulating triglyceride level J:63929
increased liver triglyceride level J:63929
Pck1tm1Rwh/Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating lipid level J:145210
increased circulating ketone body level J:145210
increased circulating triglyceride level J:145210
Pck2em1(IMPC)Tcp/Pck2em1(IMPC)Tcp
(C57BL/6N-Pck2em1(IMPC)Tcp/Tcp) 		decreased circulating triglyceride level J:211773
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating cholesterol level J:46228
increased circulating aldosterone level J:46228
increased circulating corticosterone level J:46228
increased circulating triglyceride level J:46228
Pcsk2em1(IMPC)H/Pcsk2em1(IMPC)H
(C57BL/6NTac-Pcsk2em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Pcsk5tm1b(KOMP)Mbp/Pcsk5+
(C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Pcsk9m1Bms/Pcsk9+
(B6.Cg-Pcsk9m1Bms) 		decreased circulating LDL cholesterol level J:200728
Pcsk9m1Bms/Pcsk9m1Bms
(B6.Cg-Pcsk9m1Bms) 		decreased circulating LDL cholesterol level J:200728
increased bile salt level J:200728
Pcsk9tm1.1Prat/Pcsk9tm1.1Prat
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating cholesterol level J:169834
decreased circulating HDL cholesterol level J:169834
decreased circulating LDL cholesterol level J:169834
Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal cholesterol homeostasis J:169834
decreased circulating cholesterol level J:169834
decreased circulating HDL cholesterol level J:169834
decreased circulating LDL cholesterol level J:169834
Pcsk9tm1Jdh/Pcsk9tm1Jdh
(involves: 129S6/SvEvTac) 		decreased circulating cholesterol level J:97836
decreased circulating HDL cholesterol level J:97836
decreased circulating LDL cholesterol level J:97836
Pcsk9tm2b(EUCOMM)Hmgu/Pcsk9tm2b(EUCOMM)Hmgu
(C57BL/6N-Pcsk9tm2b(EUCOMM)Hmgu/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
PctpR120H/Pctp+
(NZO) 		abnormal lipid homeostasis J:114974
Pctptm1Bor/Pctptm1Bor
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal bile salt level J:115285
abnormal phospholipid level J:115285
Pctptm1Bor/Pctptm1Bor
(involves: 129P2/OlaHsd * FVB/NJ) 		abnormal bile salt level J:115285
decreased cholesterol level J:115285
increased cholesterol level J:115285
Pcxtm1c(EUCOMM)Wtsi/Pcxtm1c(EUCOMM)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL) 		abnormal fatty acid oxidation J:332296
increased circulating free fatty acids level J:332296
increased circulating ketone body level J:332296
increased circulating triglyceride level J:332296
increased liver triglyceride level J:332296
Pcyt1atm1Irt/Pcyt1atm1Irt
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/Tg(tetO-cre)1Jaw
(involves: C57BL/6J * FVB/N) 		increased triglyceride level J:118292
Pcyt2tm1.1Suja/Pcyt2tm1.1Suja
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased circulating triglyceride level J:155630
increased liver cholesterol level J:155630
increased liver triglyceride level J:155630
Pcyt2tm1Mbak/Pcyt2+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal lipid homeostasis J:121387
Pdcd6ipem1(IMPC)Mbp/Pdcd6ipem1(IMPC)Mbp
(C57BL/6NCrl-Pdcd6ipem1(IMPC)Mbp/Mmucd) 		increased circulating HDL cholesterol level J:211773
Pde1aem1(IMPC)H/Pde1aem1(IMPC)H
(C57BL/6N-Pde1aem1(IMPC)H/H) 		decreased circulating triglyceride level J:211773
Pde3btm1Yhc/Pde3btm1Yhc
(129X1/SvJ-Pde3btm1Yhc) 		increased circulating free fatty acids level J:117353
increased circulating glycerol level J:117353
increased fatty acids level J:117353
increased glycerol level J:117353
increased triglyceride level J:117353
Pde8btm1Dgen/Pde8btm1Dgen
(B6.129P2-Pde8btm1Dgen) 		increased urine corticosterone level J:203335
Pde10atm1Smsh/Pde10atm1Smsh
(B6NTac.Cg-Pde10atm1Smsh) 		decreased circulating cholesterol level J:209032
Pdgfrbtm1b(EUCOMM)Hmgu/Pdgfrb+
(C57BL/6N-Pdgfrbtm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J) 		decreased circulating triglyceride level J:288824
Pdk1tm1a(EUCOMM)Hmgu/Pdk1tm1a(EUCOMM)Hmgu
Pdk2tm1Rhar/Pdk2tm1Rhar
Pdk3em1Eze/Pdk3em1Eze
Pdk4tm1Rhar/Pdk4tm1Rhar
(involves: 129 * C57BL/6J * C57BL/6N) 		increased circulating ketone body level J:303714
Pdk4tm1Rhar/Pdk4tm1Rhar
(B6.129-Pdk4tm1Rhar) 		abnormal glycerol level J:115895
increased circulating free fatty acids level J:115895
increased circulating ketone body level J:115895
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		decreased circulating corticosterone level J:134336
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat,-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		decreased circulating corticosterone level J:162892
Pdpntm1b(EUCOMM)Wtsi/Pdpn+
(C57BL/6N-Pdpntm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
Pdprtm1b(EUCOMM)Wtsi/Pdprtm1b(EUCOMM)Wtsi
(C57BL/6N-Pdprtm1b(EUCOMM)Wtsi/Ics) 		abnormal cholesterol homeostasis J:211773
Pdss2tm1Dalg/Pdss2tm1Dalg
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal circulating cholesterol level J:136670
Pdss2tm1Dalg/Pdss2tm1Dalg
Tg(NPHS2-cre)295Lbh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating cholesterol level J:136670
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(involves: 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:122399
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Pdzk1tm1Oko/Pdzk1tm1Oko
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		increased circulating cholesterol level J:81814
Pdzk1tm2b(EUCOMM)Wtsi/Pdzk1+
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Peak1em1(IMPC)J/Peak1em1(IMPC)J
(C57BL/6NJ-Peak1em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Peds1tm1a(KOMP)Wtsi/Peds1tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased brain plasmalogen level J:287476
decreased plasmalogen level J:287476
Peds1tm1a(KOMP)Wtsi/Peds1tm1a(KOMP)Wtsi
(B6Dnk;B6Brd;B6N-Tyrc-Brd Peds1tm1a(KOMP)Wtsi/Wtsi) 		abnormal ether lipid level J:333103
decreased brain plasmalogen level J:333103
decreased plasmalogen level J:333103
Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating cholesterol level J:83870
abnormal lipid level J:83870
decreased circulating cholesterol level J:83870
decreased circulating HDL cholesterol level J:83870
Pepdtm1b(KOMP)Wtsi/Pepdtm1b(KOMP)Wtsi
(C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg) 		decreased circulating HDL cholesterol level J:211773
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac) 		abnormal bile salt homeostasis J:278655
abnormal fatty acids level J:278655
abnormal phospholipid level J:278655
increased liver cholesterol level J:278655
increased liver triglyceride level J:278655
Pex1tm1.1Sjms/Pex1tm1.1Sjms
(involves: 129 * C57BL/6N) 		abnormal bile salt homeostasis J:210296
abnormal circulating phospholipid level J:210296
abnormal intestinal lipid absorption J:210296
decreased fatty acids level J:210296
increased fatty acids level J:210296
increased saturated fatty acids level J:210296
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster) 		decreased cholesterol level J:87591
decreased circulating cholesterol level J:87591
decreased circulating HDL cholesterol level J:87591
decreased liver cholesterol level J:87591
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal circulating free fatty acids level J:44975
decreased circulating cholesterol level J:87591
Pex3tm1a(EUCOMM)Wtsi/Pex3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pex3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Pex5tm1Pec/Pex5tm1Pec
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		abnormal bile salt homeostasis J:121804
abnormal fatty acid beta-oxidation J:121804
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6) 		decreased fatty acids level J:158845
decreased saturated fatty acids level J:158845
increased fatty acids level J:158845
lipidosis J:158845
Pex7tm1Rjaw/Pex7tm1Rjaw
(Swiss) 		abnormal lipid level J:92346
increased fatty acids level J:92346
Pex10m1Nisw/Pex10+
(129S1.B6-Pex10m1Nisw) 		abnormal bile salt homeostasis J:216140
decreased plasmalogen level J:216140
Pex10m1Nisw/Pex10m1Nisw
(129S1.B6-Pex10m1Nisw) 		abnormal bile salt homeostasis J:216140
decreased plasmalogen level J:216140
increased fatty acids level J:216140
Pex11atm1Itl/Pex11atm1Itl
(C57BL/6-Pex11atm1Itl) 		abnormal circulating triglyceride level J:195940
increased circulating free fatty acids level J:195940
increased circulating ketone body level J:195940
increased liver triglyceride level J:195940
Pex13tm1Crne/Pex13tm1.1Crne
Tg(Nes-cre)1Kln/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * SJL) 		abnormal fatty acids level J:167578
decreased brain plasmalogen level J:167578
increased plasmalogen level J:167578
Pfasem1(IMPC)J/Pfas+
(C57BL/6NJ-Pfasem1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Pgam5tm1b(EUCOMM)Wtsi/Pgam5tm1b(EUCOMM)Wtsi
(C57BL/6N-Pgam5tm1b(EUCOMM)Wtsi/Ics) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N) 		decreased circulating triglyceride level J:268130
increased circulating free fatty acids level J:268130
increased liver triglyceride level J:268130
Phb1em1(IMPC)H/Phb1+
(C57BL/6NTac-Phb1em1(IMPC)H/H) 		increased circulating triglyceride level J:211773
Phdlc1C57BL/6J/Phdlc1CASA/RkJ
(involves: C57BL/6J * CASA/RkJ) 		increased circulating HDL cholesterol level J:94547
Phdlc1CASA/RkJ/Phdlc1CASA/RkJ
(involves: C57BL/6J * CASA/RkJ) 		increased circulating HDL cholesterol level J:94547
Phdlc2C57BL/6J/Phdlc2C57BL/6J
(involves: C57BL/6J * CASA/RkJ) 		increased circulating HDL cholesterol level J:94547
PhexHyp/Y
(Not Specified) 		abnormal vitamin D level J:110579
PhexMhdabap024/Y
(C3HeB/FeJ-PhexMhdabap024) 		decreased vitamin D level J:264682
Phf8em2(IMPC)Wtsi/Phf8em2(IMPC)Wtsi
(C57BL/6N-Phf8em2(IMPC)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Phf8tm1dIcs/Y
(C57BL/6N-Phf8tm1dIcs/Ics) 		increased circulating HDL cholesterol level J:211773
Phf8tm1dIcs/Phf8tm1dIcs
(C57BL/6N-Phf8tm1dIcs/Ics) 		increased circulating HDL cholesterol level J:211773
Phkbem1(IMPC)J/Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax) 		decreased liver triglyceride level J:330539
increased circulating ketone body level J:330539
increased circulating triglyceride level J:330539
Phospq1SM/J/?
(involves: A/J * SM/J) 		abnormal lipid level J:64138
Phrf1em1(IMPC)Tcp/Phrf1em1(IMPC)Tcp
(C57BL/6N-Phrf1em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N) 		abnormal circulating lipid level J:142512
decreased circulating cholesterol level J:142512
decreased circulating free fatty acids level J:142512
decreased circulating triglyceride level J:142512
lipidosis J:142512
Piezo2em2(IMPC)J/Piezo2+
(C57BL/6NJ-Piezo2em2(IMPC)J/Mmjax) 		increased circulating triglyceride level J:211773
Pightm1.1(KOMP)Vlcg/Pigh+
(C57BL/6N-Pightm1.1(KOMP)Vlcg/J) 		decreased circulating HDL cholesterol level J:211773
Pik3ap1tm1b(KOMP)Wtsi/Pik3ap1tm1b(KOMP)Wtsi
(C57BL/6N-Pik3ap1tm1b(KOMP)Wtsi/Orl) 		abnormal cholesterol homeostasis J:211773
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating cholesterol level J:169710
Pik3c2gtm1Ehi/Pik3c2gtm1Ehi
(involves: 129 * C57BL/6) 		increased circulating cholesterol level J:223018
increased circulating triglyceride level J:223018
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J) 		decreased circulating cholesterol level J:152332
decreased circulating triglyceride level J:152332
Pik3r1tm1Khn/Pik3r1tm1Khn
(involves: 129S4/SvJae * C57BL/6J) 		abnormal lipid homeostasis J:87598
decreased triglyceride level J:87598
PikfyveGt(AT0926)Wtsi/PikfyveGt(AT0926)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid level J:190368
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi
Tg(Ckm-cre)28Arte/0
(involves: C57BL/6) 		increased circulating triglyceride level J:199213
Pikfyvetm2.1Tssk/Pikfyvetm2.1Tssk
Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased circulating free fatty acids level J:193689
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		abnormal intestinal lipid absorption J:85204
decreased circulating triglyceride level J:85204
increased circulating corticosterone level J:85204
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		abnormal intestinal lipid absorption J:85204
decreased circulating triglyceride level J:85204
increased circulating corticosterone level J:85204
Pitpnc1em1(IMPC)Kmpc/Pitpnc1em1(IMPC)Kmpc
(C57BL/6NTac-Pitpnc1em1(IMPC)Kmpc/Kmpc) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Pitpnm1tm1a(EUCOMM)Wtsi/Pitpnm1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased circulating cholesterol level J:207051
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6) 		decreased circulating cholesterol level J:156878
decreased circulating triglyceride level J:156878
Pitx3tm1.1(KOMP)Vlcg/Pitx3tm1.1(KOMP)Vlcg
(C57BL/6N-Pitx3tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Pkd1tm1.1Pcha/Pkd1tm2Som
Tg(Cdh16-cre)91Igr/0
(involves: 129 * 129S4/SvJae * C57BL/6 * ICR) 		decreased fatty acid oxidation J:244067
Pkd1tm2Som/Pkd1tm2.1Som
Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL) 		increased circulating cholesterol level J:135301
Pkd1tm2Som/Pkd1tm2Som
Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL) 		increased circulating cholesterol level J:135301
Pklrem1Appsc/Pklrem1Appsc
(involves: C57BL/6J) 		abnormal sphingomyelin level J:342736
decreased ceramide level J:342736
decreased saturated fatty acids level J:342736
Pkn2tm1b(KOMP)Wtsi/Pkn2+
(C57BL/6N-Pkn2tm1b(KOMP)Wtsi/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Pla2g1btm1Dyh/Pla2g1btm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6) 		abnormal intestinal lipid absorption J:80216
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg) 		abnormal lipid homeostasis J:201008
decreased unsaturated fatty acids level J:229035
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6J) 		abnormal phospholipid level J:161462
Pla2g4eem1Murm/Pla2g4eem1Murm
(C57BL/6NSlc-Pla2g4eem1Murm) 		abnormal lipid level J:333700
Pla2g6tm1Zyao/Pla2g6tm1Zyao
(involves: 129S6/SvEvTac * C57BL/6) 		increased cholesterol level J:203038
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal prostaglandin level J:125607
Pla2g10tm1Itl/Pla2g10tm1Itl
(involves: C57BL/6NTac) 		increased circulating corticosterone level J:164545
Pla2g12bhlb218/Pla2g12bhlb218
(C57BL/6J-Pla2g12bhlb218/J) 		decreased circulating cholesterol level J:187708, J:82961
decreased circulating HDL cholesterol level J:187708, J:82961
decreased circulating triglyceride level J:187708
Pla2g12bmpc96H/Pla2g12bmpc96H
(involves: BALB/c * C3H/HeH * C57BL/6J) 		decreased circulating HDL cholesterol level J:234901
decreased circulating LDL cholesterol level J:234901
Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv) 		abnormal circulating cholesterol level J:97471
Plaat3tm1.1Hsul/Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul) 		decreased circulating free fatty acids level J:239202
decreased circulating triglyceride level J:239202
decreased liver triglyceride level J:239202
decreased triglyceride level J:239202
increased fatty acid oxidation J:239202
Plagl2tm1Wjmv/Plagl2tm1Wjmv
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		abnormal intestinal lipid absorption J:130260
increased circulating cholesterol level J:130260
increased circulating triglyceride level J:130260
Plast1C57BL/6J/Plast1C57BL/6J
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plast1C57BL/6J/Plast1C57BL/6J
Plast2bCASA/Rk/Plast2bCASA/Rk
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plast1C57BL/6J/Plast1CASA/Rk
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plast1C57BL/6J/Plast1CASA/Rk
Plast2bCASA/Rk/Plast2bCASA/Rk
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plast1aCASA/Rk/Plast1aCASA/Rk
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:116492
decreased intestinal cholesterol absorption J:116492
Plast1bCASA/Rk/Plast1bCASA/Rk
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:116492
decreased intestinal cholesterol absorption J:116492
Plast2aC57BL/6J/Plast2aC57BL/6J
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plast2aC57BL/6J/Plast2aCASA/Rk
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plast2bC57BL/6J/Plast2bC57BL/6J
(involves: C57BL/6J * CASA/Rk) 		abnormal circulating cholesterol level J:119976
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg) 		increased circulating corticosterone level J:81694, J:94733
Pld2tm1.1Gdp/Pld2tm1.1Gdp
(involves: 129X1/SvJ * C57BL/6) 		abnormal lipid level J:166741
Pld2tm1.1Gdp/Pld2tm1.1Gdp
Tg(APPSWE)2576Kha/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		abnormal lipid level J:166741
Pld5tm1b(KOMP)Wtsi/Pld5tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Pld5tm1b(KOMP)Wtsi Tyrc-Brd/Wtsi) 		increased circulating HDL cholesterol level J:211773
Plekhf2em1(IMPC)Wtsi/Plekhf2em1(IMPC)Wtsi
(C57BL/6NCrl-Plekhf2em1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Plin1tm1Asg/Plin1tm1Asg
(B6.129S6-Plin1tm1Asg) 		abnormal circulating free fatty acids level J:113735
Plin1tm1Chan/Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal circulating free fatty acids level J:66267
abnormal circulating ketone body level J:66267
abnormal glycerol level J:66267
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg) 		decreased circulating free fatty acids level J:196302
decreased circulating triglyceride level J:196302
decreased liver triglyceride level J:196302
Plin2tm1Chan/Plin2tm1Chan
(B6.129-Plin2tm1Chan) 		decreased liver triglyceride level J:105572
Plin3tm1.1Jbki/Plin3tm1.1Jbki
(B6J.129S(Cg)-Plin3tm1.1Jbki) 		abnormal lipid homeostasis J:261132
increased fatty acid oxidation J:261132
Plin4tm1Vlcg/Plin4tm1Vlcg
(B6.Cg-Plin4tm1Vlcg) 		decreased cardiac muscle triglyceride level J:195987
Plin5tm1e(KOMP)Wtsi/Plin5tm1e(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal ceramide level J:221539
abnormal sphingomyelin level J:221539
decreased cardiac muscle triglyceride level J:221539
decreased fatty acid oxidation J:221539
decreased skeletal muscle triglyceride level J:221539
increased fatty acid oxidation J:221539
Plin5tm1Macl/Plin5tm1Macl
(involves: 129S6/SvEvTac * C57BL/6JBomTac) 		decreased cardiac muscle triglyceride level J:286482
decreased fatty acid oxidation J:286482
Plin5tm1Tosu/Plin5tm1Tosu
(involves: C57BL/6JJcl) 		abnormal lipid level J:188390
decreased cardiac muscle triglyceride level J:188390
decreased fatty acids level J:188390
decreased liver free fatty acids level J:188390
decreased liver triglyceride level J:188390
decreased triglyceride level J:188390
increased circulating free fatty acids level J:188390
increased fatty acid oxidation J:188390
increased liver free fatty acids level J:188390
increased liver triglyceride level J:188390
Pllptm1(KOMP)Vlcg/Pllptm1(KOMP)Vlcg
(C57BL/6NCrl-Pllptm1(KOMP)Vlcg/MbpMmucd) 		increased circulating cholesterol level J:211773
Plp1jp-rsh/Plp1jp-rsh
(C3H * C57BL/6 * STOCK Rb(1.3)1Bnr) 		abnormal phospholipid level J:31089
Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ) 		decreased cholesterol level J:193310
Plpp3tm1Stw/Plpp3tm1Stw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		abnormal phospholipid level J:84753
Pls3tm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Pls3tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Plscr1tm1Lex/Plscr1tm1Lex
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal lipid homeostasis J:92404
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S/SvEvBrd * C57BL/6J) 		abnormal circulating cholesterol level J:92404
abnormal lipid homeostasis J:92404
increased circulating free fatty acids level J:92404
increased circulating triglyceride level J:92404
Pltptm1Jia/Pltptm1Jia
(involves: C57BL/6) 		abnormal circulating cholesterol level J:53521
abnormal phospholipid level J:53521
decreased circulating HDL cholesterol level J:53521
increased circulating LDL cholesterol level J:53521
increased circulating VLDL cholesterol level J:53521
Pltptm2.1Jia/Pltptm2.1Jia
(involves: C57BL/6J) 		abnormal circulating non-HDL cholesterol level J:239143
decreased circulating cholesterol level J:239143
decreased circulating HDL cholesterol level J:239143
decreased circulating HDL phospholipid level J:239143
decreased circulating non-HDL phospholipid level J:239143
decreased circulating phospholipid level J:239143
decreased circulating triglyceride level J:239143
Plvaptm1.1Rvst/Plvaptm1.1Rvst
Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J) 		abnormal circulating lipid level J:191046
decreased circulating HDL cholesterol level J:191046
increased circulating cholesterol level J:191046
increased circulating triglyceride level J:191046
Plvaptm1.1Rvst/Plvaptm1.1Rvst
Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJae * C3H * C57BL/6) 		abnormal circulating lipid level J:191046
decreased circulating HDL cholesterol level J:191046
increased circulating cholesterol level J:191046
increased circulating triglyceride level J:191046
Plvaptm1.2Rvst/Plvaptm1.2Rvst
(involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL) 		abnormal lipid level J:191046
decreased circulating HDL cholesterol level J:191046
increased circulating cholesterol level J:191046
increased circulating triglyceride level J:191046
xanthoma J:191046
Plxna4em1(IMPC)Mbp/Plxna4em1(IMPC)Mbp
(C57BL/6NCrl-Plxna4em1(IMPC)Mbp/MbpMmucd) 		abnormal cholesterol homeostasis J:211773
Plxnc1em1(IMPC)Mbp/Plxnc1em1(IMPC)Mbp
(C57BL/6N-Plxnc1em1(IMPC)Mbp/MbpMmucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Pm20d1em1(IMPC)H/Pm20d1em1(IMPC)H
(C57BL/6NTac-Pm20d1em1(IMPC)H/H) 		increased circulating triglyceride level J:211773
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6) 		decreased triglyceride level J:51659
Pmp2tm1.1(KOMP)Vlcg/Pmp2tm1.1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac) 		abnormal lipid homeostasis J:211344
Pnhdlc1C57BL/6J/Pnhdlc1C57BL/6J
(involves: C57BL/6J * CASA/RkJ) 		abnormal circulating cholesterol level J:94547
Pnhdlc2C57BL/6J/Pnhdlc2C57BL/6J
(involves: C57BL/6J * CASA/RkJ) 		abnormal circulating cholesterol level J:94547
Pnhdlc3C57BL/6J/Pnhdlc3CASA/RkJ
(involves: C57BL/6J * CASA/RkJ) 		abnormal circulating cholesterol level J:94547
Pnhdlc3CASA/RkJ/Pnhdlc3CASA/RkJ
(involves: C57BL/6J * CASA/RkJ) 		abnormal circulating cholesterol level J:94547
Pnliptm1Dyh/Pnliptm1Dyh
(B6.129-Pnliptm1Dyh) 		abnormal bile salt homeostasis J:86414
abnormal intestinal lipid absorption J:86414
decreased intestinal cholesterol absorption J:86414
increased feces cholesterol level J:86414
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal intestinal lipid absorption J:124658
decreased circulating cholesterol level J:124658
decreased intestinal cholesterol absorption J:124658
Pnliprp2tm1Gru/Pnliprp2tm1Gru
(involves: 129S2/SvPas * BALB/c) 		abnormal intestinal lipid absorption J:51627
Pnpla1tm1.1Fpwr/Pnpla1tm1.1Fpwr
(B6.129P2(Cg)-Pnpla1tm1.1Fpwr) 		abnormal ceramide level J:240053
Pnpla1tm1.1Murm/Pnpla1tm1.1Murm
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6N) 		abnormal ceramide level J:240682
Pnpla1tm1a(KOMP)Wtsi/Pnpla1tm1a(KOMP)Wtsi
(B6NTac;B6N-Atm1Brd Pnpla1tm1a(KOMP)Wtsi/Ics) 		abnormal ceramide level J:242353
abnormal free fatty acids level J:242353
abnormal sphingomyelin level J:242353
decreased fatty acids level J:242353
Pnpla1tm1Murm/Pnpla1tm1Murm
(involves: C57BL/6N) 		abnormal ceramide level J:240682
abnormal free fatty acids level J:240682
increased cholesterol level J:240682
increased triglyceride level J:240682
Pnpla2tm1.1Hsul/Pnpla2tm1.1Hsul
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL) 		decreased fatty acid oxidation J:176083
Pnpla2tm1Eek/Pnpla2tm1Eek
Tg(Ckmm-cre)5Khn/0
(involves: 129S * FVB/N) 		increased cardiac muscle triglyceride level J:176252
Pnpla2tm1Eek/Pnpla2tm1Eek
Tg(Myog-cre)1Eno/0
(involves: 129S * C57BL/6) 		abnormal lipid level J:207007
increased fatty acids level J:207007
increased skeletal muscle triglyceride level J:207007
Pnpla2tm1Gam/Pnpla2tm1Gam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA) 		decreased fatty acid oxidation J:185116
increased circulating free fatty acids level J:185116
increased liver triglyceride level J:185116
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:108546
decreased circulating free fatty acids level J:108546
decreased circulating HDL cholesterol level J:108546
decreased circulating triglyceride level J:108546
decreased circulating VLDL triglyceride level J:108546
increased cardiac muscle triglyceride level J:108546
increased liver triglyceride level J:108546
increased triglyceride level J:108546
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd) 		abnormal lipid homeostasis J:160725
decreased circulating free fatty acids level J:176252
decreased circulating triglyceride level J:176252
increased fatty acids level J:176252
increased liver triglyceride level J:176252, J:160725
increased triglyceride level J:176252, J:160725
Pnpla2tm1Rze/Pnpla2tm1Rze
Tg(Myh6-Pnpla2)94Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased circulating free fatty acids level J:176252
decreased circulating triglyceride level J:176252
Pnpla3tm1.1Hobb/Pnpla3tm1.1Hobb
(involves: 129 * C57BL/6J) 		increased fatty acids level J:264475
increased liver triglyceride level J:264475
Pnpla3tm2.1Hobb/Pnpla3+
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:264475
Pnpla3tm2.1Hobb/Pnpla3tm2.1Hobb
(involves: 129 * C57BL/6J) 		increased liver triglyceride level J:264475
Pnpla6tm1Mvc/Pnpla6tm1Mvc
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal phospholipid level J:152759
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm) 		abnormal circulating triglyceride level J:333442
decreased liver triglyceride level J:333442
increased circulating ketone body level J:333442
Pnpla8tm1Rigr/Pnpla8tm1Rigr
(involves: 129X1/SvJ) 		decreased circulating triglyceride level J:333442
decreased liver triglyceride level J:333442
Polr2htm1.1(KOMP)Wtsi/Polr2h+
(B6N(Cg)-Polr2htm1.1(KOMP)Wtsi/J) 		increased circulating free fatty acids level J:211773
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased circulating triglyceride level J:291184
Polr3dem1(IMPC)Tcp/Polr3d+
(C57BL/6N-Polr3dem1(IMPC)Tcp/Tcp) 		abnormal cholesterol homeostasis J:211773
Pom121l2em1(IMPC)J/Pom121l2em1(IMPC)J
(C57BL/6NJ-Pom121l2em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * C57BL/6) 		decreased circulating corticosterone level J:102955
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low/J) 		increased circulating corticosterone level J:84463
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased circulating corticosterone level J:119240
Pomctm1Low/Pomctm1Low
Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		abnormal corticosterone level J:119240
increased circulating corticosterone level J:119240
Pomctm1Low/Pomctm1Low
Tg(Pomc)#Low/Tg(Pomc)#Low
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		increased circulating corticosterone level J:119240
Pomctm1Sora/Pomc+
(involves: 129S2/SvHsd * 129S6/SvEvTac) 		decreased circulating corticosterone level J:89244
Pomctm1Sora/Pomctm1Sora
(involves: 129S2/SvHsd * 129S6/SvEvTac) 		decreased circulating corticosterone level J:89244
Pomctm2Ute/Pomctm2Ute
(involves: 129S1/Sv * 129X1/SvJ) 		decreased circulating aldosterone level J:57503
decreased circulating corticosterone level J:57503
Pon1tm1Lus/Pon1tm1Lus
(involves: 129X1/SvJ * C57BL/6J) 		increased circulating LDL cholesterol level J:63392
increased circulating VLDL cholesterol level J:63392
Pon2Gt(XE661)Byg/Pon2Gt(XE661)Byg
(B6.129P2-Pon2Gt(XE661)Byg) 		abnormal cholesterol homeostasis J:116935
decreased circulating cholesterol level J:116935
decreased circulating LDL cholesterol level J:116935
decreased circulating VLDL cholesterol level J:116935
Pon2tm1b(EUCOMM)Hmgu/Pon2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pon2tm1b(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:211773
Pon3tm1b(KOMP)Wtsi/Pon3tm1b(KOMP)Wtsi
(C57BL/6N-Pon3tm1b(KOMP)Wtsi/Kmpc) 		increased circulating triglyceride level J:211773
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh) 		abnormal bile salt homeostasis J:234615
abnormal lipid level J:234615
decreased bile salt level J:234615
decreased circulating free fatty acids level J:234615
decreased circulating HDL cholesterol level J:234615
decreased circulating triglyceride level J:234615
decreased fatty acid oxidation J:234615
decreased liver triglyceride level J:234615
increased bile salt level J:234615
increased circulating cholesterol level J:234615
increased circulating LDL cholesterol level J:234615
increased circulating triglyceride level J:234615
increased liver cholesterol level J:234615
Portm1Ding/Portm1Ding
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA) 		decreased circulating cholesterol level J:84422
Portm1Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal bile salt level J:82951
decreased circulating cholesterol level J:82951
decreased circulating triglyceride level J:82951
Portm2Ding/Portm2Ding
(involves: 129S1/Sv * C57BL/6) 		decreased circulating cholesterol level J:119630
Portm2Wolf/Portm1Wolf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal bile salt level J:82951
decreased circulating cholesterol level J:82951
decreased circulating triglyceride level J:82951
Portm3Ding/Portm3Ding
(C57BL/6-Portm3Ding) 		decreased circulating cholesterol level J:159168
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz) 		abnormal circulating HDL cholesterol level J:72185
abnormal circulating ketone body level J:56056
increased circulating cholesterol level J:72185
increased circulating free fatty acids level J:56056
Pparatm1Gonz/Pparatm1Gonz
(B6.129S4-Pparatm1Gonz) 		increased circulating triglyceride level J:72185
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae) 		decreased fatty acid oxidation J:176083
increased circulating cholesterol level J:127793
increased circulating free fatty acids level J:127793
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6J) 		increased skeletal muscle triglyceride level J:129848
Ppardtm1(PPARD)Bsls/Ppardtm1(PPARD)Bsls
(B6.Cg-Ppardtm1(PPARD)Bsls) 		decreased circulating cholesterol level J:211453
decreased circulating HDL cholesterol level J:211453
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N) 		abnormal lipid level J:76564
decreased liver cholesterol level J:89827
decreased liver triglyceride level J:89827
increased circulating triglyceride level J:89827
increased circulating VLDL cholesterol level J:89827
increased fatty acids level J:89827
Ppardtm1Mtz/Ppardtm1Mtz
Tg(KRT14-cre)1Ipc/0
(involves: C57BL/6 * SJL) 		decreased cholesterol level J:109090
Ppargtm1.1Auw/Ppargtm1.1Auw
(B6.Cg-Ppargtm1.1Auw) 		decreased circulating cholesterol level J:144344
decreased circulating triglyceride level J:144344
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Tg(Aqp2-cre)1Dek/0
(involves: 129X1/SvJ * C57BL/6 * SJL) 		abnormal circulating aldosterone level J:99873
Ppargtm1Auw/Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J)) 		hyperlipidemia J:86705
increased circulating free fatty acids level J:86705
increased circulating triglyceride level J:86705
increased liver triglyceride level J:86705
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6) 		abnormal lipid homeostasis J:116568
abnormal triglyceride level J:116568
increased circulating triglyceride level J:116568
Ppargtm1Laz/Ppargtm1Laz
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating free fatty acids level J:135904
decreased circulating triglyceride level J:135904
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ) 		increased circulating free fatty acids level J:98786
increased liver triglyceride level J:98786
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		increased circulating cholesterol level J:125992
increased circulating free fatty acids level J:125992
increased circulating triglyceride level J:125992
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		increased triglyceride level J:155909
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		increased circulating triglyceride level J:125992
Ppargc1atm1Aztc/Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc) 		decreased circulating cholesterol level J:82809
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N) 		abnormal lipid homeostasis J:93896
decreased liver triglyceride level J:93896
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ) 		decreased triglyceride level J:137598
Ppargc1atm1Dpk/Ppargc1atm1Dpk
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N) 		decreased triglyceride level J:137598
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		decreased circulating cholesterol level J:116167
decreased circulating triglyceride level J:116167
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N) 		decreased triglyceride level J:137598
Ppargc1btm1.1Rev/Ppargc1btm1.1Rev
(involves: 129 * C57BL/6J) 		decreased circulating free fatty acids level J:120079
decreased circulating triglyceride level J:120079
increased circulating free fatty acids level J:120079
increased circulating triglyceride level J:120079
increased liver triglyceride level J:120079
Ppargc1btm1Lowl/Ppargc1btm1Lowl
(involves: C57BL/6) 		increased liver triglyceride level J:129775
Ppdpftm1Nju/Ppdpftm1Nju
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		increased circulating free fatty acids level J:307283
increased circulating triglyceride level J:307283
increased liver triglyceride level J:307283
Ppil3tm1b(EUCOMM)Wtsi/Ppil3tm1b(EUCOMM)Wtsi
(C57BL/6N-Ppil3tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating free fatty acids level J:211773
increased circulating HDL cholesterol level J:211773
Ppm1ltm1Dgen/Ppm1ltm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating free fatty acids level J:134171
Ppme1em1(IMPC)Rbrc/Ppme1+
(C57BL/6NJcl-Ppme1em1(IMPC)Rbrc/Rbrc) 		increased circulating triglyceride level J:211773
Ppp1r3btm1.1Arte/Ppp1r3b+
(involves: C57BL/6J * C57BL/6N) 		decreased circulating triglyceride level J:157291
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars) 		increased circulating triglyceride level J:83297
increased skeletal muscle triglyceride level J:83297
Ppp2r5cem1(IMPC)Mbp/Ppp2r5cem1(IMPC)Mbp
(C57BL/6N-Ppp2r5cem1(IMPC)Mbp/Ucd) 		decreased circulating cholesterol level J:211773
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(B6Dnk;B6Brd;B6N-Ppp5ctm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating triglyceride level J:175295
Pptc7em1Pagd/Pptc7em1Pagd
(C57BL/6J-Pptc7em1Pagd) 		decreased circulating ketone body level J:277086
Pptc7em2Pagd/Pptc7em2Pagd
(C57BL/6J-Pptc7em2Pagd) 		decreased circulating ketone body level J:277086
Prdm12tm2b(EUCOMM)Hmgu/Prdm12+
(C57BL/6N-Prdm12tm2b(EUCOMM)Hmgu/Tcp) 		increased circulating cholesterol level J:211773
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N) 		increased liver triglyceride level J:208683
Prdx3tm1Hjha/Prdx3tm1Hjha
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating triglyceride level J:228860
decreased fatty acid oxidation J:228860
increased circulating cholesterol level J:228860
Prdx5tm1Dsle/Prdx5tm1Dsle
(involves: C57BL/6) 		increased liver triglyceride level J:294801
Prdx6tm2Abf/Prdx6tm2Abf
(involves: C57BL/6J) 		abnormal phospholipid level J:237406
Preptm1b(KOMP)Wtsi/Prep+
(C57BL/6N-Preptm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J) 		increased circulating triglyceride level J:92260
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6) 		increased circulating free fatty acids level J:81120
Prkaa2tm1Vio/Prkaa2tm1Vio
Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N) 		increased fatty acids level J:108399
increased triglyceride level J:108399
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(B6N(Cg)-Prkab1tm1b(KOMP)Wtsi/J) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/MbpMmucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Prkab1tm1Eihl/Prkab1tm1Eihl
(involves: C57BL/6) 		abnormal lipid level J:158295
decreased liver triglyceride level J:158295
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi) 		increased circulating triglyceride level J:186658
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6) 		abnormal lipid homeostasis J:167339
Prkacatm3Gsm/Prkacatm3Gsm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J) 		increased circulating triglyceride level J:103418
Prkar1atm1Lsk/Prkar1atm1Lsk
Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased circulating corticosterone level J:161521
Prkar2btm1Gsm/Prkar2btm1Gsm
(Not Specified) 		decreased triglyceride level J:34751
Prkar2btm1Gsm/Prkar2btm1Gsm
(B6.129-Prkar2btm1Gsm) 		decreased circulating cholesterol level J:72414
decreased circulating LDL cholesterol level J:72414
decreased circulating VLDL cholesterol level J:72414
decreased liver triglyceride level J:72414
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm) 		decreased circulating cholesterol level J:196157
decreased circulating LDL cholesterol level J:196157
decreased circulating VLDL cholesterol level J:196157
decreased liver triglyceride level J:196157
decreased triglyceride level J:196157
Prkcdtm1Qxu/Prkcdtm1Qxu
(B6.129P2-Prkcdtm1Qxu) 		decreased liver triglyceride level J:173902
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal circulating lipid level J:123964
decreased circulating HDL cholesterol level J:123964
increased circulating cholesterol level J:123964
increased circulating free fatty acids level J:123964
increased circulating LDL cholesterol level J:123964
increased circulating triglyceride level J:123964
Prkcitm1Rfar/Prkcitm1Rfar
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal circulating lipid level J:123964
decreased circulating HDL cholesterol level J:123964
increased circulating cholesterol level J:123964
increased circulating free fatty acids level J:123964
increased circulating LDL cholesterol level J:123964
increased circulating triglyceride level J:123964
Prkd3tm1b(EUCOMM)Wtsi/Prkd3+
(C57BL/6N-Prkd3tm1b(EUCOMM)Wtsi/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Prkg1tm1Hfm/Prkg1tm1Hfm
(involves: C57BL/6N) 		decreased triglyceride level J:199222
Prkraem1(IMPC)H/Prkraem1(IMPC)H
(C57BL/6N-Prkraem1(IMPC)H/H) 		increased circulating cholesterol level J:211773
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon) 		increased circulating triglyceride level J:144729
increased liver triglyceride level J:144729
Prlhrtm1Dgen/Prlhrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased cholesterol level J:127335
increased circulating corticosterone level J:127335
increased circulating HDL cholesterol level J:127335
increased circulating LDL cholesterol level J:127335
Prlhrtm1Map/Prlhrtm1Map
(involves: 129S6/SvEvTac * CD-1) 		decreased circulating corticosterone level J:103932
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J) 		increased circulating corticosterone level J:94409
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		increased liver triglyceride level J:102652
Prr5em1(IMPC)J/Prr5em1(IMPC)J
(C57BL/6NJ-Prr5em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Prss8tm1.1Hum/Prss8tm1.2Hum
Tg(KRT14-cre)1Ipc/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		abnormal lipid level J:100139
Prxl2btm1.2Ksak/Prxl2btm1.2Ksak
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal lipid level J:307536
Psaptm1Ggb/Psaptm1Ggb
(involves: 129S/SvEv * C57BL/6J) 		abnormal lipid level J:121761
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd) 		abnormal lipid homeostasis J:33477
abnormal lipid level J:78223
Psaptm1Suz/Psaptm1Suz
(B6.129P2-Psaptm1Suz) 		abnormal lipid level J:120657
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J) 		abnormal lipid level J:73188, J:78223, J:120657
Psaptm4.1Ggb/Psaptm4.1Ggb
(involves: 129S/SvEv * C57BL/6J) 		abnormal lipid homeostasis J:198242
Psen1tm1Lpr/Psen1tm1Lpr
(involves: 129 * C57BL/6 * CBA) 		increased circulating cholesterol level J:128243
Psen1tm1Lpr/Psen1tm1Lpr
Tg(Thy1-APPSL)28Lpr/0
(involves: 129 * C57BL/6 * CBA) 		decreased circulating cholesterol level J:128243
increased circulating cholesterol level J:128243
Psg20em1(IMPC)Wtsi/Psg20em1(IMPC)Wtsi
(C57BL/6N-Psg20em1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Psphtm1.1(KOMP)Vlcg/Psph+
(C57BL/6N-Psphtm1.1(KOMP)Vlcg/Ucd) 		decreased circulating triglyceride level J:211773
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg) 		increased circulating triglyceride level J:256004
Ptcd3tm1.1(KOMP)Vlcg/Ptcd3+
(C57BL/6N-Ptcd3tm1.1(KOMP)Vlcg/J) 		decreased circulating HDL cholesterol level J:211773
Ptdss1tm1Jev/Ptdss1+
Ptdss2Gt(KST314)Byg/Ptdss2Gt(KST314)Byg
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		abnormal phospholipid level J:137106
Ptdss1tm1Jev/Ptdss1tm1Jev
(involves: 129S/SvEv * C57BL/6) 		abnormal phospholipid level J:137106
Ptdss1tm1Jev/Ptdss1tm1Jev
Ptdss2Gt(KST314)Byg/Ptdss2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		abnormal phospholipid level J:137106
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal fatty acids level J:88441
decreased circulating free fatty acids level J:88441
increased liver triglyceride level J:88441, J:160759
Ptentm1Hwu/Ptentm1Hwu
Tg(CAG-fat-1)1Jxk/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2) 		abnormal lipid homeostasis J:124208
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		increased liver cholesterol level J:138099
increased liver triglyceride level J:138099
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA) 		increased liver triglyceride level J:90905
increased saturated fatty acids level J:90905
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(C.129-Ptgdr2tm1Tasa) 		decreased prostaglandin level J:131146
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal prostaglandin level J:78964
Ptges3tm1Nkt/Ptges3tm1Nkt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:125188
Ptgestm1.1Gaf/Ptgestm1.1Gaf
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6) 		decreased prostaglandin level J:210141
increased prostaglandin level J:210141
Ptgestm1.1Gaf/Ptgestm1.1Gaf
Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased prostaglandin level J:210141
increased prostaglandin level J:210141
Ptgestm1.1Gaf/Ptgestm1.1Gaf
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		decreased prostaglandin level J:210141
increased prostaglandin level J:210141
Ptgestm1Aki/Ptgestm1Aki
(involves: 129P2/OlaHsd) 		decreased leukotriene level J:92047
Ptgestm1Aki/Ptgestm1Aki
(involves: 129X1/SvJ * C57BL/6) 		abnormal prostaglandin level J:91821
Ptgestm1Lpa/Ptgestm1Lpa
(DBA/1LacJ-Ptgestm1Lpa) 		decreased prostaglandin level J:106147
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thromboxane level J:79049
decreased prostaglandin level J:42275
Ptgistm1Tada/Ptgistm1Tada
(B6.129-Ptgistm1Tada) 		abnormal thromboxane level J:103380
decreased prostaglandin level J:103380
increased prostaglandin level J:103380
Ptgs1tm1Fun/Ptgs1tm1Fun
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal thromboxane level J:108957
Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:29511
Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased prostaglandin level J:106147
Ptgs1tm1Unc/Ptgs1+
(D1.129P2-Ptgs1tm1Unc) 		increased prostaglandin level J:102779
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:103388, J:117986, J:60668, J:50148, J:29511
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased prostaglandin level J:106147
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd) 		decreased prostaglandin level J:108679
Ptgs1tm1Unc/Ptgs1tm1Unc
Oxttm1Ljm/Oxttm1Ljm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:50148
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
(involves: 129S6/SvEvTac * C57BL/6) 		decreased prostaglandin level J:109548
Ptgs2tm1Fun/Ptgs2tm1Fun
(involves: 129S6/SvEvTac * C57BL/6) 		decreased prostaglandin level J:109548
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased prostaglandin level J:109548
Ptgs2tm1Unc/Ptgs2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:124756
Ptgs2tm1Unc/Ptgs2+
(D1.129P2-Ptgs2tm1Unc) 		increased prostaglandin level J:102779
Ptgs2tm1Unc/Ptgs2+
(B6.129P2-Ptgs2tm1Unc) 		decreased prostaglandin level J:67211
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:121680
decreased prostaglandin level J:109021, J:55145
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:124756
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		decreased prostaglandin level J:117986, J:60668
Ptgs2tm1Unc/Ptgs2tm1Unc
(D1.129P2-Ptgs2tm1Unc) 		decreased prostaglandin level J:102779
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc) 		decreased prostaglandin level J:67211
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac) 		decreased prostaglandin level J:141610
Pthlhtm1Ack/Pthlhtm1Hmk
Tg(LGB-cre)74Acl/0
(involves: 129 * C57BL/6 * CBA) 		abnormal vitamin D level J:86536
Ptpn1tm1Bpk/Ptpn1tm1Bpk
(involves: 129S4/SvJae * BALB/c) 		decreased triglyceride level J:53437
Ptpn1tm2Bbk/Ptpn1tm2Bbk
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased triglyceride level J:111969
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N) 		abnormal lipid level J:216593
decreased liver triglyceride level J:216593
decreased skeletal muscle triglyceride level J:216593
increased glycerol level J:216593
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating corticosterone level J:94738
increased circulating triglyceride level J:94738
increased liver triglyceride level J:94738
Ptpn11tm1Gsf/Ptpn11tm1Gsf
Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB) 		increased cardiac muscle triglyceride level J:144767
increased circulating triglyceride level J:144767
increased skeletal muscle triglyceride level J:144767
Ptpn11tm3Bgn/Ptpn11tm3Bgn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA) 		decreased circulating triglyceride level J:167406
Ptpn23tm1b(EUCOMM)Hmgu/Ptpn23+
(C57BL/6N-Ptpn23tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ptprvtm1Kry/Ptprvtm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		decreased circulating free fatty acids level J:126780
decreased circulating triglyceride level J:126780
Pttg1tm1b(EUCOMM)Wtsi/Pttg1tm1b(EUCOMM)Wtsi
(C57BL/6N-Pttg1tm1b(EUCOMM)Wtsi/Tcp) 		abnormal cholesterol homeostasis J:211773
increased circulating triglyceride level J:211773
Pycr1tm1(KOMP)Vlcg/Pycr1tm1(KOMP)Vlcg
(C57BL/6NTac-Pycr1tm1(KOMP)Vlcg) 		decreased circulating triglyceride level J:308336
Pycr1tm1.1(KOMP)Vlcg/Pycr1tm1.1(KOMP)Vlcg
(B6N(Cg)-Pycr1tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating cholesterol level J:308336
decreased circulating HDL cholesterol level J:308336
decreased circulating triglyceride level J:308336
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi) 		decreased circulating cholesterol level J:284765
decreased circulating triglyceride level J:284765
increased circulating ketone body level J:284765
Rab3gap2tm1b(KOMP)Wtsi/Rab3gap2tm1b(KOMP)Wtsi
(C57BL/6N-Rab3gap2tm1b(KOMP)Wtsi/J) 		decreased circulating HDL cholesterol level J:211773
Rab5atm1b(KOMP)Wtsi/Rab5atm1b(KOMP)Wtsi
(C57BL/6N-Rab5atm1b(KOMP)Wtsi/J) 		decreased circulating HDL cholesterol level J:211773
Rab5ctm1a(EUCOMM)Wtsi/Rab5c+
(C57BL/6N-Rab5ctm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Rab28em1(IMPC)J/Rab28em1(IMPC)J
(C57BL/6NJ-Rab28em1(IMPC)J/Mmjax) 		increased circulating triglyceride level J:211773
Rab33bem1(IMPC)J/Rab33bem1(IMPC)J
(C57BL/6NJ-Rab33bem1(IMPC)J/Mmjax) 		decreased circulating cholesterol level J:211773
Rab36tm1b(KOMP)Wtsi/Rab36tm1b(KOMP)Wtsi
(C57BL/6N-Rab36tm1b(KOMP)Wtsi/J) 		abnormal cholesterol homeostasis J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Rab43tm1.1(KOMP)Vlcg/Rab43tm1.1(KOMP)Vlcg
(C57BL/6N-Rab43tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rad1tm1b(KOMP)Wtsi/Rad1+
(C57BL/6N-Rad1tm1b(KOMP)Wtsi/J) 		decreased circulating HDL cholesterol level J:211773
Rai1tm1Jrl/Rai1+
(B6.129S7-Rai1tm1Jrl/J) 		increased circulating corticosterone level J:164451
Rai1tm2.1Luo/Rai1tm2.1Luo
Tg(Sim1-cre)1Lowl/?
(either: (involves: 129S1/Sv * C57BL/6 * FVB) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)) 		increased cholesterol level J:237687
increased circulating HDL cholesterol level J:237687
increased circulating LDL cholesterol level J:237687
increased circulating VLDL cholesterol level J:237687
increased triglyceride level J:237687
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J) 		increased circulating cholesterol level J:287672
increased circulating free fatty acids level J:287672
increased circulating triglyceride level J:287672
increased liver cholesterol level J:287672
increased liver triglyceride level J:287672
Ralgapa1tm2c(KOMP)Wtsi/Ralgapa1tm2c(KOMP)Wtsi
Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N) 		abnormal lipid homeostasis J:287672
increased circulating cholesterol level J:287672
increased circulating free fatty acids level J:287672
increased circulating triglyceride level J:287672
Ralyem2(IMPC)Tcp/Ralyem2(IMPC)Tcp
(C57BL/6NCrl-Ralyem2(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified) 		decreased circulating cholesterol level J:201171
decreased circulating HDL cholesterol level J:201171
increased circulating triglyceride level J:201171
Rapsntm1b(EUCOMM)Wtsi/Rapsn+
(C57BL/6N-Rapsntm1b(EUCOMM)Wtsi/H) 		increased circulating HDL cholesterol level J:211773
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk) 		decreased circulating free fatty acids level J:206120
Rars2tm1a(EUCOMM)Wtsi/Rars2+
(B6JTyr;B6N-Rars2tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:175295
Rasa3scat/Rasa3scat
(involves: BALB/cBy) 		hyperlipidemia J:186485
Rasal3tm1b(EUCOMM)Hmgu/Rasal3tm1b(EUCOMM)Hmgu
(C57BL/6N-Rasal3tm1b(EUCOMM)Hmgu/Orl) 		increased circulating cholesterol level J:211773
increased circulating triglyceride level J:211773
Rbl2tm1b(EUCOMM)Hmgu/Rbl2+
(C57BL/6N-Rbl2tm1b(EUCOMM)Hmgu/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rbm14tm1a(KOMP)Wtsi/Rbm14tm1a(KOMP)Wtsi
(C57BL/6N-Rbm14tm1a(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rbm20em1(IMPC)Mbp/Rbm20em1(IMPC)Mbp
(C57BL/6N-Rbm20em1(IMPC)Mbp/MbpMmucd) 		increased circulating triglyceride level J:211773
Rbpjtm1b(EUCOMM)Hmgu/Rbpj+
(C57BL/6N-Rbpjtm1b(EUCOMM)Hmgu/J) 		decreased circulating HDL cholesterol level J:211773
Rcn3tm1Rzm/Rcn3tm1Rzm
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal phospholipid level J:265611
Rec8tm1b(KOMP)Wtsi/Rec8tm1b(KOMP)Wtsi
(C57BL/6N-Rec8tm1b(KOMP)Wtsi/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6J.Cg-Reep1Gt(OST398247)Tigm) 		decreased circulating cholesterol level J:239250
decreased circulating triglyceride level J:239250
Reg3gtm1a(KOMP)Wtsi/Reg3gtm1a(KOMP)Wtsi
(C57BL/6N-Reg3gtm1a(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J) 		increased circulating aldosterone level J:169129
Resp18tm1.1(KOMP)Vlcg/Resp18+
(C57BL/6N-Resp18tm1.1(KOMP)Vlcg/J) 		increased circulating HDL cholesterol level J:211773
Resp18tm1.1(KOMP)Vlcg/Resp18tm1.1(KOMP)Vlcg
(C57BL/6N-Resp18tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Retntm1Laz/Retntm1Laz
(involves: 129S/SvEv * C57BL/6) 		decreased liver triglyceride level J:90033
Retntm1Laz/Retntm1Laz
Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating free fatty acids level J:171262
increased circulating glycerol level J:171262
increased skeletal muscle triglyceride level J:171262
Retreg3tm2b(EUCOMM)Wtsi/Retreg3tm2b(EUCOMM)Wtsi
(C57BL/6N-Fam134ctm2b(EUCOMM)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Rexo2tm1b(EUCOMM)Wtsi/Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rfc1tm1b(KOMP)Mbp/Rfc1+
(B6N(Cg)-Rfc1tm1b(KOMP)Mbp/J) 		decreased circulating free fatty acids level J:211773
increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rgntm1Aish/Y
(involves: 129P2/OlaHsd) 		abnormal phospholipid level J:88791
increased liver cholesterol level J:88791
increased liver triglyceride level J:88791
Rgp1tm1.1(KOMP)Vlcg/Rgp1+
(C57BL/6N-Rgp1tm1.1(KOMP)Vlcg/J) 		decreased circulating cholesterol level J:211773
Rgs4tm1Dgen/Rgs4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:101679
increased circulating HDL cholesterol level J:101679
Rgs16tm1Tmw/Rgs16tm1Tmw
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased circulating ketone body level J:172091
increased fatty acid oxidation J:172091
Rgsc197/Rgsc197+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc273/Rgsc273+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc333/Rgsc333+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc391/Rgsc391+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc453/Rgsc453+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc528/Rgsc528+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc545/Rgsc545+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc663/Rgsc663+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc668/Rgsc668+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc679/Rgsc679+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased circulating cholesterol level J:133634
increased circulating HDL cholesterol level J:133634
Rgsc733/Rgsc733+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating HDL cholesterol level J:133634
Rgsc855/Rgsc855+
(involves: C57BL/6JJcl * DBA/2JJcl) 		decreased circulating cholesterol level J:133634
decreased circulating HDL cholesterol level J:133634
Rgsc1851/Rgsc1851
(C57BL/6JJcl-Rgsc1851) 		increased circulating triglyceride level J:133634
Rhagem1(IMPC)Ccpcz/Rhagem1(IMPC)Ccpcz
(C57BL/6NCrl-Rhagem1(IMPC)Ccpcz/Ccpcz) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rhpn1tm1b(KOMP)Wtsi/Rhpn1tm1b(KOMP)Wtsi
(C57BL/6N-Rhpn1tm1b(KOMP)Wtsi/Ucd) 		increased circulating HDL cholesterol level J:211773
Rictortm1.1Mnh/Rictortm1.1Mnh
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev) 		increased circulating cholesterol level J:150064
Rilpl2tm1b(KOMP)Wtsi/Rilpl2tm1b(KOMP)Wtsi
(C57BL/6N-Rilpl2tm1b(KOMP)Wtsi/J) 		decreased circulating cholesterol level J:211773
Rint1tm1b(KOMP)Wtsi/Rint1+
(C57BL/6N-Rint1tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Rmrpem1(IMPC)Ccpcz/Rmrp+
(C57BL/6NCrl-Rmrpem1(IMPC)Ccpcz/Ccpcz) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rnf4em1(IMPC)Ccpcz/Rnf4+
(C57BL/6N-Rnf4em1(IMPC)Ccpcz/Ccpcz) 		increased circulating triglyceride level J:211773
Rnf7tm1a(EUCOMM)Wtsi/Rnf7+
(Not Specified) 		decreased circulating triglyceride level J:165965
Rnf10tm1a(KOMP)Wtsi/Rnf10tm1a(KOMP)Wtsi
(C57BL/6N-Rnf10tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
increased circulating cholesterol level J:175295
increased circulating HDL cholesterol level J:175295
increased circulating triglyceride level J:175295
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ucd) 		decreased circulating triglyceride level J:211773
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/MbpMmucd) 		increased circulating HDL cholesterol level J:211773
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ieg) 		increased circulating triglyceride level J:211773
Rnf14em1(IMPC)Ccpcz/Rnf14em1(IMPC)Ccpcz
(C57BL/6N-Rnf14em1(IMPC)Ccpcz/Ccpcz) 		increased circulating HDL cholesterol level J:211773
Rnf25tm1.1(KOMP)Vlcg/Rnf25tm1.1(KOMP)Vlcg
(C57BL/6N-Rnf25tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Rnf130tm1a(EUCOMM)Wtsi/Rnf130tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		decreased circulating cholesterol level J:338210
decreased circulating LDL cholesterol level J:338210
Rnf144btm1b(EUCOMM)Hmgu/Rnf144btm1b(EUCOMM)Hmgu
(C57BL/6N-Rnf144btm1b(EUCOMM)Hmgu/Ics) 		increased circulating cholesterol level J:211773
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1) 		increased circulating triglyceride level J:244583
Rnf169tm1a(EUCOMM)Hmgu/Rnf169tm1a(EUCOMM)Hmgu
(B6NTac;B6N-Rnf169tm1a(EUCOMM)Hmgu/H) 		decreased circulating free fatty acids level J:165965
Rnf180em1(IMPC)J/Rnf180em1(IMPC)J
(C57BL/6NJ-Rnf180em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
decreased circulating HDL cholesterol level J:211773
Rock2tm1Zpj/Rock2+
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal circulating cholesterol level J:224630
decreased circulating free fatty acids level J:224630
Rorasg/Rorasg
(involves: C57BL/6) 		abnormal lipid homeostasis J:52105
decreased circulating cholesterol level J:52105
decreased circulating HDL cholesterol level J:52105
Rpa1tm1b(KOMP)Wtsi/Rpa1+
(C57BL/6N-Rpa1tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Rpiatm1a(KOMP)Wtsi/Rpia+
(C57BL/6N-Rpiatm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glycerol level J:211773
decreased circulating HDL cholesterol level J:211773
Rpn2tm1a(EUCOMM)Wtsi/Rpn2+
(B6JTyr;B6N-Rpn2tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glycerol level J:175295
increased circulating free fatty acids level J:175295
increased circulating glycerol level J:175295
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
Rps6kb2tm1Gtho/Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd) 		abnormal lipid level J:129852
increased fatty acid beta-oxidation J:129852
Rps9tm1.1Geno/Rps9tm1.1Geno
(involves: C57BL/6) 		abnormal lipid oxidation J:329922
Rptortm1.1Dmsa/Rptortm1.1Dmsa
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA) 		increased circulating ketone body level J:167208
Rptortm1Rueg/Rptortm1Rueg
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating cholesterol level J:143749
decreased liver triglyceride level J:143749
Rr401em1Yushi/Rr401em1Yushi
(Not Specified) 		decreased sterol level J:334319
Rrasem1(IMPC)H/Rrasem1(IMPC)H
(C57BL/6N-Rrasem1(IMPC)H/H) 		increased circulating triglyceride level J:211773
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		hyperlipidemia J:186071
increased circulating cholesterol level J:186071
increased circulating triglyceride level J:186071
Rsbn1tm1b(EUCOMM)Wtsi/Rsbn1+
(C57BL/6N-Rsbn1tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
Rsc1a1tm1Koep/Rsc1a1tm1Koep
(B6.129-Rsc1a1tm1Koep) 		increased circulating cholesterol level J:95148
Rubcnlem1Qsun/Rubcnlem1Qsun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Rubcnlem1Qsun) 		decreased circulating ketone body level J:272052
increased liver triglyceride level J:272052
Rundc1tm1a(EUCOMM)Wtsi/Rundc1+
(C57BL/6N-Rundc1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Runx1t1tm1b(EUCOMM)Hmgu/Runx1t1+
(C57BL/6N-Runx1t1tm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Rwdd1tm1b(KOMP)Wtsi/Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Rxratm4Ipc/Rxratm4Ipc
Rxrbtm1Pcn/Rxrbtm1Pcn
Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		decreased cholesterol level J:109090
S2bpcox16em1(IMPC)J/S2bpcox16em1(IMPC)J
(C57BL/6NJ-S2bpcox16em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Saa3tm1(KOMP)Vlcg/Saa3+
(involves: C57BL/6NTac) 		decreased circulating LDL cholesterol level J:220630
Saa3tm1(KOMP)Vlcg/Saa3tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased circulating cholesterol level J:220630
decreased circulating LDL cholesterol level J:220630
decreased circulating triglyceride level J:220630
Sagtm1a(EUCOMM)Wtsi/Sagtm1a(EUCOMM)Wtsi
(C57BL/6N-Sagtm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Samd1tm1Pfi/Samd1+
(involves: C57BL/6J * C57BL/6N) 		decreased circulating HDL cholesterol level J:333561
decreased circulating VLDL cholesterol level J:333561
increased circulating aldosterone level J:333561
increased circulating corticosterone level J:333561
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr) 		decreased circulating cholesterol level J:208616
decreased circulating HDL cholesterol level J:208616
increased circulating LDL cholesterol level J:208616
Samd8tm1.1Kwi/Samd8tm1.1Kwi
(involves: 129P2/OlaHsd) 		abnormal ceramide level J:228568
Samd8tm1.1Kwi/Samd8tm1.1Kwi
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129P2/OlaHsd) 		abnormal ceramide level J:228568
abnormal sphingomyelin level J:228568
Samd8tm1Jia/Samd8tm1Jia
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal ceramide level J:220024
abnormal sphingomyelin level J:220024
Samd8tm2.2Kwi/Samd8tm2.2Kwi
(involves: 129P2/OlaHsd) 		abnormal ceramide level J:228568
Samd8tm2.2Kwi/Samd8tm2.2Kwi
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129P2/OlaHsd) 		abnormal ceramide level J:228568
Sar1bem1Emle/Sar1b+
(C57BL/6N-Sar1bem1Emle) 		abnormal circulating non-HDL cholesterol level J:319817
abnormal intestinal lipid absorption J:319817
decreased circulating cholesterol level J:319817
decreased circulating HDL cholesterol level J:319817
decreased circulating triglyceride level J:319817
Sar1bem2Emle/Sar1b+
(C57BL/6N-Sar1bem2Emle) 		abnormal circulating non-HDL cholesterol level J:319817
abnormal intestinal lipid absorption J:319817
decreased circulating cholesterol level J:319817
decreased circulating HDL cholesterol level J:319817
decreased circulating triglyceride level J:319817
increased liver cholesterol level J:319817
steatorrhea J:319817
Sar1btm1a(EUCOMM)Wtsi/Sar1b+
(C57BL/6N-Sar1btm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating free fatty acids level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
increased circulating free fatty acids level J:175295
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi
Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N) 		increased circulating corticosterone level J:337869
Saysd1em1(IMPC)J/Saysd1em1(IMPC)J
(C57BL/6NJ-Saysd1em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Sc5dtm1Fdp/Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal cholesterol homeostasis J:84450
decreased brain cholesterol level J:84450
decreased cholesterol level J:84450
Scaptm1Mbjg/Scaptm1Mbjg
Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		abnormal cholesterol homeostasis J:69592
abnormal lipid homeostasis J:69592
decreased circulating free fatty acids level J:69592
decreased liver cholesterol level J:69592
decreased liver triglyceride level J:69592
Scarb1Chohd1/Scarb1+
(C3HeB/FeJ-Scarb1Chohd1/Ieg) 		increased circulating cholesterol level J:94145
increased circulating HDL cholesterol level J:94145
increased circulating LDL cholesterol level J:94145
Scarb1Hdlq1-129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased circulating HDL cholesterol level J:144089
Scarb1Hdlq1-129S1/SvImJ/Scarb1Hdlq1-129S1/SvImJ
Hdlq16129S1/SvImJ/Hdlq16129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:144089
Scarb1Hdlq1-NZB/BlNJ/Scarb1Hdlq1-NZB/BlNJ
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:76707, J:89309
Scarb1Hdlq1-NZB/BlNJ/Scarb1Hdlq1-SM/J
(involves: NZB/BlNJ * SM/J) 		increased circulating HDL cholesterol level J:76707, J:89309
Scarb1Hlb398/?
(C57BL/6J-Scarb1Hlb398) 		increased circulating cholesterol level J:82961
increased circulating HDL cholesterol level J:82961
Scarb1Hlb398/Scarb1+
(C57BL/6J-Scarb1Hlb398) 		increased circulating HDL cholesterol level J:152482
Scarb1Hlb398/Scarb1Hlb398
(C57BL/6J-Scarb1Hlb398) 		abnormal cholesterol homeostasis J:152482
abnormal lipid level J:152482
increased circulating cholesterol level J:152482
increased circulating HDL cholesterol level J:152482
increased circulating phospholipid level J:152482
increased circulating triglyceride level J:152482
Scarb1tm1.1Thh/Scarb1tm1.1Thh
(B6.129X1-Scarb1tm1.1Thh) 		increased circulating cholesterol level J:114663
increased circulating HDL cholesterol level J:114663
Scarb1tm1b(EUCOMM)Wtsi/Scarb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Scarb1tm1b(EUCOMM)Wtsi/Bay) 		increased circulating cholesterol level J:211773
Scarb1tm1Dhu/Scarb1tm1Dhu
(involves: 129S4/SvJae * BALB/cByJ) 		abnormal circulating HDL cholesterol level J:47439
abnormal lipid homeostasis J:47439
increased circulating cholesterol level J:47439
increased circulating HDL cholesterol level J:47439
Scarb1tm1Kri/Scarb1+
(involves: 129S2/SvPas * C57BL/6) 		abnormal cholesterol level J:44187
abnormal lipid homeostasis J:44187
increased circulating cholesterol level J:44187
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129S2/SvPas * C57BL/6) 		abnormal cholesterol level J:44187
abnormal circulating cholesterol level J:73138
abnormal lipid homeostasis J:44187
increased cholesterol level J:216748
increased circulating cholesterol level J:44187
Scarb1tm1Thh/Scarb1tm1Thh
(B6.129X1-Scarb1tm1Thh) 		increased circulating cholesterol level J:114663
increased circulating HDL cholesterol level J:114663
Scarb1tm1Thh/Scarb1tm1Thh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Scarb1tm1Thh Speer6-ps1Tg(Alb-cre)21Mgn) 		increased circulating cholesterol level J:114663
increased circulating HDL cholesterol level J:114663
Scd1ab-2J/Scd1ab-2J
(DBA/1LacJ-Scd1ab-2J/J) 		abnormal lipid level J:62699
Scd1tm1Ntam/Scd1tm1Ntam
(involves: 129S6/SvEvTac) 		abnormal cholesterol homeostasis J:71350
decreased unsaturated fatty acids level J:71350
increased circulating ketone body level J:78607
increased saturated fatty acids level J:71350
Scd1tm1Ntam/Scd1tm1Ntam
(involves: C57BL/6) 		decreased circulating triglyceride level J:130441
decreased liver triglyceride level J:130441
Scd1tm1Ntam/Scd1tm1Ntam
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased liver triglyceride level J:178653
Scd1tm2Ntam/Scd1tm2Ntam
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam) 		abnormal lipid homeostasis J:130441
decreased circulating triglyceride level J:130441
decreased circulating VLDL triglyceride level J:130441
decreased liver triglyceride level J:130441
increased circulating cholesterol level J:130441
Scd2tm1Myz/Scd2tm1Myz
(129S6.129-Scd2tm1Myz) 		decreased circulating triglyceride level J:101158
decreased fatty acids level J:101158
decreased liver triglyceride level J:101158
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		increased circulating corticosterone level J:53349
Scimptm1Lex/Scimptm1Lex
(B6;129S5-Scimptm1Lex/Mmucd) 		increased circulating cholesterol level J:171883
Sclt1em1(IMPC)Tcp/Sclt1+
(C57BL/6NCrl-Sclt1em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Scnn1atm1Rss/Scnn1atm1Rss
Tg(CMV-Scnn1a)1352Rss/0
(involves: 129P2/OlaHsd * NMRI) 		increased circulating aldosterone level J:43583
Scnn1btm1.1Ipt/Scnn1b+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		decreased circulating aldosterone level J:59840
Scnn1btm1.1Ipt/Scnn1btm1.1Ipt
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		decreased circulating aldosterone level J:59840
Scnn1btm1Wsh/Scnn1btm1Wsh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased circulating aldosterone level J:53058
Sco1tm1c(KOMP)Wtsi/Sco1tm1c(KOMP)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		increased liver cholesterol level J:222036
increased liver triglyceride level J:222036
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr) 		abnormal lipid level J:124895
decreased circulating triglyceride level J:124895
decreased liver triglyceride level J:124895
increased circulating cholesterol level J:124895
increased fatty acids level J:124895
Scp2tm1Usee/Scp2tm1Usee
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal bile salt level J:73460
abnormal circulating cholesterol level J:73460
abnormal lipid level J:47280
decreased circulating free fatty acids level J:47280
decreased liver cholesterol level J:73460, J:47280
decreased liver triglyceride level J:47280
increased circulating HDL cholesterol level J:73460
increased circulating LDL cholesterol level J:73460
increased circulating triglyceride level J:47280
increased circulating VLDL cholesterol level J:73460
increased fatty acids level J:47280
Scribtm1b(NCOM)Mfgc/Scrib+
(C57BL/6N-Scribtm1a(NCOM)Mfgc/Tcp) 		increased circulating triglyceride level J:211773
Scube3m1Mhda/Scube3m1Mhda
(C3HeB/FeJ-Scube3m1Mhda) 		decreased circulating cholesterol level J:237904
decreased circulating free fatty acids level J:237904
decreased circulating glycerol level J:237904
decreased circulating triglyceride level J:237904
Sdc1em1(IMPC)H/Sdc1em1(IMPC)H
(C57BL/6NTac-Sdc1em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Sdc2tm1b(KOMP)Wtsi/Sdc2tm1b(KOMP)Wtsi
(C57BL/6N-Sdc2tm1b(KOMP)Wtsi/Ieg) 		increased circulating triglyceride level J:211773
Sdhatm2b(KOMP)Wtsi/Sdha+
(C57BL/6N-Sdhatm2b(KOMP)Wtsi/J) 		increased circulating free fatty acids level J:211773
Sec14l2tm1Arai/Sec14l2tm1Arai
(involves: 129S7/SvEvBrd) 		decreased circulating cholesterol level J:129749
decreased circulating VLDL cholesterol level J:129749
Sec16btm1a(KOMP)Wtsi/Sec16btm1a(KOMP)Wtsi
(C57BL/6N-Sec16btm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(B6JTyr;B6N-Sec24atm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating free fatty acids level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased circulating cholesterol level J:213427
decreased circulating LDL cholesterol level J:213427
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		increased circulating cholesterol level J:164159
increased circulating triglyceride level J:164159
Secisbp2lem1(IMPC)J/Secisbp2lem1(IMPC)J
(C57BL/6NJ-Secisbp2lem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Sel1ltm1c(KOMP)Wtsi/Sel1ltm1c(KOMP)Wtsi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * C57BL/6N * CBA * SJL) 		abnormal intestinal lipid absorption J:206568
steatorrhea J:206568
Selenomtm1(KOMP)Vlcg/Selenomtm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac) 		decreased circulating corticosterone level J:203545
Senp1tm1Wami/Senp1tm1Wami
Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		decreased circulating cholesterol level J:228009
decreased circulating triglyceride level J:228009
increased circulating ketone body level J:228009
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen) 		decreased circulating cholesterol level J:326672
increased liver cholesterol level J:326672
increased liver triglyceride level J:326672
Serf1tm1a(EUCOMM)Hmgu/Serf1tm1a(EUCOMM)Hmgu
(C57BL/6N-Serf1tm1a(EUCOMM)Hmgu/H) 		increased circulating cholesterol level J:165965
increased circulating HDL cholesterol level J:165965
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc) 		increased circulating triglyceride level J:343846
Serpina6tm1.1Mmp/Serpina6+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		abnormal circulating corticosterone level J:164345
Serpina6tm1.1Mmp/Serpina6tm1.1Mmp
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL) 		abnormal circulating corticosterone level J:164345
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N) 		abnormal circulating corticosterone level J:112974
Serpina12tm1Jwada/Serpina12+
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased liver triglyceride level J:208508
Serpina12tm1Jwada/Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada) 		increased circulating cholesterol level J:208508
increased circulating LDL cholesterol level J:208508
increased liver triglyceride level J:208508
Serpinb2tm1b(EUCOMM)Wtsi/Serpinb2tm1b(EUCOMM)Wtsi
(C57BL/6N-Serpinb2tm1b(EUCOMM)Wtsi/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Serpinb5tm1b(KOMP)Wtsi/Serpinb5tm1b(KOMP)Wtsi
(C57BL/6N-Serpinb5tm1b(KOMP)Wtsi/J) 		increased circulating cholesterol level J:211773
Serpinb10em1(IMPC)Mbp/Serpinb10em1(IMPC)Mbp
(C57BL/6NCrl-Serpinb10em1(IMPC)Mbp/Mmucd) 		decreased circulating triglyceride level J:211773
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		decreased liver triglyceride level J:87982
decreased skeletal muscle triglyceride level J:87982
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6 * C57BLKS/J) 		decreased circulating cholesterol level J:127478
Sertad2Gt(OST98734)Lex/Sertad2+
(B6.129S5-Sertad2Gt(OST98734)Lex) 		decreased circulating cholesterol level J:194928
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex) 		abnormal lipid homeostasis J:194928
decreased circulating cholesterol level J:194928
decreased liver triglyceride level J:194928
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd) 		increased liver triglyceride level J:189021
Setbp1tm1b(EUCOMM)Wtsi/Setbp1+
(C57BL/6N-Setbp1tm1b(EUCOMM)Wtsi/Ics) 		decreased circulating cholesterol level J:211773
Setd1atm1a(EUCOMM)Wtsi/Setd1a+
(C57BL/6N-Setd1atm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Setmartm1a(EUCOMM)Wtsi/Setmartm1a(EUCOMM)Wtsi
(C57BL/6N-Setmartm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glycerol level J:165965
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd) 		abnormal phospholipid level J:107841
Sftpa1tm1Kor/Sftpa1tm1Kor
(B6.129P2-Sftpa1tm1Kor) 		abnormal phospholipid level J:130520
Sftpa1tm2Haw/Sftpa1tm2Haw
Sftpdtm2Haw/Sftpdtm2Haw
(involves: C57BL/6J * CD-1) 		abnormal phospholipid level J:86022
Sftpbtm1Jaw/Sftpbtm1Jaw
(involves: 129S2/SvPas * Black Swiss) 		abnormal lipid homeostasis J:28289
Sftpdtm1Haw/Sftpdtm1Haw
(involves: C57BL/6J * CD-1) 		abnormal cholesterol homeostasis J:50147
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal lipid homeostasis J:50436
Sgk1tm1.2Palm/Sgk1tm1.2Palm
(129/Sv-Sgk1tm1.2Palm) 		increased circulating aldosterone level J:148648
Sgk1tm1Kuhl/Sgk1tm1Kuhl
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * 129X1/SvJ)) 		increased circulating aldosterone level J:80115
Sgms1Gt(E201D11)Wrst/Sgms1Gt(E201D11)Wrst
(B6.129P2-Sgms1Gt(E201D11)Wrst) 		abnormal ceramide level J:249941
abnormal lipid level J:249941
abnormal sphingolipid level J:249941
abnormal sphingomyelin level J:249941
decreased plasmalogen level J:249941
decreased unsaturated fatty acids level J:249941
Sgms1tm1Jia/Sgms1tm1Jia
(involves: C57BL/6) 		abnormal ceramide level J:201497
abnormal sphingomyelin level J:201497
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129 * C57BL/6) 		abnormal lipid level J:162192, J:162226
abnormal sphingomyelin level J:162192
Sgms2tm1Jia/Sgms2tm1Jia
(Not Specified) 		abnormal ceramide level J:228568, J:220024
abnormal sphingomyelin level J:228568
Sgms2tm1Kenw/Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw) 		decreased circulating triglyceride level J:175924
increased circulating free fatty acids level J:175924
Sgo1tm1a(EUCOMM)Wtsi/Sgo1+
(B6JTyr;B6N-Sgo1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
Sgpl1tm1.2Npa/Sgpl1tm1.2Npa
(involves: BALB/cJ * C57BL/6) 		abnormal lipid homeostasis J:199525
Sgpp1tm1(KOMP)Vlcg/Sgpp1tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal ceramide level J:199597
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp) 		abnormal ceramide level J:235035
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl) 		decreased circulating triglyceride level J:211773
Shhtm1b(EUCOMM)Wtsi/Shh+
(C57BL/6N-Shhtm1b(EUCOMM)Wtsi/H) 		increased circulating HDL cholesterol level J:211773
Shhtm2Amc/Shhtm2.1Amc
Tg(Nr5a1-cre)2Klp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		decreased circulating corticosterone level J:168522
Shkbp1em1(IMPC)J/Shkbp1em1(IMPC)J
(C57BL/6NJ-Shkbp1em1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Shld1em1(IMPC)Wtsi/Shld1em1(IMPC)Wtsi
(C57BL/6N-Shld1em1(IMPC)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Sidt2em1(IMPC)Wtsi/Sidt2em1(IMPC)Wtsi
(C57BL/6N-Sidt2em1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating glycerol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J) 		increased circulating triglyceride level J:236042
increased liver free fatty acids level J:236042
increased liver triglyceride level J:236042
Sik1tm1.1(KOMP)Vlcg/Sik1tm1.1(KOMP)Vlcg
(C57BL/6N-Sik1tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd) 		decreased fatty acid oxidation J:229999
increased circulating triglyceride level J:229999
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N) 		abnormal cholesterol level J:183827
abnormal lipid homeostasis J:183827
decreased circulating cholesterol level J:183827
decreased circulating HDL cholesterol level J:183827
decreased circulating triglyceride level J:183827
decreased circulating VLDL triglyceride level J:183827
decreased liver cholesterol level J:183827
decreased liver triglyceride level J:183827
increased bile salt level J:183827
increased circulating triglyceride level J:183827
increased liver cholesterol level J:183827
Sirt1tm1.2Cxd/Sirt1tm1.2Cxd
Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * FVB/N) 		increased circulating free fatty acids level J:179193
increased circulating triglyceride level J:179193
increased liver triglyceride level J:179193
Sirt2tm1a(EUCOMM)Wtsi/Sirt2tm1a(EUCOMM)Wtsi
(C57BL/6N-Sirt2tm1a(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:165965
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac) 		abnormal lipid homeostasis J:178653
increased circulating cholesterol level J:178653
increased circulating LDL cholesterol level J:178653
increased circulating triglyceride level J:178653
increased circulating VLDL cholesterol level J:178653
increased liver cholesterol level J:178653
increased liver triglyceride level J:178653
Sirt6tm1a(EUCOMM)Wtsi/Sirt6+
(C57BL/6N-Sirt6tm1a(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:165965
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv) 		abnormal lipid homeostasis J:205529
decreased circulating triglyceride level J:205529
decreased circulating VLDL triglyceride level J:205529
increased liver triglyceride level J:205529
Sisem1(IMPC)J/Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J) 		decreased liver triglyceride level J:344683
increased fatty acids level J:344683
Ska2tm1b(KOMP)Wtsi/Ska2+
(B6N(Cg)-Ska2tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
decreased circulating triglyceride level J:211773
increased circulating HDL cholesterol level J:211773
skimp/skimp
(involves: C3H/HeH) 		decreased circulating ketone body level J:77535
Sla2em1(IMPC)Ccpcz/Sla2em1(IMPC)Ccpcz
(C57BL/6N-Sla2em1(IMPC)Ccpcz/Ccpcz) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Slain2em1(IMPC)J/Slain2+
(C57BL/6NJ-Slain2em1(IMPC)J/Mmjax) 		decreased circulating cholesterol level J:211773
decreased circulating triglyceride level J:211773
Slc2a2tm1Thor/Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal lipid homeostasis J:43839
increased fatty acids level J:43839
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6) 		abnormal lipid homeostasis J:75418
abnormal lipid level J:75418
decreased fatty acids level J:75418
decreased triglyceride level J:75418
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB) 		abnormal lipid homeostasis J:110773
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL) 		decreased circulating free fatty acids level J:49328
decreased circulating ketone body level J:49328
Slc2a8tm1Khm/Slc2a8tm1Khm
(involves: 129X1/SvJ) 		increased circulating cholesterol level J:189148
increased circulating LDL cholesterol level J:189148
Slc2a9tm1Khm/Slc2a9tm1Khm
Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J) 		abnormal circulating lipid level J:221544
increased circulating cholesterol level J:221544
increased circulating free fatty acids level J:221544
increased circulating triglyceride level J:221544
increased liver free fatty acids level J:221544
increased liver triglyceride level J:221544
Slc3a1pbl/Slc3a1pbl
(C3HeB/FeJ-Slc3a1pbl) 		increased circulating cholesterol level J:85461
increased circulating LDL cholesterol level J:85461
Slc3a1pbl/Slc3a1pbl
(involves: C3HeB/FeJ * MRL/MpJ) 		increased circulating cholesterol level J:85461
increased circulating LDL cholesterol level J:85461
Slc3a1tm1.1(KOMP)Vlcg/Slc3a1tm1.1(KOMP)Vlcg
(C57BL/6N-Slc3a1tm1.1(KOMP)Vlcg/Ucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Slc4a4tm1.1Slin/Slc4a4tm1.1Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating aldosterone level J:186877
Slc4a4tm1Ges/Slc4a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss) 		increased circulating aldosterone level J:120867
Slc4a5tm1.1Boet/Slc4a5tm1.1Boet
(involves: 129 * C57BL/6) 		decreased circulating aldosterone level J:180608
Slc5a2tm1Lex/Slc5a2tm1Lex
(B6.129S5-Slc5a2tm1Lex) 		decreased circulating aldosterone level J:169917
Slc5a5tm1b(KOMP)Wtsi/Slc5a5tm1b(KOMP)Wtsi
(C57BL/6N-Slc5a5tm1b(KOMP)Wtsi/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Slc5a10tm1Csk/Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk) 		decreased circulating triglyceride level J:199406
increased liver triglyceride level J:199406
Slc6a3tm1b(KOMP)Wtsi/Slc6a3+
(C57BL/6N-Slc6a3tm1b(KOMP)Wtsi/J) 		decreased circulating free fatty acids level J:211773
Slc7a2tm1b(EUCOMM)Hmgu/Slc7a2tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc7a2tm1b(EUCOMM)Hmgu/BayMmucd) 		increased circulating cholesterol level J:211773
Slc9a3tm1Ges/Slc9a3tm1Ges
(Not Specified) 		increased circulating aldosterone level J:70885
Slc9a4tm1b(EUCOMM)Wtsi/Slc9a4tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc9a4tm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
Slc9a6tm1Dgen/Y
(B6.129P2-Slc9a6tm1Dgen/J) 		increased ganglioside level J:241124, J:229166
Slc9a6tm1Dgen/Slc9a6+
(B6.129P2-Slc9a6tm1Dgen/J) 		increased ganglioside level J:229166
Slc9a6tm1Dgen/Slc9a6tm1Dgen
(B6.129P2-Slc9a6tm1Dgen/J) 		abnormal brain cholesterol level J:241124
increased ganglioside level J:241124
Slc9a9em1(IMPC)J/Slc9a9em1(IMPC)J
(C57BL/6NJ-Slc9a9em1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Slc10a1tm1Tac/Slc10a1tm1Tac
(either: B6.Cg-Slc10a1tm1Tac or (involves: 129S/SvEv * C57BL/6J)) 		abnormal bile salt homeostasis J:274149
increased bile salt level J:274149
Slc10a2tm1Pda/Slc10a2tm1Pda
(either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J)) 		abnormal bile salt homeostasis J:85312
abnormal bile salt level J:85312
abnormal intestinal lipid absorption J:85312
abnormal lipid homeostasis J:85312
decreased intestinal cholesterol absorption J:85312
increased circulating cholesterol level J:85312
increased feces bile salt level J:85312
steatorrhea J:85312
Slc10a2tm1Pda/Slc10a2tm1Pda
(either: B6.129P2-Slc10a2tm1Pda or (involves: 129P2/OlaHsd * C57BL/6J)) 		abnormal bile salt homeostasis J:132778
Slc10a3em1(IMPC)J/Y
(C57BL/6NJ-Slc10a3em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Slc10a3em1(IMPC)J/Slc10a3em1(IMPC)J
(C57BL/6NJ-Slc10a3em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Slc10a6tm1Jmge/Slc10a6tm1Jmge
(B6N.129S5-Slc10a6tm1Jmge) 		increased circulating cholesterol level J:301761
Slc13a1tm1Mark/Slc13a1+
(involves: 129T2/SvEms * C57BL/6J) 		increased bile salt level J:86561
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J) 		increased bile salt level J:86561
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf) 		abnormal glycerol level J:176732
decreased liver triglyceride level J:176732
Slc16a1tm2.1Lupel/Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel) 		decreased circulating triglyceride level J:205481
Slc16a2tm1.1Sref/Y
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating cholesterol level J:113732
Slc16a2tm1a(KOMP)Wtsi/Y
(B6JTyr;B6N-Slc16a2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Slc16a2tm1a(KOMP)Wtsi/Slc16a2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc16a2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Slc18a2tm1Mca/Slc18a2+
(B6.129X1-Slc18a2tm1Mca) 		abnormal corticosterone level J:125273
Slc20a1tm1Lbek/Slc20a1tm1Lbek
(involves: 129S2/SvPas * C57BL/6J) 		abnormal fatty acids level J:157997
Slc22a18tm1Tgot/Slc22a18tm1Tgot
(B6.Cg-Slc22a18tm1Tgot) 		decreased liver triglyceride level J:349247
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm) 		decreased circulating corticosterone level J:85988
Slc24a4tm1b(KOMP)Wtsi/Slc24a4+
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.129-Slc25a13tm1Lct) 		increased liver triglyceride level J:124766
Slc25a21tm1a(KOMP)Wtsi/Slc25a21tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc25a21tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Slc25a24tm1Sinos/Slc25a24tm1Sinos
(B6(Cg)-Slc25a24tm1Sinos) 		decreased liver triglyceride level J:312208
Slc25a34em1Duna/Slc25a34em1Duna
(C57BL/6J-Slc25a34em1Duna) 		decreased cholesterol level J:344152
decreased triglyceride level J:344152
Slc25a48em1(IMPC)J/Slc25a48em1(IMPC)J
(involves: C57BL/6J * C57BL/6NJ) 		abnormal glycerophosphocholine level J:353858
abnormal phospholipid level J:353858
increased ceramide level J:353858
Slc26a3tm1Sole/Slc26a3tm1Sole
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating aldosterone level J:117587
Slc27a1tm1Jkk/Slc27a1tm1Jkk
(involves: 129S/SvEv * C57BL/6J) 		abnormal fatty acids level J:88657
abnormal lipid level J:88657
abnormal skeletal muscle triglyceride level J:88657
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129/Sv * C57BL/6) 		abnormal lipid homeostasis J:124917
abnormal lipid level J:124917
decreased circulating cholesterol level J:124917
decreased circulating free fatty acids level J:124917
decreased circulating ketone body level J:124917
decreased circulating triglyceride level J:124917
decreased fatty acids level J:124917
decreased liver cholesterol level J:124917
decreased liver triglyceride level J:124917
decreased saturated fatty acids level J:124917
decreased unsaturated fatty acids level J:124917
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129) 		abnormal lipid level J:124916
Slc28a1em1Govr/Slc28a1em1Govr
(C57BL/6NTac-Slc28a1em1Govr) 		increased circulating cholesterol level J:336148
Slc29a3em1(IMPC)Wtsi/Slc29a3em1(IMPC)Wtsi
(C57BL/6N-Slc29a3em1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Slc34a1tm1Hten/Slc34a1tm1Hten
(involves: 129S2/SvPas * C57BL/6J) 		abnormal vitamin D level J:47637
Slc34a1tm1Hten/Slc34a1tm1Hten
(B6.129S2-Slc34a1tm1Hten/J) 		abnormal vitamin D level J:152195
Slc34a1tm1Hten/Slc34a1tm1Hten
Slc34a3tm1Kimi/Slc34a3tm1Kimi
(B6.129-Slc34a3tm1Kimi Slc34a1tm1Hten) 		abnormal vitamin D level J:152195
Slc34a2tm1Sega/Slc34a2+
(involves: 129S6/SvEvTac * C57BL/6JJcl) 		abnormal vitamin D level J:179947
Slc34a3tm1Kimi/Slc34a3tm1Kimi
(B6.129-Slc34a3tm1Kimi) 		abnormal vitamin D level J:152521
Slc35f6tm1a(EUCOMM)Wtsi/Slc35f6tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating triglyceride level J:165965
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6) 		abnormal lipid homeostasis J:86005
hyperlipidemia J:86005
increased circulating cholesterol level J:86005
increased circulating triglyceride level J:86005
Slc38a2tm1a(KOMP)Wtsi/Slc38a2+
(C57BL/6N-Slc38a2tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Slc38a10tm2a(EUCOMM)Wtsi/Slc38a10tm2a(EUCOMM)Wtsi
(C57BL/6N-Slc38a10tm2a(EUCOMM)Wtsi/H) 		increased circulating triglyceride level J:165965
Slc39a8tm1b(EUCOMM)Wtsi/Slc39a8+
(C57BL/6N-Slc39a8tm1b(EUCOMM)Wtsi/Cnrm) 		increased circulating triglyceride level J:211773
Slc40a1tm1b(EUCOMM)Hmgu/Slc40a1+
(C57BL/6N-Slc40a1tm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		increased fatty acids level J:237439
Slc46a3tm1.1(KOMP)Vlcg/Slc46a3tm1.1(KOMP)Vlcg
(C57BL/6N-Slc46a3tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Slc51atm1Pda/Slc51atm1Pda
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal bile salt homeostasis J:132778
abnormal bile salt level J:132778
abnormal cholesterol level J:132778
decreased circulating cholesterol level J:132778
decreased circulating triglyceride level J:132778
increased feces cholesterol level J:132778
Slc52a3tm2a(KOMP)Wtsi/Slc52a3tm2a(KOMP)Wtsi
(involves: C57BL/6N) 		abnormal lipid homeostasis J:236029
decreased fatty acid beta-oxidation J:236029
hyperlipidemia J:236029
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(B6.129S1-Slco1b2tm1Cdk) 		increased circulating cholesterol level J:133919
Slco2a1tm1.2Vsch/Slco2a1tm1.2Vsch
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal prostaglandin level J:168442
Slco3a1em1Smoc/Slco3a1em1Smoc
(C57BL/6J-Slco3a1em1Smoc/Smoc) 		abnormal bile salt homeostasis J:279167
increased bile salt level J:279167
Slntm1Peri/Slntm1Peri
(involves: C57BL/6J) 		increased circulating cholesterol level J:193427
increased circulating triglyceride level J:193427
Slurp1tm1Lex/Slurp1tm1Lex
(Not Specified) 		decreased circulating cholesterol level J:210836
decreased circulating triglyceride level J:210836
Slurp2tm1Lex/Slurp2tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:231067
Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased bile salt level J:228944
decreased circulating cholesterol level J:228944
decreased circulating HDL cholesterol level J:228944
decreased circulating LDL cholesterol level J:228944
decreased circulating VLDL cholesterol level J:228944
decreased intestinal cholesterol absorption J:228944
increased cholesterol level J:228944
increased feces cholesterol level J:228944
increased liver cholesterol level J:228944
Smc5tm1b(KOMP)Wtsi/Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased circulating HDL cholesterol level J:220422
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv * C57BL/6J) 		abnormal lipid homeostasis J:26732
increased circulating HDL cholesterol level J:26732
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv) 		abnormal ceramide level J:199833
Smpd1tm1Wst/Smpd1tm1Wst
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid homeostasis J:26748
Smpd3fro/Smpd3fro
(involves: C3H/HeN * C57BL/6N) 		abnormal lipid level J:193949
Smpd3tm1Wst/Smpd3tm1Wst
(involves: 129S1/Sv) 		decreased circulating cortisol level J:97284
Smyd2tm1a(KOMP)Wtsi/Smyd2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Smyd2tm1a(KOMP)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:175295
increased circulating LDL cholesterol level J:175295
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified) 		increased circulating cholesterol level J:226064
increased circulating triglyceride level J:226064
Snf8tm1a(EUCOMM)Wtsi/Snf8+
(C57BL/6N-Snf8tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating free fatty acids level J:165965
Snorctm1Lex/Snorctm1Lex
(B6;129S5-Snorctm1Lex/Mmucd) 		decreased circulating triglyceride level J:171883
Snrktm1.1Hxu/Snrktm1.1Hxu
Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr) 		increased circulating free fatty acids level J:257980
increased circulating triglyceride level J:257980
Snrktm1Hxu/Snrk+
(C57BL/6-Snrktm1Hxu) 		decreased triglyceride level J:257980
Snrktm1Rra/Snrktm1Rra
(involves: C57BL/6J) 		abnormal lipid level J:218247
decreased circulating free fatty acids level J:218247
decreased circulating triglyceride level J:218247
increased circulating cholesterol level J:218247
Snrktm2Rra/Snrktm2Rra
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N) 		abnormal lipid level J:218247
Snx5tm1a(KOMP)Wtsi/Snx5tm1a(KOMP)Wtsi
(B6JTyr;B6N-Snx5tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Snx6em1(IMPC)J/Snx6em1(IMPC)J
(C57BL/6NJ-Snx6em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Snx8tm2a(EUCOMM)Hmgu/Snx8tm2a(EUCOMM)Hmgu
(C57BL/6N-Snx8tm2a(EUCOMM)Hmgu/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd) 		decreased vitamin D level J:289051
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd) 		decreased vitamin D level J:289051
Snx10tm1a(EUCOMM)Raba/Snx10tm1a(EUCOMM)Raba
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J) 		decreased vitamin D level J:224711
Snx12em1(IMPC)J/Y
(C57BL/6NJ-Snx12em1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Snx13tm1b(EUCOMM)Hmgu/Snx13+
(C57BL/6N-Snx13tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating triglyceride level J:211773
Snx15tm1.1(KOMP)Vlcg/Snx15tm1.1(KOMP)Vlcg
(C57BL/6N-Snx15tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6) 		abnormal cholesterol homeostasis J:37049
abnormal lipid level J:37049
increased circulating cholesterol level J:37049
increased circulating HDL cholesterol level J:37049
Soat1tm1Ishi/Soat1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:63468
Soat1tm1Ishi/Soat1tm1Ishi
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:63468
increased circulating cholesterol level J:63468
xanthoma J:63468
Soat1tm1Ishi/Soat1tm1Ishi
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal lipid homeostasis J:63468
increased circulating cholesterol level J:63468
xanthoma J:63468
Soat2tm1.1Llr/Soat2tm1.1Llr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA) 		decreased circulating cholesterol level J:184908
decreased circulating LDL cholesterol level J:184908
decreased circulating VLDL cholesterol level J:184908
decreased liver cholesterol level J:184908
decreased liver triglyceride level J:184908
increased circulating triglyceride level J:184908
Soat2tm1.1Llr/Soat2tm1.1Llr
Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL) 		decreased cholesterol level J:184908
decreased circulating cholesterol level J:184908
decreased circulating VLDL cholesterol level J:184908
decreased intestinal cholesterol absorption J:184908
decreased liver cholesterol level J:184908
decreased liver triglyceride level J:184908
increased cholesterol level J:184908
increased circulating triglyceride level J:184908
Soat2tm1Far/Soat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		abnormal cholesterol homeostasis J:82032
decreased circulating cholesterol level J:82032
decreased circulating LDL cholesterol level J:82032
decreased circulating VLDL cholesterol level J:82032
decreased intestinal cholesterol absorption J:82032
increased circulating HDL cholesterol level J:82032
increased circulating triglyceride level J:82032
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J) 		decreased liver triglyceride level J:186227
increased skeletal muscle triglyceride level J:186227
Socs3tm1Ayos/Socs3tm1Ayos
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6) 		decreased circulating free fatty acids level J:91796
decreased circulating triglyceride level J:91796
Socs3tm1Ayos/Socs3tm1Ayos
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6) 		decreased circulating free fatty acids level J:91796
decreased circulating triglyceride level J:91796
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * CD-1) 		increased circulating ketone body level J:29899
Sod2tm1Cje/Sod2tm1Cje
(D2.Cg-Sod2tm1Cje) 		increased circulating ketone body level J:73998
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J) 		increased circulating ketone body level J:73998
Sod2tm1Leb/Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J) 		abnormal lipid homeostasis J:36148
Sorbs1tm1Krc/Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc) 		decreased triglyceride level J:121762
Sorbs2tm1.1(KOMP)Mbp/Sorbs2tm1.1(KOMP)Mbp
(C57BL/6N-Sorbs2tm1.1(KOMP)Mbp/J) 		decreased circulating cholesterol level J:211773
decreased circulating free fatty acids level J:211773
decreased circulating HDL cholesterol level J:211773
Sox17SHIVA/Sox17+
(either: C57BL/6-Sox17SHIVA or (involves: C57BL/6 * C3H/HeN)) 		decreased circulating HDL cholesterol level J:219119
decreased circulating ketone body level J:219119
decreased liver triglyceride level J:219119
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk) 		increased bile salt level J:194071
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Sparttm1.1Xen/Sparttm1.1Xen
(involves: C57BL/6J) 		decreased circulating triglyceride level J:185987
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-cat,-Creg1)#Yal/0
(involves: C57BL/6J * DBA) 		abnormal lipid homeostasis J:263073
decreased liver cholesterol level J:263073
decreased liver free fatty acids level J:263073
decreased liver triglyceride level J:263073
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(CAG-Dusp26)#Jhxia/0
(involves: C57BL/6 * DBA) 		decreased liver cholesterol level J:279111
decreased liver free fatty acids level J:279111
decreased liver triglyceride level J:279111
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Trmutm1Tomik/Trmutm1Tomik
(involves: C57BL/6 * DBA) 		decreased circulating cholesterol level J:235644
decreased circulating HDL cholesterol level J:235644
Spns2tm1Tni/Spns2tm1Tni
(B6.Cg-Spns2tm1Tni) 		decreased sphingosine level J:225108
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss) 		decreased circulating triglyceride level J:127389
Spryd3tm1b(EUCOMM)Hmgu/Spryd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Spryd3tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Sptbn1tm1a(EUCOMM)Wtsi/Sptbn1+
(B6JTyr;B6N-Sptbn1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
Sptlc1tm1Jia/Sptlc1+
(B6.Cg-Sptlc1tm1Jia) 		abnormal circulating lipid level J:140627
abnormal lipid level J:140627
Sptlc2tm1Jia/Sptlc2+
(B6.Cg-Sptlc2tm1Jia) 		abnormal circulating lipid level J:140627
abnormal lipid level J:140627
Sptlc2tm1Yhir/Sptlc2tm1Yhir
Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6) 		abnormal ceramide level J:202388
Sptlc2tm2.1Jia/Sptlc2tm2.1Jia
(involves: 129S4/SvJaeSor * C57BL/6) 		abnormal sphingomyelin level J:155507
increased circulating cholesterol level J:155507
increased circulating HDL cholesterol level J:155507
increased circulating phospholipid level J:155507
SptssbTvrm122/SptssbTvrm122
(involves: A * C57BL/6) 		abnormal lipid homeostasis J:224971
Sqstm1em1Kmts/Sqstm1+
(involves: C57BL/6N) 		increased circulating cholesterol level J:342766
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N) 		decreased liver free fatty acids level J:214131
decreased liver triglyceride level J:214131
Srebf1Gt(XC354)Byg/Srebf1Gt(XC354)Byg
(either: B6.129P2-Srebf1Gt(XC354)Byg or (involves: 129P2/OlaHsd * C57BL/6)) 		decreased liver triglyceride level J:152612
increased circulating ketone body level J:152612
Srebf1tm1Jdh/Srebf1tm1Jdh
(involves: 129S/SvEvBrd * C57BL/6) 		increased liver cholesterol level J:43570
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac) 		decreased circulating cholesterol level J:75320
decreased circulating triglyceride level J:75320
increased liver cholesterol level J:75320
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal triglyceride level J:101307
decreased circulating cholesterol level J:101307
decreased circulating triglyceride level J:101307
Srebf1tm2Jdh/Srebf1tm2Jdh
(involves: 129S/SvEvBrd * C57BL/6) 		decreased circulating cholesterol level J:43570
decreased circulating triglyceride level J:43570
increased liver cholesterol level J:43570
Srebf2lop13/Srebf2lop13
(STOCK Srebf2lop13/J) 		decreased brain cholesterol level J:176249
decreased cholesterol level J:176249
decreased liver cholesterol level J:176249
Srebf2tm1Jdh/Srebf2tm1Jdh
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		abnormal lipid homeostasis J:241873
decreased circulating cholesterol level J:241873
decreased circulating triglyceride level J:241873
decreased liver cholesterol level J:241873
decreased liver triglyceride level J:241873
Srsf3tm1Pjln/Srsf3tm1Pjln
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA) 		decreased circulating cholesterol level J:205756
decreased circulating HDL cholesterol level J:205756
decreased circulating triglyceride level J:205756
decreased fatty acid oxidation J:205756
decreased liver cholesterol level J:205756
decreased liver triglyceride level J:205756
Srxn1tm1Sgrh/Srxn1tm1Sgrh
Tg(Cyp11a1-cre)16Mchu/?
(involves: C57BL/6J) 		abnormal circulating corticosterone level J:222986
Ssttm1Ute/Ssttm1Ute
(129-Ssttm1Ute/J) 		increased circulating corticosterone level J:70426
Sstr1tm1Dgen/Sstr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:101679
increased circulating HDL cholesterol level J:101679
St3gal5tm1Rlp/St3gal5tm1Rlp
(involves: 129S/SvEv * C57BL/6) 		abnormal lipid homeostasis J:82723
St3gal5tm1Skoz/St3gal5tm1Skoz
(Not Specified) 		abnormal glycosphingolipid level J:229230
St18tm1a(KOMP)Wtsi/St18tm1a(KOMP)Wtsi
(C57BL/6N-St18tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Stag1em1(IMPC)Mbp/Stag1+
(C57BL/6N-Stag1em1(IMPC)Mbp/MbpMmucd) 		increased circulating triglyceride level J:211773
Startm1Klp/Startm1Klp
(involves: 129P2/OlaHsd) 		decreased circulating aldosterone level J:43589
decreased circulating corticosterone level J:43589
Stard3tm1Jfs/Stard3tm1Jfs
(involves: 129X1/SvJ * C57BL/6J) 		increased liver cholesterol level J:89362
Stard4tm1.2Bres/Stard4tm1.2Bres
(involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL) 		decreased circulating cholesterol level J:160807
decreased circulating LDL cholesterol level J:160807
Stard10tm1Saaa/Stard10tm1Saaa
(B6.Cg-Stard10tm1Saaa) 		abnormal bile salt homeostasis J:198860
abnormal phospholipid level J:198860
decreased circulating cholesterol level J:198860
decreased circulating free fatty acids level J:198860
decreased circulating triglyceride level J:198860
decreased liver cholesterol level J:198860
decreased liver triglyceride level J:198860
increased bile salt level J:198860
Stat3tm1Flv/Stat3tm1Flv
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		increased circulating corticosterone level J:89242
increased circulating triglyceride level J:89242
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		increased circulating triglyceride level J:119237
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased circulating free fatty acids level J:127051
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL) 		increased circulating free fatty acids level J:132806
increased circulating triglyceride level J:132806
Stat5btm1Mam/Stat5btm1Mam
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		increased circulating free fatty acids level J:127051
Stat5btm1Mam/Stat5btm1Mam
Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL) 		increased circulating free fatty acids level J:132806
increased circulating triglyceride level J:132806
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru) 		decreased fatty acids level J:178294
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd) 		abnormal circulating cholesterol level J:187736
increased circulating triglyceride level J:187736
increased liver triglyceride level J:187736
Stk11tm1.1Arte/Stk11tm1.1Arte
(involves: C57BL/6J) 		abnormal lipid homeostasis J:208379
Stk39tm1.2Slin/Stk39tm1.2Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating aldosterone level J:165706
Strntm1a(KOMP)Wtsi/Strn+
(C57BL/6N-Strntm1a(KOMP)Wtsi) 		increased circulating aldosterone level J:232621
Stt3bem1(IMPC)J/Stt3b+
(C57BL/6NJ-Stt3bem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Stx2tm1b(EUCOMM)Wtsi/Stx2tm1b(EUCOMM)Wtsi
(C57BL/6N-Stx2tm1b(EUCOMM)Wtsi/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Stx6em1(IMPC)H/Stx6em1(IMPC)H
(C57BL/6NTac-Stx6em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
Sult2b1tm1Rus/Sult2b1tm1Rus
(B6;129-Sult2b1tm1Rus/J) 		abnormal cholesterol level J:186536
Surf4em1Bcgen/Surf4+
(C57BL/6J-Surf4em1Bcgen) 		decreased circulating cholesterol level J:302969
decreased circulating triglyceride level J:302969
Surf4em1Bcgen/Surf4em1Bcgen
(C57BL/6J-Surf4em1Bcgen) 		decreased circulating cholesterol level J:302969
decreased circulating triglyceride level J:302969
increased liver cholesterol level J:302969
Susd6tm1b(KOMP)Wtsi/Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay) 		decreased circulating HDL cholesterol level J:211773
Syce1ltm1.1(KOMP)Vlcg/Syce1ltm1.1(KOMP)Vlcg
(C57BL/6N-Syce1ltm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Syne3tm1b(KOMP)Wtsi/Syne3tm1b(KOMP)Wtsi
(C57BL/6N-Syne3tm1b(KOMP)Wtsi/Ucd) 		increased circulating triglyceride level J:211773
Taco1em1(IMPC)J/Taco1em1(IMPC)J
(C57BL/6NJ-Taco1em1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Tacr1tm1Rhn/Tacr1tm1Rhn
(129S/SvEv-Tacr1tm1Rhn) 		decreased circulating corticosterone level J:77640
Taf2tm1b(EUCOMM)Hmgu/Taf2+
(C57BL/6N-Taf2tm1b(EUCOMM)Hmgu/Ics) 		abnormal cholesterol homeostasis J:211773
increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Tafazzinem1Xfa/Y
Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1) 		abnormal phospholipid level J:339058
Tagap1em1(IMPC)Tcp/Tagap1em1(IMPC)Tcp
(C57BL/6N-Tagap1em1(IMPC)Tcp/Tcp) 		decreased circulating cholesterol level J:211773
decreased circulating triglyceride level J:211773
Tardbptm1.1Pcw/Tardbptm1.1Pcw
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA * SJL) 		abnormal lipid oxidation J:164406
Tars3em1(IMPC)J/Tars3em1(IMPC)J
(C57BL/6NJ-Tars3em1(IMPC)J/Mmjax) 		decreased circulating cholesterol level J:211773
Tbc1d1Gt(E140H06)Wrst/Tbc1d1Gt(E140H06)Wrst
(B6.129P2-Tbc1d1Gt(E140H06)Wrst) 		abnormal lipid oxidation J:203285
increased fatty acid oxidation J:203285
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA) 		increased circulating free fatty acids level J:194026
Tbc1d5em1(IMPC)J/Tbc1d5em1(IMPC)J
(C57BL/6NJ-Tbc1d5em1(IMPC)J/J) 		increased circulating cholesterol level J:211773
Tbc1d9bem1(IMPC)J/Tbc1d9bem1(IMPC)J
(C57BL/6NJ-Tbc1d9bem1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Tbc1d10atm2a(EUCOMM)Wtsi/Tbc1d10atm2a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N) 		decreased circulating LDL cholesterol level J:213427
Tbc1d22atm1b(KOMP)Wtsi/Tbc1d22atm1b(KOMP)Wtsi
(C57BL/6N-Tbc1d22atm1b(KOMP)Wtsi/Wtsi) 		decreased circulating triglyceride level J:211773
increased circulating free fatty acids level J:211773
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte
Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6) 		increased liver triglyceride level J:198124
increased skeletal muscle triglyceride level J:198124
Tbl1xr1tm1b(EUCOMM)Hmgu/Tbl1xr1+
(C57BL/6N-Tbl1xr1tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating HDL cholesterol level J:211773
Tbx19tm1Jdr/Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c)) 		decreased circulating corticosterone level J:82562
Tbx22tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Tbx22tm1.1(KOMP)Vlcg/J) 		increased circulating HDL cholesterol level J:211773
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(C.129P2(B6)-Tbxa2rtm1Cof) 		abnormal thromboxane level J:79049
Tcaimtm1b(EUCOMM)Wtsi/Tcaimtm1b(EUCOMM)Wtsi
(C57BL/6N-Tcaimtm1b(EUCOMM)Wtsi/H) 		increased circulating cholesterol level J:211773
Tchol1BALB/c/Tchol1KK/Ta
(involves: BALB/c * KK/Ta) 		increased circulating cholesterol level J:88209
Tchol1KK/Ta/Tchol1KK/Ta
(involves: BALB/c * KK/Ta) 		increased circulating cholesterol level J:88209
Tchptm1a(EUCOMM)Wtsi/Tchptm1a(EUCOMM)Wtsi
(C57BL/6N-Tchptm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Tchptm1Inag/Tchptm1Inag
(B6.129P2-Tchptm1Inag) 		decreased circulating cholesterol level J:304307
decreased circulating triglyceride level J:304307
Tcirg1tm1Ypl/Tcirg1tm1Ypl
(involves: 129S4/SvJae * C57BL/6J) 		decreased vitamin D level J:224711
Tcq1CAST/EiJ/Tcq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased circulating cholesterol level J:117545
Tcq2CAST/EiJ/Tcq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ) 		decreased circulating cholesterol level J:117545
Tctn3em1(IMPC)J/Tctn3+
(C57BL/6NJ-Tctn3em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Tecrem1(IMPC)Rbrc/Tecr+
(C57BL/6NJcl-Tecrem1(IMPC)Rbrc/Rbrc) 		increased circulating LDL cholesterol level J:211773
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N) 		increased cholesterol level J:199372
Tex261tm1b(EUCOMM)Wtsi/Tex261tm1b(EUCOMM)Wtsi
(C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
Tfectm1b(KOMP)Wtsi/Tfectm1b(KOMP)Wtsi
(C57BL/6N-Tfectm1b(KOMP)Wtsi/Ucd) 		increased circulating cholesterol level J:211773
Tg(Abcg1)80-90Ssf/?
(C57BL/6-Tg(Abcg1)80-90Ssf) 		abnormal phospholipid level J:94077
increased liver cholesterol level J:94077
Tg(Abcg1)123Ssf/?
(C57BL/6-Tg(Abcg1)123Ssf) 		abnormal phospholipid level J:94077
increased liver cholesterol level J:94077
Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: C57BL/6J * SJL) 		abnormal cholesterol homeostasis J:78963
abnormal feces lipid level J:78963, J:100491
decreased circulating cholesterol level J:78963
decreased circulating HDL cholesterol level J:78963
decreased circulating phytosterol level J:78963, J:100491
decreased intestinal cholesterol absorption J:78963, J:100491
increased cholesterol level J:78963
steatorrhea J:78963
Tg(Adipoq-LPL)1Fnln/?
(B6.Cg-Tg(Adipoq-LPL)1Fnln) 		decreased circulating cholesterol level J:226970
decreased circulating HDL cholesterol level J:226970
decreased circulating LDL cholesterol level J:226970
decreased liver triglyceride level J:226970
increased liver triglyceride level J:226970
Tg(ALB-cre,CMV-rtTA)#Wcyy/0
Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy/0
(involves: ICR) 		decreased circulating cholesterol level J:93624
Tg(Alb-MYLIP*)1Pton/?
(involves: C57BL/6J) 		decreased circulating triglyceride level J:228420
increased circulating cholesterol level J:228420
increased circulating LDL cholesterol level J:228420
increased circulating triglyceride level J:228420
Tg(Alb-Nos2)1Mkan/?
(FVB-Tg(Alb-Nos2)1Mkan) 		increased circulating triglyceride level J:177591
increased circulating VLDL triglyceride level J:177591
increased liver triglyceride level J:177591
increased triglyceride level J:177591
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6) 		abnormal ceramide level J:249664
abnormal lipid homeostasis J:249664
abnormal lipid oxidation J:249664
decreased saturated fatty acids level J:185313
decreased unsaturated fatty acids level J:185313
increased circulating free fatty acids level J:185313
increased fatty acids level J:185313
increased triglyceride level J:185313
increased unsaturated fatty acids level J:185313
Tg(AlbLCAT)1Jdm/0
(involves: FVB/N) 		decreased circulating triglyceride level J:121992
increased circulating cholesterol level J:121992
increased circulating HDL cholesterol level J:121992
Tg(AlbLCAT)1Jdm/0
Tg(APOA1)1Rub/0
(involves: C57BL/6 * FVB/N) 		increased circulating cholesterol level J:121992
increased circulating HDL cholesterol level J:121992
increased circulating LDL cholesterol level J:121992
increased circulating VLDL cholesterol level J:121992
Tg(AlbLCAT)1Jdm/0
Tg(APOA1)1Rub/0
Tg(APOA2)3Rub/0
(involves: C57BL/6 * FVB/N) 		increased circulating cholesterol level J:121992
increased circulating HDL cholesterol level J:121992
Tg(AlbLCAT)1Jdm/0
Tg(APOA2)3Rub/0
(involves: C57BL/6 * FVB/N) 		decreased circulating cholesterol level J:121992
decreased circulating HDL cholesterol level J:121992
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL) 		abnormal lipid level J:249664
abnormal lipid oxidation J:249664
decreased ceramide level J:249664
increased ceramide level J:249664
increased circulating cholesterol level J:50770
increased circulating triglyceride level J:50770
increased liver triglyceride level J:50770
increased unsaturated fatty acids level J:249664
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2) 		abnormal lipid level J:57075
decreased circulating triglyceride level J:57075
decreased liver triglyceride level J:57075
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N) 		abnormal lipid level J:69591
decreased circulating free fatty acids level J:69591
decreased circulating triglyceride level J:69591
Tg(APOA1)1Rub/0
(involves: C57BL/6) 		decreased circulating triglyceride level J:121992
Tg(APOA1)1Rub/0
Tg(APOA2)3Rub/0
(involves: C57BL/6) 		decreased circulating cholesterol level J:121992
decreased circulating HDL cholesterol level J:121992
increased circulating cholesterol level J:129136
increased circulating HDL cholesterol level J:129136
increased circulating triglyceride level J:129136
Tg(APOA1)1Rub/?
Tg(APOA2)3Rub/?
(involves: C57BL/6) 		abnormal lipid homeostasis J:92450, J:129704
Tg(APOA1)1Rub/Tg(APOA1)1Rub
(C57BL/6-Tg(APOA1)1Rub/J) 		abnormal circulating HDL cholesterol level J:190966
abnormal lipid homeostasis J:92450, J:129704
abnormal lipid level J:42425
increased circulating cholesterol level J:42425
increased circulating HDL cholesterol level J:42425
Tg(Apoa2)1Lus/?
(involves: C57BL/6J * DBA/2) 		abnormal lipid homeostasis J:92454, J:127063
increased circulating cholesterol level J:92454, J:127063
increased circulating HDL cholesterol level J:92454, J:127063
increased circulating LDL cholesterol level J:92454
increased circulating triglyceride level J:92454
increased circulating VLDL cholesterol level J:92454
Tg(APOA2)3Rub/?
(involves: C57BL/6) 		abnormal lipid homeostasis J:92450
Tg(APOA2)3Rub/0
(involves: C57BL/6) 		decreased circulating cholesterol level J:121992
decreased circulating HDL cholesterol level J:121992
decreased circulating triglyceride level J:121992
Tg(APOA5)1Hgc/0
(FVB/N-Tg(APOA5)1Hgc) 		decreased circulating triglyceride level J:72092
decreased circulating VLDL cholesterol level J:72092
Tg(APOB)11Rub/?
(involves: FVB) 		increased circulating cholesterol level J:78212
increased circulating LDL cholesterol level J:78212
Tg(APOB)11Rub/0
Tg(UcpDta)1Kz/0
(involves: C57BL/6J * FVB/N) 		abnormal lipid homeostasis J:73122
decreased circulating HDL cholesterol level J:73122
increased circulating cholesterol level J:73122
increased circulating LDL cholesterol level J:73122
increased circulating triglyceride level J:73122
Tg(APOB)1102Sgy/?
(B6.Cg-Tg(APOB)1102Sgy) 		abnormal cholesterol homeostasis J:151253
Tg(APOC1)1Bres/Tg(APOC1)1Bres
(involves: C57BL/6J * CBA/J) 		abnormal lipid homeostasis J:80950
hyperlipidemia J:80950
increased circulating cholesterol level J:80950
increased circulating LDL cholesterol level J:80950
increased circulating triglyceride level J:80950
increased circulating VLDL cholesterol level J:80950
increased circulating VLDL triglyceride level J:80950
Tg(APOC1)1Lmh/0
(C57BL/6-Tg(APOC1)1Lmh) 		increased circulating cholesterol level J:65036
increased circulating free fatty acids level J:65036
increased circulating triglyceride level J:65036
increased circulating VLDL cholesterol level J:65036
increased circulating VLDL triglyceride level J:65036
Tg(APOC1)1Lmh/?
(C57BL/6-Tg(APOC1)1Lmh) 		increased circulating cholesterol level J:65146
increased circulating triglyceride level J:65146
increased circulating VLDL cholesterol level J:65146
increased circulating VLDL triglyceride level J:65146
Tg(APOC1)1Lmh/0
Tg(APOC1)3Lmh/0
(C57BL/6-Tg(APOC1)1Lmh Tg(APOC1)3Lmh) 		increased circulating cholesterol level J:65036
increased circulating free fatty acids level J:65036
increased circulating triglyceride level J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh) 		increased circulating cholesterol level J:65036
increased circulating free fatty acids level J:65036
increased circulating triglyceride level J:65036
increased circulating VLDL cholesterol level J:65036
increased circulating VLDL triglyceride level J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(involves: C57BL/6J) 		increased circulating cholesterol level J:117317
increased circulating triglyceride level J:117317
Tg(APOC1)3Lmh/Y
(C57BL/6-Tg(APOC1)3Lmh) 		increased circulating cholesterol level J:65036
increased circulating free fatty acids level J:65036
increased circulating triglyceride level J:65036
increased circulating VLDL cholesterol level J:65036
increased circulating VLDL triglyceride level J:65036
Tg(APOC1)3Lmh/0
(C57BL/6-Tg(APOC1)3Lmh) 		increased circulating cholesterol level J:65036
increased circulating free fatty acids level J:65036
increased circulating triglyceride level J:65036
Tg(APOC1)3Lmh/?
(C57BL/6-Tg(APOC1)3Lmh) 		increased circulating cholesterol level J:65146
Tg(APOC2)2Bres/0
(involves: C57BL/6J * CBA/J) 		abnormal lipid homeostasis J:81186
increased cholesterol level J:81186
increased circulating triglyceride level J:81186
increased circulating VLDL triglyceride level J:81186
Tg(APOC3)2674Bres/0
(involves: C57BL/6J * CBA/J) 		abnormal lipid homeostasis J:81184
increased circulating triglyceride level J:81184
increased circulating VLDL triglyceride level J:81184
Tg(APOC3)2674Bres/Tg(APOC3)2674Bres
(involves: C57BL/6J * CBA/J) 		increased circulating triglyceride level J:81184
Tg(APOC3)2721Bres/0
(involves: C57BL/6J * CBA/J) 		decreased circulating HDL cholesterol level J:81184
increased circulating triglyceride level J:81184
increased circulating VLDL triglyceride level J:81184
Tg(APOC3)3707Bres/0
(involves: C57BL/6J * CBA/J) 		increased circulating cholesterol level J:119638
increased circulating triglyceride level J:119638
Tg(APOE-ABCA1)30Ssf/?
(C57BL/6N-Tg(APOE-ABCA1)30Ssf) 		increased circulating cholesterol level J:70494
increased circulating HDL cholesterol level J:70494
increased circulating phospholipid level J:70494
increased liver cholesterol level J:70494
increased triglyceride level J:70494
Tg(APOE-ABCG1)1Ssf/?
(C57BL/6-Tg(APOE-ABCG1)1Ssf) 		abnormal phospholipid level J:94077
decreased circulating HDL cholesterol level J:94077
increased liver cholesterol level J:94077
Tg(APOE-ANGPTL4)1Akos/0
(involves: C57BL/6 * SJL) 		increased circulating cholesterol level J:103363
increased circulating triglyceride level J:103363
increased circulating VLDL cholesterol level J:103363
Tg(APOE-Cyp7a1)1Road/?
(B6.Cg-Tg(APOE-Cyp7a1)1Road) 		decreased circulating HDL cholesterol level J:70134
decreased circulating LDL cholesterol level J:70134
decreased circulating VLDL cholesterol level J:70134
increased bile salt level J:70134
increased triglyceride level J:70134
Tg(APOE-DGAT1)1Far/0
(involves: C57BL/6NHsd) 		abnormal fatty acids level J:124005
abnormal lipid level J:124005
increased liver triglyceride level J:124005
Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd) 		abnormal fatty acids level J:124005
abnormal lipid level J:124005
decreased circulating free fatty acids level J:124005
decreased circulating triglyceride level J:124005
increased triglyceride level J:124005
Tg(APOE-DGAT2)24Far/0
(involves: C57BL/6NHsd) 		abnormal fatty acids level J:124005
abnormal lipid level J:124005
decreased circulating free fatty acids level J:124005
decreased circulating triglyceride level J:124005
increased triglyceride level J:124005
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA) 		abnormal vitamin D level J:93981
Tg(APOE-NPC1L1)20Lqyu/0
(involves: C57BL/6 * DBA/2) 		increased cholesterol level J:124193
increased circulating cholesterol level J:124193
Tg(APOE-PCSK9)1Jdh/0
(Not Specified) 		increased circulating LDL cholesterol level J:114949
Tg(Apoe-Pcsk9)#Prat/?
(involves: C3H * C57BL/6) 		increased circulating cholesterol level J:169834
increased circulating HDL cholesterol level J:169834
increased circulating LDL cholesterol level J:169834
Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
(involves: C57BL/6 * DBA) 		decreased circulating cholesterol level J:172091
decreased circulating ketone body level J:172091
decreased fatty acid oxidation J:172091
increased circulating triglyceride level J:172091
increased liver triglyceride level J:172091
Tg(APOE-SGMS2)#Jia/0
(involves: C57BL/6 * C57BL/6J * CBA) 		abnormal sphingomyelin level J:162192
Tg(APOE_i3*,APOC1)2Lmh/?
(involves: C57BL/6J * CBA) 		increased circulating cholesterol level J:228420
increased circulating LDL cholesterol level J:228420
increased circulating triglyceride level J:228420
increased circulating VLDL cholesterol level J:228420
Tg(APOM)HCchr/0
(B6.Cg-Tg(APOM)HCchr) 		increased circulating cholesterol level J:130647
increased circulating phospholipid level J:130647
increased circulating triglyceride level J:130647
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6;C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax) 		increased circulating cholesterol level J:129021
increased circulating triglyceride level J:113199
Tg(AZIP/F)1Vsn/0
(involves: FVB/N) 		abnormal lipid homeostasis J:50807
increased circulating free fatty acids level J:50807
increased circulating triglyceride level J:50807
increased liver triglyceride level J:50807
Tg(CAG-CYP27A1)23Etl/0
(involves: C57BL/6JOlaHsd * CBA) 		abnormal bile salt level J:78951
abnormal cholesterol level J:78951
abnormal feces lipid level J:78951
Tg(Cdh16-Wnk1*)#Cihu/0
(involves: C57BL/6) 		increased circulating aldosterone level J:168700
Tg(CETP)5203Tall/0
(involves: C57BL/6 * CBA/J) 		abnormal lipid level J:117482
abnormal phospholipid level J:117482
decreased cholesterol level J:117482
decreased liver triglyceride level J:117482
Tg(CETP)5203Tall/0
(involves: C57BL/6J * CBA/J) 		decreased circulating HDL cholesterol level J:48202
Tg(CETP)UCTP20Pnu/0
(C57BL/6-Tg(CETP)UCTP20Pnu) 		abnormal circulating cholesterol level J:118358, J:92448
decreased circulating HDL cholesterol level J:118358
increased circulating LDL cholesterol level J:118358
increased circulating VLDL cholesterol level J:118358
Tg(Ckm-Cd36)1Naa/0
(involves: FVB) 		decreased circulating cholesterol level J:57650
decreased circulating free fatty acids level J:57650
decreased circulating triglyceride level J:57650
decreased circulating VLDL triglyceride level J:57650
Tg(Ckm-DGAT2)10Far/0
(involves: C57BL/6NHsd) 		abnormal lipid level J:129495
increased skeletal muscle triglyceride level J:129495
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr) 		increased circulating cholesterol level J:210518
increased circulating free fatty acids level J:71205
increased circulating triglyceride level J:71205
increased liver triglyceride level J:71205
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J) 		decreased circulating triglyceride level J:101818
decreased circulating VLDL triglyceride level J:101818
increased muscle free fatty acids level J:101818
Tg(Ckm-LPL)LRze/0
(involves: C57BL/6J * CBA/J) 		decreased circulating triglyceride level J:101818
decreased circulating VLDL triglyceride level J:101818
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J) 		decreased circulating triglyceride level J:101818
decreased circulating VLDL triglyceride level J:101818
increased muscle free fatty acids level J:101818
Tg(Ckm-Pnpla2)164Eek/0
(involves: FVB/N) 		decreased skeletal muscle triglyceride level J:207007
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA) 		increased skeletal muscle triglyceride level J:129848
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased circulating corticosterone level J:95465
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL) 		increased circulating corticosterone level J:92996
Tg(CSN2-fat-1)1Vane/0
(involves: C57BL/6 * DBA) 		decreased unsaturated fatty acids level J:168456
increased unsaturated fatty acids level J:168456
Tg(Cyp21a1-Apoe)614Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased circulating cholesterol level J:130658
Tg(Cyp21a1-Apoe)619Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased circulating cholesterol level J:130658
Tg(Fabp1-Nr1h3)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:135594
Tg(Fabp1-Nr1h3)#Wexi/?
Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:135594
Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6) 		increased liver triglyceride level J:135594
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul) 		abnormal circulating glycerol level J:344362
decreased circulating free fatty acids level J:344362
increased circulating cholesterol level J:344362
increased circulating HDL cholesterol level J:344362
increased circulating LDL cholesterol level J:344362
increased circulating triglyceride level J:344362
increased liver triglyceride level J:344362
Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N) 		increased circulating free fatty acids level J:110277
increased liver triglyceride level J:110277
Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J) 		increased circulating free fatty acids level J:182179
increased circulating triglyceride level J:182179
increased liver triglyceride level J:182179
Tg(Fabp4-Fam13a)1Iked/0
(C57BL/6J-Tg(Fabp4-Fam13a)1Iked) 		decreased circulating free fatty acids level J:258290
Tg(Fabp4-FOXC2)ASven/0
(involves: C57BL/6J * CBA) 		decreased circulating free fatty acids level J:94144
decreased circulating triglyceride level J:94144
Tg(Fabp4-Hsd11b1)7Jesf/0
(FVB-Tg(Fabp4-Hsd11b1)7Jesf) 		abnormal corticosterone level J:107046
abnormal lipid homeostasis J:107046
increased circulating free fatty acids level J:107046
increased circulating triglyceride level J:107046
increased fatty acids level J:107046
Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J) 		decreased circulating cholesterol level J:67311
decreased circulating triglyceride level J:67311
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc) 		decreased circulating triglyceride level J:84349
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1) 		decreased circulating cholesterol level J:230172
decreased circulating glycerol level J:230172
decreased circulating triglyceride level J:230172
increased circulating free fatty acids level J:230172
Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl) 		decreased circulating LDL cholesterol level J:208508
decreased liver triglyceride level J:208508
Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB) 		decreased triglyceride level J:189510
Tg(GAS7)63.2Lus/0
(involves: FVB/N) 		abnormal cholesterol level J:148831
decreased triglyceride level J:148831
increased cholesterol level J:148831
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron) 		increased cholesterol level J:210298
increased triglyceride level J:210298
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish) 		decreased circulating triglyceride level J:128016
Tg(Hmgcr-PSEN1*M146L)#Lpr/0
Tg(Thy1-APPSL)28Lpr/0
(involves: C57BL/6 * CBA) 		decreased circulating cholesterol level J:128243
Tg(IGFBP2)1Miel/0
(FVB/N-Tg(IGFBP2)1Miel) 		decreased circulating triglyceride level J:121961
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL) 		increased circulating triglyceride level J:127706
Tg(Ins2-Nos2)40Okam/0
(involves: C57BL/6 * CD-1 * DBA/2) 		increased circulating ketone body level J:45520
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL) 		increased circulating free fatty acids level J:141527
increased circulating triglyceride level J:141527
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL) 		increased circulating free fatty acids level J:141527
increased circulating triglyceride level J:141527
Tg(K5-Ptgs2)19Kmd/0
(involves: NMRI) 		increased prostaglandin level J:70039
Tg(K5-Ptgs2)667Kmd/0
(involves: NMRI) 		increased prostaglandin level J:70039
Tg(K5-Ptgs2)675Kmd/0
(involves: NMRI) 		increased prostaglandin level J:70039
Tg(KB1430A10)1Ped/0
(involves: BALB/cJ * C57BL/6) 		abnormal phospholipid level J:117028
decreased cholesterol level J:117028
decreased liver triglyceride level J:117028
decreased triglyceride level J:117028
Tg(Lcat)1Ssf/Tg(Lcat)1Ssf
(C57BL/6-Tg(Lcat)1Ssf) 		increased circulating cholesterol level J:94077
increased circulating HDL cholesterol level J:94077
increased circulating phospholipid level J:94077
Tg(LCAT)A31Ssf/0
(C57BL/6N-Tg(LCAT)A31Ssf) 		increased circulating cholesterol level J:118356
increased circulating HDL cholesterol level J:118356
increased circulating phospholipid level J:118356
Tg(LCAT)A31Ssf/Tg(LCAT)A31Ssf
(C57BL/6N-Tg(LCAT)A31Ssf) 		increased circulating cholesterol level J:118356
increased circulating HDL cholesterol level J:118356
increased circulating phospholipid level J:118356
Tg(LCAT)T59Ssf/0
(C57BL/6N-Tg(LCAT)T59Ssf) 		increased circulating cholesterol level J:118356
increased circulating HDL cholesterol level J:118356
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		increased circulating cholesterol level J:120962
increased circulating triglyceride level J:120962
Tg(Lck-Tnfsf14)24Yxf/?
Tnfrsf14tm1Kpf/Tnfrsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating cholesterol level J:120962
Tg(LIPC)6784His/0
(C57BL/6-Tg(LIPC)6784His) 		decreased circulating HDL cholesterol level J:48486
decreased circulating phospholipid level J:48486
decreased circulating triglyceride level J:48486
Tg(LIPG)1Tq/0
(involves: C57BL/6) 		abnormal circulating phospholipid level J:81821
decreased circulating cholesterol level J:81821
decreased circulating HDL cholesterol level J:81821
decreased triglyceride level J:81821
Tg(Mc2r-Arntl)1Kyki/0
(C57BL/6J-Tg(Mc2r-Arntl)1Kyki) 		abnormal circulating corticosterone level J:146305
abnormal corticosterone level J:146305
Tg(MECP2)1Hzo/0
(either: (FVB/N x 129S6/SvEvTac)F1 or (FVB/N x C57BL/6J)F1) 		abnormal corticosterone level J:181213
Tg(Mt1-LDLR)93-4Reh/0
(involves: C57BL/6 * SJL) 		decreased circulating cholesterol level J:127519
decreased circulating LDL cholesterol level J:127519
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps) 		increased liver cholesterol level J:233146
increased liver free fatty acids level J:233146
increased liver triglyceride level J:233146
Tg(Myh6-Acsl1)O7Jesc/0
(FVB/N-Tg(Myh6-Acsl1)O7Jesc) 		abnormal lipid level J:68639
abnormal phospholipid level J:68639
increased cardiac muscle triglyceride level J:68639
Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno) 		abnormal circulating cholesterol level J:186193
abnormal liver triglyceride level J:186193
Tg(Myh6-Ppara)402-2Dpk/0
(involves: C57BL/6 * CBA/J) 		abnormal lipid level J:110580
increased fatty acids level J:110580
Tg(Myh6-Ppara)404-3Dpk/0
(involves: C57BL/6 * CBA/J) 		abnormal lipid level J:110580
increased fatty acids level J:110580
Tg(Myh6-Ppara)404-4Dpk/0
(involves: C57BL/6 * CBA/J) 		abnormal lipid level J:110580
increased fatty acids level J:110580
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6 * CBA) 		abnormal lipid level J:81967
Tg(Myl1-Prkag3*R225Q)1Sson/0
(involves: C57BL/6J * CBA) 		abnormal triglyceride level J:92821
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB) 		decreased liver triglyceride level J:76323
decreased skeletal muscle triglyceride level J:76323
Tg(Nphs1-ACE2)#Kdbu/0
(FVB//N-Tg(Nphs1-ACE2)#Kdbu) 		decreased circulating triglyceride level J:198181
Tg(Plp1-LMNB1)1108Qsp/0
(involves: FVB/N) 		abnormal lipid level J:226169
abnormal phospholipid level J:226169
abnormal sphingomyelin level J:226169
decreased cholesterol level J:226169
Tg(PLTP)1Pgn/0
(C57BL/6J-Tg(PLTP)1Pgn/J) 		abnormal circulating cholesterol level J:92804
decreased circulating cholesterol level J:92804
decreased circulating LDL phospholipid level J:92804
decreased circulating VLDL phospholipid level J:92804
increased circulating HDL phospholipid level J:92804
Tg(PRNP-APPSweInd)8Dwst/?
(involves: 129S6/SvEvTac) 		increased circulating triglyceride level J:113199
increased circulating VLDL triglyceride level J:113199
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA) 		decreased circulating cholesterol level J:182671
Tg(RNU6-RNAi:Cldn16)551Dago/0
(involves: C57BL/6 * DBA/2) 		increased circulating aldosterone level J:122766
Tg(RP11-578M14)5Mkru/0
(involves: FVB/N) 		decreased circulating free fatty acids level J:256501
increased cholesterol level J:256501
increased circulating phospholipid level J:256501
increased triglyceride level J:256501
Tg(rPEPCKSREBF2)788Reh/0
(Not Specified) 		abnormal lipid level J:86518
increased circulating cholesterol level J:86518
increased fatty acids level J:86518
increased liver cholesterol level J:86518
increased liver triglyceride level J:86518
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N) 		abnormal glycerol level J:91800
abnormal lipid homeostasis J:91800
increased circulating corticosterone level J:91800
increased circulating ketone body level J:91800
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL) 		increased circulating corticosterone level J:91800
Tg(SREBP1a)7343Reh/0
(involves: C57BL/6J * SJL/J) 		abnormal lipid homeostasis J:35770
decreased circulating triglyceride level J:35770
increased liver cholesterol level J:35770
increased liver triglyceride level J:35770
Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL) 		decreased cholesterol level J:93775
decreased circulating cholesterol level J:93775
decreased circulating HDL cholesterol level J:93775
Tg(tetO-Xbp1_is)#Pesch/0
Tg(Adipoq-rtTA)2Zvw/0
(involves: C57BL/6 * C57BL/6N * FVB/N) 		increased fatty acid oxidation J:260830
Tg(THY1-APOD1)1Era/0
(B6.Cg-Tg(THY1-APOD1)1Era) 		abnormal lipid homeostasis J:143809
Tg(Ttr-Foxo1)307Dac/0
(involves: C57BL/6J) 		increased circulating cholesterol level J:94423
increased circulating HDL cholesterol level J:94423
increased circulating triglyceride level J:94423
Tg(UcpDta)1Kz/?
(involves: FVB/N) 		abnormal lipid homeostasis J:78211
hyperlipidemia J:78211
increased circulating cholesterol level J:78211
increased circulating triglyceride level J:147417, J:78211
Tg(Vil1-cre)20Syr/0
Vmp1tm1.1Arte/Vmp1tm1.1Arte
(involves: C57BL/6 * DBA/2) 		abnormal lipid level J:280741
Tg(Vil1-cre)997Gum/?
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J) 		increased circulating cholesterol level J:229155
increased circulating triglyceride level J:229155
Tgfb1tm1.1Mki/Tgfb1tm1.1Mki
(C57BL/6-Tgfb1tm1.1Mki) 		decreased circulating aldosterone level J:194237
Tgfb1tm1Mki/Tgfb1tm1Mki
(C57BL/6-Tgfb1tm1Mki) 		increased circulating aldosterone level J:194237
increased circulating corticosterone level J:194237
Tgfb1i1tm1b(KOMP)Wtsi/Tgfb1i1tm1b(KOMP)Wtsi
(C57BL/6N-Tgfb1i1tm1b(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
Tgfbr2tm1Dgen/Tgfbr2+
(involves: 129P2/OlaHsd) 		increased fatty acids level J:148831
Tgl1KK/Ta/Tgl1KK/Ta
(involves: BALB/c * KK/Ta) 		increased triglyceride level J:88209
Tglq1MRL/MpJ/Tglq1MRL/MpJ
(involves: MRL/MpJ * SJL/J) 		increased circulating triglyceride level J:106033
Tglq1MRL/MpJ/Tglq1SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating triglyceride level J:106033
Tglq2MRL/MpJ/Tglq2SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating triglyceride level J:106033, J:123776
Tglq2SJL/J/Tglq2SJL/J
(involves: MRL/MpJ * SJL/J) 		increased circulating triglyceride level J:106033, J:123776
Tglq3RF/J/Tglq3RF/J
(involves: NZB/BlNJ * RF/J) 		decreased circulating triglyceride level J:123776
Tglq4NZB/BlNJ/Tglq4NZB/BlNJ
(involves: NZB/BlNJ * RF/J) 		increased circulating triglyceride level J:123776
Tglq4NZB/BlNJ/Tglq4RF/J
(involves: NZB/BlNJ * RF/J) 		increased circulating triglyceride level J:123776
Tgls1KK/Ta/Tgls1KK/Ta
(involves: BALB/c * KK/Ta) 		decreased circulating triglyceride level J:88209
Tgq1129S1/SvImJ/Tgq1C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased triglyceride level J:93243
Tgq2C57BL/6J/Tgq2C57BL/6J
Tgq3129S1/SvImJ/Tgq3129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J) 		increased triglyceride level J:93243
Tgq4NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased triglyceride level J:138463
Tgq5NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased triglyceride level J:138463
Tgq6NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased triglyceride level J:138463
Tgq7NZB/BlNJ/Tgq7NZB/BlNJ
Tgq8NZW/LacJ/Tgq8NZW/LacJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased triglyceride level J:138463
Tgq9DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq10DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq11DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq13DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq14DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq15DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq17DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq18DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq19DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq20DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq21DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq22DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq23DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq24DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq25DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq26DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq27DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq28DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgq29DBA/2J/?
(involves: DBA/1J * DBA/2J) 		increased circulating triglyceride level J:142770
Tgyl1SM/J/?
(involves: LG/J * SM/J) 		increased triglyceride level J:94605
Them5tm1Hem/Them5tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		decreased fatty acids level J:186657
increased circulating free fatty acids level J:186657
Thrap3tm1c(KOMP)Wtsi/Thrap3tm1c(KOMP)Wtsi
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA) 		decreased circulating cholesterol level J:339439
decreased circulating free fatty acids level J:339439
decreased circulating triglyceride level J:339439
decreased liver cholesterol level J:339439
decreased liver triglyceride level J:339439
Thrbtm2a(EUCOMM)Wtsi/Thrbtm2a(EUCOMM)Wtsi
(C57BL/6N-Thrbtm2a(EUCOMM)Wtsi/H) 		decreased circulating glycerol level J:165965
Thrsptm1Cnm/Thrsptm1Cnm
(B6.129-Thrsptm1Cnm) 		abnormal lipid homeostasis J:129452
decreased triglyceride level J:129452
Tial1tm1b(EUCOMM)Wtsi/Tial1+
(C57BL/6N-Tial1tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Tigittm1.1(IMPC)Wtsi/Tigittm1.1(IMPC)Wtsi
(C57BL/6N-Tigittm1.1(IMPC)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Timo/Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		increased circulating cholesterol level J:127183
increased circulating LDL cholesterol level J:127183
Timo/Timo+
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ)) 		increased circulating LDL cholesterol level J:127183
Tjp1tm1.1Whun/Tjp1tm1.1Whun
Tjp2tm2Whun/Tjp2tm2Whun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2) 		increased bile salt level J:306936
increased circulating LDL cholesterol level J:306936
Tjp2tm2Whun/Tjp2tm2Whun
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2) 		increased circulating LDL cholesterol level J:306936
Tle4em1(IMPC)Mbp/Tle4em1(IMPC)Mbp
(C57BL/6NCrl-Tle4em1(IMPC)Mbp/Mmucd) 		abnormal cholesterol homeostasis J:211773
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		abnormal circulating cholesterol level J:158035
abnormal circulating LDL cholesterol level J:158035
abnormal circulating lipid level J:158035
decreased circulating VLDL cholesterol level J:158035
increased circulating free fatty acids level J:158035
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129) 		abnormal circulating corticosterone level J:94463
decreased circulating corticosterone level J:94463
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d) 		abnormal fatty acids level J:126488
abnormal lipid level J:126488
decreased liver triglyceride level J:126488
Tlr4tm1.1Djh/Tlr4tm1.1Djh
(involves: C57BL/6 * FVB/N * SJL) 		abnormal bile salt level J:193668
Tlr4tm1Djh/Tlr4tm1Djh
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL) 		abnormal bile salt level J:193668
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		increased circulating cholesterol level J:158055
increased circulating triglyceride level J:158055
Tm6sf2em1Yech/Tm6sf2em1Yech
(C57BL/6-Tm6sf2em1Yech) 		abnormal cholesterol homeostasis J:235704
decreased circulating cholesterol level J:235704
decreased circulating HDL cholesterol level J:235704
decreased circulating LDL cholesterol level J:235704
increased circulating triglyceride level J:235704
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2+
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi) 		abnormal cholesterol homeostasis J:234195
increased liver triglyceride level J:234195
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2tm1a(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi) 		abnormal cholesterol homeostasis J:234195
abnormal intestinal lipid absorption J:234195
decreased circulating cholesterol level J:234195
decreased circulating HDL cholesterol level J:234195
decreased circulating LDL cholesterol level J:234195
decreased circulating VLDL triglyceride level J:234195
decreased intestinal cholesterol absorption J:234195
increased circulating triglyceride level J:234195
increased liver triglyceride level J:234195
increased triglyceride level J:234195
Tm6sf2tm1b(KOMP)Wtsi/Tm6sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1b(KOMP)Wtsi/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Tm9sf3em1(IMPC)Mbp/Tm9sf3+
(C57BL/6NCrl-Tm9sf3em1(IMPC)Mbp/Mmucd) 		increased circulating triglyceride level J:211773
Tm9sf4tm1a(KOMP)Wtsi/Tm9sf4tm1a(KOMP)Wtsi
(C57BL/6N-Tm9sf4tm1a(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Tmc7em1(IMPC)Mbp/Tmc7em1(IMPC)Mbp
(C57BL/6NCrl-Tmc7em1(IMPC)Mbp/Mmucd) 		increased circulating cholesterol level J:211773
Tmem9bem1(IMPC)J/Tmem9bem1(IMPC)J
(C57BL/6NJ-Tmem9bem1(IMPC)J/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Tmem30atm1.1Xjz/Tmem30atm1.1Xjz
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA) 		increased bile salt level J:249038
Tmem35atm1.1(KOMP)Vlcg/Y
(B6(FVB)-Tmem35atm1.1(KOMP)Vlcg) 		increased circulating corticosterone level J:244268
Tmem41bem1Cya/Tmem41b+
(involves: C57BL/6) 		decreased circulating cholesterol level J:316472
decreased circulating LDL cholesterol level J:316472
decreased circulating triglyceride level J:316472
Tmem42tm1b(KOMP)Wtsi/Tmem42tm1b(KOMP)Wtsi
(C57BL/6N-Tmem42tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Tmem51tm1b(EUCOMM)Hmgu/Tmem51tm1b(EUCOMM)Hmgu
(C57BL/6N-Tmem51tm1b(EUCOMM)Hmgu/H) 		increased circulating HDL cholesterol level J:211773
Tmem68tm1a(EUCOMM)Wtsi/Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi) 		abnormal lipid oxidation J:339870
decreased circulating triglyceride level J:339870
decreased liver triglyceride level J:339870
decreased triglyceride level J:339870
Tmem87bem1(IMPC)J/Tmem87bem1(IMPC)J
(C57BL/6NJ-Tmem87bem1(IMPC)J/J) 		increased circulating HDL cholesterol level J:211773
Tmem129tm1.1(KOMP)Vlcg/Tmem129tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem129tm1.1(KOMP)Vlcg/J) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Tmem132bem1(IMPC)Ccpcz/Tmem132bem1(IMPC)Ccpcz
(C57BL/6N-Tmem132bem1(IMPC)Ccpcz/Ccpcz) 		abnormal cholesterol homeostasis J:211773
Tmem167tm1a(EUCOMM)Hmgu/Tmem167+
(C57BL/6N-Tmem167tm1a(EUCOMM)Hmgu/H) 		decreased circulating triglyceride level J:165965
Tmem203em1(IMPC)H/Tmem203em1(IMPC)H
(C57BL/6N-Tmem203em1(IMPC)H/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Tmem212em1(IMPC)J/Tmem212em1(IMPC)J
(C57BL/6NJ-Tmem212em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Tmem237tm1b(EUCOMM)Hmgu/Tmem237+
(C57BL/6N-Tmem237tm1b(EUCOMM)Hmgu/Ccpcz) 		increased circulating triglyceride level J:211773
Tmem241em1Blsg/Tmem241em1Blsg
(involves: C57BL/6J) 		increased lung cholesterol level J:344360
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
Tmlheem1Plaa/Tmlheem1Plaa
(C57BL/6N-Tmlheem1Plaa) 		abnormal fatty acids level J:341247
decreased fatty acid oxidation J:341247
increased fatty acids level J:341247
increased unsaturated fatty acids level J:341247
Tmprss15tm1a(KOMP)Wtsi/Tmprss15tm1a(KOMP)Wtsi
(C57BL/6N-Tmprss15tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		abnormal lipid homeostasis J:42579
decreased circulating triglyceride level J:42579
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6) 		steatorrhea J:204922
Tnftm2Jods/Tnftm2Jods
(involves: C57BL/6 * C57BL/6J) 		decreased liver free fatty acids level J:112797
Tnfaip1tm1a(EUCOMM)Wtsi/Tnfaip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfaip1tm1a(EUCOMM)Wtsi/H) 		increased circulating triglyceride level J:165965
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr
Tg(Gfap-cre)2Brn/0
(involves: 129 * C57BL/6 * C57BL/6NTac * FVB/N) 		decreased prostaglandin level J:155398
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6NTac * SJL) 		decreased prostaglandin level J:155398
Tnfsf4Ath1-A/J/Tnfsf4Ath1-A/J
Ath2A/J/Ath2A/J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:9832
Tnfsf4Ath1-BALB/cJ/?
(involves: BALB/cJ * C57BL/6J) 		increased circulating HDL cholesterol level J:8735
Tnfsf4Ath1-C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J) 		increased circulating HDL cholesterol level J:9135
Tnfsf4Ath1-C57BL/6J/?
(involves: BALB/cJ * C57BL/6J) 		abnormal lipid homeostasis J:8735
Tnfsf4Ath1-C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:8735, J:9135
Tnfsf4Ath1-C57BL/6J/Tnfsf4Ath1-C57BL/6J
Ath2C57BL/6J/Ath2C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		decreased circulating HDL cholesterol level J:9832
Tnfsf4Ath1-PERA/EiJ/Tnfsf4Ath1-C57BL/6J
(B6.PERA-Tnfsf4Ath1-PERA/EiJ/Pgn) 		increased circulating HDL cholesterol level J:79722
Tnfsf4Ath1-PERA/EiJ/Tnfsf4Ath1-PERA/EiJ
(B6.PERA-Tnfsf4Ath1-PERA/EiJ/Pgn) 		increased circulating HDL cholesterol level J:79722
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J) 		decreased circulating cholesterol level J:241611
decreased circulating HDL cholesterol level J:241611
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Tnksem1(IMPC)Hmgu/Tnksem1(IMPC)Hmgu
(C57BL/6N-Tnksem1(IMPC)Hmgu/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
TnksGt(RRC239)Byg/TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating ketone body level J:154388
Tns2nph/Tns2nph
(involves: ICR) 		increased circulating cholesterol level J:24698
Toxtm1b(KOMP)Wtsi/Toxtm1b(KOMP)Wtsi
(C57BL/6N-Toxtm1b(KOMP)Wtsi/Tcp) 		decreased circulating cholesterol level J:211773
Tpcn2tm1b(EUCOMM)Hmgu/Tpcn2tm1b(EUCOMM)Hmgu
(C57BL/6N-Tpcn2tm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Tpgs2tm1.1(KOMP)Vlcg/Tpgs2tm1.1(KOMP)Vlcg
(C57BL/6N-Tpgs2tm1.1(KOMP)Vlcg/J) 		decreased circulating free fatty acids level J:211773
Tpoem1(IMPC)H/Tpoem1(IMPC)H
(C57BL/6NTac-Tpoem1(IMPC)H/H) 		increased circulating cholesterol level J:211773
Tra2bGt(P142D08)Wrst/Tra2b+
(involves: 129S2/SvPas * C57BL/6J) 		increased circulating triglyceride level J:176730
increased circulating VLDL triglyceride level J:176730
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		increased circulating corticosterone level J:37065
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		increased circulating cholesterol level J:294716
increased circulating glycerol level J:294716
increased circulating HDL cholesterol level J:294716
increased circulating LDL cholesterol level J:294716
increased circulating triglyceride level J:294716
Trappc10tm1b(KOMP)Wtsi/Trappc10tm1b(KOMP)Wtsi
(C57BL/6N-Trappc10tm1b(KOMP)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
TrglydRR/?
(involves: C57BL/6J * RR) 		increased triglyceride level J:94251
Trhem1(IMPC)Tcp/Trhem1(IMPC)Tcp
(C57BL/6NCrl-Trhem1(IMPC)Tcp/Tcp) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Triglq1SM/J/?
(involves: A/J * SM/J) 		increased circulating triglyceride level J:64138
Triglq2SM/J/?
(involves: A/J * SM/J) 		increased circulating triglyceride level J:64138
Trigq2KK/Trigq2KK
(involves: KK-Ay * RR) 		increased triglyceride level J:87328
Trim8em1(IMPC)Wtsi/Trim8em1(IMPC)Wtsi
(C57BL/6N-Trim8em1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Trim13em1(IMPC)Tcp/Trim13em1(IMPC)Tcp
(C57BL/6N-Trim13em1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		increased liver triglyceride level J:232482
Trim56tm1a(EUCOMM)Wtsi/Trim56tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim56tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Trim72tm1Rpx/Trim72tm1Rpx
(involves: 129/SvJ * C57BL/6) 		decreased susceptibility to hyperlipidemia J:342778
Trip13tm1.1(KOMP)Vlcg/Trip13tm1.1(KOMP)Vlcg
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Trmt1tm1b(EUCOMM)Hmgu/Trmt1+
(C57BL/6N-Trmt1tm1b(EUCOMM)Hmgu/Ics) 		decreased circulating cholesterol level J:211773
Trmt10atm1a(EUCOMM)Wtsi/Trmt10atm1a(EUCOMM)Wtsi
(C57BL/6N-Trmt10atm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:175295
decreased circulating HDL cholesterol level J:175295
decreased circulating LDL cholesterol level J:175295
increased circulating free fatty acids level J:175295
increased circulating glycerol level J:175295
Trpc2Gt(OST448844)Lex/Trpc2Gt(OST448844)Lex
(involves: 129S5/SvEvBrd) 		increased circulating cholesterol level J:103485
increased circulating triglyceride level J:103485
Trpm1tm1b(KOMP)Wtsi/Trpm1tm1b(KOMP)Wtsi
(C57BL/6N-Trpm1tm1b(KOMP)Wtsi/H) 		increased circulating HDL cholesterol level J:211773
Trpv5Hcalc1/Trpv5Hcalc1
(involves: C3H/HeH * C57BL/6J) 		abnormal vitamin D level J:196612
Trpv5tm1Bind/Trpv5tm1Bind
(involves: 129 * C57BL/6) 		abnormal vitamin D level J:86949
Trub2tm2a(EUCOMM)Wtsi/Trub2+
(C57BL/6N-Trub2tm2a(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating ketone body level J:167208
Tsc1tm1Djk/Tsc1tm1Djk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA) 		decreased circulating triglyceride level J:171445
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ) 		decreased circulating corticosterone level J:223992
Tsga13em1(IMPC)J/Tsga13em1(IMPC)J
(C57BL/6NJ-Tsga13em1(IMPC)J/Mmjax) 		increased circulating triglyceride level J:211773
Tshrhyt/Tshrhyt
(involves: BALB/cByJ * RF/J) 		increased circulating cholesterol level J:6479
Tspan17em1(IMPC)H/Tspan17em1(IMPC)H
(C57BL/6N-Tspan17em1(IMPC)H/H) 		increased circulating cholesterol level J:211773
Ttbk1em1(IMPC)J/Ttbk1em1(IMPC)J
(C57BL/6NJ-Ttbk1em1(IMPC)J/Mmjax) 		decreased circulating cholesterol level J:211773
Ttc17em1(IMPC)J/Ttc17em1(IMPC)J
(C57BL/6NJ-Ttc17em1(IMPC)J/J) 		increased circulating cholesterol level J:211773
Ttc28tm1b(EUCOMM)Hmgu/Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Ttc39btm1e(EUCOMM)Wtsi/Ttc39b+
(Not Specified) 		decreased circulating triglyceride level J:165965
Tti1em1(IMPC)J/Tti1+
(C57BL/6NJ-Tti1em1(IMPC)J/Mmjax) 		decreased circulating HDL cholesterol level J:211773
Ttpatm1Hsz/Ttpatm1Hsz
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal lipid homeostasis J:90006
Tubtub/Tubtub
(B6(AU)-Tubtub/J) 		increased circulating cholesterol level J:18161
increased circulating triglyceride level J:18161
Tuft1tm1a(KOMP)Wtsi/Tuft1tm1a(KOMP)Wtsi
(C57BL/6N-Tuft1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Txndc5tm1.1(KOMP)Vlcg/Txndc5+
(C57BL/6N-Txndc5tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating cholesterol level J:211773
decreased circulating triglyceride level J:211773
Txndc11em1(IMPC)J/Txndc11em1(IMPC)J
(C57BL/6NJ-Txndc11em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1) 		increased circulating cholesterol level J:47109
increased circulating triglyceride level J:47109
increased circulating VLDL cholesterol level J:47109
TxnipHyplip1/TxnipHyplip1
(B6.HcB19-TxnipHyplip1) 		abnormal lipid homeostasis J:102224
increased fatty acids level J:102224
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road) 		increased circulating ketone body level J:132756
increased circulating triglyceride level J:132756
Txniptm1b(EUCOMM)Hmgu/Txniptm1b(EUCOMM)Hmgu
(C57BL/6N-Txniptm1b(EUCOMM)Hmgu/H) 		increased circulating triglyceride level J:211773
Txniptm1Jjy/Txniptm1Jjy
(involves: C57BL/6 * CBA) 		abnormal circulating phospholipid level J:104563
abnormal lipid homeostasis J:104563
increased circulating cholesterol level J:104563
increased circulating free fatty acids level J:104563
increased circulating ketone body level J:104563
increased circulating triglyceride level J:104563
Txniptm1Road/Txniptm1Road
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB) 		increased circulating ketone body level J:132756
increased circulating triglyceride level J:132756
Tyk2tm1Shmd/Tyk2tm1Shmd
(either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		increased cholesterol level J:195099
increased circulating free fatty acids level J:195099
Tyk2tm2b(EUCOMM)Hmgu/Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg) 		decreased circulating HDL cholesterol level J:211773
Tysnd1tm1.1Arte/Tysnd1tm1.1Arte
(involves: C57BL/6J * C57BL/6N) 		decreased plasmalogen level J:223054
U2af2em1(IMPC)J/U2af2+
(C57BL/6NJ-U2af2em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy) 		increased circulating cholesterol level J:157049
Ubash3atm1b(KOMP)Wtsi/Ubash3atm1b(KOMP)Wtsi
(C57BL/6N-Ubash3atm1b(KOMP)Wtsi/Ieg) 		decreased circulating triglyceride level J:211773
Ube2btm1a(EUCOMM)Wtsi/Ube2b+
(C57BL/6N-Ube2btm1a(EUCOMM)Wtsi/Ics) 		decreased circulating triglyceride level J:165965
increased circulating triglyceride level J:165965
Ube2d1tm3e(EUCOMM)Wtsi/Ube2d1tm3e(EUCOMM)Wtsi
(C57BL/6N-Ube2d1tm3e(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
Ube2j1tm1.1(NCOM)Mfgc/Ube2j1tm1.1(NCOM)Mfgc
(C57BL/6N-Ube2j1tm1.1(NCOM)Mfgc/Rbrc) 		increased circulating cholesterol level J:211773
Ube2otm1.1(KOMP)Mbp/Ube2o+
(B6N(Cg)-Ube2otm1.1(KOMP)Mbp/J) 		increased circulating cholesterol level J:211773
Ube3bGt(RRJ142)Byg/Ube3bGt(RRJ142)Byg
(involves: 129P2/OlaHsd * CBA/Ca) 		decreased circulating cholesterol level J:203652
decreased circulating LDL cholesterol level J:203652
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc) 		increased circulating cholesterol level J:211773
Ubiad1em1Wwk/Ubiad1em1Wwk
(C57BL/6N-Ubiad1em1Wwk) 		abnormal phospholipid level J:268574
Ubiad1tm1.1Thka/Ubiad1+
(C57BL/6-Ubiad1tm1.1Thka) 		increased circulating cholesterol level J:221005
increased circulating HDL cholesterol level J:221005
Ubr1tm1Avar/Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J)) 		decreased circulating triglyceride level J:72859
Ucn2tm1Pbl/Ucn2tm1Pbl
(involves: 129 * C57BL/6) 		increased circulating corticosterone level J:108744
Ucntm1Abas/Ucntm1Abas
(B6.129S4-Ucntm1Abas) 		abnormal circulating corticosterone level J:122730
increased circulating corticosterone level J:122730
Ucp1tm1b(EUCOMM)Hmgu/Ucp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ucp1tm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating triglyceride level J:211773
Ucp1tm1Kz/Ucp1tm1Kz
(B6.Cg-Ucptm1Kz) 		abnormal lipid homeostasis J:81820
decreased circulating free fatty acids level J:81820
decreased circulating triglyceride level J:81820
Ucp3tm1Brnd/Ucp3tm1Brnd
(Not Specified) 		decreased skeletal muscle triglyceride level J:106901
Ucp3tm1Lowl/Ucp3tm1Lowl
(involves: 129S4/SvJae * C57BL/6) 		increased fatty acids level J:62313
Ucp3tm1Rei/Ucp3tm1Rei
(involves: 129S6/SvEvTac * Black Swiss) 		decreased circulating free fatty acids level J:62312
Ugcgtm1Hjg/Ugcgtm1.1Hjg
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		abnormal lipid homeostasis J:101155
Ugt8atm1Pop/Ugt8a+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid level J:77226
Ugt8atm1Pop/Ugt8atm1Pop
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal lipid level J:77226
Ugt8atm1Wst/Ugt8atm1Wst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal lipid level J:36558
Uhmk1tm1Enbl/Uhmk1tm1Enbl
(involves: 129/Sv * C57BL/6) 		increased circulating cholesterol level J:144737
UmodUrehd1/Umod+
(involves: C3HeB/FeJ) 		decreased circulating cholesterol level J:201084
decreased circulating triglyceride level J:201084
Umodurehr4/Umod+
(C3HeB/FeJ-Umodurehr4) 		abnormal circulating lipid level J:153895
decreased circulating cholesterol level J:153895
decreased circulating triglyceride level J:153895
Umodurehr4/Umodurehr4
(C3HeB/FeJ-Umodurehr4) 		abnormal circulating lipid level J:153895
decreased circulating cholesterol level J:153895
decreased circulating triglyceride level J:153895
Unc5clem1(IMPC)Mbp/Unc5clem1(IMPC)Mbp
(C57BL/6NCrl-Unc5clem1(IMPC)Mbp/Mmucd) 		increased circulating cholesterol level J:211773
Unc119btm1.1(KOMP)Vlcg/Unc119btm1.1(KOMP)Vlcg
(C57BL/6N-Unc119btm1.1(KOMP)Vlcg/Ucd) 		abnormal cholesterol homeostasis J:211773
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli) 		decreased circulating triglyceride level J:271949
increased circulating cholesterol level J:271949
increased circulating LDL cholesterol level J:271949
increased circulating triglyceride level J:271949
urehr1/urehr1
(C3HeB/FeJ-urehr1) 		increased circulating cholesterol level J:121470
Usp11tm1(KOMP)Wtsi/Y
(C57BL/6N-Usp11tm1(KOMP)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:211773
increased circulating LDL cholesterol level J:211773
Usp12tm1b(EUCOMM)Hmgu/Usp12tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp12tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
Usp20em1Cya/Usp20em1Cya
(Not Specified) 		decreased circulating cholesterol level J:299971
decreased circulating triglyceride level J:299971
Usp20em1Gpt/Usp20em1Gpt
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA) 		decreased circulating cholesterol level J:299971
decreased circulating free fatty acids level J:299971
decreased circulating HDL cholesterol level J:299971
decreased circulating LDL cholesterol level J:299971
decreased circulating triglyceride level J:299971
decreased circulating VLDL triglyceride level J:299971
decreased liver cholesterol level J:299971
decreased liver triglyceride level J:299971
Usp24tm1a(KOMP)Wtsi/Usp24tm1a(KOMP)Wtsi
(C57BL/6N-Usp24tm1a(KOMP)Wtsi/Wtsi) 		increased circulating triglyceride level J:211773
Usp47tm1b(EUCOMM)Wtsi/Usp47tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp47tm1b(EUCOMM)Wtsi/Nju) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Usp53em1(IMPC)Tcp/Usp53em1(IMPC)Tcp
(C57BL/6N-Usp53em1(IMPC)Tcp/Tcp) 		increased circulating cholesterol level J:211773
Uts2tm1Ags/Uts2tm1Ags
(B6.129P2-Uts2tm1Ags) 		abnormal cholesterol homeostasis J:214289
decreased circulating LDL cholesterol level J:214289
increased circulating HDL cholesterol level J:214289
Vamp7tm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6) 		increased circulating glycerol level J:181320
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd) 		increased circulating aldosterone level J:124056
Vav3tm1Xrb/Vav3tm1Xrb
(Not Specified) 		increased circulating aldosterone level J:111973
Vcpem1Kene/Vcp+
(C57BL/6J-Vcpem1Kene) 		increased circulating triglyceride level J:325062
Vcpkmttm1.1(KOMP)Vlcg/Vcpkmttm1.1(KOMP)Vlcg
(C57BL/6N-Vcpkmttm1.1(KOMP)Vlcg/J) 		abnormal cholesterol homeostasis J:211773
Vdrtm1.1Gcm/Vdrtm1.1Gcm
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal vitamin D level J:111515
Vdrtm1.1Gcm/Vdrtm1.1Gcm
(involves: 129 * BALB/c * C57BL/6 * Swiss) 		abnormal vitamin D level J:72578
Vdrtm1Gcm/Vdrtm1Gcm
Tg(Col2a1-cre)1Bhr/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal vitamin D level J:117377
Vdrtm1Rge/Vdrtm1Rge
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal vitamin D level J:77748
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal vitamin D level J:42054
Vdrtm1Tyam/Vdrtm1Tyam
(involves: C57BL/6 * CBA) 		abnormal vitamin D level J:101456
Vdrtm2.1Ska/Vdrtm2.1Ska
(involves: C57BL/6 * CBA/JNCrlj * SJL) 		abnormal vitamin D level J:196471
Vgftm1Srjs/Vgftm1Srjs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating corticosterone level J:56499
Vil1em1(IMPC)Wtsi/Vil1em1(IMPC)Wtsi
(C57BL/6N-Vil1em1(IMPC)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Vkorc1l1em1(IMPC)J/Vkorc1l1em1(IMPC)J
(C57BL/6NJ-Vkorc1l1em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
decreased circulating cholesterol level J:211773
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating cholesterol level J:117317
increased circulating triglyceride level J:117317
Vmp1tm1a(KOMP)Wtsi/Vmp1tm1a(KOMP)Wtsi
(C57BL/6-Vmp1tm1a(KOMP)Wtsi) 		abnormal lipid level J:280741
Vps33btm1a(EUCOMM)Wtsi/Vps33b+
(C57BL/6N-Vps33btm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating HDL cholesterol level J:211773
Vsig4tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J) 		abnormal cholesterol homeostasis J:211773
Wactm2b(EUCOMM)Wtsi/Wac+
(C57BL/6N-Wactm2b(EUCOMM)Wtsi/Wtsi) 		decreased circulating triglyceride level J:211773
Wdfy2tm1.1Wgz/Wdfy2tm1.1Wgz
(involves: C57BL/6J) 		increased circulating cholesterol level J:296933
increased circulating triglyceride level J:296933
increased liver cholesterol level J:296933
increased liver triglyceride level J:296933
Wdr27em1(IMPC)Ccpcz/Wdr27em1(IMPC)Ccpcz
(C57BL/6NCrl-Wdr27em1(IMPC)Ccpcz/Ccpcz) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Wdr41em1(IMPC)J/Wdr41em1(IMPC)J
(C57BL/6NJ-Wdr41em1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Wdr45em1(IMPC)J/Y
(C57BL/6NJ-Wdr45em1(IMPC)J/J) 		increased circulating HDL cholesterol level J:211773
Wdr45em1Wrst/Y
(involves: C57BL/6N * FVB) 		decreased circulating triglyceride level J:307284
Wdr47tm1a(EUCOMM)Wtsi/Wdr47tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Wdr47tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating LDL cholesterol level J:175295
Wdr53em1(IMPC)J/Wdr53em1(IMPC)J
(C57BL/6NJ-Wdr53em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Wdtc1tm1a(KOMP)Wtsi/Wdtc1tm1a(KOMP)Wtsi
(C57BL/6N-Wdtc1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
Wfdc2tm1.1Ohbo/Wfdc2tm1.1Ohbo
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		abnormal phospholipid level J:282576
Wfs1tm1Koks/Wfs1tm1Koks
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating corticosterone level J:145548
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs) 		increased circulating corticosterone level J:5538
Wnk4tm1Pfi/Wnk4tm1Pfi
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating aldosterone level J:184790
Wnt1tm1b(EUCOMM)Wtsi/Wnt1+
(C57BL/6N-Wnt1tm1b(EUCOMM)Wtsi/Tcp) 		increased circulating cholesterol level J:211773
Wnt3aem1(IMPC)Ccpcz/Wnt3a+
(C57BL/6NCrl-Wnt3aem1(IMPC)Ccpcz/Ccpcz) 		increased circulating triglyceride level J:211773
Wrap53tm1b(EUCOMM)Wtsi/Wrap53+
(C57BL/6N-Wrap53tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating LDL cholesterol level J:211773
Wrntm1Led/Wrntm1Led
(B6.129S6(BKSW)-Wrntm1Led) 		hyperlipidemia J:106446
increased circulating cholesterol level J:106446
increased circulating triglyceride level J:106446
Wrnip1tm1a(EUCOMM)Wtsi/Wrnip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Wrnip1tm1a(EUCOMM)Wtsi/Cnrm) 		decreased circulating triglyceride level J:165965
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J) 		decreased circulating cholesterol level J:138140
decreased circulating triglyceride level J:138140
Xbp1tm1a(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1a(EUCOMM)Wtsi/Ics) 		decreased circulating cholesterol level J:165965
decreased circulating triglyceride level J:165965
Xbp1tm2Glm/Xbp1tm2Glm
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		abnormal lipid homeostasis J:137188
decreased cholesterol level J:137188
decreased circulating triglyceride level J:137188
decreased fatty acids level J:137188
Xdhtm1Fink/Xdhtm1Fink
(involves: 129X1/SvJ * C57BL/6J) 		abnormal lipid homeostasis J:166326
increased triglyceride level J:166326
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA) 		increased prostaglandin level J:60201
Xrcc5em1(IMPC)Ccpcz/Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz) 		increased circulating triglyceride level J:211773
Yae1d1tm1b(EUCOMM)Hmgu/Yae1d1+
(C57BL/6N-Yae1d1tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Ydjctm1.1(KOMP)Vlcg/Ydjctm1.1(KOMP)Vlcg
(C57BL/6N-Ydjctm1.1(KOMP)Vlcg/J) 		increased circulating HDL cholesterol level J:211773
Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Ypel4tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Ywhabtm1b(EUCOMM)Hmgu/Ywhabtm1b(EUCOMM)Hmgu
(C57BL/6N-Ywhabtm1b(EUCOMM)Hmgu/Ieg) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
Zbtb20tm1.1Wpjz/Zbtb20tm1.1Wpjz
(involves: 129S4/SvJae * C57BL/6) 		increased circulating ketone body level J:148992
Zbtb22em1Yga/Zbtb22em1Yga
(Not Specified) 		decreased circulating triglyceride level J:344976
decreased liver triglyceride level J:344976
Zbtb24tm1b(EUCOMM)Hmgu/Zbtb24+
(C57BL/6N-Zbtb24tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating HDL cholesterol level J:211773
Zbtb32tm1b(KOMP)Mbp/Zbtb32tm1b(KOMP)Mbp
(C57BL/6N-Zbtb32tm1b(KOMP)Mbp/J) 		decreased circulating free fatty acids level J:211773
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		increased bile salt level J:304105
Zc3h12cem1(IMPC)Tcp/Zc3h12cem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12cem1(IMPC)Tcp/Tcp) 		increased circulating triglyceride level J:211773
Zc3h13em1(IMPC)J/Zc3h13+
(C57BL/6NJ-Zc3h13em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Zdhhc4em1Smoc/Zdhhc4em1Smoc
(C57BL/6-Zdhhc4em1Smoc) 		abnormal lipid homeostasis J:270120
increased circulating free fatty acids level J:270120
increased circulating triglyceride level J:270120
Zdhhc5tm1.1Smoc/Zdhhc5tm1.1Smoc
Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/NJ) 		abnormal lipid homeostasis J:270120
increased circulating free fatty acids level J:270120
increased circulating triglyceride level J:270120
Zeb1tm1.1Ajg/Zeb1tm2.1Ajg
(C57BL/6-Zeb1tm1.1Ajg/Zeb1tm2.1Ajg) 		abnormal circulating lipid level J:177274
increased circulating corticosterone level J:177274
increased circulating free fatty acids level J:177274
increased circulating triglyceride level J:177274
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw) 		abnormal circulating lipid level J:177274
increased circulating corticosterone level J:177274
increased circulating free fatty acids level J:177274
increased circulating triglyceride level J:177274
Zfand6em1(IMPC)Mbp/Zfand6em1(IMPC)Mbp
(C57BL/6N-Zfand6em1(IMPC)Mbp/MbpMmucd) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Zfp84tm1b(KOMP)Wtsi/Zfp84tm1b(KOMP)Wtsi
(C57BL/6N-Zfp84tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Zfp175tm1b(EUCOMM)Wtsi/Zfp175tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfp175tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating HDL cholesterol level J:211773
Zfp182tm1b(KOMP)Wtsi/Zfp182tm1b(KOMP)Wtsi
(C57BL/6N-Zfp182tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating HDL cholesterol level J:211773
Zfp202em1(IMPC)J/Zfp202em1(IMPC)J
(C57BL/6NJ-Zfp202em1(IMPC)J/Mmjax) 		increased circulating cholesterol level J:211773
Zfp346tm1.1(KOMP)Vlcg/Zfp346+
(C57BL/6N-Zfp346tm1.1(KOMP)Vlcg/J) 		increased circulating free fatty acids level J:211773
Zfp532em1(IMPC)J/Zfp532+
(C57BL/6NJ-Zfp532em1(IMPC)J/J) 		increased circulating HDL cholesterol level J:211773
Zfp605em1(IMPC)J/Zfp605em1(IMPC)J
(C57BL/6NJ-Zfp605em1(IMPC)J/Mmjax) 		increased circulating HDL cholesterol level J:211773
Zfp637em1(IMPC)Wtsi/Zfp637em1(IMPC)Wtsi
(C57BL/6N-Zfp637em1(IMPC)Wtsi/Wtsi) 		increased circulating free fatty acids level J:211773
Zfp638em1(IMPC)J/Zfp638+
(C57BL/6NJ-Zfp638em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
Zfp644em1(IMPC)Ccpcz/Zfp644em1(IMPC)Ccpcz
(C57BL/6N-Zfp644em1(IMPC)Ccpcz/Ccpcz) 		increased circulating HDL cholesterol level J:211773
Zfp697em1(IMPC)J/Zfp697em1(IMPC)J
(C57BL/6NJ-Zfp697em1(IMPC)J/Mmjax) 		decreased circulating triglyceride level J:211773
Zfp704tm1a(EUCOMM)Wtsi/Zfp704tm1a(EUCOMM)Wtsi
(Not Specified) 		decreased circulating triglyceride level J:165965
Zfp715tm1a(EUCOMM)Hmgu/Zfp715tm1a(EUCOMM)Hmgu
(C57BL/6N-Zfp715tm1a(EUCOMM)Hmgu/H) 		decreased circulating cholesterol level J:165965
increased circulating cholesterol level J:165965
Zfp750tm1b(EUCOMM)Wtsi/Zfp750tm1b(EUCOMM)Wtsi
(B6(Cg)-Zfp750tm1b(EUCOMM)Wtsi) 		abnormal ceramide level J:335426
abnormal cholesterol homeostasis J:335426
abnormal phospholipid level J:335426
abnormal sphingomyelin level J:335426
decreased triglyceride level J:335426
Zfp763em1(IMPC)Wtsi/Zfp763em1(IMPC)Wtsi
(C57BL/6N-Zfp763em1(IMPC)Wtsi/Wtsi) 		increased circulating glycerol level J:211773
Zfp787em1(IMPC)J/Zfp787em1(IMPC)J
(C57BL/6NJ-Zfp787em1(IMPC)J/Mmjax) 		abnormal cholesterol homeostasis J:211773
decreased circulating HDL cholesterol level J:211773
Zmym4em1(IMPC)Wtsi/Zmym4+
(C57BL/6N-Zmym4em1(IMPC)Wtsi/Wtsi) 		increased circulating cholesterol level J:211773
increased circulating glycerol level J:211773
increased circulating HDL cholesterol level J:211773
Zranb3em1(IMPC)Mbp/Zranb3em1(IMPC)Mbp
(C57BL/6N-Zranb3em1(IMPC)Mbp/MbpMmucd) 		increased circulating triglyceride level J:211773
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		decreased circulating corticosterone level J:221010
Zzef1tm2.1(KOMP)Vlcg/Zzef1tm2.1(KOMP)Vlcg
(B6N(Cg)-Zzef1tm2.1(KOMP)Vlcg/J) 		decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory